City University of New York (CUNY)

CUNY Academic Works
Dissertations, Theses, and Capstone Projects

CUNY Graduate Center

6-2016

Saving: Stem Cell Science, Christian Adoption, and Frozen Embryo
Potential in the United States
Risa Cromer
Graduate Center, City University of New York

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/gc_etds/1226
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

SAVING:
STEM CELL SCIENCE, CHRISTIAN ADOPTION,
AND FROZEN EMBRYO POTENTIAL IN THE UNITED STATES

by
Risa D. Cromer

A dissertation submitted to the Graduate Faculty in Anthropology in partial fulfillment of the
requirements for the degree of Doctor of Philosophy, The City University of New York
2016

© 2016
RISA D. CROMER
All Rights Reserved

i	
  

This manuscript has been read and accepted for the
Graduate Faculty in Anthropology in satisfaction of the
dissertation requirement for the degree of Doctor of Philosophy.

Katherine Verdery_________________________________
_______________
Date

________________________________________________
Chair of Examining Committee

Gerald Creed
____________
Date

___

_________________________________

________________________________________________
Executive Officer

John Collins________________________________________
Dana-Ain Davis_____________________________________
Jeff Maskovsky_____________________________________
Rayna Rapp________________________________________
Supervisory Committee

THE CITY UNIVERSITY OF NEW YORK

ii	
  

ABSTRACT
SAVING: STEM CELL SCIENCE, CHRISTIAN ADOPTION,
AND FROZEN EMBRYO POTENTIAL IN THE UNITED STATES
by
Risa D. Cromer
Adviser: Katherine Verdery

This dissertation examines the controversial fates of frozen human embryos left over
from in vitro fertilization procedures and frozen for future in the United States at the turn of the
twenty-first century. Stem cell researchers covet human embryos as wellsprings of biovalue for
curing human diseases and generating new forms of wealth. At the same time, pro-life Christians
target excess embryos for rescue as adoptable orphans and mobilize the frozen unborn within
legal strategies to redefine personhood. As a comparative ethnography, this dissertation reveals
what these putatively opposing solutions share in common by examining why and how frozen
reproductive remainders are saved.
Based on twenty-seven months of ethnographic field research in California following the
global financial crisis (2008-2013), this dissertation draws from in-depth interviews, document
analysis, and participant observation in two organizations on the vanguard of managing frozen
biological assets: a Christian embryo adoption program and a university stem cell tissue bank.
Both solutions for America’s embryo surplus agree about what makes embryos valuable, which
is their potential.
This dissertation develops saving as a theoretical framework for examining the processes
through which frozen IVF embryo potential is produced and valued. First, the lens of saving
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gives voice to evangelical Christians, IVF patients, and stem cell scientists, whose perspectives
offer a revision to scholarly understandings about the imbrications between the life sciences and
finance capital. Perspectives from American embryo savers illuminate how the opposing
missions of stem cell researchers and Christian adopters belie common efforts within financial
crises that transform frozen forms of capital—like reproductive remainders—from devalued
trash into potent treasure. Additionally, the saving framework reveals that stem cell tissue
bankers and embryo adoption proponents share a commitment to “doing good” today on behalf
of a better tomorrow. On the one hand, stem cell researchers strive to adhere to and model the
principles of “good science,” at the heart of which are responsibilities to not be wasteful. Embryo
adoption proponents, on the other hand, strive to live according to Christian values of equality,
dignity, and duty by modeling social forms of inclusion through “good family.” This dissertation
contributes to knowledge about the politics of regenerating value when “life” is in surplus and
provides insight into political formations that cohere around saving when futures are felt to be
uncertain.
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INTRODUCTION
Saving: Freezing Reproductive Remainders for the Future
Alice is the second child of Adam and Julie Gold, an orthodox Jewish couple living in
Georgia with their three children.1 At eighteen months old, Alice was diagnosed with
Mucolipidosis IV (ML4), a rare genetic disorder more common among people of Ashkenazi
Jewish descent characterized by motor and verbal skill dysfunction, vision trouble, and decreased
life expectancy. Learning this news was understandably devastating for her parents. To a CNN
journalist, her father Adam shared what it meant for their family: “It was more than a sad
moment but the beginning of what became a lot of sad moments.” Her mother Julie echoed a
similar sentiment: “Anything that we had dreamed and hoped for our family at that point was
broken. Done.”
Compounding the devastation of Alice’s diagnosis was their utter surprise. In anticipation
of getting married, the Golds sought genetic testing in consultation with their rabbi and genetic
counselors to prevent passing on to their children autosomal recessive diseases more common
among Jewish families. Adam was screened for two disorders and Julie was screened for six;
when neither test suggested that they were positive carriers for inheritable diseases, their minds
were eased about creating a family together. They were unaware at the time they were screened
in 2003 that there did not exist a standard genetic test that included the nineteen known diseases
occurring more frequently (though not exclusively) among Jewish individuals.
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  Considerable efforts have been made to protect the confidentiality of individuals and
organizations participating in this study. All names of individual people (except for public
figures, such as elected officials and Hollywood actors), ethnographic field sites, and geographic
locations in this dissertation are pseudonyms or disguised to the best of the author’s ability to
maintain the anonymity of study participants.
1

Soon after Alice was born, Adam and Julie became concerned about her developmental
milestones, but were told by doctors to not worry. At nine months old, Alice began physical
therapy to address low muscle tone and had surgery to correct her crossed eyes. They spent
months searching for answers and, against their doctor’s advice, took Alice to a specialist who
did an MRI scan on her brain. When the results were troubling, the neurologist referred the
Golds to a geneticist who would call Adam and Julie late one August evening in 2009 with tragic
news about their daughter’s health.
As carriers of ML4, any children the Golds conceived naturally would have a 25%
chance of being born with this inheritable genetic disease. Feeling that their family was
incomplete, they weighed their options for having another child.2 “We looked beyond our current
sadness and knew that we had more love to give,” Julie explained, but they worried that “the
clock was against us.” Julie was 39 years old when Alice was diagnosed, which prompted them
to wonder about time: “How long would it take to get pregnant, and what if we had to terminate?
What would happen after we terminated? How long would we have to wait to start trying again
and what happens if we lost twice in a row?”
Because they did not want to put any future child at risk for ML4, natural conception felt
like a gamble. The Golds settled on using reproductive and genetic technologies to try for their
third child. “The best option for us was IVF coupled with PGD [preimplantation genetic
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  The main alternatives to natural conception for people with inheritable genetic conditions are
assisted reproductive technologies or adoption. ART options include using a sperm, egg, or
embryo donor, or, using their own gametes, pairing IVF and with PGD, a technique for
determining which IVF embryos are genetically normal and abnormal. For already established
pregnancies, genetic screenings like amniocentesis or CVS can provide information for couples
to determine whether or not to continue a pregnancy. Genetic screening results are typically
reviewed in consultation with a genetic counselor or obstetrician to discuss risk and options. For
pregnancies screened positive for genetic abnormalities, pregnancies can be terminated or carried
to term for adoption placement or parenthood.	
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diagnosis] so we could have another healthy child of our own,” Julie explained. “Other carrier
couples may decide on something different…but we decided we wanted to go this route.”
Preimplantation genetic diagnosis, or PGD, is a test conducted on embryos in vitro before being
transferred into the uterus for pregnancy.3 Embryologists remove a cell from the embryo and
send it to a genetics lab to be tested for disorders associated with a single gene, such as cystic
fibrosis, Tay Sachs, or muscular dystrophy. When the Golds came to their fertility clinic, no
PGD test existed for the rare ML4 disease. To address this problem, Adam and Julie
commissioned Dr. Mark Hughes of Genesis Genetics, a world leader in preimplantation genetic
testing for single gene disorders, to create a test using DNA from cells from their cheeks to
screen the Golds’ IVF embryos for the ML4 gene. With the PGD test, they could identify which
embryos were affected with the disease and not transfer them into Julie’s uterus. Insurance
covered some portion of the cost to develop the test, but the Golds still paid thousands of dollars
out of pocket for this genetic screening technology.
IVF with PGD was a “pretty intense process” for Julie, as it is for many fertility patients
(Franklin and Roberts 2006). Her eggs were harvested, fertilized, cultured in vitro, genetically
tested, and transferred into her uterus over the course of three IVF cycles, none of which
established pregnancy. Although emotionally and financially drained, they committed to one last
round with a new doctor and medication regimen; this cycle produced one genetically normal
embryo that led to pregnancy and the birth of their third child. They named her Shai, which
means “gift” in Hebrew. As Adam recounted the story for me, he remarked with pride and
surprise that “it just takes one.” Once Shai was born, Julie felt that the emotionally, physically,
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  Preimplantation genetic diagnosis (PDG) differs from preimplantation genetic screening (PGS),
which is a similar biopsy procedure on in vitro embryos that tests for chromosomal
abnormalities, such as Down syndrome, as well as sex. 	
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and financially challenging process was worth it: “It’s definitely not an easy process, but
knowing that you can have healthy children of your own even if you carry the same disease
mutation is important to any family.”
The Golds’ final IVF cycle produced another kind of gift: one extra embryo that screened
positive for ML4. In IVF clinics, genetically abnormal embryos are typically discarded as
medical waste because they are of no clinical value to patients trying to become parents. But at
Adam and Julie’s request, the ML4 embryo was frozen and stored for they considered it anything
but waste. Rather, it held the potential for a cure. “We always expected [through IVF] that we
would have an embryo that was affected,” explained Adam, which came as great news because
the Golds, as he explained, were “working for a cure.” Before starting IVF, they asked their
geneticist what the possibilities would be for embryos that screened positive for ML4. Dr.
Hughes introduced the Golds to Dr. Dunn of Sutter University’s REDEEM Biobank, the Director
of the most active tissue bank in the country receiving donated human embryos for research. Dr.
Dunn shared information with the Golds about disease-specific stem cell research underway at
Sutter University and the process entailed in donating frozen embryos to the Biobank.
After Alice’s diagnosis, Julie and Adam became active with the ML4 Foundation, an
organization that supports research of the genetic disease in hopes of finding a cure. Based on
what they learned from Dr. Dunn about research potential at Sutter University for their diseased
embryo, Adam and Julie decided to donate any ML4 embryos that their IVF procedures
generated to the REDEEM Biobank. By donating, their hope was
…to try to produce stem cells that, in theory, would help in research for helping to find a
cure for ML4. The hope was that the stem cells would provide something that the
researcher would want in order to start studying ML4 at a different level and at some
point we would be able to create a drug that would be able to benefit ML4.

4

Fewer than 250 people worldwide are living with ML4, which means that there are very few
couples like the Golds who are known carriers, want to expand their family, and have the means
and desire to utilize IVF with genetic testing. At the time of our first conversation in 2012, Adam
knew of only one other couple in the world attempting to have children, and they were trying via
natural conception. “For us, we saw this embryo as a once in a lifetime, one-shot deal,” a chance
at a cure that could save lives, including Alice’s.

The Remainders
“What becomes the value of this thing, the remainder?”
- Warwick Anderson, “The Frozen Archive, or Defrosting Derrida”
The Golds’ embryo is one of approximately a half million human embryos left over from
in vitro fertilization procedures that have accumulated in the 486 fertility clinic freezers across
the United States.4 Despite the mainstream practice of saving excess embryos in the United
States since the mid-1980s, what to do with the growing supply of frozen remainders like the
Golds’ has become the subject of controversy. Fertility clinics quietly banked embryos for fifteen
years until two events in 1998 thrust the future of frozen embryos into a public debate. In a
University of Wisconsin lab that year, biologists established the first human embryonic stem cell
line from a donated leftover embryo (Thomson, et al. 1998). Stem cell researchers responded by
procuring donated embryos from IVF patients for their invaluable promise to revolutionize
medicine in the quest for life-saving cures for diseases like diabetes, Alzheimer’s, and cancer
(Scott 2006). Meanwhile, a Christian adoption agency created the first embryo adoption program
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A 2003 RAND study reporting 400,000 is the most commonly cited estimate (Hoffman et al.
2003). More recent estimates suggest increasing numbers, such as the 600,000 figure reported in
the Department of Health and Human Services website on embryo adoption:
http://www.hhs.gov/opa/about-opa-and-initiatives/embryo-adoption/
5

for placing unwanted embryos with adoptive families and turning extras into born children. They
decried the devaluing of unborn human life by championing embryo personhood and facilitating
their chances to be born.
Controversy about the future of America’s IVF embryos centers on saving, or the
preservation of something considered valuable. In this dissertation, I enter into the U.S. frozen
embryo debate to explore why and how such reproductive remains are saved. To do so, I develop
saving as a conceptual framework for understanding how the preservation of valuables occurs
through ethical orientations, daily practices, and infrastructures. I explore the circumstances
within which frozen IVF embryo potential is produced and valued; the kinds of values, for
whom, and within which contexts; the conditions that propel people to make, store, want, and
give excess embryos; and what the potentiality attributed to these frozen remains suggests about
life in uncertain times.
I addressed these topics during twenty-seven months of field research between 2008 and
2013 within organizations offering Christian and scientific solutions for the excess embryo
problem: an embryo adoption program and a stem cell tissue bank. The first program of its kind,
the Blossom Embryo Adoption Program works with IVF patients and clinics to transfer unused
embryos from giving to receiving families. As proponents of embryo personhood and Christian
values, they strive to provide embryos the opportunity to achieve their full potential through birth
into an adoptive family. By contrast, the REDEEM Biobank within Sutter University’s Stem Cell
Institute manages a gold mine of donated embryos from across the country that supports stem
cell biologists whose ambitions to produce exceptional science have collectively positioned
Sutter at the world’s forefront of regenerative medicine. California, often considered a frontier
for stem cell and reproductive technologies (Scott 2006; Thompson 2014) and a crucible for the

6

Religious Right (Dochuk 2011; McGirr 2001), offered a coherent historical, legal, and social
setting for studying the scientific and evangelical pioneers who prospect left over embryo
treasures for America’s future.

Making Remainders: Freezing for the Future
Basile Luyet, a Catholic priest, biologist, and physicist, is often regarded as the “Father”
of cryobiology, or the science of life at the frosty extremes. In the first book on “life and death at
low temperatures,” Luyet introduced the concept of latent life—a zone where organic life is
liminal and neither fully alive nor dead (Luyet and Gehenio 1940; Radin 2013). Early twentieth
century studies of latent forms of life, such as animal hibernation and freeze-resistant plants, took
interest in pragmatic ways to harness the cold for solving practical problems in medicine, health
care, and the environment (Fuller, et al. 2004). The field took a pivotal turn in 1949 following
the chance discovery by a team of British scientists that glycerol—a simple sugar compound—
protects cells from damage during freezing and thawing (Polge, et al. 1949). The ability to
preserve cellular life in a suspended state with power to stop and start biological time
revolutionized the biological sciences and industries now common within contemporary life
(Landecker 2007).
Cryobiology figured centrally in the late 1940s revolution in domestic animal breeding
through the freezing of sperm (Bavister 2001; Foote 2002); the post-war 1950s eruption of
frozen foods and home freezers (Smith 2001); the 1960s cryonics movement to preserve one’s
brain or body for later revivification (Farman 2013; Sheskin 1979); and the banking of genetic
materials from exotic or endangered plant and animal species in the 1970s (Watson and Holt
2001). The first successful pregnancy after cryopreservation occurred in a mouse in 1972

7

(Whittingham, et al. 1972), followed by a cow named Frosty in 1973 (Wilmut and Rowson
1973). In vitro fertilization technology made its world debut in human fertility with the birth of
Louise Brown in 1978 to a British couple, followed in 1984 by the birth of Zoe Leyland in
Melbourne, the first frozen human embryo to be born. Freezing human embryos quickly
mainstreamed in the United States after the technique’s introduction in 1984.
While the cryopreservation of extra embryos in the United States has been common
practice for over thirty years, storing human embryos in liquid nitrogen at -196 Celsius is neither
customary nor legal in many regions of the world providing IVF (Inhorn and Balen 2002;
Roberts 2012). Germany and Italy, for instance, have the strictest IVF laws in Europe. Germany
banned cryopreservation in 1991 with the “Federal Embryo Protection Law” whereas Italy, once
one of the “wildest” places for assisted reproduction in Europe, took a dramatic turn in 2004
when lawmakers passed a highly restrictive bill outlawing embryo cryopreservation, gamete
donation, surrogacy, and usage by same-sex couples. In response to restrictive embryo freezing
laws in Italy, scientists became experts in egg freezing techniques that are now being offered
within IVF clinics around the globe.
Other European countries, like France and the U.K., also highly regulate IVF and
cryopreservation, but more leniently. A requirement of the U.K.’s Human Fertilisation and
Embryology Act of 1990 is that embryos cannot be stored for longer than ten years, which
prevents the growing embryo glut that now burdens U.S. IVF clinics. Also, the U.K. National
Health System created “interfaces” between IVF and stem cell research, which fosters an
efficient system of fresh and frozen embryo donations for research (Franklin 2006a; Franklin
2006b).

8

Scholarship in countries with fewer assisted reproduction regulations reveals other forces
at play that affect cryopreservation practices. In India, where little national regulation currently
exists for assisted reproduction (though the Indian government may soon ban international
surrogacy), patient embryo donations fuel the country’s burgeoning stem cell industry
(Bharadwaj and Glasner 2009). Similarly, with the exception of Costa Rica where an IVF ban of
fifteen years was reversed in 2015, Latin America is known for its absence of IVF regulations. In
Ecuador, this allowed one scholar to discern regional cryopreservation differences between Quito
and Guayaquil that reveal the power of religion and kinship to regulate assisted reproductive
technologies in places without formal state-based secular restrictions (Roberts 2007b).
Religious traditions shape assisted reproduction in other settings as well. In Muslim
countries practicing IVF, like Egypt, Lebanon, and Iran, freezing embryos is considered halal—
or permissible by Islamic law—and thus a widely accepted practice in line with Sunni fatwas on
assisted reproduction (Inhorn 2006). The United Arab Emirates is the one exception to the rule;
they banned embryo freezing in 2010, leaving many international fertility patients who traveled
there for services not offered in their home countries wondering about the fates their frozen
remainders stored abroad (Inhorn 2015). The variegated policies and practices in IVF and
embryo cryopreservation around the world contribute to growing flows of people, gametes, and
capital that comprise new networks of “cross-border reproductive care” (Inhorn and Gürtin
2011). As these examples suggest, the presence or absence of regulations is not prescriptive of
how patients, donors, and doctors will use assisted reproductive technologies, nor are regulatory
systems guarantees for what will pan out. The growing surplus of frozen embryos in freezers
across the free-market fertility industry in the United States is one such unforeseen example.
---

9

No two of the IVF patients that I met or clinics I visited were alike, though Sandra’s case
at Harrington Fertility’s Paloma clinic was typical in many ways. Harrington Fertility, discussed
in greater detail in Chapter 2, began as a small fertility clinic in the late 1980s in Southern
California and grew to become one of the California’s highest volume providers. Sandra, a white
banking associate living in Irvine, CA, was thirty-six when she and her husband first went to
Harrington after two years of multiple miscarriages. After a series of tests, she was diagnosed
with “unexplained infertility” and encouraged by her physician to consider IVF. On the day of
Sandra’s first egg retrieval, she produced thirteen eggs that were co-incubated with her partner’s
sperm in a Petri dish, a procedure that facilitates fertilization. A few days later, ten viable
embryos showed positive signs of development in the warmed dish. Two were selected for
transfer into her uterus while the extra eight embryos were frozen for potential later use. Her
embryologist immersed the leftover embryos in individual droplets of cryoprotectant media,
carefully packaged them in straws, labeled each with Sandra’s name and birthdate, and plunged
the straws into liquid nitrogen for storage. When Sandra and her husband’s efforts to build a
family through IVF came to an end, they had a few options for embryos that remained: they
could donate them for research or procreation, discard as medical waste, or keep cryopreserved
indefinitely.
Derek, an embryologist at Harrington, explained why embryos like Sandra’s are routinely
saved in fertility clinics across the United States:
The patient has been through high doses of drugs, a needle into her vagina and ovaries,
and paid the costs of lab embryology. You’ve got some good embryos – why waste
them? You don’t bin them. You want to freeze them for the future.
But saving spare embryos for the future has become an increasing burden in the present for
fertility clinics and patients alike. Charging each patient anywhere from $350-$1000 a year for
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storage makes freezing embryos seem like easy money for fertility clinics, yet many IVF staff
feel that the liabilities outweigh the revenue. The accrual of frozen embryos in storage tanks
represents a growing problem and worry for the hundreds of IVF clinics in the United States.
“We have embryos from the 1990s in those tanks,” Ken, a senior embryologist at
Harrington Fertility, explained as he pointed toward the room off the lab where twelve
cryopreservation tanks are located. For Ken, this is a burden rather than a boon. In addition to his
daily activities working under the microscope with human eggs, sperm, and embryos, Ken
manages the physical inventory of frozen embryos preserved at Harrington. This involves
maintaining expensive equipment stored in a room designed to keep precious materials secure.
At Harrington, tanks are strapped to the wall to withstand earthquakes and wired with multiple
monitoring systems for security from theft and risk of exposure to unsafe temperatures. Such
safeguards are in place to protect embryos as much as fertility clinics for within the litigious U.S.
legal environment, fertility patients have successfully sued for damages to their frozen embryos
that are legally considered forms of property (Andrews 1986; Litman and Robertson 1993).
Part of Ken’s job also involves caring for abandoned embryos that are no longer being
paid for by fertility patients. Unlike storage units filled with furniture that can be auctioned off to
the highest bidder, determining what to do with the contents of abandoned embryo accounts is
more complicated. “We don’t discard them after patients stop payment because we are worried
about lawsuits,” expressed a concerned embryologist to a panel of lawyers convened at the 2011
American Society for Reproductive Medicine annual meetings. For the same reason, Harrington
keeps unclaimed embryos in their tanks rather than discarding old inventory. In the absence of
legal guidance in U.S. law about how to proceed when patients forego cryostorage payment,
fertility clinics are stuck caring for a growing glut of reproductive remainders that nobody seems
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to want. Despite profits gained from storage fees, IVF clinics have come to realize that freezing
leftover embryos is risky business.
Saving embryos also poses burdens to IVF patients who agree to keep them on ice.
Having backup embryos appeals to thousands like Sandra who desire the chance to become a
parent, yet bearing the responsibility for leftovers comes with unanticipated costs. Beyond the
financial expense of annual storage fees, many patients report feeling differently about their extra
embryos at the end of IVF than at the time of freezing (Lyerly, et al. 2010; Nachtigall, et al.
2005). Some express being overwhelmed by the responsibility of deciding what to do with
embryos they no longer need but that for various reasons are hard to let go. Other difficulties
arise for patients in cases of divorce or death, which have thrust leftover embryos into the middle
of court proceedings that attempt to determine to whom these reproductive leftovers belong.
Why freeze embryos at all when saving them presents legal, financial, ethical, political and
emotional burdens on the individuals and institutions tasked with their management?

Saving Embryos
As any computer user knows when she clicks to save an electronic document, saving is
fundamentally about preserving something considered valuable. While this dissertation addresses
the saving of embryos at the turn of the millennium, embryo saving in the United States is
traceable into the prehistory of the Americas. Saving may be one of the oldest technologies in
human history evident within the practice of preserving seeds—the embryos of plants.
Archeologists of North America have unearthed seed deposits stored in birch-lined cache pits,
ash-filled baskets, and clay pots in locales around the continent. Scientists presume that these
preserving techniques protected seed reserves from the threat of animals, elements, and time.
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Whether collected for consumption, trade, or farming, the saving of seeds suggests a desire
among early humans to preserve valuables with regenerative possibility. When reimagined as the
twenty-first century’s answer to Pueblo seed pots, contemporary cryopreservation tanks immerse
IVF techno-seeds into liquid nitrogen to preserve the promise they too contain for the future.
Today’s IVF remainders, akin to ancient plant seeds, are thought to hold the potential to bring to
fruition various kinds of tomorrows.
Saving is a dynamic keyword with a rich etymological history (OED). The earliest
meaning of saving comes from the fourth century A.D., signifying heroic healing efforts that
delayed death and rescued bodies from disease. In the tenth century, saving evoked Christian
notions of rescuing the soul, delivering persons from evil, and offering salvation in the eyes of
God. By the sixteenth century, saving took on an economic tone through discourses about the
frugal expenditure of money and the storing of resources for later redemption or use.
Each of these meanings operates vibrantly within the contemporary American
controversy concerning the afterlives of excess IVF embryos. In this dissertation, I utilize the
multiple valences of saving to explore the many ways in which frozen embryo leftovers are
valued at the turn of the twenty-first century: as resource, orphan, insurance, treasure, burden,
promise, waste, etc. An advantage of a framework that holds multiple meanings simultaneously
is the ability to examine the intersections of realms presumed to be incommensurable. Toward
this end, I develop saving as a conceptual framework for illuminating convergences among
putatively disparate realms within politics addressing life’s uncertainties; for this project, I direct
my attention to the imbrications between medico-science, Christianity, and capitalism in the
United States.
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Based in California after the 2008 global financial crisis, this project develops saving to
analyze the politics of regenerating value when “life” is in surplus. The saving framework puts
into relief ways the Blossom Embryo Adoption program and REDEEM Biobank operate as
intermediary organizations at the vanguard of managing frozen biological assets, or what may be
considered “cryocapital.” Like traditional banks, embryo-saving organizations oversee the
receipt and distribution of reproductive remainders whose values are suspended—or frozen—
until they can be realized. Moreover, saving illuminates how the opposing missions of stem cell
researchers and Christian adopters belie common efforts evident within financial crises to
transform frozen forms of capital—like mortgages, as well as biological remains—from
devalued trash into potent treasure. Why and how each group strives to redeem excess embryos
reveals a shared faith in what they consider to be most valuable about frozen embryos: their
potential. Importantly, saving gives voice to evangelical Christians, IVF patients, and stem cell
scientists, whose perspectives collectively offer a revision to scholarly understandings of
biocapital (Cooper 2008; Dumit 2012; Franklin 2006c; Hayden 2003; Helmreich 2007; Peterson
2014; Sunder Rajan 2006; Sunder Rajan 2012). Frozen embryos and other reproductive
remainders emerge as a new species of speculative biocapital whose valued potential fuels the
increasing financialization of reproductive health and technology worldwide.
When viewed through the lens of saving, stem cell tissue bankers and embryo adoption
proponents also express a shared commitment to “doing good,” which I use to describe ethical
frameworks guided by duty and desire to improve life in uncertain times. On the one hand, Sutter
University researchers try to adhere to and model the principles of “good science”; Blossom
Embryo Adoption proponents, on the other hand, try to live according to Christian values in
order to foster conditions for “good family.” Saving puts into relief the nuances of these
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coexisting ethical terrains, futures people envision beyond their horizons, and how they try to
enact those visions.
In the following chapters, I demonstrate that saving operates within stem cell research
and embryo adoption in three main ways: as an ethic, practice, and infrastructure. Saving
describes a widely felt ethical, moral, or religious obligation to value and preserve potentiality in
uncertain times. The obligatory quality of saving is especially pronounced within “anticipatory
regimes” that shape how the present is increasingly felt to be contingent upon unknowable
“futures” for which each of us are encouraged to prepare (Adams, et al. 2009). Saving operates
in and through stem cell labs and Christian adoption agencies as a temporal ethic and timely
politics. Moreover, saving functions as a moral force that cultivates attitudes of responsibility in
the present and fosters conditions for ethical action on behalf of the future.
Saving is also practiced and enacted through daily activities, techniques, and ways of
being that “make things audible, visible, tangible, knowable” (Mol 2002: 33). I consider
mundane happenings within each program, like waste prevention in labs or treating Blossom
clients as adoptable parents, to be saving practices that help realize their visions for redeeming
life in America. Saving practices are informed by diverse notions of “good” and assume various,
sometimes conflicting, form. The saving practices I examine in the following chapters are
myriad, from ranking and grading embryos in IVF labs, maximizing the use of precious cells for
research, rescuing frozen orphans via adoption, sorting for “precious” embryos, to submitting tax
returns.
As an infrastructure, saving subtends, suffuses, and surrounds the interpersonal,
organizational, and social aspects of life in the United States. It inhabits the quiet grammars that
prop up spaces, including lab standards, classificatory systems, funding grants, California’s
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economy, and racial logics. An infrastructural view of saving illuminates previously invisible
connections that crosscut settings and topics (Landecker 2007). In this dissertation, property and
personhood operate as the main structuring conditions that produce frozen wastes and orphans,
their potentials, and their savers. These saving conditions predated the frozen embryo
controversy and will continue operating long after it cools down.
Frozen embryos are unsettling entities without simple definition, nor can they be reduced
to a “singular entity” (Franklin and Roberts 2006). For this reason, my analysis in this
dissertation is premised on the polysemous—rather than singular—meanings of saving and
angles from which to understand them. Such an approach is imperative for understanding how
and why we save embryos because, as Marilyn Strathern reminds, “it matters what ideas one
uses to think other ideas (with)” (Strathern 1992: 10).

Finding Homes for Embryos
It became clear to me as I traced the afterlives of frozen embryos from fertility clinic
freezers to tissue banks, adoption agencies, research labs, and waste bins that they defy simple
categorization. As biological cells existing outside the human body, frozen embryos are plunged
into liquid nitrogen where they become fixed developmentally in time and storable for possible
future use. Yet while suspended in time, they prove to be socially vibrant matters that are
enlivened and affected by circumstances outside the tank (Bennett 2010). It is unclear if frozen
embryos are alive or pre-dead, tissue or kin, proto-persons or precious things, and constrained by
the past or promising of the future.
A brief review of the philosophical and legal topics that have dominated discussions for
decades about what should be done with America’s unwanted but un-wastable remainders
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illustrates the kinds of categories within which embryos are awkwardly pressed. At the first sign
of controversy over frozen embryos, philosophers and lawyers flock to the scene while
sociologists, anthropologists, and historians remain cautiously on the sidelines. I suspect part of
the reason for this is because the terms for the debate are set in ways that make social scientists,
or at least me, somewhat uneasy. While legal and philosophical scholarship differ in many ways,
each tradition attends to the ontological status of embryos—what they are—as a method for
figuring out where they belong. As an ethnographer of the turmoil stirred around leftover
embryos, my contribution to the debate begins by taking note of how embryos are being
discussed. I consider this an entry point for understanding the processes of trying to shoehorn
unprecedented entities into ill-fitting spaces.
Philosophical considerations about the future of frozen embryos focus on the moral status
of embryos, a topic of dispute for over two millennia (Maienschein 2003). For example, do they
accrue status as they develop or is their value inherent to them at any stage? Do embryos bear
natural rights as biologically human? Are they owed dignities and protections equivalent to
adults? Contemporary discussions about frozen embryos ask other questions, such as: Are we
morally obligated to make use of abandoned embryos so that they are not wasted? What are the
rights of children born through embryo donation, and how are they best respected? Catholic
theologians, bioethicists, and philosophers of science often situate their arguments within
longstanding debates about the origins of “life.” As such, thinkers like Aristotle, St. Thomas
Aquinas, and Kant figure regularly within philosophical literatures striving to resolve what
embryos are in order to inform what should be done with them.
Western legal thought can similarly be understood as a “process of categorization”
(Vandevelde 1980: 327). For this reason, it is not surprising that headline-catching courtroom
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divorce disputes over frozen embryos in the United States center around their legal definition:
are they persons, property, or something else? Consider the highly publicized Davis v. Davis
trials (1989-1992), one of the first divorce cases involving frozen embryos. The disagreement
between Mary Sue and Junior Davis about the future of their seven frozen IVF embryos pressed
three Tennessee courts, including the state Supreme Court, to weigh in on the best legal category
for frozen embryos.
Mary Sue argued that she be able to use their extra embryos for pregnancy, to which
Junior objected and, in later trials, argued for their disposal. Judge Young of the Tennessee
Circuit Court sided with Mary Sue by ruling that embryos are not property but persons whose
lives began at conception. In his ruling, Judge Young wrote: “By whatever name one chooses to
call the seven frozen entities—be it preembryo or embryo—those entities are human beings; they
are not property.”5 Judge Young applied family law to determine which parent would meet the
frozen “children’s” needs best, which resulted in awarding “custody” to Mary Sue.
The testimony of Dr. Jérôme Lejeune, the internationally acclaimed French Catholic
geneticist who “discovered” in 1959 that people with Down’s syndrome have an extra
chromosome, which was latter called Trisomy 21, contributed influentially to the lower court’s
judgment. Though a widely regarded geneticist, Lejeune ardently protested the uses of his work
in expanding biomedical technologies, like amniocentesis (Rapp 1999), that were used to detect
this condition in established pregnancies. He was brought to stand in Tennessee to wield his
authority as a scientist and to deliver a moral argument concerning the legal classification of
human embryos. Lejeune testified that embryos are forms of “human life at the moment of
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  Davis v. Davis, 15, E-14496 (Tennessee Circuit Court, Blout County, September 26, 1989)	
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conception” and expressed feeling “deeply moved that the mother wants to rescue babies from
this concentration can” (Annas 1989: 21).
Junior challenged the decision in the Court of Appeals, which rejected the lower court’s
designation of embryos as persons in favor of a “suspiciously property-like” (Litman and
Robertson 1993: 260) model instead. The appellate court ruled that the embryos were fated for
the freezer until the Davises jointly resolved what to do with them, which it based on their
“shared interest” in the frozen marital possessions.6 The case was taken up by the Tennessee
Supreme Court, which decided upon review of the two lower court rulings to “side fully with
neither” (Strathern 1999: 136). The court found the definition of embryos as persons and
property too extreme, and came up with an alternative: “Pre-embryos are not, strictly speaking,
either ‘persons’ or ‘property’, but occupy an interim category that entitles them to special respect
because of their potential for human life.”7 While the Davis case concluded thirteen years ago,
the jury remains out as to how to categorize frozen embryos—legally, philosophically, or
morally.
The confusion about where frozen embryos fit within social schemes continues to
provoke public debate and, at times, media frenzy. News in April 2015 about the suing of
Modern Family TV sitcom star Sofía Vergara by her ex-fiancé Nick Loeb over the future of their
two cryopreserved embryos is such an example. Vergara expressed wishes for their embryos to
remain frozen indefinitely while Loeb, as he stated in an op-ed letter that the New York Times
published in April 2015, regarded the embryos as his two daughters that he wishes to save and
raise (Loeb 2015). The letter from Loeb landed a spot in the New York Times because,
according to the Op-Ed page editor, his “strong pro-life position…reflects an important debate
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that is going on around the country [concerning the] so-called personhood movement” and “is
intended to spark discussions, debate, controversy, and even some yelling” (Sullivan 2015).
To help his legal suit against Vergara, Loeb used moral language to make a case for
embryo personhood and his right to parent. In the Op-Ed letter, Loeb questioned what he
perceived to be a misalignment between the legal and moral classification of frozen embryos:
“When we create embryos for the purpose of life, should we not define them as life, rather than
as property?” Bringing frozen embryos to court has occurred only a dozen times in the United
States, while deciphering what to do with leftover embryos is a challenge facing thousands of
other modern families within life after IVF. Even though legal scholars and philosophers have
sought categorical clarity so that the question of what to do with frozen leftovers can better be
answered, frozen embryos are hard to classify.
The discussion thus far illustrates how the dominant literature concerning leftover
embryos is structured around what embryos are and where they fit. In anthropologist Mary
Douglas’s terms, philosophers and legal scholars seem to consider frozen embryos
uncomfortable types of “matter out of place” (Douglas 1966) and work hard to find them a
place—conceptually, if not practically. These literatures provide insight into the predominant
categories into which embryos are being encouraged, which to date are notions of persons and
property. Following Foucault’s genealogical method of examining the making of a category, I
take interest in what notions of property and personhood describe as well as how they produce
what they are describing. To borrow James Ferguson’s useful distillation of this approach, I ask
about personhood and property: “not simply ‘what does this concept mean; what does it really
refer to?’; but, ‘How and to what effect is this concept deployed; what does it do?’” (Ferguson
1999: 205).
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While these analyses draw from discursive traditions, I ground my categorical interest
within ethnography of everyday practices. Finding “homes” for embryos conceptually is also a
practical matter that staff within fertility clinics, the Blossom Embryo Adoption program, and
REDEEM Biobank manages each day. Embryologists at Harrington fertility discussed in Chapter
2 routinely decide where IVF embryos belong clinically: which are ideal for being “put back”
into a uterus, which should be frozen as “back up,” and which are destined for the garbage.
Similarly, I trace in Chapter 3 the waste prevention practices among stem cell biologists that
serve as an organizing framework for turning clinical trash into laboratory treasures for
experimentation within warm Petri dishes. I illuminate parallel process in Chapter 4, where
classificatory systems within the Blossom program produce frozen orphans awaiting adoption
and the chance to be transferred into the warmth of a uterus. Finally, how each program
addresses the challenge of donated embryos that nobody wants is the topic of Chapter 5. Where
embryos belong—categorically, materially, and politically—is no simple matter.

Unsettling Things
If you ask a science studies scholar, novel biological entities are proliferating and frozen
embryos are in the vanguard. After being confronted with the adoptable embryo in her email,
Susan Squier took new interest in cultured cells, organ donor recipients, and other “liminal lives”
in the frontiers of biomedicine that populate the margins of our everyday life (Squier 2004).8 On
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  In anthropologist Victor Turner’s rendering of liminality, the condition of “being on the
threshold” and “betwixt and between” occurs within spaces of “potency and potentiality” (Turner
1977: 33). Turner studied liminality in the context of cultural rituals marking rites of passage,
within which he maintains the idea of neatly divided natural and cultural worlds. Turner’s notion
of liminality inspired ideas about how embryos are transformed from clinical waste into
laboratory treasures and orphaned children, yet I do not sustain in my work the boundary he does
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page 8 of Bruno Latour’s morning newspaper, frozen embryos feature alongside genetically
modified foods, endangered species, and other “imbroglios of science, politics, economy, law,
religion, technology, fiction” (Latour 1993: 2). Latour’s encounter of a “proliferation of hybrids”
prompted his thinking about the presumptions of modernity that maintain a solid distinction
between nature and culture. Frozen embryos, likened to cloned transgenic animals and
genetically modified seeds, exemplify for Sarah Franklin how “new biologicals” are
defamiliarizing “the very nature of what it means to do or be biological” (Franklin 2001: 303).
As Levi-Strauss might say, frozen embryos prove to be “good to think” among social scientists
about the boundaries and dissolutions of our vital taxonomies. Here, I discuss how I approach the
study of these cool things.
Despite the heightened prominence of frozen embryos within debates about life itself,
feminist scholarship reminds us that they should not be considered inherently controversial. In
the case of embryos and fetuses, cross-cultural and historical studies demonstrate the various
ways they operate as “actors” conscripted within diverse socio-historical agendas (Addelson
1999). Across a range of settings, embryos and fetuses have been deemed testable (Rapp 1999),
tentative (Rothman 1986), dangerous (Reagan 2010), haunting (Gammeltoft 2014), born as well
as made (Franklin and Roberts 2006). They are put to work as patients (Casper 1998), consumers
(Taylor 2008), citizens (Berlant 1997), icons (Morgan 2009), persons (Hartouni 1999), and kin
(Roberts 2012). Sometimes they are lost (Layne 2003) or let go (Scheper-Hughes 1992); other
times they are made to tell tales about tails (Morgan 2003), race (Tsing 2007), and environmental
risk (Steingraber 2001). In this dissertation, I consider the controversial status of frozen embryos
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
between nature and culture. Rather, I follow recent rearticulations of Turner’s liminality thesis
that challenge such dualisms (Squier 2004).
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in the United States an ethnographic question rather than a natural given. Assuming this
perspective during field research prepared me for the profoundly naturalizing tropes about
embryos and their potential, and began drawing forth the hidden forces of their production.
In addition to denaturalizing the idea that frozen embryos are inherent troublemakers, I
am intentional about how I “think” them. Specifically, I am cautious about reifying them as
already fetishized objects within American politics and, arguably, social science. Anthropologist
Margaret Lock’s insights about brain death in Japan and the United States illustrate why in
certain controversies it is important to “name the hybrid.” In her study, bioethical controversies
around definitions of death focus on the technologies in question, like life support machines. At
the same time, the ways in which brain dead individuals may pose a threat to the moral ordering
of life remain undiscussed. For this reason, Lock sees the ethnographer’s task as “naming the
hybrid,” the “ambiguous, technologically created entities—neither alive nor dead, both dead and
alive” (Lock 2002b: 41). She even gives clues about how to identify it: “Its attributes will be
suppressed, and it will appear to reside fully either in the domain of society, or that of nature”
(Lock 2002b: 42).
The frozen embryo hybrid in this study is already multiply named—as resource, child,
promise, insurance, surplus, etcetera. And for any reader of American news, frozen embryos are
simply hard to miss. Rather than name the frozen embryo hybrid in the midst of controversy, I
decenter it by focusing my analysis on saving—the processes, practices, and props that
participate in the handling of frozen leftovers. Through the lens of saving, I emphasize
movements and relations rather than fixate on the saved entity. I distinguish my approach from
recent scholarship on IVF embryos; rather than examine how embryos became “tools,” as Sarah
Franklin creatively and successfully argues (Franklin 2013), this project is about the re-tooling
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processes that transform clinical excesses into precious promises of possibility. Frozen embryos
are constituted in, as well as constitutive of, the many fields from which I draw my conclusions,
though I argue that they are minor characters in the dramas that play out in their name.
Feminist science studies scholar Donna Haraway sets the tone for this mode of inquiry in
a few ways. Haraway challenges the neat taxonomies and singular meanings that prop up
America’s social order, especially at the intersections of science, technology, and bodies. In the
classic essay “A Cyborg Manifesto” (Haraway 1991),9 Haraway describes the binaries that
organize Western discourse and notions of modernity as “antagonistic dualisms,” such as
nature/culture, female/male, self/other, civilized/primitive, etcetera. She sees such dualisms as
artificial, and argues that they “have all been systematic to the logics and practices of domination
of women, people of color, nature, workers, animals... all [those] constituted as others” (Haraway
1991: 177).
Like Haraway, I attend to the ordering of frozen things because these processes—unlike
embryos—are intrinsically political. Saving, as I demonstrate in this dissertation, provides a lens
for seeing new vital taxonomies. In the following chapters, I highlight many sites of convergence
and alignment between stem cell researchers and Christian embryo adopters that challenge the
way America’s embryo savers are often antagonistically polarized. In disrupting this particular
form of binaristic thinking, my dissertation makes space for the quieted politics and remaindered
ideas that do not fit neatly within the dominant trope of saving in the United States during
uncertain times.
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  Sociologist Jackie Orr is right: “It is hard to be a feminist graduate student in the U.S.
humanities or social sciences after 1985 and not be touched in some way by the cyborg
manifesto” (Orr 2012: 276).
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If frozen embryos merit any name, I opt for Haraway’s notion of “knots,” or the
entangled fibers of:
knowledge-making practices, industry and commerce, popular culture, social struggles,
psychoanalytic formations, bodily histories, human and nonhuman actions, local and
global flows, inherited narratives, new stories, syncretic technical/cultural processes, and
more (Haraway 1997: 128).
Within these “sticky threads,” we begin to see the many stakes involved in saving embryos.

Coming to Terms
“The importance of things for people lies, in part, in the ways they may contribute to new
futures.”
- Webb Keane, “On Multiple Ontologies and the Temporality of Things”10
I have touched on two key terms—value and potential—that are central to this study
about saving embryos and merit some explaining:

Value
Like saving, value is one of those double-hinged words with multiple meanings. Within
social theory and everyday discourse, value describes aspects of life presumed to be radically
opposite, namely with respect to markets and morals. In the singular form, value connotes the
material ranking and pricing of things within economic markets. In the plural form, values
represent the practices and spaces associated with morals, ethics, and meaning. Given its
multivalent meanings, and as David Graeber’s history of the concept thoroughly demonstrates
(Graeber 2001), there is no shortage of ideas about value or approaches to studying it.
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Anthropologists have shown renewed interest in value in recent years, though
ethnographic attention to value spans the history of the discipline. HAU: Journal of
Ethnographic Theory dedicated two issues to the study of value, in which commentators
identified three dominant trends within anthropological inquiry: 1) how value is created through
exchange, 2) how systems of meaning express value, and 3) how value is enacted at the
intersection of exchange and meaning (da Col 2013a; da Col 2013b). In this dissertation, my
questions about value touch on literatures from all three lines of reasoning, though I draw
inspiration mainly from the latter group due to their emphasis on value in action (Munn 1986)
and curiosity at the crossroads of morals and markets (Maurer 2005).
A question guiding this project is how embryos are valued, at the core of which is the
premise that value is created. The creation of value, as anthropologist Katherine Verdery notes
with respect to the de- and re-valuation of land in postsocialist Transylvania, is often a highly
political process and one contingent on context (Verdery 2003). I develop my study of the values
created around excess embryos from literatures on exchange, within which we learn that the
value of the thing does not emerge inherently from the thing itself.
A key figure in this line of thinking is Karl Marx, who challenged classical economic
theories that the value of commodities was inherent to their qualities. Instead, Marx forwarded a
labor theory of value in which he described how value accumulates through the alienated
energies of workers expressed in making a product, or what he called labor (Marx 1981 [1885]).
Sociologist Georg Simmel also challenged economistic thinking through a theory of value in
which he located value within the context of exchange and described it as the effect of individual
desire (Simmel 1900). While Marx and Simmel offer contrasting perspectives about how value is
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made, what both usefully do is denaturalize the idea that value arises from the essence of a
commodified thing. Specifically, they show how value is actively produced.
Economic theories of value continue to garner interest among social theorists seeking to
understand how value is generated within advance capitalist economies. Biovalue, for example,
is a concept coined by feminist scholars of tissue economies to make sense of the way biological
matters—especially the products of women’s reproductive labors, like eggs and embryos—
produce new forms of wealth (Cooper and Waldby 2014; Waldby 2002). Central to the study of
biovalue is troubling the naturalizing idea that biology itself—given form through embryos,
marine algae, cancerous cervical cells, etcetera—is inherently generative of surplus value
(Cooper 2008; Cussins 1998; Franklin 2007; Helmreich 2008). Like feminist scholars of
biovalue, I too am dedicated to revealing the hidden forces beyond the biological materials that
transform their cellular matters into valuable workhorses. Even in the new context of biology,
theorists of value still take interest in its creation.
An advantage of studying values in production is that it redirects attention focused
intently on frozen embryos to the broader processes through which they come to matter. As a
result of intense focus on embryos themselves as “icons of life” (Morgan 2009) within the
United States, they increasingly appear to be autonomous things detached from their physical
contexts and social ties (Morgan and Michaels 1999; Petchesky 1987). I am aware that my
attention to them contributes to naturalizing them as free-floating, potent things, even while I
endeavor to critique these effects. In response to severing of embryos from their many social ties,
feminist scholars compensate by addressing the “hidden sources of production” (Morgan 2009)
and other methods for laying bare how they are made, not born. It is within these efforts that I
approach my study of the enigmatic excess embryo and the multiple values that condition their
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possibilities. And as is perhaps becoming clear, not only is the creation of value a highly political
process—so too is the study of it.

Potential
Another question guiding this dissertation is why potential is considered valuable and
worth saving. Over the course of investigating how frozen embryos are saved within embryo
adoption programs and stem cell tissue banks, participants regularly directed me to the topic of
potentiality. In answer to Warwick Anderson’s question what becomes the value of this thing, the
remainder?, study participants across my field sites, in striking agreement, suggested frozen
embryos are valuable because of their potential. What is potential and how did embryos get it?
Potential is defined as the latent quality, ability, or capacity to develop into something
one day (OED). When embryos are said to have or contain potential, one is likely speaking about
the qualities perceived to be inherent or essential to an embryo. For reasons explained below, I
explore the idea of potential as a naturalizing concept at the same time that I highlight the many
ways it is produced and preserved. Similar to how I address the topic of value, my questions
about potential arise from two intellectual traditions: political economic identifications of forces
that propel and produce potential, and discursive tracings of what potential—as a concept,
substance, and process—does.
Potentiality is a new area of interest within anthropological literatures, as discussed in a
recent special issue in Current Anthropology on potentiality and biomedicine. The editors
suggest three definitions of potential: 1) a hidden force determined to bring about a future
already built in; 2) plasticity to transform into something entirely different; and 3) latent
possibility available to human modification toward something else (Taussig and Helmreich
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2013). Similar to the way science studies scholars mobilize frozen embryos to illustrate their
respective theories about liminal lives, cyborgs, hybrids, and new biologicals, the journal editors
use the example of an IVF embryo to demonstrate their three definitions of potential. “It is a sign
of the complexity of the concept of potentiality that an embryo can be understood in terms of all
three of these articulations” (Taussig and Helmreich 2013: S4), they suggest, though I see it in
reverse: it is a sign of the complexity of saving embryos that refracted meanings of potentiality
become intelligible.
The papers within the Current Anthropology edition approach the study of potential in
multiple ways: as an analytic, an ethnographic object, and a cultural process, and they gesture
toward future intellectual work on potential as an imaginary and a method. In broader social
science literatures, potentiality is one of those “future tense” concepts (Selin 2011) akin to ideas
about expectations, promise, speculation, vision, hope, and anticipation. Such conceptual
innovations are evidence that social science scholarship is taking increasing interest in how
tropes of promise and redemption commingle with anxieties about the uncertain.
Countless thinkers within Western philosophy and Christian theology have engaged with
the concept of potentiality since Aristotle first introduced the idea in Book Theta of Metaphysics.
As a result of musing about potential within Western traditions for multiple millennia, Agamben
suggests that “the vocabulary of potentiality has penetrated so deeply into us” (Agamben 1999:
178) so as to seem a natural given. Core features of Aristotle’s argument are that potentiality is in
a teleological relationship with actuality and actuality is superior to potentiality. Potential in
Aristotelian thought is construed as amorphous matter that yearns to become an active, specific
form, and achieves this by moving unidirectionally toward actuality. Aristotelian notions of

29

potential are profuse within social theories that involve teleological premises like progress,
revolution, becoming, and emergence, as well Christian theologies of redemption and end times.
In this dissertation, I take interest in the Aristotelian suppositions that subtend Christian
and scientific ideas about surplus embryos. While IVF embryologists, stem cell researchers, and
pro-life activists differently mobilize the concept of potentiality for their respective purposes
(Morgan 2013), they similarly recapitulate Aristotle’s naturalized, linear story of human
generation from a fertilized egg to adult human. Their renderings reveal slippages between the
idea of embryos containing potential and embryos being potential. However embryos are cast,
my analytic work involves unraveling the seams of narratives that presuppose a synchrony
between embryos and potentiality. In doing so, I bolster a central claim of this dissertation,
which is that while excess embryos operate as icons of potential within efforts to save in
America, the equation of embryos with potentiality is a product of social creations rather than a
natural given.
Despite the growing ethnographic and theoretical interest in potentiality, the ways in
which the concept operates as a stand-in for ideas about reproduction remain unexplored. To
address this lacuna, I situate this dissertation within efforts that began forty years ago among
feminist scholars to systematically “drag” reproduction to the center of social theory and identify
the ways that reproductivity is at work within social life (cf. Ginsburg and Rapp 1995). This
scholarship usefully expands the definition of reproduction beyond the naturalized framework of
biological procreation. For example, feminists have long critiqued social theory’s overemphasis
on production with the effect of obscuring and naturalizing reproduction as a social and political
process (Harding 1981; Harris and Young 1981). Recent scholarship continues the tradition by
articulating new theories of value that address global hungers for the “biovalue” presumed to be
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latent within newly circulating reproductive materials, like donated eggs and surplus embryos
(Cooper and Waldby 2014). Ethnographic insights from the lived experiences of people with and
wanting leftover embryos contextualize feminist theories of reproduction, and invariably
reconfigure them. In my examinations of how potential is produced, valued, and preserved
within embryo remainder economies, I highlight the centrality of reproduction within Christian
and medico-scientific visions for redeeming life in America.
In the everyday conversations I had across field sites, I noticed that potential is often
considered a natural quality of frozen embryos. In the truest sense of the word “resource,”
coming from the French source meaning a spring of water, the people I spent time with in
diverse settings thought of embryos as resources, lying in wait of human creativity to transform
their inherent potency into a product or child for human enrichment. For pro-life Christian
donors and adopters within the Blossom program, embryos are considered valuable because their
essential worth as humans is already contained within them and vibrates with possibility that
many described as potential. For researchers and staff of Sutter University’s Stem Cell Institute,
embryo potential is also already contained within them, rooted in their cellular potency. In
current cell biology, it is commonly accepted that embryos contain potent cells described as
“pluripotent,” which is a kind of cell that could become any one of the 220 cell types in the
human body.
But as a group of ethnographers on the timely topic of resources argues, such wellsprings
of value are better understood as made, not found (Ferry and Limbert 2008). The promising
qualities that are presumed to be latent in the “nature” of a resource, such as crude oil or mined
silver, is a product of social, historical, and political processes. In this dissertation, understanding
how potential is naturalized is key to understanding how and why frozen embryos are saved.
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At the same time that Blossom and REDEEM program staff and participants conveyed to
me that embryos are naturally potentiated, and therefore valuable, my experiences within each
organization suggested instead that embryo potentials are produced, and contingent. In Chapter
2, I explore the role of embryologists at Harrington Fertility clinic in culturing potential through
clinical systems of ranking and grading in vitro embryos. In Chapters 3 and 4, I look at how the
organizing logics of waste and rescue within the respective donation programs transform IVF
embryo potentiality into new possibilities as research treasures and adoptable orphans. After
examining how embryo potentials are sorted out within Blossom and REDEEM in Chapter 5, I
ask what happens to the potential among the donated embryos that nobody wants. And in
Chapter 6, I return to the story of Adam and Julie Gold’s ML4 embryo to discuss their
unprecedented tax experiments as a way to open up the question about the “liveliness” of
potential and the role of embryo givers and receivers in producing it.
Common to these chapters is an emphasis on the labors and forces that go into making
embryo potential. As stem cell biologists working at the microscope spoke matter-of-factly about
the powers unique to stem cells, they detailed in the same breath the intensive hours they work
around the clock feeding and culturing their cells; described the volatile political and funding
climate that determines what kinds of research questions they can pursue with their cells; and
conveyed how lucky they felt to be based in a well-resourced lab in a prestigious university that
provides an environment abundant with instruments, media, and colleagues key to the success of
their experiments. If embryonic stem cells are the potent “golden eggs” of stem cell research, I
take interest in the labors involved in tending the goose.
The story is much the same within the Blossom Embryo Adoption program. There, all
embryos are considered precious preborn children whose value is morally fixed and indisputable.
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This has not precluded Blossom staff members from working intensively to turn IVF remainders
into adoptable frozen orphans, an outcome good for their moral principles and their business.
Their efforts include: maintenance of a “special embryos” website to help “find homes” for the
hardest to match embryos; monthly webinars to reach adoption agency staff, fertility clinic
professionals, and prospective embryo donors and adopters about the benefits of adopting
embryos; required adoption parenting education classes for clients receiving embryos; secured
grant funding from the Department of Health and Human Services to promote awareness of
embryo donation and adoption; attendance of Blossom families and children at national events in
opposition to embryonic stem cell research. These labors are the hidden sources of production
that make embryo potentials, and by extension, make embryos valuable.
As a future-oriented concept, potentiality provokes thoughts about how frozen embryos,
regarded by Haraway as materializations of the “future-in-the-present” (Haraway 1997), relate
to, and are located in, time. Anthropologist Kevin Birth acknowledged the challenge of studying
time ethnographically by suggesting, “Cultural conceptions of time do not lie by the side of the
road waiting for an ethnographer to wander by and pick them up” (Birth 2004: 70). Yet potential
seems to be one of these roadside findings that refracts, like a prism, how embryo savers today
relate to the unknowns of tomorrow.
In the following chapters, I demonstrate how frozen embryos are subject to simultaneous
temporal imaginings that arise in debates about their futures. The stem cell scientists of Sutter
University express a future-oriented morality toward the natural world, which they consider to be
available—and proper—for human use in order to realize the potential of left over embryos.
Otherwise they perceive unused embryos as remainders lying unnecessarily in waste, a
perspective that echoes John Locke’s treatise on the making of property from inert nature
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through creative human energies (Locke 1964 [1689]). Embryo potential, in the eyes of stem cell
biologists, is a promising, positive, and in potentia force.
By contrast, embryo adoption proponents express a more nostalgic lament about the
exploitation of embryos as a resource by modern technologies. They challenge the destructive
effects of treating embryos within IVF as being “cheaper by the dozen” because they believe it
cheapens human experience more broadly, a view that resonates with Heidegger’s critique of
transforming nature into a “standing-reserve” (Heidegger 1977: 320). Embryo adoption
advocates also express longing for a return to white middle-class Christian American values
premised on the traditional ways we likely never were (Coontz 1992; Stacey 1996). Such
simultaneous visions of pasts and futures come into relief as I approach frozen embryo
remainders as timely resources relevant to the embryo saving programs I studied.
Haunting the margins of this ethnographic consideration about the valuing of frozen
embryos is the question about the value of the remainder itself, or what Derrida calls the
“spectral effect” of the commodity and “apparition of the inapparent” (Derrida 1994).
Anthropologists have attended thoughtfully to the hauntings of various collected matters—such
as brain tissue of kuru epidemic victims (Anderson 2008), DNA samples of Native Americans
(TallBear 2013), and unearthed indigenous graves in museum storehouses (Fine-Dare 2002)—
and concluded that the spirits of their “donors” cannot be easily conjured away by the rigors of
science or law. In the pages that follow, I make space for the hauntings within embryo
potentialities and my analyses of them. I also keep an eye out for traces of the past within
figurations of the future.
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Methods: Field Sites and Data Collection
The Field
Fieldwork for this project occurred over the course of twenty-seven months (2008-2013)
in the United States, and primarily in the state of California. Entry into the highly charged
controversy meant engaging with some of the polarizing terms. By design, this project confronts
the tensions between secular science and Christian fundamentalism by studying comparatively
two organizations offering solutions for the problem of what to do with leftover IVF embryos: 1)
the Blossom Embryo Adoption Program of the Pacific Christian Adoptions agency located in
Orange County and 2) the REDEEM Biobank within Sutter University’s Stem Cell Institute
located in the Bay Area. Similar to other comparative ethnographic projects at the crossroads of
controversy (Ginsburg 1989; Lock 2002b), this research approached the opposition between
science and Christianity, as well as other dualisms, as an ethnographic starting place—rather
than a foregone conclusion—for understanding how and why surplus embryos are saved.
To my surprise, driving in my car countless miles on Interstate 5 and Highway 101 in
California became a vehicle for understanding the interconnected afterlives of frozen embryos.
Driving was a fortuitous and unintended method by which I became familiar with tacking back
and forth between the adoption agency and stem cell institute and their associated systems for
making embryos matter. The 500-mile stretch of highway between my two field sites turned out
to be one of many connectors linking these field sites and the activities within them. This
sensation of moving between realms that blurred ideas about what happens in one place versus
another is one that I strive to maintain in my analysis and writing. For these reasons, I do not
treat the cases of embryo adoption and stem cell research as isolated realms for comparison but
as simultaneous solutions that are actively in conversation.
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Though I began the project aiming to put the “realms” of stem cell science and pro-life
Christianity into conversation, I soon realized through field research that the conversations
between them were already ongoing. This occurred to me at various points, including felicitous
moments when I learned that some of people I knew so well from each site knew each other too.
Such an occasion arose when a patient at Sutter’s IVF clinic wanted to use embryos adopted
from the Blossom program to become pregnant. Over the multi-month saga that ensued between
the Sutter IVF clinic manager and Blossom staff about whether it would be possible, people from
both organizations shared their struggles with me about the case. Examples like this were
reminders for me about the relative smallness of California’s IVF and reproductive remainder
economy within which these saving programs forward their missions.
I chose the Blossom program and REDEEM Biobank because they are at the vanguard as
national leaders in saving embryos in the United States. I provide a more thorough description of
each organization in Chapters 2 and 3, but introduce some particulars of each to clarify why they
were ideal primary field sites.

Blossom Embryo Adoption Program: Saving Lives through Adoption and Birth
Topping the backside of a Blossom Embryo Adoption brochure is a statement explaining
their mission and name: Like a tiny seed, each embryo is small but contains everything it needs
to blossom into a beautiful flower. Blossom emphasizes the uniqueness contained within each
embryo and its value as a pre-born child deserving the chance to be born. The program operates
within Pacific Christian Adoptions agency that uses adoption as a model to facilitate the transfer
of remaining IVF embryos from donors to recipients. The first program of its kind, Blossom is a
leading proponent of extending the rights of persons to frozen embryos.
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Blossom’s mission is twofold. Their first goal is to extend the dignity and protections of
personhood to frozen embryos. In their official embryo adoption contract, they define embryos
as “pre-born children who are endowed by God with unique characteristics and are entitled to the
rights and protection accorded to all children, legally and morally.” The program’s second goal is
to recognize all embryos as equally deserving of the opportunity to achieve their full potential
through birth. “We consider that every embryo is a potential continued life,” said Stacy, one of
the program’s social workers. “We want to give them all a chance.” For this reason, Blossom
accepts all frozen embryos into their program for placement with adoptive families, regardless of
how they are ranked clinically. “We’re not looking at the embryology report saying, ‘Oh this
one’s not really worth saving.’ That’s just horrible to us,” Stacy explained. Blossom challenges
the prevailing fertility clinic practice of grading embryos into categories connoting their clinical
worth. For donors, they offer a life-giving alternative to destructive embryonic stem cell research
by finding homes for all embryos considered equally valuable and awaiting the chance to be
born. The Blossom Embryo Adoption program serves a clientele across the United States as well
as internationally from a modest office building in Southern California.
The financial means to forward their mission is supported in part through program fees
paid for by adoptive clients, but the lion’s share of their budget comes from federal grant monies.
Since 2002, Pacific Christian Adoptions has received multiple millions of dollars in federal
grants administered by the Office of Population Affairs for increasing awareness around embryo
donation and adoption. In 2002, the United States Congress began earmarking funds for an
Embryo Donation and/or Adoption Awareness campaign authorized under Section 301 of the
Public Health Service Act. The grant program received Congressional approval and backing by
the George W. Bush administration, though its origins are attributed to Pennsylvania Senator
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Arlen Specter, a pro-choice, pro-stem cell research Republican. Senator Specter chaired the
subcommittee responsible for determining appropriations for the Departments of Labor, Health
and Human Services, and Education.
In reference to the $123 billion dollar bill Sen. Specter’s subcommittee helped pass, and
the $2.9 billion dollar increase in funding to the National Institutes of Health that year, he spoke
about the allocation of $1 million dollars to a new program for embryo adoption awareness
during the December 20, 2001 Senate session:
A controversy has arisen because some object to stem cell research because they are
extracted from embryos and embryos can produce life… If any of those embryos could
produce life, I think they ought to produce life and not to be used for stem cell
production. But if they’re not going to produce life, then why throw them away? Why not
use them for saving lives? We put into this bill $1 million, sort of a test program on
embryo adoption. Let us try to find people who will adopt embryos and take the
necessary next steps on implanting them in a woman to produce a life. If that can be done
and use all of the embryos, that would be marvelous to produce life. But where those
embryos are going to be discarded, then I think the sensible thing to do is to use them for
saving lives.11
Since 2002, three to five awardees each year received hundreds of thousands of public grant
dollars to “educate Americans about the existence of frozen embryos (resulting from in-vitro
fertilization), which may be available for donation/adoption for family building.”12 The Office of
Population Affairs within the Office of the Assistant Secretary of Health administers the grant of
which Pacific Christian Adoptions has been a regular recipient for promoting embryo adoption
generally and the Blossom program in particular.

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
11	
  See transcript and archived video of the session here:	
  http://www.c-span.org/video/?1679431/senate-session&start=5231	
  
12	
  See the Office of Population Affairs description of the awareness program here:
http://www.hhs.gov/opa/about-opa-and-initiatives/embryo-adoption/	
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REDEEM Biobank: Saving Lives through Science
A decade after the Blossom program began and a few hundred miles away, the REDEEM
Biobank’s first coordinator Tori brainstormed a list of names for the new tissue bank she was
tasked with launching. Tori searched for words she hoped would capture the intent of newly
funded embryo and oocyte resource center. She tried words like regrow, revive, strive, pluri, and
potent, eventually settling on the program name, REDEEM, which she made into an acronym:
REgenerative Medicine and Discovery through the Ethical Procurement of Embryonic
Materials.
The precipitating context for REDEEM Biobank was the limiting of U.S. federal funding
for research on human embryonic stem cell research (Scott 2006). Soon after the establishment
of the first human embryonic stem cell line in 1998, President George W. Bush announced to the
nation on August 9, 2001 during his first Presidential address an executive policy that limited
federal funding for embryonic stem cell research. This policy restricted federal dollars—though
not state or private funds—to research on human embryonic stem cell lines that were derived
before August 2001. Although Bush’s executive order had a cooling effect on the burgeoning
field of embryonic stem cell research in the United States (Korobkin and Munzer 2007), places
like California experienced it as a boon. Several states responded by filling gaps in federal
funding with state tax funds while others went beyond the Bush policy to pass laws prohibiting
all human embryonic stem cell research at the state level. President Bush remained firm in his
position and vetoed two bipartisan Congressional bills in 2006 and 2007 that would have freed
up federal funding for embryonic stem cell research. Soon after entering the White House in
March 2009, President Barack Obama also announced an executive order on the topic, this time
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revoking the Bush-era funding restrictions and allowing the National Institutes of Health to
finance research on a wider range of embryonic stem cell lines.
In response to the restriction of federal dollars and the hope of curing diseases, California
voters passed Proposition 71 in 2004, entitled the Stem Cell Research and Cures Initiative.
Voters agreed to invest $3 billion dollars of taxpayer funds into the promise of human embryo
stem cell research over a decade’s time. This unprecedented budget quickly surpassed in dollars
the entire National Institute of Health’s annual funding for human embryonic stem cell research
in the United States, which in 2003 totaled $24.8 million (Benjamin 2013: 13). California’s $300
million annual budget for human embryonic stem cell research still dwarfs the NIH’s, which
totaled $166 million in 201413, as well as all public investments made by other countries
committed to embryonic stem cell research, including the United Kingdom, Israel, Singapore,
and Japan (Benjamin 2013). With the passage of Proposition 71, California catapulted onto the
international scene as a world leader committed to the promise of research with human embryos.
Proposition 71 established the granting agency, the California Institute for Regenerative
Medicine (CIRM), that oversees the allocation of funds for human embryonic stem cell research
within California and the Independent Citizens’ Oversight Committee as CIRM’s governing
body. REDEEM Biobank was established through a CIRM grant meant to launch a Sutter
University-based frozen embryo resource center that provides expert management of and access
to human embryos for scientists around the university and state.
REDEEM’s mission, according to the current director, Dr. Pat Dunn, is altruistic and
twofold. An early Biobank brochure describes the first part of its mission in formal terms: “To
optimize the use of precious resources for an increased knowledge of basic science and the future
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
13
See NIH “Estimates of Funding for Various Research, Condition, and Disease Categories”
table, February 5, 2015: https://report.nih.gov/categorical_spending.aspx
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treatment of human diseases.” The precious resources Sutter scientists needed were embryos in
order to continue the work of deriving stem cell lines, studying disease development, and testing
therapies on human tissues that may lead to cures.14 “The situation was that we need
blastocysts,” Dr. Dunn explained, “so we decided that we’ll take any unwanted embryos.”15 This
began a multi-year process of grant writing, legal consulting, and protocol development to be
able to begin receiving the first frozen embryo donations from fertility patients in June 2008.
REDEEM’s welcoming of all leftover IVF embryos without exception for stage or grade made
the REDEEM Biobank one of the premier donor sites for fertility patients around the country.
“By the same token,” Dr. Dunn explained, “the Biobank provides an ethical disposition
option for patients who have a difficult decision to make.” For IVF patients considering donation
options, Dr. Dunn feels that REDEEM “provides a way for people to dispose of their embryos in
an honorable way. It is truly a tremendous savior option for people who spent money and effort
to get to what they achieved. Now they want to stop paying but don’t want to throw embryos
away and don’t want to give them to someone else.” Serving also as Sutter University’s IVF
clinic director, Dr. Dunn is committed to patient satisfaction and maintaining the university’s
good name. Thus, one of her primary concerns is providing a smooth donation process for
patients. For researchers and fertility patients, the dual purpose of REDEEM Biobank is to
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
14	
  Embryonic stem cells are considered precious because they provide scientists alternatives and
complements to traditional disease research based on animal models. Alzheimer’s disease, for
example, has proven challenging to mimic in animal models. Therapies with promising results in
animals exhibiting a form of Alzheimer’s have proved ineffective in human trials. Embryonic
stem cells allow researchers to develop stem cell models in vitro that illuminate how Alzheimer’s
develops as a disease as well as provide the opportunity to test drugs and therapies on actual
human cells. Additionally, the ability of embryo cells to become nearly any type of the 220 cells
that make up human bodies has inspired researchers to try developing therapies, such as
regenerative tissue transplants, that may replace cells destroyed by degenerative diseases like
Alzheimer’s.	
  
15
Blastocyst describes the developmental stage of a fertilized egg typically 5-6 days after
fertilization.
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provide invaluable research opportunities for saving lives and a pleasant donation experience,
and to serve as a salve for all.
--Studying the afterlives of frozen embryos in the United States is invariably a multi-sited
affair. While Pacific Christian Adoptions and Sutter University functioned as my primary field
sites, I considered them nodes of activity from which to trace flows of people, things, ideas,
practices, and resources. For this reason, I spent four months conducting field research at
Harrington Fertility, a private IVF clinic in Los Angeles unaffiliated with either program. I also
carried out interviews and site visits with other organizations around the country: two embryo
adoption programs (Washington and Tennessee), two fertility clinics (California, Illinois), and
two long-term cryostorage businesses (Texas, Nevada). These explorations helped me
contextualize the themes arising from my research at Pacific and Sutter.
Excursions beyond my primary field sites introduced new scales that proved important
for investigating the re-valuation of frozen embryos. This challenged the coherence of “primary”
sites being located at any one organizational, regional, state, and national level. For example,
important to understanding Sutter University’s prominence within worldwide regenerative
medicine research is its position at the center of “Biotech Bay.”16 The San Francisco Bay Area is
one of the nation’s hotbeds for biotech research and development collaborations between
industry and academia, fueled by nearby Silicon Valley bust-and-boom startup culture and
landmark legal cases like Moore v. Regents of the University of California.17 The Bay Area is
also the seat of power for Proposition 71 grants that fund speculative ventures within stem cell
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
16	
  See other biotech hotbed maps around the United States here:
http://www.biospace.com/hotbed.aspx?regionid=11	
  	
  
17
See Chapter 3 for more discussion about this case. Moore v. Regents of the University of
California, 51 Cal 3d 120, (California Supreme Court, July 9, 1990)	
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science; San Francisco won the bid as hosting site for the proposition’s oversight and granting
agency, the California Institute for Regenerative Medicine.
Similarly, Southern California’s national significance in the history of Christian
evangelism and New Right politics makes it a meaningful region for understanding how embryo
adoption fits within “Sunbelt” society values. The roots of California evangelism originated with
white Christian migrants moving in massive waves to California from the South from the 1930s
through the 1960s. The Depression-era migrants carried their plain-folk churches with them, as
historian Darren Dochuk argues, and over time “forged a vigorous cultural force, one that
melded traditionalism into an uncentered, unbounded religious culture of entrepreneurialism,
experimentation, and engagement—in short, into a Sunbelt creed” (Dochuk 2011: xviii). The
Sunbelt society of Southern California became a crucible for the conservative revolution that
burst onto the national scene in the 1970s with the election of Jimmy Carter (1976-1980)—the
first self-professed evangelical Christian elected president—and helped maneuver Christian
politics into power with Ronald Reagan’s governorship (1967-75) and presidency (1980-1988).
Characterizations of the Bay Area and Orange County map on to a narrative about a
cultural and economic divide between Northern and Southern California, a story I am familiar
with as someone who was raised in the state. The tale of two Californias is an old one, within
which lingers a story about the divided American nation along North-South lines indicative of
incommensurable worldviews. While there are notable truths to the differences between the Bay
Area and Orange County, I remain cautious of the obscuring and othering effects of binaristic
thinking. For this reason, the state of California as observed within national and international
contexts serves as another “site” for thinking about the admixture of IVF embryo afterlives
across shared geographic, historical, political, economic, and social circumstances.
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Once the Western frontier of the American nation and its manifest imaginaries (Turner
1920 [1893]), California is still often considered the “Wild West” for reproductive politics. The
state is well known for laws and policies that smooth the way for all forms of third-party
reproduction, including sperm, egg, and embryo donation; surrogacy; and adoption. The Johnson
v. Calvert18 surrogacy case, for example, secured the parenting rights of couples commissioning
surrogates, which contrasted with the famous “Baby M” case in New Jersey where the woman
who gave birth—the surrogate—was declared the legal mother (Rose 1996). As a result,
California ranks as a national leader when it comes to the business of making families. Of the
486 IVF clinics in the United States, California is home to 75 where clinicians performed over
25,000 IVF cycles in 2012.19 Also, more adoptions are completed each year in California than
any other state (Gailey 2009). In this dissertation, I do not consider California a microcosm of
America, which is the productive angle Faye Ginsburg takes in her comparative study of pro-life
and pro-choice activism in Fargo, North Dakota (Ginsburg 1989). Rather, I think of California as
a very large Petri dish where different experiments are underway to cultivate the potential of
particular futures in and for America.
	
  

Data Collection
With saving practices situated at the heart of this analysis, I utilized three main
ethnographic methods—participant observation, interviews, and document analysis—to trace the
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
18	
  Johnson v. Calvert, 851 P. 2d 776 (California Supreme Court, May 20, 1993).
19
Official IVF statistics are tracked in the United States per mandate by the Fertility and Clinic
Success Rate and Fertilization Act of 1992. This Congressional law requires clinics in the United
States performing IVF to annually submit data to the Centers for Disease Control, which
compiles and publishes annual reports of reproductive technology trends and outcomes. See the
Center for Disease Control Assisted Reproductive Technology Success Rates site:
http://www.cdc.gov/art/reports/index.html
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making of frozen embryo potentials from IVF clinic freezers to adoption agencies, tissue banks,
research labs, wombs, and waste bins.

Participant Observation
My first visit to Pacific Christian Adoptions (June-July 2008) involved exploring the
feasibility of the project. I later returned to Pacific for research stints lasting two to six weeks at a
time over a period of two years (February 2011-April 2013). During those visits I learned
through observations of life within the Blossom Embryo Adoption program how IVF embryos
were transformed into adoptable orphans and clients into parents. My initial liaison was the
agency Director of Public Affairs, whom I first contacted by calling with expressed interest in
conducting a pilot study during Summer 2008. Upon my return in 2011, the Blossom program
manager Monica became my main contact for the duration of field research. She and I worked
out the practicalities of being on site for weeks at a time, such as what files I could look at and
where I should sit. Monica was responsible for my presence in the agency and was consistently
generous with her time and ideas.
I commuted to the office most weekdays and finished field notes at a café after work
while waiting for highway traffic to slow. I became a regular fixture in the “engine room” of the
Blossom program, a windowless office on the second floor of the agency wherein three staff
were stationed: the program manager Monica, the social worker Kathy, and the Program
Assistant Sarah. I set up a table in the middle of the room from where I felt comfortable asking
questions about files I was looking at or pulling my chair over to look at someone’s screen with
them. I worked alongside staff with my laptop open and documenting what occurred around me,
which was intermixed with conversations and activities like team meetings, embryo matching
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sessions, and parenting education classes for adoption clients. Overhearing half of a phone call
conversation was sometimes a prompt to ask about why they devised a particular rule for the
adoption program. Advice they sought from each other about a challenging file allowed me to
chime in with clarifying questions. Normal outbursts of surprise, worry, and joy were the starting
points of stories about their experience with a donor or adopter. The Blossom team also shared
their opinions with me about shifts in agency leadership and personal feelings about their job
satisfaction. What to them was mundane stuff of an office illuminated for me how IVF leftovers
became adoptable orphans, a task that involved a dedicated, full-time team. My presence became
familiar to the Blossom team as well as other agency staff who would greet me with kind smiles
and questions about how long I would be with them this time.
Beyond the office, I participated in events with or hosted by Pacific Christian Adoptions,
such as tabling at conferences, attending annual summer picnics and winter galas, and visiting
the homes of embryo donors and adopters around the country (CA, IL, OR, WA). Also, as I
developed working relationships with the Blossom team, I began spending time with them
beyond the agency. Monica became a primary informant with whom I spent the most time
debriefing our days on long walks, cooking dinner with her husband, and bonding over one of
her favorite things: line dancing. Sarah was also an exceptional informant, keeping notes about
news topics from her day that she knew I would be excited to hear about. She and I kept a
regular phone dates during the stretches between my visits in which she would update me about
ongoing cases and program shifts. Spending time in a place where embryo personhood is the
status quo provided invaluable insight into the making of frozen embryo orphans awaiting
adoption and deserving a chance to be born.
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Gaining access to research at Sutter University was a more tumultuous journey. In June
2009, I visited another university’s Center for Women’s Health through contact with the IVF
clinic’s staff psychologist. She and I established a research plan with for carrying out future field
research. Their center maintained an active IVF program, tissue bank, and research lab, which
seemed like a trifecta for examining the making and movement of excess embryos. When I
followed up the psychologist in 2010 with positive news of my funding grant, the door that I
thought was open had closed. She shared that the embryo donation program had not gotten off
the ground and expressed doubt about convincing the clinic director to allow an outside
researcher on site. This was my first lesson in the goodwill of gatekeepers in research, as Marcia
Inhorn notes about research in fertility clinics (Inhorn 2004). At the time, it seemed like the end
of being able to study the donation of embryos to stem cell research. I would later discover
through field research at Sutter University that it was actually the beginning: this was my first
piece of data about the logistical hardships and eventual closure of many research tissue banks
around the country, on which I elaborate in Chapter 5.
My first trip to Sutter University was a brief two-day visit in October 2011, from which I
was able to negotiate returning for the following year for a few weeks in September 2012. The
Sutter IVF clinic manager was my initial point of contact, whom I initiated communication with
as a result of an email introduction from a friend of a family friend based in the Bay Area. The
clinic manager forwarded my requests for lengthier stays to the IVF clinic director, Dr. Dunn,
whose willingness to have me as “an extra pair of eyes” opened many doors for me at Sutter
University. Once on campus, I was welcomed to stay the 2012-2013 school year from September
2012 to April 2013. There I learned through everyday life in a fertility clinic and laboratory how
IVF trash was transformed into laboratory treasure.
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I conducted field research at Sutter within two connected sites: the IVF clinic and within
Dr. Christine Moto’s research lab in the Stem Cell Institute where the REDEEM Biobank was
housed. Within the IVF clinic, I shadowed doctors, nurses, and embryologists to understand how
embryos are made, managed, used, stored and planned for within a fertility clinic. Since activity
in the IVF clinic occurred in differing locations, I spent time documenting, listening, and
conversing in the embryology lab and main staff office. When based initially in the clinic, I
walked the oft-traveled path from the IVF clinic to the Stem Cell Institute, where I attended
weekly lectures and journal clubs, audited a graduate course in stem cell biology, and conducted
interviews.
Once based within the REDEEM Biobank office, I was provided a desk across from the
lab manager and next to the Biobank, which was a choice spot for observing the arrival and
management of embryos donated to the bank. The office doorway opened into one of two large
lab spaces where I shadowed stem cell institute faculty, student and postdoc researchers, and
tissue bank staff as they carried out their everyday desktop and bench top activities. The “embryo
team” of researchers working most often with donated human embryos became some of my
closest informants: Dr. Moto’s lab manager Wendy, the German postdoc Luke, the senior
postdoc Caitlin, the genetics doctoral student Madison, and the Biobank program coordinator
Donna.
While much of my field research involved observation, a couple of opportunities to
participate arose at the Stem Cell Institute. I spent a week in a CIRM funded laboratory crash
course in deriving stem cells, which allowed me to learn hands-on about what everyone around
me was constantly doing: working with media and instruments, dissecting mice, following
detailed protocols, and looking through microscopes. Another participation opportunity involved
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helping the Biobank staff do inventory, through which I learned about the major organizational
challenges facing tissue banks. Through these activities, I traced the systems within which
embryos at REDEEM Biobank are transformed from excess reproductive waste into precious
resources for research.
In addition to field research activities within Blossom and REDEEM, I strived to stay
abreast of the broader contexts for reproductive remainder economies by attending ten national
and regional conferences that attracted professionals on abortion (National Abortion Federation
annual meetings), infertility (American Society for Reproductive Medicine annual meetings),
adoption (Mapping Adoption), Christian politics (Values Voter Summit), and embryo disposition
(Emerging Issues in Embryo Donation/Adoption).

Interviews
I interviewed two main groups: relevant professionals (e.g., doctors, nurses, social
workers, counselors, embryologists, students, study coordinators, lab managers, researchers,
lawyers, theologians, bioethicists) and embryo program participants (e.g., donors, adopters, and
stem cell researchers). I recruited interviewees in person at Sutter and Blossom as well as
through an email posting to Blossom’s client listserv. Interviews with people recruited in person
were often conducted in person; most of the people recruited by email, who often lived all
around the country, were conducted over the phone.
During the period of research, I conducted 200 formal, semi-structured interviews with:
38 embryo adoption professionals; 65 embryo adopters; 30 embryo donors; 30 fertility clinic
professionals; 10 tissue bank professionals; 10 stem cell scientists; 10 stem cell biology PhD
students; and 7 active fertility patients.
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Document Analysis
Documents, in anthropologist Annelise Riles’s view (Riles 2006), are intermediaries
between systems of meaning and material practices; they are storable hybrids of their own kind.
Given the focus of this study on frozen embryo hybrids at the confluence of meaning and matter,
documents were essential for my ethnographic study. I gathered documents of countless kinds,
though generally documents internal to program organization (donation and adoption files, client
databases, donor consent forms, embryology reports), for embryo program donors and clients
(applications, letters, contracts, consents, brochures, template emails), for external advertising
materials from each program (brochures, websites, webinar power points, quarterly newsletters,
books published by adoptive clients for their children). I also gathered 90 matched embryo
adoption files (every tenth file in their database counting up to 900), specifically the donor and
recipient letters, applications, and matching fact sheets.
--To conclude, I reflect on the effect of my positionality on research and my reception in
the field. As a feminist ethnographer, I remain mindful that all methodological and analytical
choices that informed this study come from situated knowledges (Haraway 1988). As a U.S.
ethnographer studying “at home,” I was regularly confronted with the circumstance of being an
insider on some occasions, and an outsider on others. My interest in frozen embryos derived
from an ongoing participation in reproductive politics and advocacy in the United States.
Leftover embryos came to my attention first in Katherine Verdery’s property course as an entity
within divorce cases that fit awkwardly within legal categories of property and personhood. As a
reproductive justice advocate involved in grassroots efforts in New York and Oregon, I remained
keenly aware of the role that frozen embryos increasingly played in the erosion of abortion
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access and criminalization of pregnant women. As embryo and fetal personhood gained
prominence within these politics, the potentiality that frozen embryos contained for partners in
my advocacy groups was the capacity to dismantle hard won reproductive freedoms. This
invariably informed my interests in the field and in writing.
Even though I was at “home” in California—my state of origin—I was an outsider in
many ways: I have not experienced infertility or IVF, have not participated in adoption, do not
identify as pro-life or Christian, and am not trained in the biological sciences. Yet in many others
ways, I passed: at Sutter, I was another doctoral student in training conducting a research study.
At Pacific, my whiteness, gender presentation, age, and college education were similar to agency
staff, which tempered the ways in which I stuck out as a non-Christian and an anthropologist.
My reception as an anthropologist at Sutter involved finding a preexisting category
within which I could fit, which was as a “visiting student researcher.” Not long after my arrival,
Dr. Dunn introduced me to others as her “student,” a designation of mentorship that helped
leverage opportunities for me within the IVF lab, Stem Cell Institute, and beyond. Science at the
Stem Cell Institute is premised on interdisciplinary collaborations, though I was the first
anthropologist to ask Dr. Moto to do research in her lab. Like the other 30 students and postdocs
that Dr. Moto supported, she made room for me to “join” her lab where it was not always clear to
me who was being researched. Luke teased me when I shadowed him during experiments and
during coffee breaks about feeling like a mouse being studied. Yet he also regarded me as a
colleague; Luke wondered if I planned to start my own lab one day as principal investigator, as
he did. He also warned me to be aware of my data being “scooped,” or stolen and published first,
by a competitor in my field—an anxiety of many lab scientists who are racing to publish findings
in journals that are critical for career advancement. Each person I encountered was generous with
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their time, with some wondering when they would get a turn to be interviewed as I worked my
way down the bench rows. Others, like the past and current Biobank coordinators, were
noticeably guarded when I pulled out a tape recorder or laptop. I chalk this up to rapport; they
did not know me but were told that I would be learning the ins and outs of their daily work, a
circumstance that could make anyone—myself included—feel cautious. When my recording
devices for data collection seemed to hamper easy conversation, I relied instead on handwritten
notes and my recollections.
My reception at Blossom paralleled what I came to learn about adoption and evangelical
Christianity. The embrace of “outsiders” is a part of the evangelical process of missionizing,
which Christian adoption takes to another level within the family structure of welcoming
outsiders in. As the flagship embryo adoption program with a visible presence in the public eye
around stem cell research, they were accustomed to talking with journalists about their work.
They knew that even bad press had been helpful for their program, which is why the agency
expressed disappointment when we discussed not using the agency’s name in my publications in
accordance with human subjects protections. Despite their disappointment, Pacific was
accustomed to participating in research; they had helped various students at the local evangelical
university and a few M.A. and Ph.D. level researchers by posting recruitment flyers to their
listservs. But having an ethnographer show up each day was unprecedented at the agency. In
many ways, I felt adopted into the organizational family; at times, the joke was made that I might
as well be added to the payroll. The bulk of my time was spent in the company of the Blossom
team, and the lines between what was on and off the record were often blurred. Although I was
prepared to discuss the fact I identify neither as Christian nor pro-life, staff and program
participants never raised it for discussion, which was both surprising and a relief. I expect that all
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participants used their own perceptive knowledge and evaluations about me to inform how,
when, and what they shared in our conversations.

Organization of Dissertation
I organized this dissertation around keywords—saving, value, culture, conversion,
redemption—that capture, as doubles entendres, the simultaneous meanings words and embryos
often contain.
Chapter 2, “Culturing: Making Potentiality within an IVF Laboratory,” argues that IVF
labs are places where embryo potential is made and born. This chapter establishes how frozen
embryo potential is produced through clinical grading practices, and how their potentiality is
suspended in a limbo state once cryopreserved in anticipation of future redemption.
Chapters 3 and 4 analyze embryo revaluation through processes of wasting and rescuing.
Through the lens of saving, I examine each program’s respective commitment to prevent waste
and to rescue. I argue that each serves a parallel role within speculative economies by converting
IVF potentials into new forms: on the one hand, turning clinical trash into laboratory treasure,
and on the other, making extra embryos into abandoned orphans waiting for a chance.
Chapter 3, “Wasting: Making Embryo Trash and Treasure in a Stem Cell Institute
Biobank,” argues that waste prevention is a paradigmatic feature of stem cell science. Despite
the common regard for frozen embryos as un-wastable, I argue that the REDEEM Biobank’s
procurement practices “trash” valued materials in order to ready them for use as precious and
promising research materials.
Similarly, Chapter 4, “Rescuing: Making Embryo Orphans in a Christian Adoption
Program,” explores the centrality of saving ethics within the Blossom Embryo Adoption’s
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efforts to leave none in the cold. I argue that rescue practices facilitate the making of orphan
embryos from IVF remainders, which are simultaneously regarded as without origins and
deserving of a chance to be born. Rescue in the Blossom program, like the waste prevention at
Sutter, serves as a guiding ethical rubric for doing good during uncertain times.
At the time of donation, leftover IVF embryos contain “potencies” (Munn 1986) to
become anything. Chapters 5 and 6 examine efforts to manifest ways for embryos to realize their
potential, or what I understand through the concept of redemption. Chapter 5, “Sorting:
Archiving Embryos for Viable Futures” illustrates how once donated, frozen embryos are
differentiated through valuation systems that render frozen embryos differently viable for
particular futures. In both settings, various circumstances render some remainders “hot
commodities” while others as destined to “wait.” I examine what happens when the least viable
embryos within Blossom and REDEEM embryos appear to be unredeemable. Specifically, I
analyze the concept of circumstantial viability through two stories about the programs’ most
logistically burdensome and hardest to match donated embryos. Problem embryo cases reveal
how powerful potentiality is, once produced.
Chapter 6, “Redeeming: Claiming Potential Makes Moral Cents,” tells two stories—one
family’s adoption of nine embryos and another’s donation of a genetically abnormal embryo for
research—in which both filed tax returns attempting to save money as well as save lives. One
family filed for an adoption tax credit while another filed for a tax exemption based on their
charitable donation of “property” to REDEEM Biobank. These accounts suggest that the
priceless child often has a price and intimate relations are not beyond purchase (Zelizer 1979;
Zelizer 1985).
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The Conclusion, “What Remains,” reviews this dissertation’s extended answer to the
question posed by Anderson—what becomes the value of the remainder?—and makes some
suggestions about why such an answer matters at all.
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CHAPTER 2:
Culturing: Making Potentiality in an IVF Laboratory
On my third day at Harrington Fertility’s Paloma clinic, Zhao expressed his frustration
with the amount of paperwork he and Ken have assumed as senior embryologists within the IVF
lab. Rather than manage all of the files resulting from the hundreds of IVF cycles they perform
each year, he prefers working with pipettes and under the microscope. In an ideal scenario, Zhao
and Ken would like to see the administrative tasks of embryo storage and disposition, inventory
logs, and shipment delegated to other staff or subcontracted out to other businesses. This would
allow them to focus on what they consider their real work to be: “An embryologist's job,” Zhao
explained, “is to make babies.”20
Over the next few months at the Paloma clinic, I took interest in the work embryologists
do. I shadowed Zhao, Ken, and other clinic staff while observing the mundane tasks and
everyday practices that comprise IVF laboratory life. Babies, I learned, are not the only things
embryologists make. At the bench, embryologists create embryos through processes of
fertilization, grading, selection, and transfer. They generate reports, manage files, update
logbooks, and maintain databases. They establish classificatory systems and standardized
protocols for monitoring lab conditions and cellular matter. And embryologists make
opportunities for their clients to become parents through the possibility of pregnancy. Within
Paloma’s IVF lab, the many bench top and desktop activities elucidate what else is produced in
the process of making IVF babies.
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On one level, Zhao’s statement echoes a common trope about IVF as a “baby-making”
technology. While critics of IVF invoked dystopic images of scientists in laboratory-factories
where fetuses are made and grown to term in artificial wombs, IVF in the United States was
quickly mainstreamed as a method for assisting conception. Within the curiously normalized
context around ARTs, Zhao’s claim to “make babies” suggests a different picture: of helping
fertility patients become parents.
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In this chapter, I argue that the IVF clinic is a setting where embryo potential is
“cultured,” or made and mediated by processes extrinsic to the embryo itself. Like historian of
science Hannah Landecker, whose history of cellular life in vitro inspired this chapter
(Landecker 2007), I approach culturing as a way to understand how cellular life forms are
produced utilizing the whole apparatus supplied by the IVF laboratory. Culturing involves an
assemblage of protocols, techniques, methods, and infrastructures within the biological sciences
that manage cells in vitro. Specifically, I focus on the role of embryo grading within the IVF
embryology lab, which is a technique for sorting out which embryos are perceived to have the
best chance to establish pregnancy. My analysis of how IVF embryo potential is cultured
provides the foundation for understanding what is taken up in the next four ethnographic
chapters: how frozen embryo potential is revalued within REDEEM Biobank and Blossom
Embryo Adoption program. In order to understand how frozen potential is revalued, we must
first establish how IVF embryos come to contain potential, and how that potential is deemed
valuable, a story that involves a mixture of paperwork, Petri dishes, and protocols.

Culturing Embryos
Zhao’s description of embryologist-as-maker stands in tension with the deeply
entrenched belief within Western scientific traditions that embryos are naturally occurring
biological facts. For multiple centuries, the narrative of science as a process of discovery cast
embryologists as the founders and describers of embryos, rather than their makers and producers.
Like other feminist social science scholars, I suggest that embryologists have always been
makers and embryos have always been made.
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Consider, for instance, the images common to contemporary pregnancy literature and
prenatal classes depicting embryological growth from zygote to fetus to baby. Today’s expectant
parents can download a pregnancy app through which they receive weekly images or videos
explaining, “how your baby is growing” over time (See Figure 1). Historian Nick Hopwood
(Hopwood 2000) identified the origin of this now common view of embryological
“development” in 1799 in Frankfurt where biologist Samuel Thomas Soemmerring created the
first drawing that depicted embryo growth in successive, linear stages (See Figure 2). Hopwood
argues that Soemmerring’s series did not discover and describe, but produced, the idea of human
embryological development. This idea contained within it the narrative of a linear march of
progress from conception to zygote to fetus to baby—a modernist trope that has been naturalized
as scientific fact since Aristotle’s first philosophical remarks on animal generation over two
millenia ago.
Fig. 1. What to Expect Pregnancy app

Fig. 2. Soemmerring’s series21
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Samuel Thomas Soemmerring, Icones embryonum humanorum, accessed at the Making
Visible Embryos online exhibition directed by Tatjana Buklijas and Nick Hopwood of University
of Cambridge, http://www.hps.cam.ac.uk/visibleembryos/s2.html. 	
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Anthropologist Lynn Morgan utilizes Hopwood’s insight about embryological
development to examine early twentieth century embryo specimen collecting in Baltimore. Her
work reveals the “enormous amount of theoretical, methodological, technical and ideological
work” (Morgan 2009: 111) involved in transforming embryo and fetal remains into specimen
objects of scientific inquiry. In an illustrative example, Morgan describes the forces that shaped
how Carnegie embryo specimen #836, the model for Stage 13 of the Carnegie’s 23
developmental stages, came to be.22 She discusses laws, customs, and social inequalities in
Baltimore at the turn of the twentieth century that impacted pregnancy, abortion, and miscarriage
rates. Morgan analyzes cultural norms around mortuary practices and disposal of human remains
that clarified how embryologist Dr. Franklin Paine Mall was able to collect miscarried fetuses
without raising many eyebrows. In detail, she describes the laboratory techniques of fixing and
sectioning fetal remains for display and study. And though little could be learned about the
source of the specimen, her ethnographic detective work elicited evidence that linked the fetus
that became specimen #836 to Mrs. R., a married woman in her twenties from West Virginia
who had a hysterectomy in 1914. It was within her removed uterus that the fetus-turnedspecimen was found. These “hidden sources of production” of the #836 specimen illuminate
factors within and beyond the lab that were involved in transforming the dead fetus into a
scientific specimen. Morgan argues that Dr. Mall’s greatest achievement was shaking “the
embryo free of its social trappings and reconfiguring it as a naturalized biological specimen,
where it could eventually be re-presented as an icon of life” (2009: 197).
The case of Mrs. R echoes the story of another woman seeking medical treatment in
Baltimore whose biological tissues became one of the most important tools in twentieth century
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
22	
  See Carnegie’s Stage 13 embryo on the Virtual Human Embryo site:
https://www.ehd.org/virtual-human-embryo/intro.php?stage=13	
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biology. I am referring to Henrietta Lacks, a poor black tobacco farmer from Clover, Virginia
whose story journalist Rebecca Skloot uncovered sixty years after Lacks’s cancerous cervical
cells were removed during treatment at Johns Hopkins Hospital and used for experimentation
(Skloot 2009). Lacks died a couple of months after the procedure, but her cells were
immortalized as the first human cell line, which scientists called HeLa (Landecker 2000). HeLa
has served vitally in medical advances since the 1950s, such as testing and treating numerous
human diseases like polio. Lacks’s cells are also the basis of a multibillion-dollar industry in
biological tissue sales that have shipped the HeLa line around the globe and even into space.
Skloot’s study tells the untold story about the segregated medical wards in Baltimore where
Lacks received care; the subsequent experiments performed on Lacks’s husband and children
without their consent; and the countless other forces that made the unusual regenerativity of
Lacks’s cells the fount of late twentieth century biological research. The immortality of
Henrietta’s cells produced in vitro, like Mrs. R’s fetus, was a product of culturing forces within
the lab and beyond.
Thus, in response to the presumption that embryos like Mrs. R’s are found entities,
Hopwood and Morgan highlight the social, and often hidden, dimensions of embryo production.
Morgan and Hopwood also show how the labor entailed in producing embryos reflects the
“rational, empirical, laboratory-based vision of the material world” (Morgan 2009: 42) that
embryologists in each era hold. In this chapter, I explore how the same is true for frozen IVF
embryos at the turn of the twenty-first century: even when wearing the cloak of nature, they are
in fact quite cultured.
The application of IVF technology to human reproduction inspired late twentieth-century
embryologists to ask a new question about human development, namely: what makes a “good”
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embryo? As IVF became mainstreamed in the U.S. as a private market unregulated by state or
federal law, the fertility industry sought ways to improve “take home baby” rates for clients
(Spar 2006). Fertility research over the past thirty years reflects consistent interest in how to
identify a so-called good embryo that had “take home baby” potential. In 1986, a team of
Australian scientists proposed one of the first classificatory schemes for “predicting pregnancy”
by scoring embryo growth rates based on criteria visible through a microscope (Cummins, et al.
1986). From papers and discussions like this came standardized agreement about the stages of
embryological development—from zygote, cleavage, morula, to blastocyst—that are now
common to fertility professionals and patients. Such developmental categories are as
fundamental to making IVF embryos as the media, incubators, and embryologists that bring
these life forms materially to fruition.
Thirty years ago, the Australian team acknowledged the difficulty of sorting out which
embryos contain the most promise for pregnancy, a sentiment that remains true for embryologists
today: “In defining embryo ‘quality,’ it seems impossible at present to arrive at an objective
definition of a ‘good’ embryo, that is, one that will implant successfully and give rise to a
normal, healthy term infant” (Cummins, et al. 1986: 284). Nearly the same idea was echoed in a
2012 workshop on non-invasive embryo selection techniques at the American Society for
Reproductive Medicine (ASRM) annual conference. I attended this workshop with Ken at which
he received continuing education units to learn about the current science behind predictive
technologies for identifying the best embryos for achieving pregnancy. One presenter reported
that as many as 85% of IVF embryos transferred into uteruses do not establish pregnancy, a rate
that continues to inspire the search for better embryo selection methods. Despite the limitations
of current embryo grading systems, none of the new predictive technologies presented at the

61

ASRM workshop—ranging from genomic testing to video technology—were available for
clinical application. Upon return from the conference, I asked Dr. Frank of the Paloma clinic
about his perspective on these screening methods for embryos. Dr. Frank, a self-described
Christian man who regards embryos as valuable lives, considered the current screening
techniques imperfect. “We have not yet found the holy grail,” he stated, referring to the idea that
a godsend type of selection and transfer technique may be found one day. To this end,
embryologists continue to search for improved selection methods for identifying embryos with
pregnancy potential.
As I explore the making and grading of IVF embryos in this chapter, I draw attention to
how potential is stabilized as a “natural fact” of an embryo. IVF embryologists presuppose that
embryos contain potentiality. Paloma’s embryologists describe embryos as having inherent
capacities that “speak,” communicating to Ken and Zhao how the embryos should be graded and
revealing what their destinies may be: for a warm uterus, a cold freezer, or a dry waste bin. I
argue that examining the evaluative techniques within the IVF lab reveals instead that embryo
potential is compelled into existence through “culturing” practices. I explore how IVF lab
protocols, methods, and practices collaborate in the production of embryo potentiality,
specifically by analyzing the processes of grading in vitro embryos. Grading is a mechanism for
sorting out the embryos good enough for transfer into uteruses while others are slated for the
freezer or waste bin.

Harrington Fertility – The Paloma Office
California is home to 75 fertility clinics, which is the largest concentration in the United
States. Over a period of twenty-two months (June 2011 – April 2013), I gathered observational
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data and conducted formal and informal interviews within three California IVF clinics and
embryology labs: Sutter University IVF, Western Reproductive, and Harrington Fertility. The
bulk of my time was spent in the Paloma office of Harrington Fertility, the state’s largest fertility
clinic group representing nine locations around Southern California.23
Harrington Fertility began as a small “mom and pop” service in the late 1980s in
Southern California and has since grown to become one of California’s highest volume
providers. Ken and Zhao joined staff in the late 1980s and have been an integral force in
Harrington’s development in the competitive IVF market in California. Harrington Fertility
provides the lion’s share of fertility services in California. Of the 25,500 IVF cycles performed
across California in 2012, clinics ranged in performing 16 to 1737 cycles, for a state average of
331 cycles per clinic. Harrington, by comparison, completed 1500 IVF cycles.24 One reason
Harrington attracts a large number of patients is because it is one of the first clinic groups on the
West Coast to offer cutting-edge—and controversial—technologies like intracytoplasmic sperm
injection (ICSI), preimplantation genetic screening (PGS) for chromosomal screening and gender
selection, and egg freezing. Physicians wanting to offer these services to their patients rely on
skilled embryologists in the lab able and willing to learn the newest techniques. Zhao, for
example, traveled to Belgium in 2002 for a training course on ICSI technique and brought new
technical skills back to Harrington’s Paloma office. As a result, Harrington facilitated the first
pregnancy on the West Coast resulting from ICSI.

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
23
References to Harrington or Harrington Fertility signify the network of nine clinics dispersed
around Southern California sharing the same name. References to Paloma mean the one
Harrington clinic where I did field research.
24
Ken kept an unofficial, handwritten record of every cycle for keeping track of rates over time.
In 2007 and 2008, Paloma performed twice as many cycles a year than there were when I visited
in 2011 and 2012.
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The Paloma clinic is located on the second floor of an office building along a well
trafficked, palm-tree lined street in old town Paloma, a wealthy city near Los Angeles. Patients
enter from the elevator into a waiting room of muted earth tones, gold-rimmed mirrors, neatly
stacked magazines, and soft music on a constant loop. For initial consultation meetings, patients
meet with their respective physician in their private office along the north hallway. Each of
Paloma’s reproductive endocrinologists has a large, professionally designed and decorated
office. Behind Dr. Johnson’s large mahogany desk is mounted a large flat screen TV; all of Dr.
Lohl’s massive office furniture is made of gray granite; Dr. Frank’s office suggests ‘Captain’
with nautically themed furniture, a comfortable couch, and wall-sized aquarium; and Dr. Rupia’s
office, the only woman reproductive endocrinologist, is furnished modestly with pictures of her
sons and dog on her desk.
Procedure rooms with bright windows run along the south and west hallways with the
IVF lab positioned in between. To enter the lab, you need a special access card to unlock the
door, which brings you into a small entry room with a sticky pad on the floor and stacks of blue
booties for covering one’s shoes. In conjunction with a special air filtration system, these
measures help limit extraneous dust and debris from entering the lab. Across a hallway from the
entry room is Ken and Zhao’s bright office filled with a couple of computers, dozens of binders,
stacks of papers, and family photos. To the left of the entry way is a storage room with eight
cryopreservation tanks chained to the wall and wired with temperature monitoring devices. To
the right of the entry way is the windowless lab area furnished with varying types of microscopes
sitting atop lab benches, incubators stacked two high, and a couple of computers and phones.
Each area of the lab is designated for certain activity, from sperm analyses to PGD to
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cryopreservation. One small “hatch” door exists between the egg retrieval room and lab where
freshly retrieved eggs are passed to embryologists for processing.
Harrington supports a large patient load by keeping a full schedule of back-to-back
procedures most mornings. The Paloma clinic schedules egg retrievals (ER), embryo transfers
(ET), and egg freezings (EF) 15 to 30 minutes apart. Ken and Zhao arrive at 5 a.m. to prepare for
the morning’s procedures that begin at 7:30 a.m. and, on busy days, run through 11 a.m.
Harrington also maintains a robust staff of eleven reproductive endocrinologists, seven
embryologists, a dozen accounting specialists, and over thirty nurses and medical assistants; the
Paloma clinic supports four reproductive endocrinologists, two embryologists, a few accounting
specialists, and a dozen nurses and medical assistants as staff.
Zhao and Ken manage the daily goings on within Paloma’s lab. Both have decades of
experience building IVF labs from the ground up as well as establishing various systems,
routines, and protocols for maintaining Paloma’s clinic flow. Lab management involves various
tasks, such as topping up cryopreservation tanks with liquid nitrogen, managing supplies of
media and tools, and working at the microscope readying materials for grading, transfer, or
cryopreservation. Ken and Zhao form a collaborative team that has worked together for over
twenty years. They trade lead responsibilities in the lab so that neither takes the heaviest load and
both have alternating weekends off to spend time with their kids. For instance, on days that Zhao
does embryo fertility checks and ICSI procedures, Ken takes care of the nitrogen tanks, freezing,
embryo pictures on transfer days, and paperwork. They alternate attending professional
conferences each year, the largest being the American Society for Reproductive Medicine, where
they receive continuing education credit and gather information about current trends in embryo
selection and other lab technologies. The next section focuses on one kind of document made
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within IVF labs—embryology reports—to understand how grading practices are key to the
production of embryo potential.

Making the Grade: Culturing Potential through Grading Practices
“Right now, we don’t fully know what a healthy embryo in a Petri dish looks like.
Because of this, IVF clinics often insert multiple embryos into women to try to
increase the odds of a successful implantation. Patients frequently have multiple
births or devastating miscarriages. Half the time, the embryos don’t make it. If we
could figure out what a healthy embryo looked like and what the best media was
to grow it in, we’d cut down on that.”
- Christine Moto, Sutter University Stem Cell Institute Principal Investigator and
REDEEM Biobank Director
Ethnographers over the past decade have described the “pull of documents” (Riles 2006)
while in the field, a feeling that I too experienced. Fertility patients and clinicians, embryo
adoption staff and clients, tissue bank professionals, and research scientists all expressed interest
in one kind of document—the embryology report—in ways that attracted my curiosity too. As I
approached them as ethnographic objects, I wondered how these documents were produced,
noticed where they traveled, asked how they were interpreted, investigated what they were made
to do in disparate settings, and took note with what effects. Embryology reports, I learned, are
artifacts of the processes that produce embryo potentiality.
I began to understand embryology reports by exploring how others made sense of them.
A perusal of IVF patient blogs and fertility discussion boards elicits reference to what some
curiously call “baby’s first report card.” Consider these gleanings:
“Sometime during your embryo’s time in the lab, your embryos will get their first
report card. Seems like too much performance pressure already, doesn’t it? Pretty
soon, elite schools will probably be asking applicants for embryo reports.”
– Fertility Lab Insider, blog by an embryologist of 15 years,
http://fertilitylabinsider.com/2010/05/embryo-score-and-maternal-ag/

66

“We aren't even fully pregnant yet, and already we are getting report cards, yikes.
At least there is no major homework, yet.”
– Fertility patient, “Report Cards Never Looked So Good”
http://kristysnewnormal.blogspot.com/2010/09/report-cards-never-looked-sogood.html
“We have seven embryos total frozen, four of which are graded AA, one is AB,
and 2 are BB… It’s the valedictorian in me being hopeful that they would be all
straight As, A+s, top quality, but I think it’s perfect… We might have to frame
this [holds up a Post-it note with grading handwritten on it]. I feel like this is a
mini report card on my babies.”
– Jena, in a video blog at Someday Mama,
https://somedaymama.wordpress.com/2014/03/12/embies-report-card/
“It's their first report card of hopefully many in the future.”
– Fertility patient, http://malamako.blogspot.com/
Rarely are writers talking about the grades doled out to their school-aged children born through
IVF. Rather, “baby’s first report card” is a metaphor for an embryology report, a document that
tracks clinical evaluations ranking egg, sperm, and embryos within an IVF lab. What do these
two kinds of report cards—grades given to children by teachers in a school and clinical
assessments from an IVF embryologist—have in common? Exploring below the surface of the
analogy provides useful insights into the role grading practices and corresponding documents
play in the culturing of embryo potential. The following analysis illuminates the quiet grammars,
or how Bowker and Star describe classificatory systems (Bowker and Star 1999), which underlie
grading schemes in schools, factories, and IVF labs. Embryology reports themselves are artifacts
of processes that reveal how IVF embryos come to contain potential.

In Class or In Glass? Understanding Baby’s First Report Card
At first glance, “baby’s first report card” evokes new associations between normally
unaffiliated professionals, persons, and places, or what Max Black describes as an interactional
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process of similarity-making (cf. Stepan 1993). Fertility patients, for instance, are cast as
already-parents to IVF embryos that are perceived as children at the earliest stages of
development. Taking the metaphor further, embryologists—the report card authors—become
observant teachers who nurture and guide early pupils along their pathways of cellular
development. Further still within the analogy, embryology labs become akin to high-tech
classrooms where skilled evaluators assess the quality of an embryo’s performance according to
scales measuring quality.
When related through analogy, school and embryology reports reveal similar worries that
fertility patients and parents have about their offspring’s promise for future success. Just as
scholarship on the historical and cross-cultural making of embryos reveals them to be products of
myriad factors, potentiality too is not a naturally occurring quality awaiting discovery. Rather,
potential is something compelled into existence and stabilized as a seemingly natural fact that
children or embryos contain. These culturing processes invite further inquiry into how
classificatory schemes, grading systems, and documentary practices collaborate in the making of
potential.
Going deeper into the metaphor, I examine three key qualities the grading systems of
classrooms and embryology labs share: 1) grading systems are universally present, 2)
standardization is the goal of modern grading institutions, and 3) grades are used as tools for
predicting future potential.

Universal Presence of Grades in Classrooms and IVF Labs
In both classrooms and embryology labs, assessment scales are universally present. The
familiar A-F letter grades, 4.0 grade point average, and 100-point percentiles are institutionalized
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measures across the United States for ranking the performance of school children. Grading
systems are also ubiquitous within IVF labs. Every embryo produced by IVF in the U.S.
undergoes evaluation by embryologists. Even though all IVF embryos are made in the controlled
environment of an embryology lab, they vary widely in terms of how they develop, an insight
made possible by the advent of in vitro fertilization technology. Through IVF, scientists of
human embryology—a field dating back for millennia, to Aristotle—had the first opportunity to
observe and investigate variations within human development at its earliest moments.
Scholarship in the early years of IVF that brought to light the developmental variations among in
vitro embryos also made the first proposals of systems for sorting embryos out (e.g., Cummins,
et al. 1986). These proposals were among the first classification schemes for grading IVF
embryos.
Grading embryos through visual assessment of morphological characteristics has been in
practice since the inception of human IVF and remains the “gold standard” method across
contemporary IVF labs. In biology, morphology is the study of the form and structure of a plant
or animal without regard to function; it is the study of how organisms look. Embryo morphology
takes into account the structural aspects of human embryo development, such as cell symmetry,
cell clarity, and cell fragmentation. “Grading embryos is a beauty contest,” Ken explained,
echoing a sentiment shared by many colleagues. I became accustomed to hearing Ken describe
the embryos he observed through the microscope in ranking terms; some were regarded as
“beautiful” or “nice” and others as “cruddy” or “ugly.” Clear, symmetrical, un-fragmented
embryos received “slam dunk” grades while clumpy, dark, misshapen embryos got the lowest
marks. Whether in class or in glass, embryos and school children are similarly subject to
assessments that measure and rank their performance.
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Standardization as the Goal of Grading Institutions
Standardization marks a second point of overlap between school and embryo grading
systems. That a B+ in an American classroom means the same in another is the result of massive
historical efforts to standardize school grades. These efforts arose during the late nineteenth
century era of industrialization, a period driven by modernist principles of efficiency,
predictability, and control. Paralleling similar trends in commodity markets, the standardization
of school grades served as a key tool in scaling up and nationalizing the decentralized American
education system (Schneider and Hutt 2014), a process that allowed for bringing to market
uniformly assessed graduates ranked and ready for the labor force. The history of standardization
within American education provides fodder for critiques of assembly line classrooms and
conveyor belt criteria that sort children onto different educational tracks. “Special education” is
one such track that is often made possible by another set of standards emerging from the arena of
medicine, namely medical diagnostic categories of “learning disabled” (Ginsburg and Rapp
2013b).
Industrial era trends in standardization reveal how school children and crops were
similarly regarded as commodity stock of significant national worth in part because of their
perceived potential. School children and cereal crops were subject to standardized systems of
assessment at the turn of the twentieth-century, systems that helped leverage idiosyncratic, local
structures onto the national scale. For example, farmers and school administrators refashioned
their work in industrial terms. While farmers established quality control mechanisms to define
and rank good quality grain through standard measures of “plumpness,” school administrators
likened report cards to merchant ledgers in the ways both “emphasized the accumulation of
success over time and provided a running account of a student’s academic success” (‘The Credit
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System’ 1862). The factory effect on classrooms and farms at the turn of the 20th century parallel
what occurred with IVF embryos—a hybrid figure of potential child and commodity—at the turn
of the twenty-first century.
Contemporary IVF clinics have a different relationship with processes of standardization
than do American schools. Despite the fact that standards originated from the domains of science
and industry (Timmermans and Epstein 2010; Williams 1985), no uniform embryo grading
system exists within the U.S. fertility industry. Instead, contemporary IVF labs are more akin to
Civil War era schools where grades were universally present but scoring systems varied
significantly across locales. According to Dr. Dunn, Director of Sutter University’s IVF clinic,
there is growing agreement across fertility clinics around the goal of establishing a standardized
grading system. Dr. Dunn’s perspective on the current state of embryo grading echoes the desires
of late nineteenth century education reformers who saw standardization as a way to create a
modern system for a modern world. She argues: “The development of a universally accepted,
accurate, noninvasive, easy, simple, and quick grading system to select the best possible embryo
with maximum implantation potential is one of the greatest challenges in in vitro today.” As
discussed in Chapter 5, the current non-standardization of embryo grading leaves embryology
reports open for interpretation within REDEEM Biobank and the Blossom program.25
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How might such a universally accepted standard arise within IVF? In order to preempt
regulation by federal or state policy, the U.S. fertility industry may institute standards, like
embryo grading protocol across clinics, to function as soft forms of regulation (cf. Brunsson and
Jacobsson 2000). Alternatively, if IVF shifts from a private, boutique-like clinical service to
become accessible to broader populations (e.g. through classification as a disease or covered by
health insurance), labs may feel pressure to scale up and standardize grading much like late
nineteenth century schools did. Another possible pressure point toward standardization may
occur if leftover embryos become ever more mobile in their afterlives—like nineteenth century
Americans did during periods of mass migration—and more embryo redemption programs are
created.
	
  
71

Grades as Predictive Tools of Potential
A third similarity between the grading systems within schools and embryology labs is the
predictive purpose each system serves. Both school grades and embryo ranking systems
document developmental achievements and failures, which are used as tools for predicting future
potential. Since the era of frontier schoolhouses through America’s test-driven classroom today,
scholastic rankings play a role in student transitions from the schoolyard into the workplace.
According to one observer of the early twentieth century American educational system, records
of academic activities have bearing on a pupil’s future, a point that remains salient within today’s
educational system:
They are accepted as real and fairly exact measurements of ability or of performance.
Moreover, they not infrequently are determiners of the student’s career. They constitute
the primary basis for election to honorary societies, for the award of various academic
honors, for advancement from class to class, for graduation, and may even determine in
some measure the student’s career after leaving the institution in which they have been
assigned (Finkelstein 1913: 6).
In some ways, universities and employers look to grades and other standardized markers of
achievement as indices of future success.
Similarly, embryology reports are also interpreted for insight about the future potential of
offspring. Ken explained that “the goal” of embryo grading “is the same across fertility clinics:
to identify the best embryo for achieving pregnancy.” Embryos are evaluated multiple times over
the in vitro period of 1-6 days. Embryo assessments are read as forecasts to inform clinical
decisions about which (and how many) embryos to transfer for pregnancy, save for future use, or
discard as nonviable medical waste. For instance, Harrington’s informed consent for IVF
explains how assessments of embryo development in the lab “help distinguish embryos with
more potential from those with less or none.” Even though morphology remains the standard
method for selecting embryos, many regard its predictive capacity as rough and imperfect.
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Morphological assessment is the best method IVF clinics have currently, though it has
many shortcomings. For starters, morphology tells you visual information only. With the advent
of preimplantation genetic screening and diagnostic technologies, embryologists discovered that
morphologically “beautiful” embryos are sometimes genetically abnormal, meaning they are
chromosomally incompatible with development or indicative of disabilities. Almost every
embryologist has a story about transferring “perfect” embryos that did not establish pregnancy
while “ugly” ones “with no business being put back” do. Such stories suggest that there are
factors beyond embryo morphology that are not being measured and impact pregnancy chances,
like genetics, uterine health, or environmental factors.
Patients in the process of signing Harrington’s informed consent for assisted reproduction
are notified about the challenge of predicting embryo outcomes through morphological
assessment. Harrington’s thirty-page consent form states:
It is important to note that since many eggs and embryos are abnormal, it is expected that
not all eggs will fertilize and not all embryos will divide at a normal rate. The chance that
a developing embryo will produce a pregnancy is related to whether its development in
the lab is normal, but this correlation is not perfect. This means that not all embryos
developing at the normal rate are in fact also genetically normal, and not all poorly
developing embryos are genetically abnormal. Nonetheless, their visual appearance is the
most common and useful guide in the selection of the best embryo(s) for transfer.
Also, embryologists are the first to admit that embryo grading is a subjective process. Neither
Ken nor Zhao was ever formally trained in embryo grading, and Ken acknowledged that they
each score embryos differently but consistently, e.g., what is a 4 for Ken is often a 3 for Zhao.
Studies examining intra- and inter-observer variability among embryologists confirm the
subjective dimension of grading by finding both to be factors within embryo assessments (Baxter
Bendus, et al. 2006).
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Although the scientific search for better embryo selection methods continues, selecting
embryos for transfer is considered “a large part of the art of assisted reproductive technologies”
(Behr and Hedge 2012: 398). Fertility professionals hoped to identify more effective ways to
predict which embryos will likely establish pregnancy in order to reach the industry goal of
reducing multiples pregnancies toward a safer gestation rate of one baby at a time (American
Society for Reproductive Medicine 2012). Report cards and embryology reports both
communicate to (would be) parents how their (hoped for) children are measuring up and any
developmental struggles they face, which provide forecasts about the future (e.g., for establishing
pregnancy, scholastic performance, or as laborers in the workplace). Grade reports show
materially how potential is cultivated through recordings of past performance that are interpreted
to predict future outcomes.

How Grading Systems Culture Potential
“Baby’s first report card” is a quaint metaphor shared casually among fertility patients
and staff, in part to clarify the unfamiliar grading embryos undergo through a common analogy
to school. When analyzed more closely, the metaphor evokes associations between classrooms
and IVF labs that clarify what grading systems do. In schools and IVF labs, grading is a process
of defining, classifying, and evaluating something’s “quality.” Grading establishes comparative
categories for ranking on scales that range from higher to lower quality, which are processes
integral to the production of potential. Also, grade reports and associated documents track
evaluations systematically over time; through certain interpretive lenses, past rankings structure
how future outcomes are forecasted. Within IVF clinics, grading is a key practice through which
an embryo’s potential is compelled into existence through “culturing” apparatuses within the lab.
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Although embryo rankings are not standardized across U.S. clinics as grades are in
classrooms, grading practices serve as structuring logics or grammars (Tyack and Cuban 1995)
within classrooms and IVF labs. Bowker and Star’s (1999) study of classificatory systems
suggests that such logics and grammars often sink quietly into the taken for granted space of
infrastructure that props up everyday life. The exploration into the metaphor of “baby’s first
report card” highlights the grammar of potentiality within IVF labs as a quality that embryos are
assumed or hoped to contain. Though often in the background, culturing mechanisms of
classification, grading, and documentation are not without political or ethical import, a point
salient to the overall goal of this dissertation.

Document in the Making: Materializing Potential in Embryology Reports
Sociologist Carol Heimer argues that the bureaucratic existence of contemporary
American embryos and fetuses begins well before birth. She attributes this to documentary
practices during prenatal visits that bring fetuses to life via records, such as ultrasounds, skeletal
measurements, birth date prognoses, and genetic screenings (Heimer 2006: 100). The
bureaucratic existence of some contemporary American embryos begins even earlier.
Embryology reports give birth, so to speak, to IVF embryos as objects of bureaucratic knowledge
from the first moments of fertilization. Also, embryology reports materialize in documentary
form the process by which embryos are graded—a culturing process through which their
potentiality is generated and naturalized.
Most fertility practices in the U.S. maintain a medical file for each patient that documents
her journey to and through IVF, a file that typically includes an embryology report. Embryology
reports are forms unique to each fertility clinic on which IVF laboratory activities are recorded,
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from oocyte retrieval to embryo evaluations to uterine transfer decisions. An explicit function of
an embryology report is to track clinical evaluations that are used to inform which embryos to
transfer into a uterus, which to save for future use, and which to discard. Another role of
embryology reports is to travel beyond the bounds of the fertility clinic of origin when
accompanying frozen embryos into their afterlives within tissue banks, embryo adoption
programs, stem cell labs, and long-term storage facilities.
Despite the fact that many ethnographers have taken Bruno Latour to task for his once
dismissing documents as “the most despised of all ethnographic subjects” (Latour 1988: 54), the
ethnographic record shows little interest in embryology reports. This comes as a surprise given
the sustained ethnographic attention to reproductive technologies over the past four decades
(Franklin 1997; Inhorn 2003; Ivry 2010; Kahn 2000; Strathern 1992; Thompson 2014) in
conjunction with the ubiquity of embryology reports within IVF clinics. The following analysis
provides a close reading of Susan and Chris Heller’s embryology report from Paloma’s
embryology lab. Detailing one couple’s IVF cycle over one week reveals the way incremental
grading practices recorded over time materialize as an embryology report. Ken’s jottings formed
a report that I argue contributes to and illuminates the process of making things come into being
(Frohmann 2008), and specifically embryos with potential. I approach the Heller embryology
report as a clinical artifact of how potential is cultured in IVF labs.
In the following discussion, I show how IVF embryos become objects of and through
documentary practices, suggesting they and their potential are cultured in Petri dishes as much as
in the classificatory and grading records kept by embryologists. I also discuss the multiple ways
embryology reports are “documents in the making” (Miyazaki 2006: 220), or in the process of
becoming. Finally, I suggest that embryology reports imbricate the present and future by
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“stretching the present,” as Miyakazi puts it, into an open-ended, unresolved tomorrow.
Embryology reports—the artifacts of grading practices and documentary efforts—show how
potentiality is produced in IVF labs. Or as Derrida once said, “Archivization produces as much
as it records the event” (Derrida 1996: 17). Embryology reports are undeniably potent documents
that, like frozen embryos, are good to think about and good to think.

Heller Embryology Report: Harrington Fertility - Paloma, October 2011, IVF Cycle #2
“Embryo development in the lab helps distinguish embryos with more potential
from those with less or none.”
- Harrington Fertility Informed Consent for Assisted Reproduction, page 7
Harrington’s embryology report is a two-page form that is filled in progressively by lab
embryologists over the course of an IVF cycle. Susan Heller, a 42-year-old patient at the Paloma
clinic, began her second IVF cycle on the first day of October in 2011. At the top of the
embryology report, Ken handwrote Susan’s full name, her partner Chris’s name, and her date of
birth, social security number, and age. Susan’s fertility history was summarized by her “GPAE,”
an acronym that stands for Gravida (number of pregnancies), Para (number of live births),
Abortus (spontaneous abortion/miscarriage), and Elective abortions. She had four pregnancies,
three miscarriages, and one live birth. The cause of her infertility was also noted: secondary
infertility, recurrent HAB (habitual abortion, or miscarriage). Additionally, some details from the
ovarian stimulation regimens began weeks prior to egg retrieval were transferred to the
embryology report by Susan’s IVF nurse, including: the thirteen maturing follicles observed by
Susan’s physician via ultrasound before her scheduled retrieval, the note that she was prescribed
a follicle stimulating HMG drug (e.g., Follistim), and the date and time she took the “trigger”
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shot of hCG hormone thirty-five hours before the retrieval to help her eggs reach maturity (See
Figure 3).
Evaluations about Susan’s oocytes began halfway down the page. The retrieval procedure
began at 8:50 a.m. the morning of October 11, 2011, ten days after beginning the cycle, and was
completed ten minutes later. She received conscious sedation (SED) versus general anesthesia
(GA) and the names of the anesthetist, physician, and nurse who were in the room with her when
she went under are recorded. She showed no signs of premature ovarian failure (POF) during the
transvaginal oocyte aspiration procedure—a technique involving a long needle inserted through
the vaginal wall into the ovaries guided by ultrasound. Eleven eggs were collected from Susan’s
ovaries.
After follicle fluid was suctioned by needle from Susan’s ovaries, vials containing the
cloudy pink fluid were passed through a “hatch” in the wall from the procedure room to the
embryology lab. Ken was ready on the other side to locate and count the retrieved oocytes. He
poured the contents of each vial into a Petri dish, swirled it around with his hand, and peered into
the microscope. When he found an oocyte, he used a glass pipette to move it to a dish with an
enzyme that would help “clean” the oocyte in preparation for IVF. On the embryology report, he
noted that eleven eggs were collected and the type of culture media used for the collection (HTF
Hepes and HSA).26 Ken numbered and evaluated each of Susan’s eleven oocytes based on
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Culture media for embryo growth has a long history that began in 1912 with observations
about the in vitro media to culture a rabbit embryo. By the mid-1980s, specialized media were
developed for human IVF. In 1985, Quinn et al. published a media formula that mimics human
tubal fluid (HTP), or the in vivo environment a mature egg or fertilized embryo is exposed to. In
conjunction with the proposal by Menezo et al. in 1984 to add protein (HSA, human serum
albumin) to culture media to help prevent sticking of eggs and gametes to pipettes and dishes,
most IVF handling media today are based on Quinn’s formula and contain some percentage of
protein.
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Figure 3. Sample embryology report (front)27
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Photo by author.
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maturity, which is an indication of their preparation for fertilization: ten eggs were graded fully
mature (MII), one as partially mature (MI), and none as immature (GV).28
Next to the egg retrieval section on the embryology report was an area for sperm analysis
results. Susan’s partner, Chris (indicated by the circled “H” on the form for husband), donated
fresh sperm for this IVF cycle. Ken documented two evaluations of Chris’s sperm before and
after the sample was “washed.” Similar to cleaning the oocytes of extraneous follicular tissue,
washing sperm was the process of preparation to enhance fertilizing capacity by separating
sperm from seminal fluid. Ken records Chris’s sperm sample volume (MLs), concentration
(#x10^6/MLs), motility (%), and progression (1-4). In both sections, Ken noted the specific
media used to nourish the egg and sperm while in vitro, including the protein content of each
media and their lot numbers.
The bottom half of the report summarized the series of embryo assessments over an IVF
cycle. The corresponding grid on the backside of the report tracked Ken’s evaluations over the
six-day fertilization period. These portions of the embryology report accounted for how twelve
eggs removed from Susan’s ovaries became four viable embryos: two transferred into her uterus
and two frozen for future use. They also translated a sequence of laboratory moments, each an
instance of hopeful anticipation, that together crafted a “narrative” (Davis 1987) justifying each
egg’s potentiality toward womb, waste bin, or freezer. These records show how grading systems
make visible the work of classifying systems around embryos, which I suggest are central to the
culturing of potentiality.
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
28
GV means “germinal vesicle,” or an egg that has not undergone the process of meiosis and is
considered immature. MI, or metaphase I, describes the first phase of meiosis. MI oocytes are
not yet completely mature but may mature while in vitro. MII, or metaphase II, oocytes are in the
second phase of meiosis and considered fully mature and ready for fertilization.
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Paloma offers patients two methods for fertilization: conventional IVF (CONV) or intracytoplasmic sperm injection (ICSI). Sandra’s eleven eggs were fertilized using ICSI, which
involved the microinjection of a single sperm into each egg. Some clinics use ICSI only in cases
of severe male factor infertility, some use it routinely on every case, and most fall somewhere in
the middle. Ken performed the ICSI procedure on all eleven eggs at 11:30 a.m. and noted the
type of media used to support insemination.
At 8:20 a.m. the next morning, Ken did a “fert check” to determine which eggs fertilized
overnight. On Day 1, embryologists look for certain characteristics to signify successful
fertilization, which are the presence of two pronuclei (pn) and two polar bodies (pb). “Normal
development is evident by the still single cell having two nuclei,” stated Harrington’s informed
consent document. “This stage is called a zygote.” Ken noted in the First Evaluation column that
nine of Susan’s ten mature eggs fertilized successfully; all of the MIIs had two polar bodies, all
showed two pronuclei, and one showed only one pronucleus.29 Ken called these results a “good
fert.”
The embryos remained in a gas and temperature controlled incubator for the next two
days before Ken reviewed them again under a microscope. For the Day 3 assessment, Ken’s
observations shifted to embryo “stage,” “type,” and “decision.” Stage described how many cells
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The presence of only one pronucleus on Day 1 generally indicates genetic abnormality, often
meaning the egg has been activated but that there is no genetic contribution from the sperm.
Susan and Chris’s embryo with one pronucleus developed typically until the third day, which is
how long the egg genome drives development, after which it arrested and was discarded. The
observation on Day 1 of there only being one pronucleus negated the high score it received on
Day 3 with 8 cells and a highest ranking morphological score of 3. Also, the MI egg that did not
fertilize did not receive marks in the first evaluation column, indicating the end of its IVF
trajectory. This outcome was expected. MI eggs fertilized through conventional IVF processes of
coincubation have the chance to mature in the Petri dish, with ICSI, unless eggs are fully mature
MIIs at the time of the procedure, they will not fertilize. Like all other materials over the IVF
cycle, the unfertilized egg was left in the dish where it would perish on its own.
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each embryo contained (e.g., 5C means five cells). Type is the morphological quality of an
embryo. Paloma ranked embryo Type on a scale of 0-3 with 3 denoting the most “beautiful”
morphology of symmetrical, clear, and unfragmented cells; scores dropped incrementally as cells
showed increasing signs of unevenness, darkening, and fragmentation. By Day 3, Sandra and
Chris’s ten embryos ranged from 4-8 cells, and all but one embryo received the highest score of
3.
Today within many IVF clinics, it is customary to “grow out,” or incubate, embryos for
another 48-72 hours after the Day 3 observation. When Ken first started his career in embryology
in 1985, each lab mixed their own culture media and embryo transfers happened on Day 1 to
limit the embryo exposure to media: “Back then, media was harsh on them.” Media became
commercially available in the mid-1980s and increasingly less harsh, which allowed embryos to
grow in vitro longer. These developments extended the time between retrieval and transfer: by
1990, Day 3 transfers were standard in fertility clinics, and by 1998, Day 5 was the norm.
Embryologists have come to expect a fifty percent attrition rate of embryos during the in vitro
period between Day 3 and 5. Even though half of embryos fail to make it to Day 5, the benefit of
growing embryos in vitro for another 48 hours, according to Ken, was to “let embryos select
themselves.” Depending on the case and physician, Ken often suggested letting embryos
incubate longer: “You don’t know their potential until you get to Day 5.” Once he decided that
Susan and Chris’s embryos looked good enough to grow to Day 5, Ken “flipped” the media to
prepare their nine embryos for another two days of incubation toward blastocyst stage.
Blastocysts at Paloma are graded according to the Gardner scale (Gardner, et al. 2000),
the most commonly used rubric for evaluating embryos that have reached this developmental
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stage.30 The Gardner scale is based on an alphanumeric scoring of three elements: degree of
expansion of the embryo’s cavity (1-6), inner cell mass development (A-C), and trophectoderm
development (A-C) (see Fig. 3). The best score a blastocyst can receive on the Gardner scale is
4AA. “Like in school,” Harrington’s other embryologist Zhao reminded me, “As are better than
Bs and Cs.” (See Figure 4)
Five days after Susan’s egg retrieval on the morning of October 16th, Ken peered into the
microscope to find four promising blastocysts, which he graded as 4AA, 4AB, 3AA, and 3BB.
He also noted in the Decision column that four other embryos slowed deleteriously in their
development. Their “no progress” designation sealed their fate for discard as medical waste. The
remaining embryo fell somewhere in between; it had reached the very earliest stage of blastocyst
development (Grade 1), so Ken held it in vitro one extra day to see if it would catch up
developmentally to meet the lab’s criteria for freezing (minimum Grade 3BB). When it showed
to be only Grade 2 on Day 6, Ken marked the report as “no progress” and it was slated for
discard.
The range of differences among Susan and Chris’s embryos five days after fertilization
was expected, which Harrington’s informed consent for IVF explained: “Since many eggs and
embryos are abnormal, it is expected that not all eggs will fertilize and not all embryos will
divide at a normal rate.” Ken explained the reason for the variation as an outcome of embryo

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
30	
  David K. Gardner, lead author of the journal article that published the Gardner scale, is a
world-renowned Australian embryologist who trained in the UK and served as Director of the
Colorado Center for Reproductive Medicine for ten years. Gardner is best known for his
innovations in optimizing cell culture media; one of his most famous contributions to embryo
research and IVF was providing cell culture media to James Thomson’s team at the University of
Wisconsin for use in isolating the first human embryonic stem cell line in 1998. Gardner’s
professional impacts within IVF and human embryonic stem cell research highlights the strong
interface between the two fields (Franklin 2006b). 	
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Figure 4. Gardner scale31

self-selection: “The embryos are telling me which ones are good.” Claims like this separating the
observer from the observed are common among producers of scientific documents like Ken.
Similar to other scientists adhering to ideas of objectivity, Ken described his work with embryos
as engaging with autonomous entities that he considered independent from his labors and the
“culturing” work through which they are produced (Hoag 2011). While IVF embryologists
readily agree to be makers of embryos, protocols, documents, and babies, they do not consider
themselves as participants in the production of embryo potential. By contrast, I do.
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
31
Original scale published in Fertility and Sterility (See Gardner, et al. 2000).
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At the end of the six-day in vitro period, Ken reviewed the embryology report to form a
recommendation based on which embryos, made and graded in his lab, contained the most
promise for pregnancy, which contained enough potential to freeze for the future, and which
contained too little for destiny other than discard. Patients are prepared for the IVF lab results
based on description in the informed consent paperwork where two classes for developing
embryos are described: the “best-looking” and the “second-best.” The document explains that
“after a few days of development, the best appearing embryos are selected for transfer to the
uterine cavity” while “excess embryos of sufficient quality that are not transferred can be
frozen.”
Ken met with Susan, Chris, and their physician that morning to share his interpretation,
from which they developed a plan that he charted on the grid: transfer two Grade 4 blastocysts
into Susan’s uterus and freeze two Grade 3 embryos for future use. Although Ken describes his
job as listening passively to what each embryo says about how good it is based on its past
progression from fertilization to blastocyst, his interpretation of an embryo’s future potential for
implantation—like all of the lab activities under his management—is active, productive, and
generative. Ken, like all IVF embryologists culturing life in vitro, is unavoidably in the business
of cultivating knowledge about their potential.
The bottom section of the embryology report summarized the processes of embryo
transfer and cryopreservation. At 10 a.m., the phone rang in the lab alerting Ken that Susan was
ready for the embryo transfer procedure. He quickly and carefully suctioned the two chosen
(ICSI) blastocysts into a catheter (Wallace type) and walked it down the hallway from the lab to
the transfer room. There, Susan was waiting on the exam table in stirrups with Chris holding her
hand. Ken handed the catheter to the physician, who inserted the instrument into her uterus on
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the first try and, while all watched the ultrasound screen, released fluid high into her uterine
cavity. Ken quietly left the room to check the contents of the catheter to make sure no embryos
were stuck inside, and called moments later with news that all was clear. Susan’s physician
visited the lab after the procedure to relay that that she showed no signs of bleeding or cramping
during the transfer, details that Ken noted on the report.
An hour after Susan’s transfer, Ken prepared the two remaining blastocysts for
cryopreservation (See Figure 5). Since 2008, all embryos at Paloma have been frozen using
vitrification, a quick freezing method with higher survival rates after thaw. Over the course of
the ten-minute procedure, Ken transferred the two blastocysts between drops of increasingly
potent cryoprotectant media to acclimatize them. Once the embryos were equilibrated in the full
strength media, Ken had ninety seconds to transfer them into straws, seal both ends, and
submerge the straw in liquid nitrogen. As he dropped the straw in to a Styrofoam cup sitting on
his desk, he turned to me and said: “Instantly frozen.”
The embryos were vitrified in one straw identifiable by a green plug assigned an
accession number 30-02 and a sticker with Susan’s social security number and date of birth was
attached to it. The frozen straw was inserted into a numbered cane that Ken stored in Canister 2
of Tank 5, a randomly selected location in one of Harrington’s cryopreservation tanks. That midOctober morning, while Susan and Chris’s hopes were suspended in expectation of news about
their second IVF attempt, two embryos were suspended in liquid nitrogen, along with hundreds
of other IVF remainders, for possible future use.
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Figure 5. Sample embryology report (back)32
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Photo by author.
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Conclusion
This chapter focused on the IVF clinic as a place where the work of embryologists
reveals what else is made in the process of making babies through IVF. I argued that the IVF lab
is a setting where embryos as well as documents, protocols, chances, and potentials are produced
through the bench top and desktop activities of embryologists.
Also, I explored the metaphor of baby’s first report card to distill how grading practices
culture potentiality by tracking the past as a means to predict the future. Whether the graded
entity is a child, a load of wheat, or an IVF embryo, grading mobilizes classificatory systems that
define quality based on past evaluation and produce possibility in the present that manifests itself
differently according to potential future outcomes. I showed the similar way that classroom and
laboratory grading systems emerged from historically rooted but arbitrary classifications that
were aligned for modern system-building. Grading embryos is compulsory practice in IVF labs
today; while non-standard and far from perfectly predictive, grading produces embryology
reports laden with authority about the “goodness” of IVF embryos that informs their clinical
value.
Lastly, I analyzed Susan and Chris’s embryology report to illustrate how embryos,
embryology reports, and potential are generated in IVF labs. First, I showed the ways Ken’s
record-keeping practices bring to documentary life embryos as objects of bureaucratic
knowledge from the first moments of fertilization. Second, I traced how embryology reports
function as “documents in the making” (Miyazaki 2006) that emerge over time through multiple
grading processes. These two-dimensional reports capture dynamic processes at the intersection
of systems of meaning and material practices that I argue produce the notion of embryo potential.
Third, I showed that potentiality is presumed by IVF embryologists to be something embryos
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contain intrinsically. By contrast, I argued that potentiality is made, not found, through culturing
techniques of tracking, compiling into a report, and interpreting by expert eyes. In sum, I came to
understand embryology reports as documentary artifacts that make visible how potentiality is
brought into existence within the IVF lab.
In the ways that many documents are “about or oriented toward some other entity,
structure, or patch of the world” (Smith 1996: 13), embryology reports prove to be distinctly
oriented to the idea of the future. Temporality is a critical variable for understanding how IVF
labs make embryos and produce their potential. Although all of the areas of Susan and Chris’s
embryology report were filled in, the perceived completeness of an embryology report is also a
product of IVF laboratory labor. Signatures and dates index its authority and solidity. Instead,
embryology reports remain open-ended and partial. They stretch time from the past to an
indefinite future, which sustains an anticipatory quality to the report. Answers to curiosities
about what comes next remain off the page, prefigured in the grid, and something only time may
tell.
To examine further the idea about the future orientation of embryology reports, let us
revisit Susan and Chris’s story by reading off the page about what happened after their IVF
cycle. Within IVF clinics, potentiality pools into three categories based on the goal of the clinic
to “make babies”; embryos are classified as transferable, savable, or discardable. Transferable
embryos are judged to be the most promising for producing a pregnancy, and thus are transferred
fresh into a uterus for their chance to do what they were made to do: make babies. Of Susan and
Chris’s five blastocysts on Day 5, the highest graded two were transferred into her uterus.
Twelve days later when they returned to Paloma for a pregnancy test, they learned it was
positive.
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Discardable embryos are thought to contain the least promise because they fail to meet
the minimum laboratory standards for transfer. The one blastocyst left to grow another day was
given a chance to meet the minimum laboratory criteria for saving, but was fated for discard in
the medical waste bin when it failed to develop further. As a result of Paloma’s specific
cryopreservation protocol, the potential perceived within the discarded embryo on Day 5
disappeared by new observations that Ken made on Day 6. Throwaway embryos reveal the
precariousness of potential in an IVF lab and how quickly it can dissolve.
The middle category is the one of interest in this dissertation: the savable embryos that
are passed over today but banked for tomorrow. Susan and Chris had two savable embryos slated
for cryopreservation. These embryos were good enough to preserve for potential future use but
not good enough for being “put back” yet. The promise of embryos like these is frozen in time,
suspended between desirability for transfer and undesirability of discard. Their potential hangs in
anticipation of what purpose they may be thawed for and what outcome they may produce. The
unsettled zone within which frozen embryos categorically exist mirrors their cellular suspension
in liquid nitrogen where they are paused developmentally and await future use.
My approach to “culturing” in this chapter focused closely on the techniques and
documents within the IVF lab in producing embryo potentiality, though, as I mentioned above,
forces beyond the lab also undergird and constitute the potentials cultivated within it.
Acknowledging factors beyond the apparent laboratory productions of potential is important
because, as Lynn Morgan argues, “potentiality as an analytic object cannot be isolated from the
political and economic contexts in which it is catalyzed” (Morgan 2013: S22). For example, my
discussion of the standardization of grading school children and wheat in American history
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highlights parallel standards and techniques that inform how Ken and Zhao approach their task
of “making babies” via IVF.
To conclude, I examine facets of Susan and Chris’s story that also conditioned the
circumstances of their experience with IVF and the potentials of their resulting embryos. As IVF
patients in the United States, the Hellers represent an elite group with ample resources to afford
the financial, emotional, and physical costs of fertility treatment. Unequal access to fertility
treatment and disparate exposure to risk factors directly inform which babies are likely to be
“made” through IVF, and which people’s reproductive potentialities remain underserved by
assistive technologies or neglected entirely. In the U.S., ethno-racial categories, class statuses,
and sexual and gender identities function as societal “grading” mechanisms that stratify
reproductive potential such that couples like the Hellers have access to IVF while many others
do not.
In the 1980s, the United States witnessed a heightened pro-natalism in response to an
increased presence of white women in career-track jobs and a falling birth rate among the same
population. “Practically overnight,” legal scholar Dorothy Roberts observed, “the media created
an infertility epidemic plaguing middle-class America” (1997: 269). Within the United States,
assisted reproductive technologies are consumed by a limited population, which is typically
white, heterosexual, and of higher socioeconomic status. This group is not the only one affected
by infertility, nor the group most often affected. Roberts argues that “the profile of people most
likely to use IVF is precisely the opposite of those most likely to be infertile… poor, Black, and
poorly educated” (Roberts 2007a: 252-253). She cites a range of causes, including untreated
sexually transmitted diseases, nutritional deficiencies, previous complications with birth or
abortion, and exposures to environmental and workplace toxins. Roberts also highlights the
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economic barriers and professional manipulations that “steer” black women away from
reproductive technologies, which are reinforced by media hyped anxieties about the underproduction of white babies (1997: 253-256).
Insurance coverage is another factor limiting access to infertility therapies for wider
populations. Most states and insurance programs do not cover infertility costs in private or public
plans, and when they do, coverage is often restricted through requirements of marriage or
fertilization with the “husband’s” sperm. Hetero-centric definitions of infertility as being unable
to conceive after a set period of unprotected sexual intercourse excludes single, lesbian, gay, and
transgender people from coverage (Arons 2007). These examples illustrate anthropologist Gay
Becker’s observation that “who uses these [reproductive] technologies is not simply a function of
who wants to use them but also of whom society permits to use them” (2000: 20). Disparities
between infertility users and those excluded shed light on yet another circumstance of stratified
reproduction, or “the hierarchical organization of reproductive health, fecundity, birth
experiences and child rearing that supports and rewards the maternity of some women, while
despising or outlawing the mother-work of others” (Rapp 2001: 469).
Culturing forces beyond the Paloma clinic raise questions about how the business of
making babies might look if clinical priorities shifted from improving techniques for identifying
“good” embryos to identifying and mitigating the causes of infertility; improving methods to
limit exhausting trial-and-error cycles that IVF patients commonly endure; or increasing access
to and affordability of fertility treatments. If “making babies thrive” became our collective task,
how might our educational systems, farming practices, health care system, and housing policies
change? Such topics may seem tangential to the making of potential in an IVF lab, but in my
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view, are fibers of the sticky threads that weave the conditions making it possible for Ken,
Susan, and Chris to team up in turning the Hellers into a family.
--The three categorical options for Susan and Chris’s embryos—transferable, savable,
discardable—represent a scale of value created by IVF clinics and archived in embryology
reports to achieve what embryologists set out to do: make babies. The next two chapters explore
how the goals of the REDEEM Biobank and Blossom Embryo Adoption program participate in
transforming the potential of leftover IVF embryos for new possibilities. These programs convert
the unwanted but un-wastable remainders using different saving techniques, for each strives in
their respective way to harness the promise of the future.
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CHAPTER 3
Wasting: Making Trash and Treasure in a Stem Cell Institute
Paulo, the friendly manager of the research lab neighboring Dr. Christine Moto’s in the
Sutter University Stem Cell Institute, and I took a shortcut one morning to walk along a verdant
path from the train station en route to campus. On the outskirts of Sutter University where plants
grow in a tangle, Paulo directed my attention to a man in the bushes with a shopping cart of
items. Paulo took interest in this man after noticing one of his daily tasks: he collects cigarette
butts strewn on the ground, removes the unsmoked tobacco remains, and rolls new cigarettes for
trade or sale. As Paulo and I wended our way toward the paved university pathways flanked by
manicured flowerbeds and grassy lawns, we discussed the man’s resourcefulness in connection
to the documentary Redemption we both heard reviewed on the radio the day before. Neither of
us had seen the film about the bottle and can collectors of New York, but we reflected on the
lives of people like this cigarette collector whose “treasures,” according to the filmmaker, “are in
the trash.” We parted ways upon arriving at the prominent steel and glass Stem Cell Institute,
each to work alongside scientists who, I came to learn, also consider themselves recyclers of
societal refuse; whose daily efforts repurposing cellular remnants may generate life-saving
medicines, therapies, and knowledge. Over the course of the 2012-2013 school year that I joined
Dr. Moto’s lab and shadowed researchers and staff affiliated with the REDEEM Biobank based
within it, I thought often about the cigarette collector toiling just beyond the front door, living in
the literal and figurative fringes. I wondered which of the lives talked about in Sutter University
research labs are considered worth saving and which, like many refuse pickers of the world,
become synonymous with the wastes they gather (Gidwani 2008).
---
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Dr. Christine Moto leads a research laboratory in the largest stem cell building in the
world. As a principal investigator in Sutter University’s Stem Cell Institute, Dr. Moto’s lab is
comprised of thirty graduate and postgraduate scientists from across the world. She has received
over $28 million dollars in grants and an endowed professorship at Sutter University to support
her lab’s investigations in human fertility and degenerative diseases. She was recognized
nationally as one of the nation’s twenty most influential women in 2006 and acknowledged by
Time magazine for developing one of the top ten biomedical breakthroughs of 2010.
Dr. Moto’s research makes headlines around the globe, in response to which she has
become accustomed to answering questions about the ethical nature of her work with human
embryos. In an interview with the New York Times in 2008, Dr. Moto explained her experience
experimenting with human embryos:
There are people who believe that when we use embryos for research at all, our
society becomes hardened. I’ve searched myself on that and I don’t think I’m
hardened. I can honestly say I still get goose bumps when I see embryos develop.
You hope you are humble enough to take in the information and not change your
course. If there was truly a substitute that was better for understanding human
development than embryo research, that is what I’d do. But there isn’t. That’s
where the data is.
In our first conversation, Dr. Moto explained that she was raised a Christian and described
herself as “deeply religious.” She believes that “life begins at fertilization,” and experiences the
feeling of awe when watching an embryo develop: “It’s incredibly difficult to become an atheist
when you watch it.” She carries along with her reverence for human life “an ironic sense that it
was pretty special to be born” because she understands that life itself is precarious. Sometimes as
she rides her bike or cares for her aging mother-in-law, she is struck by the feeling that “the odds
are against the fact that we’re here at all.” As a result, she has come to believe that “life is more
special and precious than you would imagine.”
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As a public figure in a controversial profession, she had been challenged on the ethics of
her work as an embryologist. Dr. Moto explained that she has “checked in” with herself
numerous times to clarify if her work in human embryonic research feels right. She believes that
walking with humility and the desire to do the right thing is important, as is her faith in God’s
forgiveness should she be wrong. But each time she reflects on it, she comes to the same
conclusion: “I’m sure there have been moments in my life when I haven’t been a model
Christian, but my work on embryonic stem cells isn’t one of them.”
Connected to her feeling of reverence for human life, Dr. Moto takes issue with the idea
that embryonic stem cell research is destructive. She engages the rhetoric of destroying in
response to what has become a common argument against the destruction of embryos among
opponents of embryonic stem cell research in the United States (Berg and Furton 2006; George
and Tollefsen 2008). For example, President George W. Bush dramatized his opposition to a
stem cell funding bill that passed in Congress by staging a press conference with twenty-one
children born through embryo adoption. The press conference and photo lends a striking image
of unused embryos becoming “blossom babies” rather than research material (See Figure 6).
Notably, he praised the practice of embryo adoption for its effort “to ensure that our society’s
most vulnerable members are protected and defended at every stage of life.” The reason
President George W. Bush gave for vetoing the bill that passed in the Senate was that he morally
opposed the destruction of human life. Similarly, the treatise Embryo: A Defense of Human Life
argued against the moral permissibility of “treat[ing] human embryos as disposable research
material that may be used and destroyed to benefit others” (George and Tollefsen 2008: 3), and
likened the use of embryos in research to the killing of a human being.
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Figure 6. President Bush Press Conference with Blossom Families33

Dr. Moto understands destruction differently:
People say embryonic stem cell research destroys embryos. I guess you can say that
but stem cell research is not the main driver of embryo destructions. When five to
ten cell lines are made, five to ten embryos are used, in contrast to the 350,000+
embryos thrown away in IVF each year.
This ethical issue, from her vantage point, is not the destruction of embryos as human life, but
the waste of their potential. “I believe that it is not good to throw human embryos away,” she
stated, “—without studying them.” Dr. Moto and many opponents of human embryonic stem cell
research find common ground critiquing the fertility industry on the overproduction and wastage
of embryos, but differ in a distinct way on the issue of what constitutes waste. For former
President George W. Bush, the noble end of stem cell therapies did not justify the immoral
means of destroying potential lives. By contrast, the disposal of embryos into medical waste bins
without making good use of them is, in Dr. Moto’s view, wasteful.
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
33	
  Photo credit to Alex Wong and Getty Images, published in New York Times (See Stolberg
2006).	
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In this light, Dr. Moto’s career in stem cell biology may be described as dedicated to
preventing various kinds of waste. In interviews and speeches over the past decades, she has
described stem cell research as a women’s health issue. Her research projects range from efforts
to improve infertility treatments to addressing female incontinence. She is particularly critical of
the IVF industry for the exploitative way fertility patients are subjected to imprecise technologies
that waste time and money, invade women’s bodies, and produce paltry results.
In my lab, we’re using stem cell research to look for ways to make fertility
treatments safer and more rational. Considering all the heartbreak and expense of
infertility treatments, this sort of research is something I believe women have a big
stake in defending.
In order to continue pursuing her research commitment to women’s health, she secured grant
funding to establish the REDEEM Biobank as a resource. By seeking to remedy the waste of
time, money, and remnants from IVF, Dr. Moto hopes her efforts might help women and men in
their search for technological solutions for their reproductive health challenges.
Waste in Dr. Moto’s lab, from the first moments of my time at Sutter University, was never
a simple matter. In this chapter, I explore the role of waste with respect to leftover IVF embryos
donated to REDEEM Biobank in Dr. Moto’s lab. I examine the processes of making, managing,
and preventing waste through classificatory schemes and laboratory practices within Sutter’s
Stem Cell Institute. I argue that Biobank donors and recipient researchers similarly regard frozen
embryos as un-wastable and make great efforts to prevent their misuse. Despite the generally
universal regard for embryos as un-wastable, I explore how and why the Biobank’s procurement
practices common to contemporary tissue economies do the necessary work of “trashing” valued
materials in order to ready them as treasured lab resources. This chapter expands on a hunch by
Helena, Dr. Moto’s assistant lab manager, that frozen embryos donated to the REDEEM Biobank
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go through “one of those trash-to-treasure scenarios.” I argue that the trashing of treasured
embryos reveals how the systemic production of surpluses—a signature of capitalist systems—
collaborates with propertization within the contemporary life sciences to convert wastes into
extractable forms of value seemingly ad infinitum. Making and preventing waste within a stem
cell lab act as saving practices that convert embryo potential for other intended purposes.

Of Mice, Embryos, and the Paradoxes of Waste
My introduction to waste at Sutter University’s Stem Cell Institute occurred during my
first week of field research within Dr. Moto’s lab. Wendy, the lab manager, handed me a list of
online orientation tutorials about lab safety that all researchers and personnel are required to
complete. Since I would be based in Dr. Moto’s lab for the next school year, I needed to learn the
basics of laboratory life. Wendy set me up at a desk in her office that became my home base for
several months. The desk was situated next to a bright southern window with Biobank inventory
all around: hundreds of informed consent files were stored behind me in a large filing cabinet
and the large stainless steel tank housing the frozen IVF leftovers caught my eye when I looked
up from the computer screen. (See Figure 7)
As I clicked through online lessons about general safety, I was prompted to respond to
quiz questions concerning waste management, collection and disposal practices, and associated
hazards and risks. Wastes, according to the tutorial, are “materials that are no longer needed for
their intended purpose.” The tutorial also prompted me to wonder about the leftover IVF
embryos no longer needed by fertility patients. Could the tank just beyond my desk storing
thousands of donated embryos be a freezer full of wastes?
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Figure 7. REDEEM Biobank34

Despite the fairly general definition of wastes in the tutorial, I encountered circumstances
almost every day in Dr. Moto’s lab that revealed greater subtleties about the category waste. One
mouse experiment in particular captures some of the nuances. Luke, a postdoc from Germany
and the resident mouse expert, fell ill one week in the middle of an ongoing experiment. His
research involves euthanizing—more commonly described by lab scientists as “sacrificing”—
male and female mice to extract their gametes in order to study the gene expression of mouse
embryos. “That is a downside of research,” he explained to me through a stuffy nose. “I could
not do the experiment but then the mouse is just wasted and I would feel badly.”
The laboratory mouse is a paradigmatic figure and everyday tool within the biological
and human sciences (Haraway 1997; Lemov 2005). Researchers like Luke order mice through a
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Photo by author.
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company that breeds research animals commonly used in biological research. Such catalog
creatures are slated for one purpose: experimentation. He ordered the female mouse a few weeks
in advance and prepared it daily with hormone shots to maximize the number of eggs she
ovulated. If he missed the narrow window of opportunity to extract the mouse’s eggs, his
experimental subject would be rendered useless. Even though the mouse would be euthanized
whether he stayed home sick or came in, allowing it to become useless without fulfilling the role
it was designed to play in his experiment would expose it a different kind of sacrifice—to being
wasted. Wastefulness is the opposite of what good science and good scientists strive for.
Luke chose not to stay home when he felt ill because he believed that sacrificing the
mouse without studying it would be wasteful. The research mouse is made for sacrifice, a point
Donna Haraway develops in her analysis of OncoMouse; allowing the mouse to perish without
experimentation denies it, and perhaps the rest of us, the chance for redemption:
The laboratory animal is sacrificed, her suffering promises to relieve our own; she is a
scapegoat and a surrogate. She is the object of transnational technoscientific surveillance
and scrutiny, the center of a multicolored optical drama. This mouse is a figure in
secularized Christian salvation history and in the linked narratives of the scientific
revolution and the New World Order—with their promises of progress; cures; profit; and,
if not of eternal life, then at least of life itself (Haraway 1997: 47).
Dr. Moto expressed a similar opinion about the use of human embryos for scientific research.
Her belief that it is “not good to throw human embryos away—without studying them” suggests
that waste does not result from the destruction of embryos through experimentation; rather, waste
results from discarding embryos without mobilizing them to contribute to the redemptive
promises of progress, cures, and profit. Together, Luke’s and Dr. Moto’s perspectives on their
research subjects reveal more subtleties about laboratory waste than the online tutorial definition
lets on. Each researcher perceives their role in science as extracting valuable data, knowledge,
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and information from their research subjects. While the process of extracting value from
experimental creatures may result in a certain kind of destruction, they believe that the more
grave ethical concern is allowing the potential perceived within embryos, mice, and etcetera to
go uncollected and unused.
Dr. Moto’s and Luke’s perspectives distill a few seeming paradoxes of stem cell
biological research: that scientists participate in destruction without destroying and sacrifice
without sacrificing. The question explored in this chapter is if there can be waste without wasting
within embryo research labs too. During the school year that I spent at Sutter University, I made
a number of observations about waste in the Dr. Moto’s lab. First, embryo donors as well as
recipient researchers consistently regard frozen embryos as precious, invaluable, and supremely
un-wastable. At the same time, REDEEM Biobank categorically “trashes” embryos in order to
facilitate their donation and use by researchers. The seeming contradiction of frozen embryos
being both waste and non-waste makes sense, according to sociologist Martin O’Brien, within
“rubbish societies” (1999).
How stem cell scientists waste without wasting hinges on clarifying a key distinction
between the types of research subjects common to Dr. Moto’s lab. Laboratory mice, for instance,
are made for experimentation while human embryos are the by-products of IVF, the technology
that makes embryos for the purpose of establishing pregnancy. To redirect their potential from
fertility clinic to research lab, frozen embryos are “trashed” via informed consent processes and
classificatory framings that shift ownership from patient to tissue bank. I argue that waste is the
transformative category embryos pass through that changes IVF by-products into laboratory
treasures. The next section reviews general and theoretical approaches to waste, after which I
detail how donors and recipient researchers cherished embryos as un-wastable entities.

102

Keyword: Waste
Waste is a contemporary keyword that shares conceptual kinship with various other
terms, such as detritus, excreta, discards, filth, garbage, refuse, rubbish, surplus, excess, and
trash. Waste entered the English lexicon in the thirteenth century from an Old French term rooted
in the Latin, vastum. Waste (n.) is generally regarded as unproductive matter pushed beyond the
bounds of society. From deserted lands to material garbage to social rejects, waste is assumed to
be the extraneous, useless byproducts of life (OED). Waste is also defined as the opposite of
value. Acts of wasting (v.) are described as destroying, deteriorating, and diminishing things
considered precious, like time, land, money, and health. Wastrels are those who throw away
opportunity and squander chances for profit. Wasteful practices are characterized by lavish
consumption without regard for consequences or return.
Among scholars who theorize waste, some recapitulate commonplace notions of it as
negative excess and absence of value. John Locke’s (1964 [1689]) treatise on property, for
instance, established within the Western liberal tradition a regard for uncultivated land as res
nullius, or lying in waste, which reified it as unclaimed, un-owned, and abandoned matter. Mary
Douglas’s (1966) symbolic study of dirt and pollution helped put waste on the theoretical map,
but located it outside the material realms of production and consumption and beyond the
symbolic order of society. Waste, in Douglas’s terms, is matter that is categorically “out of
place.” Similar to Julia Kristeva’s (1982) psychoanalytic theory of abjection—or the horrific,
rejected, and liminal other—Douglas emphasizes the role space plays in sequestering
unacceptable objects, populations, and practices from normative society.35
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Naomi Pfeffer (2007) and Julie Kent (2008) analyze one form of reproductive waste—aborted
fetuses—through Kristeva’s lens of “abjection” to understand the contours of fetal tissue
economies.
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In response to the relative sidelining of waste in social nomenclature and theory, scholars
started dragging discards to the center of analyses to challenge the common refusal of the role
that leftovers play materially and symbolically within everyday life. Scholarship that refuses to
let waste remain in the intellectual dustbin articulates the many ways in which it matters socially,
politically, economically, and morally. For this chapter’s purposes, I identify approaches to
waste that illuminate its multi-dimensional role within frozen embryo disposition through themes
of economies, value, and time.

Waste & Economies
Discard scholars argue that waste is essential for understanding all forms of economy
(Waldby and Mitchell 2006). Rather than merely the byproducts of symbolic and material
systems of production and consumption, waste and wasting practices are integral for
understanding how economic systems work (O'Brien 1999). For capitalist systems in particular,
waste is considered to be a signature feature. Some examine the systemic production and
luxurious expenditure of excesses inherent to the function of capitalism (Bataille 1988). Others
emphasize capitalism’s generation of surplus populations in the form of workers whose life,
health, and labor are, as Marx describes, “squandered” (Gidwani and Reddy 2011; Marx 1981
[1885]; Marx 1993 [1894]). Feminist scholarship on reproduction illuminates a different facet of
the role waste plays within capitalist systems. For example, within medical textbooks that liken
women’s reproduction to industrial forms of production, anthropologist Emily Martin noticed
that menstruation is depicted as “the waste product of a failed conception, composed of debris,
dead tissue, and useless scrap” (Martin 1987: xvi). For critics of neoliberal capitalism, like
Melinda Cooper (2008), waste represents the sphere of activity where ideals of “continual,
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euphoric growth” play out through seemingly endless projects of value extraction. In this
chapter, I draw from Cooper’s approach to “life as surplus” to elucidate how IVF leftovers
become promising research materials within contemporary bioeconomies.

Waste & Value
Material analyses of waste, wasting practices, and waste management systems provide
novel approaches for understanding the relationship between waste and value (O'Brien 1999).
Rather than the simple characterization as being absent of or opposite to value, some argue waste
to be “a source of latent value” (Cooper 2006; Waldby and Mitchell 2006) that can be extracted
endlessly. In a challenge to Douglas’s premise that wastes are “out of place” socially and
materially, scholars highlight the ways societies actively manage these potent leftovers by
creating and mobilizing intricate systems that convert and extract value from materials
designated as waste. My interpretation of frozen embryo donation utilizes sociologist Michael
Thompson’s (1979) notion of waste as a liminal space for transforming—rather than losing—
value, which he calls a realm of “pure potential.” I take particular interest in the ways waste and
frozen embryos become “potent” entities within circuits of recycled tissues.

Waste & Time
William Viney (2014), in dialogue with Douglas, suggests that waste should also be
considered “matter out of time,” which helps draw attention to the ways temporality conditions
waste and vice versa. Certain forms of waste, like nuclear radiation and environmental pollution,
introduce extreme temporalities that refigure how humans, things, and places relate (Masco
2006). Time also amplifies relationships between pasts, presents, and futures. For instance, waste
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is always a waste of something, which implies the lingering of past residues even as wastes are
transformed toward new futures. My analysis of REDEEM Biobank’s informed consent
processes highlights how “trashing” embryos seeks to catapult them “out of time” by cutting
historical ties and hitching them to speculative futures.

Unwanted and Un-wastable: Embryo Donors Give to Research for Greater Good
dispose (v)
a. to put in place
b. to settle a matter finally
Since the late 1990s, frozen embryo disposition—or what people decide to do with their
remaining embryos after IVF—has attracted the attention of researchers around the world in
places where IVF and cryopreservation are practiced. Reports indicate that the desire among IVF
patients to donate to science is becoming an increasingly popular disposition option (Lyerly and
Faden 2007; McMahon, et al. 2003; Parry 2006). I spoke to one New York mother in the midst
of her second IVF cycle as a result of secondary infertility who recalled the factors that informed
her embryo disposition interests. On the day of her egg retrieval while sitting in the clinic, she
and her husband contemplated what to do with their unused embryos.
I had the pen in my hand and thought that my sister is a doctor and I have two siblings
with multiple sclerosis, so I know that stem cell research has been significant, or could
be. So I was like, ‘Science, that’s good.’ The idea of discarding our three embryos
doesn’t work. If it could be used, make it useful.
An Oregon mother of two described different circumstances for her openness to donating
remaining embryos to research. After a devastating car accident that resulted in the loss of her
eight-month pregnancy as well as her uterus, Suzie endeavored to continue her family through
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IVF and surrogacy but faced severe financial obstacles. Short of being able to afford a surrogate
to receive any of her four frozen embryos, she described “this immense connection to the idea
that these [embryos] are my babies” that informed the feeling that she “probably wouldn’t donate
embryos to another couple, but would donate to research in helping to better their testing.”
Staff at REDEEM Biobank noticed the upward trend in donor activity since opening in
2008, though as Donna the coordinator explained, “we have no idea what they think about the
donation.” The Biobank’s informed consent process does not ask donors to report their reason
for donating nor does the Biobank have a mechanism for tracking donor motivations. This left
some staff wondering why people go through the sometimes arduous process of donating. “They
could be giving away their potential children for all we know,” Donna stated, which echoed one
donor’s joke about their motivations: “This is the only way our kids will ever get into Sutter
University!” Yet the range of impressions staff shared with me about why people donate suggest
that they have some ideas. I did not have the opportunity to speak directly to more than one
REDEEM Biobank donor, though found that being in the Biobank office allowed me to glean
staff impressions and experiences that illuminated how donors regard their embryos. Even
though Biobank staff do not ask patients directly about factors around donation, Sophia
explained that she often finds out anyway: “People dump a lot of their stuff in the call saying,
‘I’m donating and here’s why.’”
Many professionals across my varying field sites identified the embryo cryostorage bill as
the precipitating factor for patients to make a disposition decision. Sophia initially believed that
relief from the financial expense of storage was a chief motivator for Biobank donors, but came
to see it differently once she began assisting in the Biobank office. “Patients could stop the
billing tomorrow by saying, ‘Discard them,’” she noted. “Many do, but these people choose to
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give to the Biobank.” Why? Fertility patients report that cryopreservation storage fees, which
range annually between $300-$1000, do impact their embryo disposition decisions (Brzyski, et
al. 2000), though numerous other factors and motivations inform whether fertility patients from
clinics around the world donate to scientific research or not. Variables range across reproductive
history, clinic information, life circumstances, embryo quality and quantity, personal values, and
conceptualizations about embryos (Samorinha, et al. 2014). Storage bills reminded patients about
their frozen remainders, but financial considerations are just one part of the decision-making
process for potential embryo donors. Also, since donation to REDEEM is rarely a seamless
process, donors that follow through to completion are likely driven by more than the desire for
relief from financial expenses, which, as Sophia pointed out, can be easily achieved by choosing
to discard. The next sections examine donor motivations and the obstacles they confront through
the donation process. Together, they suggest that even though fertility patients who donate to
REDEEM Biobank regard their embryos as unwanted, donors consider them equally unwastable.

Donating Embryos to Help Others
Biobank staff believes that, for many donors, the decision to donate can be difficult. “It’s
kind of a big decision,” stated Tori, the former Biobank coordinator, about the process fertility
patients experience when donating their remaining embryos. “It is an embryo and they did pay
$25,000 to get it made and paid storage for however long.” From Dr. Dunn’s perspective,
donating embryos is a process of “honorable discard” and a “savior option” for those she
perceives to be making challenging decisions. Their hunches echo findings from studies with
fertility patients in the United States who describe their decisions as “agonizing” and

108

“anguishing” (de Lacey 2005), consider the typical four disposition options as unsatisfactory
(Lyerly, et al. 2006; Lyerly, et al. 2010), and delay their decisions for multiple years
(Lanzendorf, et al. 2010).
One of the primary reasons Biobank staff believes that donors give up their remaining
embryos is to help others. Adam and Julie Golds’ donation of their ML4 embryo was motivated
by the desire to do something to prevent another family’s pain, and they believe their embryo
with a rare genetic disease could be instrumental in such a mission. “I’d be devastated if
someone else had to suffer daily the tragedy that we suffer,” explained Adam. The Golds are
guided by a strong sense of responsibility, which Adam described in this way: “It’s when you
feel in your gut and it tells you in a real tangible sense [that] this is something you have to do.
It’s the difference between right and wrong. There’s a line.” Through the embryo donation
process, Adam came to understand it is a way to address unmet need and provide opportunity.
Why would you take that incredibly meaningful good deed away from yourself
and your child, and take that potential benefit away from another family and
another child?… I hope that [fertility patients] would donate the embryo to a
family that needed it or donate it to science. Discarding it would just be travesty
to me. Because of the scientific opportunity to help other folks or because of the
ability to help somebody else have the family that they want. It would be sad to
lose those two opportunities.
Similarly, Jessica expressed hope that the donation of her embryos to the Biobank could help to
improve IVF techniques for other patients. After detailing her infertility journey over the phone
with Donna, she described wanting “to give someone the chance in the future to have a child as
great as ours.” Rather than donate her embryos to someone for the chance at pregnancy, Jessica
hopes her embryos can be used to improve clinical techniques so that a more general “someone”
may benefit from improved IVF rates of success. Like Adam and Jessica, patients from fertility
clinics around the world choosing to donate their embryos to research express similar beliefs in
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the social benefits of scientific research and desires to contribute to individuals in need as well as
to a healthier world more generally (Samorinha, et al. 2014).
REDEEM Biobank donors also emphasize the hope that their specific donation will
generate direct results. After hanging up the phone with a donor one afternoon, Donna shared
with me a sentiment she heard often during such calls: “She really wanted hers chosen for
research and to be the one that will cure something.” Few donors inquire, as the Golds did, about
contributing to specific research and ongoing projects but some discuss their passion for stem
cell research, citing the hostile political climate as a motivating factor for their donation. In fact,
a few Biobank donors are impassioned to the point of becoming frustrated when learning that
they are not able to donate to Class 2 stem cell research because their embryos were made with
donor gametes (which, because of consenting protocol, are not allowed to be used for
establishing cell lines). Staff sense that donors are “really hoping that something turns out with
their donation,” which highlights donor expectations that their donated gifts will be purposefully
utilized. Tori believed that Biobank donors are specifically hopeful “that someone can learn
something and get useful information instead of us putting it in the trash.” Impressions from
Biobank staff about donor motivations reveal donors to be consistent with other fertility patients
who are driven by the belief that donation to research is a better alternative to “wasting”
resources through discard considered to be “precious” (Nachtigall, et al. 2010).

Overcoming Challenges to Donating
The process of donating embryos to REDEEM is, on paper, straightforward, though daily
life in the Biobank office revealed aspects of the process that slow, interrupt, and sometimes
preclude donations altogether. Donors that follow through with donating to REDEEM despite the
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logistical headaches they sometimes experience reflect a commitment to their embryos being
utilized for a greater scientific good.
Sophia is an embryologist from Venezuela who has worked in Sutter University’s IVF
clinic for nearly two decades. She and her lab colleague Pamela were asked to assist the Biobank
during a period of transition between coordinators that coincided with my arrival. Their
perceptions as IVF embryologists of the embryo donation process changed once they witnessed
the difficulties entailed in donating to research; patients donate not just to avoid paying their
cryopreservation bill, but to follow through with an underlying desire to contribute their unwastable remainders for scientific use. This section looks closely at the Biobank’s donation
protocol, which was designed intentionally to give people autonomy and time for thoughtful
decision-making, although the design also contributes to mistakes, delays, and confusion.
REDEEM’s donation process follows these steps: Fertility patients interested in donating
to REDEEM contact the coordinator, who follows up inquiries with an introductory letter, sixpage informed consent form, and voluntary health questionnaire. Patients are instructed to review
the materials at home; if they decide to donate, they mark their preferences for how researchers
may use their embryos,36 sign the donation forms in the presence of a witness, and return the
paperwork to REDEEM for review and final consenting over the phone. REDEEM considers
embryo donations “complete” when patients submit their consent forms free of error to the
Biobank office at Sutter University. REDEEM established this multi-stage, interactive, and
donor-driven consenting process in response to heightened ethical and political concerns in the
United States about using embryos for stem cell research (Scott 2006; Thompson 2014). The
consent process is designed to promote donor choice through the core principles of informed
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  Class 1 human development research, Class 2 stem cell research, or approval for both.	
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consent and build in extra time for donors to consider their preferences, make a decision, and
review it before finalizing their embryo donation.
Every word of REDEEM’s paperwork and protocols was approved under the scrutiny of
Sutter University’s Institutional Review Board and the Embryonic Stem Cell Research Oversight
committee to ensure that Biobank’s donation process is in compliance with U.S., state, and
California Institute of Regenerative Medicine guidelines concerning the protection of embryo
donors. It took nearly two years for the protocols to be developed and approved by the various
oversight committees. All of these efforts reflect “ethical accounting procedures” (Thompson
2014), or the principled actions taken by groups like the REDEEM Biobank to adhere to
standards for utilizing donated embryos in research. Within the bureaucratic procedures of
consent protocols and committee approvals, it is possible to see how the “pro-cure” rhetoric of
stem cell science translates into “procuratorial” practices—like embryo donation—that shape the
way human embryonic stem cell research is conducted in labs at universities like Sutter.
Efforts that went into designing REDEEM’s embryo donation process contribute to the
myriad “problem” files that Biobank staff confront and try to resolve each day. In addition to
dozens of calls and emails Biobank staff juggle from prospective donors, Pamela described the
reality of the consenting process in this way: “Eighty percent of the consents are incorrectly
filled out and fifty percent of patients don’t respond to requests to correct their forms. The other
fifty percent don’t have return phone numbers or clinic contact information written on the form
to reach them, so that list grows.”
While Biobank staff reports “drowning in work,” potential donors sometimes feel
overwhelmed too. For example, Nathan, a divorced Veteran wanting to donate his leftover
embryos sent in his consent forms to REDEEM twice, both times containing mistakes. “When I
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got him on the phone,” Sophia said, “he was exasperated, saying that he has mental and physical
trauma that makes filling out the form impossible and that he wants me to just fill it out for him.
I told him, ‘I am so sorry but we just cannot do that.’” REDEEM staff makes every effort to
provide a smooth donation process for donors, but staff and patients still experience a variety of
bumps along the way that make donation to research not as simple as signing a form. Strict
institutional protocols that strive for high ethical standards and legal safeguards within the highly
political climate of human embryo research make it sometimes challenging to donate precious
leftovers to Sutter University at all. Donors who see the donation process through to completion
are committed to making their reproductive remainders available for use by scientists because
they hope to contribute to a greater scientific good.
Potential Biobank donors are not the only groups that consider embryos un-wastable
entities. Dr. Moto’s lab members also regard the embryos they utilize in their human
development and stem cell experiments as invaluable resources for which they feel privileged to
have access. Embryo donors and recipient researchers similarly treasure frozen embryos by
considering them too precious to waste.
Wanted and Un-Wastable: Scientists Prevent Waste in the Name of Good Science
“As a scientist, you try to ask key questions, do good science, do good work, and
not be wasteful.”
- Simone, Postdoctoral researcher in Dr. Moto’s lab
Dr. Moto’s lab is the largest in Sutter’s Stem Cell Institute and one receiving the strongest
financial support. At the surface, Dr. Moto’s well-funded lab with full benches, stocked supply
cabinets, and state of the art instruments appears to be a space where few would learn the merits
of thrift. At worst, lab members may fall into a habit of expending resources mindlessly. A non-
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biologist, I did not have a baseline for understanding how “lucky” lab members feel by
comparison to colleagues in other labs and institutions.
Wendy, the Moto lab manager who approves all supply requests from researchers in the
lab, finds it “difficult to make researchers aware of how much money they are spending.” As an
example, she notices that researchers use chemical wipes to clean up a lab space instead of paper
towels—the cheaper option—that she chides them to use instead. Caitlin, a senior-level postdoc,
similarly perceives “quite a bit of wastefulness” within the lab. She completed her doctoral
studies at a private university that “had money, but we were very mindful of it.” Everyone in her
home lab, for instance, made his or her own phosphate buffered saline (PBS), a common solution
for working with cells in vitro. “The first thing that shocked me coming to Dr. Moto’s lab is they
buy PBS. Dr. Moto is more than willing to pay the money,” which Caitlin believes leads to a
lack of awareness among some lab members about the material expense of running a lab, and
results in buying duplicate supplies or too much media that expires before being used.
Researchers, like Aanya, a Masters-level lab assistant, came to Sutter from a nearby state
university where she became accustomed to reusing gloves to save costs. “People who work here
don’t realize how fortunate they are. The resources are amazing.” If a principal investigator like
Dr. Moto has a seemingly endless supply of financial resources, lab members might not learn the
practices of waste prevention that are considered a cornerstone of how scientists “do good
science,” according to Simone.
Despite the abundance of resources within Dr. Moto’s lab, efforts to prevent waste are also
in vast supply. Lab members feel privileged to have access to “scarce” and “precious” research
materials like human embryos. These sentiments inform the ways researchers strive to “do good
science” through everyday practices with the lab. In this section, I explore the sentiments and
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practices of scientific researchers within Dr. Moto’s stem cell lab. Just as embryo potential is
produced through fertility clinic IVF lab practices of ranking and grading, I argue that laboratory
efforts to prevent waste make visible how the frozen discards of IVF become the treasures of a
stem cell lab.

Between Abundance and Scarcity: Privilege, Stress, and Respect in the Lab
Researchers in Dr. Moto’s lab work daily with a range of cells—gametes, embryos, fetal
cells, stem cells, and adult cells—from a wide range of species. Regardless of cell type or species
origin, researchers express reverence for cells that are difficult to obtain, scarce in supply, or
impossible to replace. For those who work with renewable cell types, such as induced pluripotent
stem cells (iPSCS) or established human embryonic stem cell (hESCs) lines, like the standard H1
or H9 lines, being cavalier with cells, as some learned the hard way, puts the researcher at risk of
losing time and energy invested into their experiments.
For those who work with human embryos, the challenges are different. “Embryos are a
difficult reagent to work with because you can’t ask someone really nicely for more,” explained
Madison, a late twenties doctoral student in genetics. She works primarily with iPSCs, cells that
allow her to start a new cell line relatively easily if needed. But with human embryos, she
explained, “you can’t get more just willy-nilly.” Diya, one of the lab assistants, suggested that
the origin of the tissue impacts its supply. Her sense is that human tissues samples will always be
limited:
When it comes to any kind of human sample, whether from skin or embryos, I
think it’s always valuable because of access to it. It’s not easy to get any kind of
sample any time. That’s the reason. Any kind of human tissue—embryos, skin,
muscles—it’s of value.
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Caitlin was reminded of the rare opportunity she has at Sutter to utilize the REDEEM
Biobank as she sought faculty positions at the end of her postdoc in Dr. Moto’s lab. She traveled
a lot during the spring quarter to other academic labs where she presented her data from
experiments with human embryos. When we caught up between trips, she conveyed impressions
such as:
I feel very, very privileged and lucky to have this source of embryos and it's very
clear as I go out on the job market, that people are like, ‘You are so lucky that you
get to work with human [materials]. I work with mouse and bovine and it would be
great to work with human [materials]’. Everyday I think to myself, I'm very
privileged.
Access to the Biobank for Caitlin’s research informs her waste prevention efforts in the lab.
Helena sees the privilege Caitlin described as not limited to the Biobank but extending to the
opportunity to study at a top ranked research university like Sutter: “I think it’s one of those
things where you’re privileged to work here, go to school here. It’s what keeps Sutter ahead of
other schools, because we do have access to these things. It takes a lot of funding, politics,
meetings, paperwork, and red tape.”
Because of this feeling of privilege, some researchers experience increased stress and awe
when working with human materials. Simone, a postdoc and mother of three from the Northern
California coast, is prone to saying “mousey prayers” and giving gratitude to frogs that she
sacrifices for experiments. She feels that,
With the human system, it’s even more nerve wracking… You do get a little frantic
and nervous. It’s an important sample. It’s such an important, precious thing, in
your hands. It’s very hard to not be shaky. Maybe it’s just me but I worry that I will
drop them or mess this up or suck them up too far and lose them [in the pipette]
because these kinds of these happen, right? Little technical things that you can’t
control.
Others, like Lucia, a visiting doctoral student from Spain who works primarily with two
pronuclear stage (2PN) human embryos, feels lucky to have easy access to human materials. She
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clarified that she structures her lab practices around the respect she feels for having privileged
access rather than from a feeling of awe for the human material she works with. It is conceivable
that researchers accustomed to Dr. Moto’s well-resourced lab could take for granted the supply
of precious materials in the REDEEM Biobank, but, instead, all of the lab members I
encountered express awareness, privilege, and respect for the range of cells in their respective
dishes.
The stress such privileges entail leads researchers to act respectfully within the lab with the
ultimate goal of preventing waste. “You feel privileged and nervous all at the same time. You
don’t want to mess anything up,” explained Simone about the way stress informs her behavior at
the bench. “You have a precious commodity and you don’t want to ruin it.” For Caitlin, the
awareness of privilege conjures feelings of respect: “I feel, because it’s such a privilege that I
need to be respectful of it, respectful of what I get to use, respectful of how I treat them.”
Vivian’s sense of awe and privilege generates for her feelings of respect for the suppliers of her
coveted research materials, the Biobank donors:
We just need to be respectful, whoever these people are. They are helping us in
their ways, so we just need to do the right thing… I guess we are really grateful to
the patients who agree to donate their embryos. It’s just—what’s the right word?—
they are really supporting us.
Preventing wastefulness is a motivating force among researchers in Dr. Moto’s lab, and
arguably much of contemporary biological sciences. Sentiments of privilege, stress, and respect
arise among Dr. Moto’s lab members due to access to human embryos for their experiments.
After reviewing various saving techniques operating within Sutter University, I explore how
making precious embryos conspires with the ways scientists try to “do good science.”
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Avoiding Waste in a Stem Cell Lab
Waste prevention practices are part of everyday life around Dr. Moto’s lab and take
various form: 1) rigorous planning of experiments, 2) committing to timelines necessitated by
experiments with living cells, 3) making mindful requests for and maximal use of scarce
resources, and 4) behaving with vigilance, persistence, and care. These practices bring to life
saving ethics that inform how Dr. Moto’s lab members do good science.

A Developed Plan with Good Questions
Waste prevention begins well before launching an experiment as researchers make a plan
to determine what they need materially to achieve their goal, no more and no less. Simone
believes scientists “have a certain obligation to do your best, to be rigorous, and to have a good
question.” Diya emphasized the importance of having “good intent to evaluate the sample that
you have, trying to use it to the maximum and to get the maximum data from it that you want to
get.” In order to obtain maximal data by using minimal resources, researchers are clear that
preparations are essential. Learning how to strike such a balance involves being considerate
about waste.
My field research started at Sutter University at the beginning of the 2012-2013 school
year, which coincided with the matriculation of the Institute’s first PhD program students in
Stem Cell Biology and Regenerative Medicine. The program is one of the first in the nation and
world to support doctoral studies in translational science, which is an approach that provides a
critical link between basic science, clinical therapies, and biomedical entrepreneurship. The goal
of the program, according to the website, is to offer “specialized training in the development and
clinical application of discoveries in the basic sciences to achieve regenerative therapies” with
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hopes to “produce future leaders in translational science” who are passionate about “improving
the human condition.” Sutter distinguishes its program from others by emphasizing its “applied
culture,” as a first year student described, by regularly featuring clinical researchers working
with disease as guest speakers as well as “literally passing samples back and forth” between the
medical school and Stem Cell Institute. Being in close proximity to California’s vibrant startup
community also attracts doctoral students planning careers in the biotech industry; students
pursuing entrepreneurial careers in stem cell biology are encouraged to submit business plans
rather than funding grants for final course projects, and conduct internships in venture capitals
firms rather than clinical departments. My participation in the inaugural program’s core courses
and journal clubs as well as conversations with faculty and students introduced me to key
ingredients in the making of a stem cell scientist. Good questions within scientific inquiry are
fundamental to their training.
One way that researchers across the Stem Cell Institute develop rigorous research
questions is through regular presentation of ongoing data, collaboration, and mentorship. At any
give hour during an average weekday, lab scientists can be found sitting around a large table in
one of the Institute’s glass-walled seminar rooms snacking on pastries or pizza while a journal
club, lecture series, or open seminar is underway. At the front of the room, stem cell researchers
move through their obligatory Power Point presentations that follow a conventional formula of
“telling a story” about their project. Describing experiments as stories, one research assistant
suggested, is because “when we start something we want to finish it, with a good ending.”
Presentations follow a similar structure: introduce a health problem, articulate hypotheses,
describe methods, review experimental evidence, and offer discussion points about findings.
Lectures attract questions from colleagues, provoke the sharing of ideas, and contribute to
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participants’ skills around refining their methods of inquiry. For presenters and attendees, such
presentations reinforce the way good scientists plan and execute experiments.
During the fall quarter, I attended one of the program’s core courses twice a week.
Faculty investigators from around the Institute delivered lectures on topics deemed fundamental
for preparing the next generation of leaders in the field of stem cell biology, including: human
embryological development, epigenetics, cellular reprogramming, pluripotency, and
bioinformatics. In both the graduate course classroom and open campus seminars, engagement
with scientific studies in progress in the Institute contribute to the cultivating of habits among
students, postdocs, and professors alike that kept mindfulness about waste at the forefront of
their bench activities.
In Dr. Moto’s lab, an “embryo interest group” formed among the scientists working with
human embryos, which is accompanied by a few clinical staff from the IVF clinic interested in
research. This small, informal group meets monthly to present issues around ongoing
experiments, solicit feedback, identify opportunities to collaborate together, and discuss topical
issues relevant to participants’ shared fields of interest. Dr. Moto provides project guidance and
financial support by meeting weekly with each of her graduate and postdoc mentees. Caitlin, the
lab’s senior-level postdoc, offers mentorship to junior researchers from the group, including
Lucia, the visiting Spanish doctoral student, Vivian, the Chinese postdoc, and Rachel, the
American third year reproductive endocrinology fellow doing a lab experiment for her capstone
project. As the self-described “embryo firewall,” Caitlin also serves a key role in the lab as the
liaison between Donna, the Biobank coordinator, and researchers requesting embryos for
experiments.
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Various systems—from research presentations to individualized mentorship to an embryo
firewall—are in place in the Stem Cell Institute to reinforce methods of scientific inquiry that
plan with care around resources. Thus, prior to requesting embryos from the Biobank for use
within an experiment, scientists are trained to plan thoughtfully and economically with respect to
the invaluable frozen assets.

Committing to a Timeline
Another form of waste prevention among stem cell researchers is time management. A
key facet of running an experiment with cells is scheduling a timeline for activities and adhering
to it rigorously. Aanya, a research assistant who migrated from India, worked straight through
one weekend with a migraine because she had an experiment in progress: “Experiments with
mice are huge for me if I have to sacrifice. These cells that I extracted from them, [if I didn’t
come in] I would just think the whole effort is being wasted. So because of that I wouldn’t take a
day off.” One reason that rigid time schedules sometimes feel “like a lot” is because, as many lab
members acknowledged, it is uncommon to ask each other to do the labor of running another’s
experiment. Fellow lab members actively collaborate to offer planning advice, share culture
media, and occasionally help change media for another, but as Aanya explained, “unless it’s
something really simple, we don’t normally ask for help.”
The idea of odd hours does not exist for researchers because cells might require changes
of media or monitoring at all times of the day. Researchers often block off weeks at a time for
running experiments around which their personal lives have to fit. Madison described the time
management involved in her stem cell work:
For the first two years here I never went on vacation except for holidays and when I
didn’t feel too guilty asking people to take care of my cells… I’m organized and like
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following a schedule but sometimes it’s a huge pain, like being up at 4 a.m. so that I can
go out with friends when they go to the city at 9 a.m. Or when I’m here at midnight to
make sure I can start something the next morning.
Lucia picked an apartment near campus so that she can bike over easily to accommodate late
nights and early mornings dictated by the in vitro embryos she studies. My efforts to
accommodate the rigorous scheduling of biological research failed a few times. Since I, like
many at Sutter University and the Stem Cell Institute, commuted an hour each way by train, I
missed some early morning and late night opportunities to shadow during certain experiments.
Many researchers liken the time management required for stem cell research to the tasks
of parents. “I say that I’m going to feed my cells,” Madison tells friends. Like babies, cells need
regular feeding, monitoring, and cleaning in order to thrive. Some lab members with children
understand intimately the dueling challenge of commitments around care that are shaped by
schedules. Nena, a postdoc from India and mother of a one year old, believes she is still “trying
to manage how I structure my time.” Key to her ability to manage the duties of a parent, wife,
and caretaker of her in vitro “babies,” as she called the iPSC cell colonies she creates, is having a
“very supportive partner”: “Whenever I have to come to the lab, he is fine taking care of the
baby, or if I can’t manage to do things at home, he is fine with that.” Similarly, Aanya opted to
postpone her research timeline by one year when her daughter’s spring break fell in the middle of
an experiment cycle. In order to prevent the waste of time and materials, researchers like Aanya
rely on family and childcare providers to support them in the care for their cells.

Maximal Use of Resources: Anticipating Need and Freezing Down for the Future
Researchers also prevent waste by requesting only the amount of material they need.
“You don’t thaw an embryo and realize that you don’t actually need it,” explained Vivian.
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“That’s not acceptable.” For example, Luke requested six 2PN stage embryos from Donna, and
Caitlin worked with him to thaw the embryos for his experiment. He initially asked her to thaw
only two of them because “each embryo counts,” as he said to me. Researchers are aware that
embryos, especially 2PNs, are highly valued, so they plan their use of them carefully in order to
avoid unnecessary waste. “I think the majority of us in the embryo group have that attitude that
you only thaw what you need,” Caitlin reflected. “You need to obviously consider that probably
not everything is going to survive when you thaw, so we try to ask for a little bit more… You
just don’t overuse and don’t thaw more than you need.”
Once materials were thoughtfully and thriftily requested, researchers strive to use their
materials to the fullest capacity. “You try to make the most out of it,” Diya shared, “because you
never know if you’re going to have the same sample back again.” Researchers describe this
approach as “maximizing” the biological materials they worked with. Eric, an Austrian doctoral
student of genetics who graduated the same month I left Sutter, worked primarily with adult cells
and iPSCs. “Waste is something I am always concerned about,” he began. “When I’m done with
an experiment and I don’t need the cells anymore, I could either just toss them because, for now,
I don’t need them. But even though the experiment is done, I always like to freeze them down.”
“Freezing down” involves saving the remainders from an experiment for potential future use.
Eric, for example, froze down extra cells to use as a control line for testing new media that
companies rolled out regularly. Freezing down, or banking, the remainder cells from experiments
captures what Helena meant when she described stem cell science as “kind of like a recycling.”
The potential value of an embryo is so great that the left overs from an experiment with surplus
embryos merit saving too.
Since researchers regard human embryos as “very precious,” most have contingency
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plans in case of unforeseen circumstances, errors, and accidents. Caitlin described times where
she thawed embryos that turned out to not be what she requested or expected. When she thawed
the embryos and looked into her microscope, she was shocked:
My goodness, it was the wrong stage. Even though [the embryology report] said it
was 2PN, the embryo was cleavage stage. What are we going to do now? I make
the point, even if we don't have a use for it now, I'm not going to throw it in the
trash. I'm going to disassemble it, have single cells, and I just know two months
from now somebody is going to come along and say, ‘Hey, I need some single
blastomeres.’ I feel really strongly about doing that.
Caitlin’s practice of freezing down and banking the extra cells—the remainders of remainders—
reveals preparedness against the risk of squandering potential, which many of her lab mates
agree is a primary ethical concern within stem cell science. It also suggests the way an embryo’s
preciousness does not cease, even when the embryo itself is destroyed through the experimental
processes of disaggregation. Even when thawed by mistake, its value is worth preserving and
preventing from going to waste. Diya, Eric, and Caitlin’s efforts to maximize the use of valuable
biological materials by managing risk and saving for the future help prevent the wastage of
valuable cells.

Care in the Lab
Feelings of privilege, anxiety, and preparedness breed careful lab practices that help
researchers prevent waste. When Vivian, a postdoc from China, works with human embryos, she
notices that she becomes “super, super careful.” She meticulously cleans the embryo room in
preparation for an experiment without using ethanol, a chemical thought to have negative effects
on incubating embryos. She also monitors the temperature of the room and gas percentages more
frequently than usual to ensure the best environment for culturing embryonic cells. “I make sure
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everything is perfect for the embryos. [These are] good procedures for cell culture in general,”
she explained, “but I don’t know if people do it” as regularly or religiously with all cell types.
Caitlin is similarly vigilant when working with human cells at the bench. “Things are
going to happen, whether it’s due to human error, mechanical problems with the pipette, or
inherent to the embryo itself,” and when an accident inevitably happens, Caitlin chooses to not
give up. When an embryo goes missing in the dish, for example, Caitlin described how she
responds: “I sit there for twenty minutes looking for it… I just feel the need, rather than have the
attitude of letting it go, that I’m going to do everything I can to find it.” An embryo can go
missing, she teased, because:
It's not like it’s the size of a cat or something; it’s small and there’s a lot of handeye coordination. I think the first time you lose [an embryo] you get really upset
and then you try to get over it. The same goes for even single cells. Even with
single blastomeres, I’m so upset if I lose a blastomere. That’s my attitude but I
can’t say that I necessarily expect everybody to share that. I mean you are going
to lose some. It’s kind of natural. I still make an effort even now to do what I can.
Caitlin’s concerted efforts are tempered by awareness that the unexpected can be expected in the
lab, despite her best-laid plans and mindfulness. Moreover, her efforts suggest that it is not the
outcome of experiments that define “good science” so much as scientists being careful in
anticipation of surprises and uncertainties.
For Nena, a postdoc who works primarily with adult stem cells, vigilance and diligence do
not adequately capture her approach to care at the bench. How she behaves in the lab reflects her
broader philosophy for practicing in the life sciences, which is premised on respect for cells as
living entities rather than tools for her to manipulate.
My philosophy is to treat cells as if they are my own babies, to take care of them,
to not just use them as a tool to get higher in our career. That’s how I like to treat
them. They have a life of their own. Just as we treat our pets and our kids at
home, I feel we need to treat [our cells] with respect and study them, not just to
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use them.
Nena came to Dr. Moto’s lab as a postdoc three years earlier after completing her doctoral
studies in India. She describes herself as a religious person who is “practical.” She believes in
God and draws from religious texts, like the Baghadavita and writings from J.K. Krisnamurti, to
inform how she leads a life of intention with the people and things receiving her care, including
her daughter, her vegetarian grandmother, and the cells she works with at Sutter University.
Even if people give biopsy samples, it is so important and crucial for scientists
like us to treat it well and not use them just as some tools for studying something
that we are interested in. We need to value them. Sometimes when we have a
busy schedule, we think, ‘Oh, I can do that tomorrow. It’s okay to skip a feeding
today.’ We can’t keep them hungry. Though they can’t say anything, we should
change the media and know that the cells are going to be in a good state, and then
your experiments will reflect the same state.
Nena’s remarks challenge her lab mates to consider how the end goals of their experiments
inform their means. For her, respect and sincerity are core values that shape her participation in
stem cell science and belief that such endeavors ought to hold sacred the value of cellular life.
--Waste prevention values are in abundant supply in Sutter’s Stem Cell Institute and evident
through various practices in which Dr. Moto’s lab members “care for the data” (Fortun and
Fortun 2005). Planning experiments, adhering to strict time schedules, requesting and using cells
efficiently, and caring illustrate how researchers do the best scientific work they can.

Understanding Good Science
“For me, doing good means helping people suffering from neurodegenerative diseases…
I believe that is the ultimate goal, to treat each other as nicely, as kindly as possible and
to do good.”
- Christine Moto, Sutter University Stem Cell Institute Principal Investigator and
REDEEM Biobank Director
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What remains unclear is how preventing the waste and misuse of frozen human embryos
relates to doing good science, as Simone and Dr. Moto describe it. According to anthropologists
Kim and Mike Fortun, “articulations of ‘good science’ must be rooted in a tradition of thought
and practice, even when intended to establish new agendas and open up new lines of work”
(Fortun and Fortun 2005: 47). Sociologist Charis Thompson’s recent study about stem cell
research in California clarifies the traditions and practices pertinent to the new agendas within
stem cell biology (Thompson 2014). My approach to “good science,” like the Fortuns’ and
Thompson’s, does not assert a value judgment about which scientists or scientific practices are
good, bad, ethical or otherwise; instead, I take interest in the role that “good” plays within the
daily efforts to save at Sutter University’s Stem Cell Institute.
Thompson, a professor at UC Berkeley, was an active participant in the public
engagement process following the passage of Proposition 71. In her book on the topic, she
describes three senses of the concept “good science.” The first two meanings refer to common
judgments of “good” circulating within scientific communities, specifically 1) science that is
considered to make a definitive contribution to the field and 2) science that is practiced
according to established procedures that adhere to values of transparency, accountability,
integrity, and replicability. Both are essential to the modern scientific enterprise, and are in some
sense “internal to the science itself” (Thompson 2014: 61). Dr. Moto’s lab members prove to be
sincerely motivated by these descriptors of good science. Each for their respective reasons came
to Sutter University to be among the finest thinkers and to work with cutting-edge materials on
visionary projects; Sutter is a place where many feel lucky and well positioned to make impacts
in their field. Whether driven by aspirations to be a leader in basic science discovery, translating
“bench” discoveries to “bedside” therapies, or biotech entrepreneurship, researchers at the Stem
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Cell Institute align their daily labors with norms and values about doing “good” science that are
the “sine qua non of a flourishing research environment” (Thompson 2014: 61). My observations
within Dr. Moto’s lab and conversations with researchers reveal that preventing waste is a core
value within stem cell science that shapes how scientists achieve these two types of good in their
work.
Thompson offers another perspective on “good science” that broadens the framework
beyond the normative values of science to include ethics and politics. Thompson’s third
definition of good science addresses the ways science engages with evolving regulatory ethical
considerations. Soon after the first human embryonic stem cell line was established in 1998, stem
cell research became embroiled in high profile debates about ethical mandates to save lives—
saving people living with debilitating disease on the one hand, and saving the frozen unborn on
the other. Thompson “followed the ethics” within California’s stem cell controversy and
identified two ethical “landscapes” that dominate the terrain: a “pro-cure” framework focused on
overcoming barriers to research with embryos and a “snowflake” framework dedicated to
protecting frozen embryos from destruction.37
The originators of the REDEEM Biobank navigated these ethical landscapes to establish
and open the bank for embryo donations. Within the pro-cure logic, REDEEM exemplifies
“good science” by managing an invaluable supply of human embryos that are ready for research
in accordance with guidelines set out by the National Institutes of Health, CIRM, and Sutter
University’s Stem Cell Oversight Committee.38 In other words, the Biobank helps overcome the
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In Chapter 4, I examine the other predominant framework articulated by the Blossom Embryo
Adoption program not as a “snowflake” ethical landscape, but through a familial notion of good
premised on Christian values of equality, dignity, and inclusion.
38
For history about Stem Cell Research Oversight committees, see Thompson 2014, especially
pages 35-36 and 106-107.	
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common obstacle of embryo supply within stem cell research. Simone’s wish that more people
understood how stem cell scientists regard and handle all types of cells, especially human
embryos, reflects the pro-cure framework of valuing embryos as scarce resources:
We all treat these things like gold. These are very precious samples. There’s no way we’d
be throwing things away or wasting. We collaborate, we group up, and we try to maximize
our resources. We take it very seriously. It’s an honor actually to work with human
samples because there’s so little.
The work of Biobank staff also conforms to the pro-cure landscape; like curators of art for
museums, they select, care for, guard, safely transport, and analyze valuables whose value cannot
be reduced to market prices (Thompson 2014: 37). As discussed previously, REDEEM embraces
pro-cure “ethical accounting procedures” to keep resources flowing to the Biobank—both CIRM
funding and embryo donations—and out of the bank to researchers’ Petri dishes.
Consider, though, what the accounting practices for the REDEEM Biobank might be if
the ethical landscape were framed by social justice, disability rights, health care access, or the
fair compensation of tissue donors. Or, as Ruha Benjamin suggests, was a landscape shaped by a
“people’s science” (Benjamin 2013). It is reasonable to wonder if REDEEM would even exist
within these other frameworks. Understanding the REDEEM Biobank as a product of a broader
ethical landscape, which has been forged through social, political, financial, and moral forces
beyond the researcher’s bench, clarifies the fundamental role of waste prevention within the procure ethical terrain. Preventing waste is evident through laboratory practices, but is exemplified
by the fact that excess embryos are saved at all, in this case for possible use by grateful
researchers in a contentious political environment. “Good science,” when seen through the lens
of ethical landscapes, proves to be a dynamic terrain comprised of neither fixed rules nor
practices; rather, “good science” is better understood as being contingent upon social tectonics
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and political winds, which are powerful forces that shape saving priorities.
--This section and the previous one showed that fertility patients and Sutter researchers
similarly regard frozen embryos as un-wastable and make efforts to prevent their waste. These
examples set up the beginning of a paradox that I explore below, which is how such treasured
leftovers become trash through the Biobank’s procurement practices. I argue that informed
consent procedures common to contemporary tissue economies do the work of “trashing” valued
biological materials in order to disentangle treasured tissues from their progenitors and ready
them for their promising futures as research materials. Specifically, REDEEM’s informed
consent process illuminates how embryos become “waste” by being severed from donor ties of
kinship and ownership, thus rendered available for new property claims by the biobank and
researchers.

On the Way to the Waste Bin: Trashing Treasured Embryos
“By conferring the category of waste upon an object, we must narrate its past and
speculate as to its future, an act of narration that attempts to chart the comings and
goings of utility, and necessarily, the passing of different orders and disorders.”
- William Viney, Waste: A Philosophy of Things
Dr. Moto established the REDEEM Biobank to serve as a repository for procured
embryonic materials awaiting scientific research. In REDEEM’s brochure for advertising
donation services, they express hope that embryo donations will facilitate “necessary” and
“important” research that could “produce valuable information” and “may some day lead to new
treatments” for adult diseases and infertility. In order to fulfill this mission, REDEEM facilitates
the categorical trashing of embryos in order to foster their donation and reclaim by researchers.
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How and why donated embryos become waste runs counter to common intuition in the United
States where the moral, ethical, and ontological status of embryos is actively debated (Berg and
Furton 2006; Brakman and Weaver 2007; George and Tollefsen 2008; Maienschein 2003;
Maienschein 2014). The previous section detailed many ways frozen embryos are regarded as
neither waste nor wastable in the eyes of fertility patients and stem cell researchers. Others
scholars have made similar observations. Catherine Waldby and Robert Mitchell discuss
donating “spare” embryos in the U.K., which they argue are “emphatically not waste” due to
their “ontological significance” as the beginnings of human life (Waldby and Mitchell 2006: 84).
I suggest as emphatically that donated frozen embryos are paradigmatic forms of waste. A close
examination of the REDEEM Biobank’s informed consenting process makes visible the ways
donated frozen embryos become trash as a mechanism for becoming new forms of treasure.
Rubbish theorist Michael Thompson (1979) helps clarify how frozen IVF embryo are
exemplary forms of waste. Thompson, a student of Mary Douglas’s, makes the astonishing claim
that waste is a “realm of pure potential” (quoted in Squier 2004: 207) as opposed to the
commonly held understanding of waste as absent of value and vacant of purpose. He comes to
this conclusion by examining how value operates with respect to transient objects (whose value
declines over time) and durable objects (whose value endures over time), like antiques and
junkyard cars. For objects to shift categories, he argues that they enter the third realm of rubbish,
a “transformative category” that functions like a “machine through which objects acquire new
values and properties” (Ibid.). In other words, waste is a category that facilitates the production,
conversion, and redemption of value.39
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I dispense with some aspects of Michael Thompson’s fruitful argument in the making of my
own. Thompson argued that value converted from transient to durable forms by passing through
rubbish in one linear direction. I maintain a more open-ended, multi-directional, and messy
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Frozen embryos, figures of pure potential in the realm of IVF clinics, find a classificatory
companion in waste. Once IVF remainders are donated to REDEEM, they are transformed into
research materials banked for their potential to generate promising futures. IVF embryos are
wasted through processes of informed consent that are designed to sever the social relations and
property ties between donors and embryos. By conferring donated embryos to the category
waste, they become available for reclamation and reuse.

Informed Consent: How Embryos Become Waste
“The moment when magic is required is when scientists try to cut one network
and make possible another network, a scientific network.”
- Warwick Anderson, “The Frozen Archive, or Defrosting Derrida”
Simone is concerned that many non-scientists misunderstand how IVF embryos that were
made for pregnancy become research materials intended for experimentation. She worries that
people believe IVF embryos and experimental embryos are the same while she recognizes them
as categorically distinct. “They think that there is just this pool of embryos and they could
potentially be implanted [into uteruses], but here we [scientists] are using them to generate lines
because we think it’s so important.” Simone wants people to know that the leftover frozen
embryos stored in the Biobank and used in experiments “were never going to be put back into a
female or destined to become a baby.” Instead, she understands that the original intended
purpose of IVF embryos expires at the time of donation to the Biobank, which renders the
embryos available for repurposing by scientists. Most of the researchers, students, and staff I met
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
awareness about the transient forms value takes for any entity with respect to matters of place
and time. Also, Thompson argued that rubbish is a category of zero-value, yet a realm of pure
potential. This dissertation utilizes a more capacious notion of value that sees the contentious
multiplicity, rather than a zeroing, of value, especially values associated with markets and
moralities.
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at Sutter University regard frozen leftover embryos in the same way Simone does: as being on
the way to the waste bin.
REDEEM’s informed consent procedure reflects the common refrain expressed to me
around the lab that Helena captured well: “Leftover embryos would just be discarded or
incinerated anyways, so why not use them for good?” A brief history of what informed consent
procedures are designed to do clarifies how the category waste is conferred upon frozen embryos
when donated and the role waste classifications play within two related outcomes—the
dispossession of donors and disentanglement of embryos.
Informed consent became a standard process in the twentieth century within U.S.
scientific research involving human subjects. The principles of informed consent were enshrined
in international human rights conventions as early as the Nuremberg Code of 1947, as well as
national commissions, such as the Belmont Report of 1978. It is one of the core bioethical
principles that strives to protect patient autonomy and prevent risk to research participants.
Moreover, informed consent procedures are commonly described as providing subjects
information about risks, rights, and benefits as well as the opportunity for them to give or deny
consent for participation.
Critics of bioethics describe various functions other than protecting patient rights that
informed consent procedures perform. For instance, legal scholars argue that informed consent
forms were first developed to mitigate risk for medical professionals rather than being an
instrument for protecting the rights of patients. The first informed consent forms were used in
U.S. clinical trials in the 1940s and 1950s in response to worries of litigation from research trial
participants. As a result, some conclude that informed consent procedures provide medical
professionals a “state of exception” wherein patient rights are reduced rather than expanded (e.g.,
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Menikoff and Richards 2006 quoted in Cooper and Waldby 2014: 143).
Once fertility patients decide that they want to donate leftover embryo for research, they
are required to sign two forms indicating their consent: one for the IVF clinic and one for the
Biobank. At Harrington Fertility’s Paloma clinic, patients make their first disposition decisions
prior to beginning IVF by marking in the thirty-page informed consent form their wishes for
their embryos should the patient experience death or divorce. To notify the clinic about
disposition desires after IVF, Harrington patients are asked to submit the two-page Disposition of
Frozen Embryos form along with their final cryopreservation bill. Patients who decide to donate
their remaining IVF embryos to REDEEM need to fill out a six-page informed consent form
available for download from REDEEM’s website. Once submitted, the Biobank confers with the
fertility clinic to coordinate shipping of the frozen remains to the lab.
Each document captures a different angle on the same process of donating IVF embryos
for laboratory research. In places, they echo similar language and serve as legal contracts to
protect all parties. What intrigues me is their difference. A comparative reading of the clinic and
tissue bank embryo disposition forms shows how waste serves as a useful category for donating
embryos to scientific research. My attention to seemingly innocuous, even dull, paperwork
extends the argument from Chapter 2 that documents produce things (Frohmann 2008).
Specifically, I am interested in the production of leftover embryos as clinical waste within the
Biobank’s consent literature, and specifically the classificatory language that frames frozen
leftovers as already en route to becoming waste. To use Warwick Anderson’s turn of phrase, this
analysis lays bare the processes behind the “magic” of transforming embryos into trash because
they are so treasured.
At first look, Harrington and REDEEM’s consent forms for donation share many
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qualities. Each are lengthy legal documents organized by boldface titles and lettered categories
about “Embryo Disposition” directing signers to “Initial Here” and “Choose One.” Each opens
with a statement that narrates the original intention for IVF embryos, which they agree is to help
patients become pregnant. And each describes IVF as a process through which “materials” are
made to assist with pregnancy. After IVF, they acknowledge that some patients face decisions
about “discarding” what are described by each as “excess” embryos.
Here is where they began to differ. Harrington’s forms approach the “additional”
embryos that “may remain in the lab after the transfer is complete,” noting that the
cryopreservation of leftovers is common. The forms communicate that Harrington follows
national guidelines to help “curtail the problem of multiple pregnancies” by limiting the number
of embryos they transfer at one time. How many embryos are transferred at once, which impacts
how many remain after the IVF cycle, is determined by “the developmental stage of the
embryos,” their “quality,” as well as the patient’s personal history. Depending on the
“developmental normalcy” of the untransferred embryos, “it may be possible to freeze them for
later use.” The embryos to be frozen are described as “second-best,” and their “viability to
provide additional chances for future pregnancy” is determined by clinical probabilities as well
as by patients’ “choices” and “future wishes” for future thaw and transfer.
REDEEM’s form also evokes the notion of clinical viability, yet reframes embryos
through waste and need. REDEEM describes IVF as a technique that produces some “nonviable”
cells “in excess of clinical need… which may not be further required for your treatment.” Prior
to detailing the options patients have for donating the IVF materials they “no longer require,” the
consent form echoes the sentiment common among stem cell scientists that embryos are en route
to becoming trash. REDEEM donors are made aware that: “All cellular materials to be used in
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this research would normally be discarded because you, the patient, have chosen to discard the
material.” This language articulates a kind of embryo that was already a form of waste, even
prior to donation.
In a fertility clinic, leftover embryos are perched in a place where their potential to
become many things is vibrantly alive whereas a tissue bank for research identifies embryos as
already en route to the medical waste bin. On Harrington’s disposition form, patients and their
partners initial boxes next to an open-ended list of options that depend on their “desires for future
use” of their frozen remains. These potential trajectories contrast with REDEEM’s specific
vision of the future predicated on the needs and desires of science. The Biobank’s form invites
patients to consider the “opportunity” of donating “unusable biological materials” that they “no
longer require” to researchers at Sutter University. Rather than let embryos “go to waste,” as
they say on their website, the REDEEM Biobank frames embryos as clinical waste to justify
their procurement as IVF byproducts. Making use of invaluable materials that are as good as
trash provides the opportunity for the Biobank to transform them into treasures.

Severing Ties: Disentangled Embryos and Dispossessed Donors
Frozen IVF embryos are profoundly “entangled” entities (Callon 1998) within multiple
webs of relations and intersecting ties of kinship, ownership, and stewardship (Haraway 1997;
Hayden 2007; Strathern 2005). Entangled entities may circulate within networks, though some
are more strongly grasped and bound by connections that are sustained even when seemingly
given away (Weiner 1992). Frozen embryos offer a striking example of a kind of entity whose
alienability—or ability to be disentangled—is essential to scientific research and hard won, if
ever fully (Svendsen and Koch 2008).
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The Biobank’s donation protocol allows donors to have continued connections with
donated embryos in some notable ways. Upon donation, donor information is made anonymous
to protect identifying information and donors are made aware that they will not receive
information about study results from the use of their embryos. But on the consent form,
REDEEM donors have the opportunity to be re-contacted by researchers at an unknown future
date for two reasons: to be asked for additional health information or to receive genetic
information that investigators learned from testing on their cellular materials. Based on
unpublished research Donna and I conducted on consenting trends at REDEEM between October
2010 and March 2013, more than half of the 841 consented donors during that period wished to
be re-contacted to give health information (57.2%) or to receive genetic information (62%). It is
difficult to qualify these numbers without having the opportunity to ask donors themselves why
most opted to keep contact open with Sutter around health and genetic information. If one looks
to other kinds of donations, such as of eggs, sperm, and embryos for procreation (Almeling
2007), or organs (Sharp 2001), the reason may be simple: some people wish for any information
about their biological matters when anonymity remains the status quo within tissue economies
(Everett 2007).
Another pathway REDEEM provides donors for remaining bound through kinship and
ownership with their embryos involves the standard human subjects protection of being able to
withdraw from the research at any time. When signing the consent form, donors agree to let their
embryos be manipulated and destroyed at some point in the future by researchers at Sutter or
elsewhere. Yet even once embryos are shipped and stored within the Biobank, donors can
withdraw consent and pull their embryos from the bank at any time prior to the release of their
embryos to researchers. Written into REDEEM’s consent is a narrow window of opportunity
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available to donors should they wish to reclaim responsibility for their embryos.
Over the five years since the Biobank opened, only once has a panicked donor called
requesting her embryos back. Six months passed when she realized that she made a “terrible
mistake” and wished to use them for another try at pregnancy. The Biobank agreed to return
them and even agreed to pay the $300 shipping, but the donor’s fertility clinic was not
comfortable taking back the embryos because of risks like cross contamination by other stored
samples. As a solution, Dr. Dunn invited the donor to become a patient at Sutter’s IVF clinic
where they offered to perform the frozen embryo transfers she wished to have. I first heard this
story while on a walk with Wendy one afternoon as we brought an empty cryotank to the FedEx
drop site near the campus medical center, though the story would be repeated to me a few more
times by Dr. Dunn, Dr. Moto, and other researchers. The Biobank’s generosity in this account
presents them as helpmates for fertility patients, aware of the tender ties that may linger with
their donated matters, and not an indifferent bioprospector of IVF patients’ embryonic gold.
Despite these examples, informed consenting processes disentangle embryos from donor
ties. At REDEEM, the consent process serves as a “magical” mediating force that severs the
relational network between donor and recipient (Strathern 1996) in order to make possible, as
Anderson described above, a new scientific network. Once consents are finalized and embryos
are considered officially donated, a series of shifts occurs: embryos are declared forms of
“unimproved waste,” severed from historically relative ties of belonging (Rabinow 1996b),
rendered a microscopic terra nullius awaiting productive cultivation in vitro, and hitched to new
speculative futures through mechanisms that transform their potential. Informed consent protocol
helps catapult embryos “out of time” (Viney 2014) by loosening the strong grips of kinship and
ownership through which they originate. Disentanglement allows clinical embryos to become
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anonymous research materials that are freer to circulate to researcher Petri dishes without the
burdens and liabilities of their histories in tow. In these ways, the trashing of embryos dovetails
with dispossessing donors.
One tie most surely severed through embryo donation is the possibility of donors to claim
profits from the promising potential embryos might manifest. In the language of the REDEEM
Biobank consent form, donors read on page two that researchers—not donors—can own and
profit from experiments utilizing donated embryos:
Any materials you have donated to research, or results of research including new
products, tests or discoveries, may be patentable or have commercial value. In
some instances, research results may be developed and owned by the
Investigators, Sutter University, and/or others. Under California law and rules, if
you consent to donate materials to the biobank, you will have no legal or financial
interest in any commercial development resulting from the research.
This kind of language is typical of tissue procurement around the United States and characterizes
the “implosion” (Sunder Rajan 2006) between the life sciences and capital starting in the 1970s.

Embryo Cryocapital
The postwar engine for the U.S. economy began to sputter in the late 1960s and early
1970s, followed by mounting economic crises and forecasting literatures about possibilities for
postindustrial economic growth. The emergent neoliberal project played a decisive role in
fostering the biotech revolution and growth of life sciences. The advent of recombinant DNA in
the 1970s, more commonly known as tissue engineering (Rabinow 1996a), and the opening of
the first genetic engineering company, Genetech, shifted scientific attention to the molecular and
reprogrammable body. This redirection incited both anxiety and exhilaration as the “gold
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standard” (Brodwin 2000) in biology of the integrated, whole body was superseded by newer
forms of value extracted from fragments of biological tissue.
By the 1980s, the Reagan administration dramatically increased federal funding for
research and development in the life sciences, which directed funds away from social services
toward private industry. The Reagan administration also reformed intellectual property law in
support of patenting new biological products. The Patent and Trademark Act of 1980, or the
“Bayh-Dole Act,” responded to waning industry innovation and patent production by
encouraging new public-private alliances that allow publicly funded researchers to patent their
inventions, which they could license or sell to private industry. The hope was that capital
investment in the life sciences would rejuvenate America’s “inventive spirit” and ensure that
“innovations, whatever they might be, were constantly channeled into economic growth”
(Waldby and Mitchell 2006: 104). Narratives of profit-driven salvation imbued biotechnologies
with messianic promise to resurrect the American economy. The “spirit of biocapitalism” in the
late twentieth century was enlivened by a “born-again ethic” of gambling, chance, and excess
(Sunder Rajan 2006: 199).
The 5-4 Supreme Court ruling in Diamond v. Chakrabarty40 gave the increasingly
“intense traffic” (Rabinow 1996a) between capital and the life sciences enhanced significance.
The case arose when General Electric microbiologist Ananda Chakrabarty appealed the denial of
his patent claim for a genetically engineered bacterium able to consume and digest oil slicks. In
review of the criteria for patentable inventions, which required them to be novel, useful, and nonobvious, the U.S. Supreme Court determined that the critical line of demarcation for a patentable
invention was not between living and non-living matter, but between naturally occurring and
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Diamond v. Chakrabarty, 447 U.S. 303 (United States Supreme Court, June 16, 1980)
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fabricated entities. In their words, “Congress intended statutory subject matter to include
anything under the sun that is made by man” (Rabinow 1996b: 132). Their ruling in favor of
Chakrabarty paved the way for the patenting of and profiting from genetically engineered plants,
oysters, OncoMouseTM, and ultimately, human cell lines.41
Such administrative, legal, and economic events of the 1970s-80s fostered conditions for
new tissue economies characterized by capital investments in life technologies and their
promising forms of profit. Moreover, leading scholars of biocapital—or the novel life-forms and
forms of value generated by the impolsions between capital and the life sciences—agree that
“life itself” has become increasingly “isolated, delimited, stored, accumulated, mobilized and
exchanged, accorded a discrete value, traded across time, spaces, species, contexts, enterprises”
(Rose 2006: 7).
Yet most theorists of biocapital limit their understanding about the intense traffic between
capital and the life sciences by emphasizing capital in production, or industrial biocapital. As a
result, little attention has been paid to the impact of finance and speculative logics at
bioeconomic junctures. Frozen embryos and other reproductive remainders serve as a useful
vehicle for understanding forms of biofinancial practices that increasingly characterize global
reproductive technologies. For instance, frozen embryos banked by REDEEM are, in the
language of venture capitalists, “upstream” materials that may one day lead to “downstream”
therapies and profits (Sunder Rajan 2006). The promise of human embryonic stem cells hinges
on the perception of their “biovalue,” or the presumed latent “capacity of tissues to lead to new
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  In 1987, the Assistant Secretary of Commerce and Commissioner of Patents and Trademarks
issued this memo about the patenting of human biological parts: “A claim directed to or
including within its scope a human being will not be considered to be patentable subject matter”
(Cooper 2008: 146). John Moore’s “waste” spleen tissue was already patented in 1981 (patent
number 4,438,032) and pluripotent human embryonic cells were first patented in 2001 (patent
number 6,200,806).
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and unexpected forms of value” (Waldby and Mitchell 2006: 108). The “aura of potential value”
assigned to frozen embryos increasingly renders them “negotiable assets” for public and private
enterprises (Waldby and Mitchell 2006), and therefore a novel species of speculative biocapital.
Activities within Sutter University’s Stem Cell Institute exemplify the financialization of
the life sciences begun decades ago and the increasing difficulty of distinguishing basic research
from speculative profit. Dr. Moto, for instance, is an exemplar; an amply funded academic
scientist, she is also the innovator behind four startup companies. One company has raised over
$45 million in venture capital, employs more than 100 people, and is currently licensing a
technology for use in IVF embryology labs. Similarly, though the REDEEM Biobank is funded
by public grants, the bank receives embryo “wastes” to be used in experiments that Dr. Moto and
her lab members have already utilized to develop patent applications. Also, the Institute’s stem
cell biology Ph.D. program offers a distinctive mixture of basic science training with
translational medicine and entrepreneurial opportunities for students. How the program links
science and the biotech industry within academic training may model how the nascent field of
stem cell biology will shift in training future leaders.
--Informed consent plays a key role in serving commercial interests in the life sciences by
severing donors’ ties to their invaluable materials and making them available for scientific patent
and profit. Consider the Moore v. Regents of the University of California case, which was among
the first legal considerations in the United States of whether a living person has property rights in
his or her extracorporeal body parts. In 1984, John Moore filed suit against Dr. Golde and his
associates of the University of California who developed and patented the multi-billion dollar
“Mo” cell line from Moore’s rare excised spleen cells. He consented to the surgery that removed
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his tissue, but not to the use of the “waste” tissue in research. The case made its way to the
California Supreme Court where two things happened: Moore’s ownership claim to the cells
removed from spleen in a clinical procedure was denied while the University’s patent hold on the
“Mo” cell line was upheld. The Supreme Court majority opinion argued that it was better not “to
force the round pegs of ‘privacy’ and ‘dignity’ into the square hole of property in order to protect
the patient” (Rabinow 1996b: 141), though many have questioned how such a ruling protects
patient rights against such exploitations. While John Moore could not lay claim to owning his
bodily tissues, the University of California could. Since the Moore case, informed consent forms
like REDEEM’s now include language about tissue donors having “no legal or financial interest
in any commercial development resulting from the research.” While informed consent adheres to
many ethical principles, it also collaborates with the profiteering of science and industry by
providing the “enabling regulatory conditions for the market” (Cooper and Waldby 2014: 14).
Highly treasured leftover IVF embryos are put into the trash—categorically speaking—at the
same time donors are dispossessed so that clinical wastes become available for property claims
allegedly foundational to scientific research and development.

Trashing for Good
“Making an embryo into waste is an outcome not a by-product.”
- Charis Thompson, Making Parents: The Ontological Choreography of
Reproductive Technologies
What is the strategic utility of “wasting” frozen embryos otherwise regarded as
precious and invaluable? The classification of remaining IVF embryos as waste at the
time of donation renders them available to the “procure/pro-cure” practices of stem cell
research in the name of good science. In this light, classifying donated embryos as
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clinical waste situates REDEEM Biobank within a salvational hue as an institution that
makes respectful use of something no longer needed for its original purpose. Simone
shared what was a common sentiment among her lab mates:
Instead of being thrown away, that’s where the scientists will say, ‘No, don’t
throw them away. Give them to us.’ Instead of throwing them away or discarding
them, they are being used for these critical, insightful scientific studies… They
were destined for the garbage and then scientists are using them… They are very
precious things because we can address really critical things about human
development that we couldn’t otherwise address if we didn’t have access to these
discarded samples.
By framing embryo procurement efforts as recycling society’s nearly wasted treasures on
behalf of the greater scientific good, the REDEEM Biobank positions itself as an ethically
oriented organization at a critical juncture between a good and a wasteful society. Recall the
mission-driven language of REDEEM’s brochure advertising donation services, such as the hope
that embryo donations will facilitate “necessary” and “important” research that can “produce
valuable information” and “may some day lead to new treatments” for adult diseases and
infertility. When IVF embryos are at risk of being destroyed without study, the Biobank and its
affiliated researchers emerge as redeemers who respond ethically through making good use of
valuable resources.
In another light, REDEEM Biobank operates as a kind of “waste-exploiting club,” to
borrow O’Brien’s phrase about life within rubbish societies. The Biobank leverages the category
of waste to bestow potential value on embryos conceived by researchers as untapped resources
and timely assets (Ferry and Limbert 2008). Like other forms of waste within rubbish societies
and tissue economies, embryos donated to the Biobank become “simply another raw material”
that can be turned into profit with the help of “modern day alchemists” (O'Brien 1999: 281).
Biobank staff contribute to the alchemy by allying with Dr. Moto’s lab members who are in a
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“search to renew, revitalize, refurbish and reaffirm the value of something that appears,
superficially, to possess no value” (O'Brien 1999: 282). As detailed above, the informed consent
process, including dispossession and disentanglement, facilitates such endeavors to spin straw
into gold.
As one of the only active tissue repositories for all types of leftover IVF embryos in the
United States, REDEEM Biobank’s recycling work plays a key role within what I describe as the
reproductive waste sector: the political economy of regenerative tissue that organizes labor,
adjudicates different systems of value, structures the articulation of values within and between
institutions, and manages complex controls, consents, and conditions for accessing biological
resources defined as waste. Within this sector, waste serves as a strategic and necessary passage
point in the process of tissue donation, a role that Lynn Morgan (2009) reveals to have been in
place for over a century.
Morgan’s study of early twentieth century embryo-collecting projects provides a
comparative example and historical context for understanding the role of waste within
reproductive tissue economies. Before prominent embryologists spearheaded a national embryocollection network, women typically discarded miscarried and aborted fetuses in unceremonious
ways through burial in the backyard or by tossing down a privy. In order to secure the flow of
precious reproductive remains to his Baltimore lab, Franklin P. Mall and other embryologists
collaborated with state officials to ensure the classification of embryo and fetal remains as
“medical waste” rather than corpses based on their assurance that the remains would be “put to
good use” by researchers (Morgan 2002; Morgan 2006). In both examples of being “wasted,”
dead fetal tissue of the early twentieth century and frozen IVF embryos in the early twenty-first
century became “constitutive tissues” as a result of moving within the reproductive waste sector.
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Constitutive waste tissue contains the promise of value as well as a “precondition for producing
‘the new’” (Waldby and Mitchell 2006: 109), which returns us to the idea of waste as a space of
pure potential.
Conclusion
This chapter examined what appears initially to be a series of paradoxes: that Sutter
University’s Stem Cell Institute is a place where there exists destruction without destroying,
sacrifice without sacrificing, and waste without wasting. The strikingly simple definition of
waste I encountered in the online tutorial during my first week in Dr. Moto’s lab—as materials
that are no longer needed for their intended purpose—betrayed what I came to realize about
waste, which is that it is no simple matter.
I began the chapter with descriptions of sentiments and practices that revealed how fertility
patient donors and researcher recipients similarly regarded embryos as emphatically un-wastable.
In doing so, waste came to seem like a classificatory companion for frozen embryos rather than
their opposite. Like frozen embryos, wastes are neither stable nor neutral categories nor
singularly identifiable as object, person, or place. Both function as liminal forms where values
intersect and differently operate as matters out of place as well as time. Moreover, each is
suspended within realms of pure potentiality. The qualities shared in common between waste and
frozen embryos inspired my claim that frozen IVF embryos—those supremely un-wastable
entities—are paradigmatic forms of waste. Within California’s pro-curatorial ethical landscape,
preventing the misuse of waste is a core value that shapes how stem cell researchers “do good
science.” The processes through which REDEEM Biobank “wastes” treasured embryos without
wasting them illustrate how fundamental saving is to the daily rigors of stem cell research.
To conclude, I consider what the cigarette collector on the edges of Sutter’s campus offers
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to my considerations about saving, value, and potential in this dissertation. Though I never spoke
with him directly, my encounter with this man on the fringes of the Stem Cell Institute provoked
my curiosity about alternative stories to the familiar one about Sutter University as a center of
power fueled by a moral and political mandate to save lives. For whose bodies and which lives
are novel therapies being developed? How may communities benefit—economically, medically,
socially—from the trickle-down logic of investing in the promise of stem cell science? What
would it take for historically marginalized populations, as racial justice health activist Joseph
Tayag asked, to “be taken off the table and brought to the table” (Benjamin 2013: 41)?
These questions assume greater poignancy when considering the wider context for
Proposition 71’s passage, the $3 billion investment by the voters of California in the promise of
stem cell science to generate curative therapies and regenerate the flailing state economy.
According to supporters, part of the proposition’s appeal was that it claimed to be able to close
the gap on disease, minimize long-term health expenses, and serve as an “economic engine for
California’s future.”42 At the outset, Proposition 71 seemed like a real contender for delivering
on its promises and democratizing stem cell research as a publicly informed “people’s science,”
which is a noteworthy achievement in an era of commercialized science (Benjamin 2013). The
voter initiative passed by a landslide margin of 59 to 41%, signaling the beginning of a new
social contract between scientists, entrepreneurs, and the people of California.
This massive state investment in stem cell research came at a precarious time in
California’s financial and social stability: the state budget deficit had surpassed $16 billion;
housing foreclosure rates ranked among the highest in the nation; more than 1 in 5 Californians
were living without health insurance; and the income gap continued to widen (Benjamin 2013:
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
42
See the text of Proposition 71, the “California Stem Cell Research and Cures Initiative of
2004”: https://www.cirm.ca.gov/sites/default/files/files/about_cirm/prop71.pdf
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12). Poor and other historically marginalized communities disproportionately carry the weight of
California’s economic burdens, adding urgency to concerns about how the benefits of stem cell
research would reach communities in need. Additionally, Proposition 71’s success at the ballot
box obscured the failure of Proposition 72, a law that would have extended health insurance to
working classes of under- and un-insured people. Investing in the potential of medical
breakthroughs in a state where access to basic health care remains insecure reveals a tension
between banking on the promises of tomorrow and redistributive justice for the public goods of
today. The procuratorial ethical landscape that focuses attention on the rigors of doing good
science diverts attention from other “goods” within which $3 billion state dollars could be
invested. For instance, the underlying causes of health disparities, if systemically acknowledged
and redressed, could also save myriad lives.
This line of inquiry provokes questions about which lives matter, and which are wastable.
At the time of writing this dissertation, the Black Lives Matter movement catapulted such
questions onto the national stage where demands for an end to the systemic violence against
African American communities are building unprecedented momentum. As this topic assumes
increasing significance extending well beyond fixations in California with saving life, procuring
valuables, and preventing waste, many people’s lives—including the cigarette collector’s whose
name I never learned—are implicated in the activities within the laboratories of Sutter
University’s Stem Cell Institute. The next chapter shifts from waste to consider the logic of
rescue that informs the saving efforts within the Blossom Embryo Adoption program. It begins
with a story about the politics of life, value, and abandonment in the context of national disaster.
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CHAPTER 4:
Rescuing: Making Embryo Orphans in a Christian Adoption Program
rescue (v)
a. to prevent someone or something from being lost, abandoned, or damaged
b. to deliver from evil, trouble, or harm; e.g., salvation
c. to set free or liberate those enchained or at risk

By the time Hurricane Katrina made landfall on the morning of August 29, 2005, staff of
the Fertility Institute of New Orleans topped off their cryopreservation tanks with liquid nitrogen
and relocated fourteen hundred frozen embryos from the first to third floor of their Lakeland
Hospital clinic. Within hours, power lines were down. Days later, floodwaters from broken
levees swelled eight feet into the hospital’s ground floor. The embryos in storage would have
been safe from the sweltering August heat for twenty-seven days, though danger mounted
quickly for the survivors of the storm left behind. Adding insult to the injured city, forecasts of
tropical storm Rita loomed on the horizon.
On September 11th, the Fertility Institute’s lab director Roman Pyrzak led a team of state
troopers into the flooded hospital with one mission in mind: rescue. One meaning of the word
involves the prevention of things from being lost, abandoned, or damaged (OED). This is what
Pyrzak meant when he proclaimed to reporters, after leading the successful relocation of fourteen
hundred embryos by boat to another hospital on higher ground: “I’m the guy who rescued those
embryos” (Reid 2007). In anticipation of the monster storm, the Fertility Institute implemented
their emergency preparedness protocol to mitigate the loss of their clients’ frozen assets (Dickey,
et al. 2006). Once the levees broke, Dr. Brenda Sartor contacted her state legislator seeking help:
“We were troubled about the embryos and how we could easily access the hospital. The city was

149

still in lockdown mode, and we knew it would have to be coordinated through a civil authority”
(Goldenberg 2007). Her request made it to the desk of Louisiana Governor Kathleen Blanco,
who dispatched troops and trucks to rescue the clinic’s frozen embryos. (See Figure 8)

Figure 8. Louisiana State police officers rescuing frozen embryos from Hurricane Katrina
floodwaters43

Such rescue stories from post-Katrina New Orleans operate, as historian Karen Dubinsky
notes, to “smooth out or even submerge complicated political issues under the veneer of
sentiment” (Dubinsky 2010: 44). The rescue of frozen embryos from Pyrzack’s clinic stands in
stark relief to the social abandonments that informed who survived and who died in the wake of
the storm, or what social critic Henry Giroux calls a “biopolitics of disposability” (Giroux 2006).
The abandonments in New Orleans glossed by stories of rescue are well known. Media reports
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Photo originally published in Fertility and Sterility (See Dickey, et al. 2006).
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about the devastation befalling New Orleans circulated unforgettable images that exposed the
“ruts of social difference” (Smith 2005) eroded by the hurricane and floods. These ruts rendered
certain populations of New Orleans—namely poor, African American, elderly, and ill people—
extremely vulnerable to abandonment after the storm. Images emerging from the devastated delta
depicted people stranded on rooftops and barren highways, crowded with low food and water
supplies in the Superdome, delivered so-called relief by rifle-wielding military, and floating dead
in the toxic floodwaters. According to then-Senator Barack Obama, the residents of New Orleans
were abandoned not just during the disaster but long before through the ravages of extreme
poverty, racial segregation, and governmental neglect that characterized the city well before
Katrina. While rescue was at work in the delta cultivating notions of worth and value,
abandonment operated too.
I endeavor to “go deeper than ‘rescue’” in this chapter, as historian Karen Dubinsky
encourages, in order to explore how embryo potentiality is valued within submerged and
complicated Christian life-saving politics. I begin with the flooded Louisiana delta because it
highlights the coincidence between rescue and abandonment that is also evident within the
practice of embryo adoption. Through the lens of saving, I examine the prominent role of rescue
in efforts to place IVF embryos for adoption through the Blossom Embryo Adoption program of
Pacific Christian Adoptions agency. I describe the beginnings of the Blossom program and
situate them within traditions of humanitarianism and responsibility. Rescue facilitates the
making of an orphaned embryo crisis for which embryo adoption is presented by pro-life
Christians as the moral solution to the problem of IVF’s cheapening of life. Despite the appeal of
embryo adoption being a responsible act for Blossom donors and adopters, I discuss their
criticisms of the abandonments entailed in the embryo orphaning process. Lastly, I argue that
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race and gender politics are integral to cultivating frozen embryos as cultural innocents worthy of
rescue.
This chapter also illuminates the parallel functions that rescue and waste serve within
American saving politics. Blossom emerges, like the REDEEM Biobank, as a program in the
business of salvaging reproductive leftovers and repurposing frozen treasures for future use.
Christian strategists and stem cell biologists mobilize IVF surpluses to forward life-saving
missions that sustain visions for redeeming life in America. The lens of saving shows how rescue
and waste management are similarly dedicated to “doing good” by stripping embryos from their
IVF origins so that their potentiality can be realized anew.

Embryo Salvation
“We are dealing with the seeds of the next generation.”
- President George W. Bush, Speech delivered on August 9, 2001 about federal funding for
human embryonic stem cell research
Another kind of rescue mission brewed in the aftermaths of Hurricane Katrina that
expresses an alternative meaning of rescue—as salvation through deliverance from evil or harm.
Robert George and Christopher Tollefsen begin their philosophical case for “embryo
personhood” with a story about Noah’s rescue from the flood:
Noah Benton Markham's life had been jeopardized by the winds and rain of
Hurricane Katrina. Trapped in a flooded hospital in New Orleans, Noah depended
upon the timely work of seven Illinois Conservation Police officers, and three
Louisiana State officers who used flat–bottomed boats to rescue Noah and take him
to safety. Although many New Orleans residents tragically lost their lives in
Katrina and its aftermath, Noah's story of rescue is, nevertheless, one of many
inspirational tales of heroism from that national disaster. What, then, makes it
unique?... The answer is that Noah has the distinction of being one of the youngest
residents of New Orleans to be saved from Katrina: when the Illinois and Louisiana
police officers entered the hospital where Noah was trapped, he was an embryo, a
human being in the very earliest stages of development, frozen with fourteen
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hundred embryos in canisters of liquid nitrogen. Noah's story had a happy ending:
Noah's parents were overjoyed those sixteen months later [on January 16, 2007]
when Noah emerged, via cesarean section, into the light of the wide world. His
parents named him in acknowledgment of a resourceful survivor of an earlier
flood… In later years, if Noah were to look back to that troubled time in New
Orleans and ask himself whether he was rescued that day, whether it was his life
that was saved, we believe that there is only one answer he could reasonably give
himself: "Of course!" (George and Tollefsen 2008: 1-2)
As the only state in the nation to legally accord embryos the status of “persons,” Louisiana is a
fitting birthplace for Noah’s rescue story.44
Since Katrina, right-to-life proponents have mobilized Noah’s birth to argue for extending
the legal rights of persons to the moment of fertilization. They argue that the half million frozen
IVF embryos stored across the United States are at risk of drowning in the metaphorical
tidewaters of indifference, or, more nefariously, at the hands of stem cell scientists who consider
their use in research justifiable for the greater good. Embryonic stem cell research, according to
George and Tollefsen, is “one of the most morally and politically troubled issues of our day”
(2008: 3). They use Noah’s story to leverage one national disaster in order to make a moral case
for delivering embryos from the grips of what they perceive to be another: the destruction of
human embryos regarded as persons.
George and Tollefsen consider the threat brought upon frozen embryos in a devastated
New Orleans hospital to represent the danger that all frozen embryos in cryostorage currently
face: “It cannot be denied that there are many more persons in precisely the same predicament as
was Noah, and whose need for rescue is independent of the contingencies of the weather”
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Louisiana passed revised statutes in 1986 defining IVF embryos as “juridical” persons, a
category more commonly utilized for corporations. Louisiana is the only state in the U.S. to
accord special legal status to embryos. The law stipulates that once frozen, embryos cannot be
discarded or donated to scientific research but thawed only with the intention of being transferred
into a uterus (LA Rev Stat § 9:133, 1986).
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(George and Tollefsen 2008: 217). In the final pages of their book, George and Tollefsen
champion embryo adoption in their “Cultural Proposal” for “address[ing] the fate of the millions
of embryos currently trapped in cryopreservation” (George and Tollefsen 2008: 216).
Tim Shoener, the Executive Director of Pacific Christian Adoptions45 and originator of the
Blossom Embryo Adoption program, could not agree more. He helped initiate the world’s first
embryo adoption program as a solution to a perceived social need. “I think there is a problem,”
Tim explained.
Part of the problem is as a society we are valuing life less and I think one of the symptoms
of that is 500,000 embryos frozen that we, as a society, have commodified because it’s
more economical. There’s an attitude in IVF that as long as you are doing it, you might as
well make it by the dozen. But life isn’t cheaper by the dozen. Embryo adoption is a
movement to remind people that life begins at conception.
The Blossom Embryo Adoption program was established in 1998 from the desire to rescue those
left, literally and figuratively, in the cold. Rescuing embryos is one way pro-life Christians may
redress the moral problem in American society of devaluing life.

From Seed to Bloom: The Origin of the Blossom Embryo Adoption Program
“I was adopted as a seed and put in my mommy’s tummy to grow.”
- Rachel Dryler, First child born through the Blossom program
The following narrative is a composite story that describes how the Blossom program
originated, based on perspectives shared with me by various embryo adoption professionals and
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
45	
  Tim served Pacific as Executive Director for nineteen years (1994-2013). After finishing law
school in in 1973, Tim worked in the private medical device sector before opening a private
adoption practice after being asked by his pastor to assist some friends with legal aspects of an
adoption. In 1994, he established Pacific Foundation and joined Christian Adoption and Family
Services as the Executive Director in 1995. Under Tim’s leadership, the foundation and agency
merged in 2000 as Pacific Christian Adoptions where Tim would stay until retirement in 2013.
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program participants during field research between June 2008 and April 2013.

A Program takes Root to Revalue Life
As an example of the cheapening of life Tim hoped to counterbalance by starting the
Blossom program, he cited the planned destruction of 3300 unclaimed frozen embryos in the
U.K., a controversy that circulated on international airwaves in 1996 (Forster 1998). The
deadline for the mass discarding of the British embryos was a stipulation of the Human
Fertilization and Embryology Act, which limited embryo cryopreservation to five years
(Kennedy and Kallenbach 1996). Thirty-three hundred frozen embryos remaining unclaimed
signified to Tim a pervasive ambivalence among fertility patients who were faced with, as he
believed, unsatisfactory disposition options: “People are just not happy with the choices that they
have.”
Individuals unwilling to discard or donate to science already had the option of anonymous
donations within fertility clinics, a practice that seems to Tim an invitation to “drop your kids in
a black hole.” Anonymous embryo donation mirrors many of the facets of mid-century domestic
adoption premised on secrecy, shame, and closed records. By contrast, Tim believes the Blossom
program provides fertility patients with a “very viable alternative” rooted in contemporary
adoption values around openness.
My theory was that if a family with embryos had the ability to know whether any children
were born, to know where they were, and possibly to be able to have a relationship with the
new family if they chose to, that it would be easier for them—not harder—to make this
decision [to donate].
From a southern California suburb, Tim and two infertile couples forged the first legal
transfer of twenty frozen embryos through the protocols and practices of an adoption agency. A
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practical goal of the new embryo adoption program was to allow people to give birth to their
adopted child. “Blossom sort of bridged the gap between infertility work and adoption,” Tim
explained. “It is kind of the middle road.”
From Blossom’s inception, the most common question Tim fields about the program
concerns language: why call it embryo adoption? On a practical level, he feels “from a
counseling and social service perspective [that] it recognizes the needs of the donor family, the
adoptive family, and of the child in the future, so we called it embryo adoption.” On a societal
level, Tim acknowledges that conjoining embryo with adoption is powerful:
What we call things matters. Of course using the word adoption means something. Does it
mean I’m trying to outlaw abortion? No. It means we’re trying to give the status of what is
happening between these families and the baby that is involved some meaning and some
dignity. It’s instead of answering the question ‘How did I come to be in your family?’ with
‘Hey Junior, you were donated!’ I think that by elevating the conversation and the
terminology that applies to embryos may have some aftereffect. Just like the abortion
language has had a tendency to devalue life, I hope the embryo adoption debate helps to
revalue life.46 (Crockin 2005)
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
46	
  The study of embryo adoption involved entering an ongoing debate around language. The first
embryo adoption/donation conference held in May 2008 in Washington D.C. was my first entrée
into key arguments in the debate. The clunky conference name itself—“Emerging Issues in
Embryo Donation and/or Adoption”—underscores the ongoing challenge of language to describe
the practice of giving and receiving embryos for procreation. The conference was hosted by the
National Embryo Donation Center and funded by one of the “awareness” grants funded by the
Department of Health and Human Services. It attracted 80-100 attendees across legal, adoption,
activist, clinical, religious, social work, and governmental professions. Varying speakers and
participants addressed the political and social implications of terms like donation or adoption;
others forwarded alternative descriptors, such as transfer, placement for parenthood, donation
for procreation, embryo rescue, etc. One bioethicist argued that a new language is needed for the
words commonly used concerning embryos (e.g. fresh, frozen, thawed, storage, cost, amount,
services, used) objectify them as things and undermine their intrinsic personhood. Adoption
surfaced as the most passionately defended or contested term. Thomas Attwood, President of the
U.S. Council for Adoption, advised choosing a “name that is accurate and doesn’t dip into
controversy and inhibit consensus”; he preferred the term placement over adoption.
The debates at the conference occurred within a community of professionals involved in
the movement of embryos from freezers to families. Beyond the supportive circle, embryo
adoption has inspired numerous critics to weigh in on Blossom’s language choices. The
American Society for Reproductive Medicine and RESOLVE, an infertility patient advocacy
group, oppose the language of adoption because, as one ASRM spokesperson wrote, of the
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The Blossom program is based in Pacific Christian Adoption agency, a non-profit that first
opened its doors in 1959. Pacific is headquartered in southern California though had offices in
three other states during my research period, and has since expanded their presence to seven
states. My field research (2008-2013) coincided with a period of severe economic devastation in
the United States that saw the bankrupting of many businesses, including adoption agencies. As
agencies around the country reduced program offerings or were shuttered completely, Pacific, by
contrast, absorbed struggling agencies and expanded its programming and payroll. In the midst
of the economic turmoil of the recession, Pacific staff noted that the Blossom program was the
agency’s financial saving grace. Thomas, the agency’s new Executive Director (2013-present)
who followed Tim’s retirement from eighteen years of service (1994-2013), confirmed in
hindsight that “Blossom kept us in a good position” through the recession.
A team of college-educated, white, Christian women ranging in age from 22 to 50 manages
the Blossom program, which is a demographic that characterized many other Pacific staff.
During my period of field research, the Blossom staff shifted over time as individuals came and
went and program emphases evolved. The core Blossom team is comprised of a program
manager, social worker, program assistants, and a web developer. Aside from the web developer,
who works remotely, Blossom staff work alongside each other at computer terminals in a large
room tucked away on the second floor of Pacific’s suburban office park building.

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
“insurmountable legal, moral and political difficulties for patients and membership.” Legal
scholar Susan Crockin, calls out the misleading nature of the term. “There is no such thing as
‘embryo adoption,’” she argued. “It isn’t adoption, and it isn’t legal.” Crockin addresses Tim’s
dismissal of the Blossom program as a tactic to undermine abortion rights by suggesting that, in
fact, it is: “Maybe, just maybe, the real goal behind this ‘language creep’ is to change the
public’s perception of embryos. Rather than a collection of undifferentiated cells, they become
‘preborn’ children and part of a thinly disguised anti-choice agenda and an all-out cultural war
on modern reproductive medicine, stem cell research, and personal choice” (Crockin 2005).
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The reception area of the agency is decorated with a wooden cutout of the word “family”
that hangs next to a large painting of Jesus walking hand in hand with a child. Large metal filing
cabinets lining the walls contain hundreds of Blossom client files, each brimming with personal
letters, family photos, health histories, and matching preferences. The Blossom office is speckled
with Anne Geddes images of newborns, angel figurines, and flower iconography. A placard
stating, “Life is fragile, handle with prayer,” rests on a bookshelf beneath the Dr. Seuss Horton
Hears a Who movie poster with the tagline: “A person’s a person no matter how small.” A faux
cryotank—used as a prop for Blossom outreach events—is stored in the conference room with an
accompanying sign that reads: “Frozen Embryo Nursery: where children wait for their dreams to
come true.” (See Figure 9)
Pacific is one of numerous Christian evangelical adoption agencies in the country.47
Although the agency operated under different names, starting as the Evangelical Welfare
Agency, shifting to Christian Adoption and Family Services, and settling in 2000 on Pacific
Christian Adoptions, their Christian mission remained constant. Pacific strives “to share God’s
love” by realizing four main goals: 1) help children find loving homes, 2) assist birth parents and
embryo donors in making a plan for their children’s future, 3) prepare adoptive families, and 4)
recognize and advocate for the personhood of pre-born children.
As a “biblically driven Christian ministry,” Pacific leadership regards the agency as
“uniquely pro-life.” According to Thomas, Pacific puts its pro-life Christian values into practice,
and cited the Blossom program as the chief example: “The embryo adoption program is beyond a
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  Some adoption watchdogs estimate that roughly half of the U.S. adoption industry is
composed of evangelical agencies, though David Smolin found the tally to be lower in a survey
of 200 accredited adoption service providers. Even if evangelical adoption agencies do not
constitute the majority, Smolin suggests the biggest and most powerful agencies are Christian
(Joyce 2013: 65).
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Figure 9. Faux frozen embryo cryotank48

mission statement; it’s pro-life work.” The Blossom program helps Pacific exercise its pro-life
Christian values by serving as a “talking point” that “awakens evangelicals” to the biblical
imperative around adoption. “There is undoubtedly an adoption mandate in the Bible,” explained
Thomas. As a former Baptist pastor and Christian college professor, he is surprised when
pastors, even from “Bible-believing churches… need some education on the [adoption] issue.”
Upon my expressing interest in his remarks about rescue, Thomas printed for me a list of
biblical passages from a keyword search of “fatherless”—a theological synonym for orphan—
through an online version of the New International Bible. “It’s clearly there, that we are to care
for the widow, fatherless, stranger, oppressed,” Thomas explained. “This is not just a command,
but is rooted in God’s concerns.” He then paraphrased a passage from Proverbs about the perils
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Photo by author.
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of not rescuing those in need to describe the core value that he sees driving the Blossom Embryo
Adoption program. “God has a heart for orphans,” he said, “and therefore so should we.”49

A Blossom Blooms
In the summer of 2008, I visited the home of Jack and Susan Dryler—the Blossom
program’s first adoptive family—where I learned about their daughter Rachel’s origin story. The
Drylers are a wealthy white couple living in a northern suburb of San Diego in an impressive
home surrounded by avocado trees. Susan met her husband, a journalist, while she was working
as a hotel clerk in her mid-twenties. During their first years of marriage she took night classes
toward a degree in occupational therapy, a career that she eventually left to focus on parenting
her only child as a stay-at-home mother. The Drylers attend the nearby Lutheran congregation in
their small town.
Minutes after my invitation for interviewees posted to the Blossom program’s adoptive
parent listserv in 2008, Susan phoned me, curious if she was “the first to call.” Susan seemed
comfortable being recognized as the first Blossom family. Over the years, she seized numerous
opportunities to share publicly how her family came to be. Susan and her daughter, Rachel,
joined other Blossom families on three trips to the White House and twice met President George
W. Bush personally. “We were standing behind him at the podium [in 2006] when he announced
the veto of the stem cell bill. Who would have guessed? I just wanted to have a baby, but God
had other plans for our family,” she explained.

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
49	
  Proverbs 24:11-12 (NIV): “Rescue those being led away to death; hold back those staggering
toward slaughter. If you say, “But we knew nothing about this,” does not he who weighs the
heart perceive it? Does not he who guards your life know it? Will he not repay everyone
according to what they have done?”	
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The Drylers struggled with infertility for two years in the early 1990s before Susan found
out that she had premature ovarian failure. As a solution, her fertility doctor suggested egg
donation and IVF, but they felt strongly that this was not an option because “using a donor egg
would be creating life outside the marriage bond.” In a conversation with a co-worker, Susan
shared another one of her concerns about IVF: what would they do if they created embryos, had
triplets, and weren’t able to parent the ones unused? Her co-worker suggested that another
Christian couple could parent them. The idea was novel, and sparked something in Susan: “I
think it was the Holy Spirit planting the seed in me.”
Susan sought counsel by contacting three Lutheran pastors and the evangelical pro-life
organization Focus on the Family for religious advice. James Dobson, the organization’s
conservative leader, called Susan directly, stating that he had never heard of such a practice and
would look into it. Meanwhile, the Drylers met with their friend, Tim Shoener of Pacific
Christian Adoptions, whom Susan first met when she participated in his youth group as a
teenager. They discussed the domestic and international adoption options available through
Pacific when Susan expressed interest to Tim in “adopting” an embryo. “Tim didn’t even flinch,”
Susan recalled. “He took it and ran with it.” Tim also sought counsel by investigating the
contractual legality of transferring embryos between parties and if there existed a fertility clinic
that would be willing to do the procedure. Focus on the Family helped connect the Drylers with a
couple in the Midwest who had twenty extra frozen embryos that they were willing to place for
adoption. Like many Blossom donors and adopters, Susan described the alignment of
circumstances that made the adoption possible, “a God thing.”
Once the first embryo adoption agreement was drafted and signed, the Drylers received
twenty frozen embryos via FedEx to their Los Angeles fertility clinic in March 1998. Early
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clinical results were devastating: most of the embryos failed to survive the thaw process and the
first frozen embryo transfer was unsuccessful. Susan’s final transfer with the last three embryos
resulted in the pregnancy that delivered their “blossom” baby on December 31, 1998. The
following year, Dobson announced his support for the new Blossom Embryo Adoption Program
through a radio showcase of the Drylers (Focus on the Family 1999). This broadcast was the first
public attention brought to embryo adoption, and according to many donating and adopting
clients, how they first discovered Blossom.
Supporters of embryo adoption accommodate the cutting-edge technologies required to
create families through the exchange of IVF embryos by situating the practice in a tradition
within which Christians are familiar: adoption. According to Susan:
The techniques [involved in embryo adoption] are new but the family building is not
new. It is just adoption nine months prior to traditional adoption… I carried her providing
all those things that she needs now—oxygen, nutrients, and a warm place to grow. We
just got to do it with my body and nine months earlier.
Rachel, the oldest of the “blossom” children born through embryo adoption, describes her origin
through a metaphorical reference to one of humanity’s oldest reproductive technologies: the
planting of seeds. In an interview with a journalist when she was seven years old, Rachel
explained: “My mom had bought this packet of seeds and she planted them and froze them. And
she was like, ‘That was you, you were a frozen seed and we put that seed in my tummy to
grow.’” Susan liked reminding her, “Only God could see you because you were so tiny.” The
seed metaphor traveled to my mailbox across the country on Valentine’s Day of 2009 when I
received a homemade card from Rachel. She made a red flowerpot with construction paper and
glued a packet of flower seeds from the American Seed company inside. Her note to me read:
“Hey Valentine… Life begins as a seed… just like you!” (See Figure 10)
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Figure 10. Valentine from the first child born through embryo adoption50

--The Blossom Embryo Adoption program began in response to the perceived crisis of
devaluing of life in America. Though embryo adoption raises suspicions from many corners of
political and religious spectrums, the Blossom program has taken root—especially among prolife evangelicals—as paradigmatic pro-life work and a solution for its time. Since 1998, about
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Photo by author.
163

4000 embryos have been adopted through the Blossom program and 460 “blossoms” born to
hundreds of adoptive families.51

Christian Rescue Scripts
Blossom spokespersons propose resolving the problem of leftover IVF embryos by
putting the discourse of rescue to work. This section introduces how rescue as a “script”
operates, what Christian rescue scripts are, and the work they do through tropes of
humanitarianism and responsibility.

Christian Rescue Scripts
Social science scholars who examine the theoretical and practical contours of rescue
discover it within diverse arenas, from postcolonial gender politics to animal studies to adoption
(Bracke 2012; Briggs 2003; Joyce 2013; Scoggin Mckee 2013). Across these various contexts
are common “scripts” that illuminate how rescue operates in a given setting, and suggest that
rescue does three main things: 1) constructs certain entities as morally and economically worthy
of being spared; 2) frames specific contexts or conditions as risky; and 3) promotes courses of
action in order to meet alleged needs.
Within Christian theology, rescue scripts are discernible within Biblical stories that
identify those considered worthy of redemption, describe circumstances that threaten salvation,
and justify worldly actions based on godly behaviors. In the New Testament, the sacrifice of
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Four hundred sixty is the reported number of children born through the Blossom Embryo
Adoption program as advertised on the agency’s website at the time of depositing this
dissertation in March 2016. At the time of writing, current agency staff provided estimates of
embryo adoption numbers, or 4000 embryos, which is roughly consistent with the 12 percent
chance of successful thaw, implantation, gestation, and birth for each frozen embryo transferred
into a uterus (Keenan et al. 2008).	
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Jesus on the cross—“who gave himself for our sins to rescue us from the present evil age”
(Galatians 1:3-4 NIV)—represents the ultimate act of rescue through which all sinners were
made redeemable.
Christian rescue is fundamentally a discourse about family expressed through kinship
language of fathers, families, orphans, and adoption. Orphans in the Bible, or those who are
“fatherless” and outside the family of God, are targeted for rescue through adoption into God’s
family. Christian Scripture describes adoption as the central means by which God rescues souls
by delivering the gospel to sinners and transforming them from the realm of fallen humanity into
a familial relationship with him and his redeemed body, the Church (Smolin 2011). The kin
language of “adoption into God’s family” is a metaphor for religious conversion, or the “great
act of redemption in which sinners are forgiven, justified, sanctified, and made into a ‘new
creation’” (Smolin 2011: 70). Scholarship also highlights how Christian notions of rescue both
draw from and intersect with forms of race, caste, and class (Dirks 1996; Goetz 2012). These too
are types of familial discourses that put into relief how Christian tropes of inclusion are
intermixed with logics for exclusion.

Humanitarianism and Responsibility
Modern Christian projects (Keane 2007) like the Blossom program that translate divine
forms of rescue—such as Jonah’s rescue from the belly of a whale and the Israelites’ delivery
from bondage in Egypt—into worldly action are often expressed through discourses of
humanitarianism and responsibility. Blossom taps into these traditions to legitimize embryo
adoption as the moral solution for remaining IVF embryos and the broader problem it represents
of cheapening life. Humanitarianism expressed by Blossom proponents makes legible the plight
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of abandoned embryos while responsibility helps cultivate a sentiment of duty for providing
embryos the chance to be born. Both discourses justify Blossom’s goal of finding “homes” for
IVF leftovers, which for embryo adoption means finding receptive uteruses.
Blossom turns to humanitarianism and responsibility traditions because they align with
their core Christian values of equality, dignity, and duty. Humanitarianism represents the moral
imperative to relieve human suffering based on the belief that “the lives and welfare of those
now living fundamentally matter and cannot be consciously sacrificed in the pursuit of other
goals” (Redfield and Bornstein 2011: 6). Humanitarianism first emerged in the early nineteenth
century as a form of Christian charity (Calhoun 2008). Later secular forms of humanitarianism—
such as international aid organizations like the Red Cross and Doctors Without Borders—share
with Christian humanitarianism an ethic of dignity and equality among all humans, though these
ethics does not always translate into practice (Fassin 2012; Redfield 2013; Ticktin 2011).
Responsibility is a moral concept premised on the societal imperative to manage risk
(Jonas 1984). In law, responsibility concerns a person’s fair and just obligation for repayment in
the case of past wrongdoing. Legal responsibility parallels the Christian notion of judgment
before God and accountability for one’s sins. Over time, responsibility has become a manifest
duty for everyone and everything, simultaneously at the level of individual and wide collective,
and connected to times passed and anticipated futures (Ricoeur 2000).
The Blossom program deploys Christian rescue scripts, including the familial discourse
of assisting the “fatherless” orphans of the world, and draws from the traditions of
humanitarianism and responsibility in order to make adoptable orphans from IVF remainders. In
the following sections, I show how these frameworks operate in the making of orphaned
embryos—an entity simultaneously without origins, with potential, and deserving of a chance.
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The transformation of IVF leftovers into orphans illuminates how the practice of embryo
adoption “salvages” frozen treasures (Anagnost 2000) through a conversion process that turns
what one adoption scholar describes as “needy objects” into “treasured subjects” (Eng 2003).
Rescue practices, like the trashing of embryo treasures in a stem cell lab, abandon embryos so
that their potentiality as unborn children can be realized.

Making Orphan Embryos
“What is the ideal future for frozen embryos in storage? The question sounds like what to
do with all the orphans in Africa.”
- Jackie, Blossom embryo adoptive parent
In 2001, Blossom staff and supporters testified before Congress during hearings about
federal funding for stem cell research. In her remarks, the first manager of the Blossom program,
Anna Douglas, likened remaining IVF embryos to orphaned children:
These children are not a product of some wonderful medical research. They’re a
product of the fact that a huge problem exists, that too many embryos have been
created…This [embryo adoption] program is not here to provide a new way for
families to get children. It’s here to eliminate a problem that currently exists, in
that there are children waiting to be born. It’s no different than an orphanage, an
orphanage that has never been really looked at as a really neat opportunity for
somebody to add children to their families. It’s been seen as a travesty that these
children are not being parented (U.S. Congress 2002: 91).
During the same Congressional hearing, Susan delivered testimony as the parent of the “first
adopted former frozen embryo.” She recounted her story in detail for the committee of fifteen,
ending with another statement about orphanages: “Looking into Rachel's eyes, I weep for the
roughly 188,000 frozen human embryos like her placed in frozen embryo orphanages, who could
be adopted, rather than terminated with assistance from my federal tax dollars.” Frozen embryos,
in both testimonies, were presented as orphaned children in need of rescue.
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Rescue is at work in nuanced ways within the testimonies of Anna and Susan to
configure IVF embryos as orphans. The lens of rescue reveals that orphanhood acts as a
necessary precondition (Oh 2012), or an obligatory passage point (Callon 1999), through which
leftover IVF embryos become adoptable children deserving a chance to be born. In order to
describe the processes through which embryo orphans are transformed into “needy objects” then
“treasured subjects” (Eng 2003), I draw connections to how other orphans have been made.
Rescue, like the making and preventing of waste in a stem cell lab, is another kind of saving
practice that converts embryo potential for alternative futures.
Historian Arissa Oh analyzes how postwar Korean children became adoptable orphans in
the 1950s and 1960s. She argues that the Korean child, at first a “war waif,” was “imagined as an
orphan” through rescue scripts common to the Christian Americanist movement that fueled the
international adoption industry in the mid-twentieth century. Rescue operated in making Korean
orphans through processes that obscured children’s families and communities of origin, which
wiped clean their pasts and readied them for potential futures as adoptee-immigrants (Oh 2012).
“In order for the ‘rescue’ narrative to work” in the making of orphans, historian Karen Dubinsky
echoed Oh’s argument that “you really have to erase the families of origin” (quoted in Joyce
2013: 98). Once the Korean child was regarded as without history, orphaning processes
fashioned her as a blank slate on which to draw a new future via immigration. Oh’s analysis of
orphanhood shows how it served for Korean children as a precondition for transitioning them
from needy war waifs into adoptable immigrants for American families.
The Blossom program operates similarly to Korean adoption in the U.S. by transforming
salvaged IVF remnants into abandoned embryos without origins, with potential, and deserving of
a chance. In order to understand this transformation, I will discuss two facets of the orphaning
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process—erasing origins and facilitating chances—as well as the mechanisms that make
orphaning possible, which are classifying, quantifying, and facilitating potential. In the next
section, I explore how classification and quantification collaborate in producing the orphan
embryo crisis and justifying adoption as the solution, which result in the erasure of embryo
origins. The definition and counting of orphans is similar to the trashing process discussed in the
previous chapter through which embryos are disentangled from ties of kinship and ownership en
route to becoming adoptable. Then I examine how embryo chances are facilitated through donor
and adopter efforts to embrace responsibility with respect to embryos, God, and each other.
Cryopreservation tanks, presented as frozen orphanages by embryo adoption proponents, operate
as realms of “pure potential” where the future chances of treasured embryos are sustained and
enlivened.
How embryo orphans are made illuminates the ways rescue and waste are parallel
techniques for transforming the perceived potential of these frozen remains. Waste prevention
and rescue are core saving values that inform and characterize the respective embryo saving
organizations. They are also practices that operate to preserve embryo potential through
transformative processes that ready them for new futures. The trashing of IVF treasures by the
REDEEM Biobank echoes the role the Blossom program plays in the orphaning of embryos in
order to render them adoptable children deserving of a chance.

Making Orphan Embryos: Erasing Chances
Anna’s testimony conveyed Blossom’s belief that “a huge problem exists… too many
embryos have been created.” Susan’s testimony quantified the “travesty” with a figure—
188,000—to indicate the number of frozen embryos “who could be adopted.” Rescue is at work
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in such statements where they classify embryos as adoptable and quantify the supply.
Classification and quantification are accounting processes that generate authoritative statistics
(Bowker and Star 1999; Porter 1995), which are then used to forward embryo adoption as a
solution to the perceived frozen remainder crisis. Such accounting processes are also evident
within the contemporary Christian led movement concerning the “worldwide orphan crisis.” A
comparative look between the testimonies of Anna and Susan and the evangelical orphan
movement reveals the work rescue does in severing familial ties for IVF embryos and
transforming IVF surpluses into parentless orphans in need of homes.

Making an Embryo Crisis by Defining and Counting Orphans
“With 143,000 orphans in the world and over 600,000 embryos in storage, we are facing
a crisis that will require more help than our existing clients can provide. Please join me in
continuing to support Pacific Christian Adoptions.”
- Tim, Pacific Christian Adoptions Executive Director, End of 2012 donor solicitation
letter
For both embryo adoption and orphan care movements, statistical estimates serve as
effective rallying cries for their respective causes. The worldwide orphan crisis became a
passionate issue among evangelical Christians when, in the twenty-first century, the Church
embraced adoption as its signature issue. These international “child–catchers” incorporate into
promotional campaigns an oft-cited estimate of the number of orphans around the world—143
million—a number that has ticked upward among orphan crisis proponents to 153 million, 163
million, and in some instances to 210 million (Joyce 2013: 61-67).
Similarly, embryo adoption advocates actively publicize the estimated number of frozen
embryos in fertility clinics nationwide that, as discussed in detail below, are alleged to be
available for adoption. Since Blossom testified before Congress in 2001, the reported number of
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frozen embryos increased from 188,000 (Andrews 1999) to 400,000 (Hoffman, et al. 2003) to
more than 600,000 when I left the field.52 By reporting increasing numbers of orphaned children
and embryos, each movement makes a case about growing crises. Just as 143 million is now
“shorthand for a belief system” that the orphan crisis exists and international adoption is the
solution (Joyce 2013: 62), the Blossom program keeps the increasing estimate of frozen embryos
at the forefront of their advocacy for adopting embryos that they believe are deserving of rescue.
The frozen embryo crisis brings rescue to the workplace where Blossom staff struggle
with how to face the monumental task of saving mounting numbers of embryos in need. Blossom
staff wonders if they can possibly make a dent in the frozen embryo estimates that continue to
climb. Pacific leadership expressed hope that, in an ideal world, the Blossom program would
“work ourselves out of a job.” While such a sentiment may mean to simply communicate the
Blossom program’s altruistic rather than financial incentives, it adds unspoken pressure to the
daily tasks of the Blossom team. On top of the growing rates of frozen embryos on ice, agency
leadership asked the Blossom team to double the embryo adoption births in the 2012-2013
calendar year so that more babies would be born. At the time of the request, Tim and Thomas
were aware that at least one newer embryo adoption program had outpaced Blossom in terms of
births and they wanted to do what they could to catch up.
When Monica assumed the role of Blossom program manager in 2005, the outgoing
manager told her to be aware that she was entering a “spiritual battlefield.” Over the seven years
Monica served as the Blossom Program Manager, she coped with the pressures of crisis and
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
52	
  In 2009, Blossom shifted to advertising that more than 600,000 embryos were frozen based on
an unpublished “embryo census” conducted by the grant-funded arm of the Blossom program.
The 600,000 number is currently featured in all of Blossom’s literature as well as on the Office
of Population Affairs website of the U.S. Department of Health and Human Services website:
http://www.hhs.gov/opa/about-opa-and-initiatives/embryo-adoption/	
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spiritual battle by “not adhering to the pro-life mission” of the Blossom program “too much”
because the task of saving every embryo felt daunting. Rather than a crusade to rescue every
embryo from a frozen orphanage, Monica approaches the daily tasks of coordinating contracts,
matching families, and scheduling embryo shipments as logistical efforts that help donors “find a
home” for the embryos they want to give a chance at life. Simply, Monica stays focused on the
embryos in front of her:
As far as going out to the world to save every embryo, it’s not really on my heart, which I
think is a good thing to save my own sanity. Thinking of 500,000 embryos in storage,
thinking about that whole picture, is way too overwhelming for me. When I have six over
there that we can’t find a home for, or two, I think, ‘Oh my gosh, these two little tiny’
and then I imagine them as little babies. It helps me. Sometimes I even name them, the
ones that are really hard to place, because I have to personalize them so that I can keep
working for them.
Sarah, the driven and gregarious Blossom program assistant (2011-2013) who came to
Pacific after graduating from a local evangelical university, also feels stressed by the program’s
saving mission.
I’m a task-oriented person. I like to cross things off my task list. If you look at this as
saving every embryo, that would be very stressful. For a lifetime, I feel like that task
would never be over. There are, right now, 600,000 embryos and not every one of them is
going to be a human being.
Sarah resolves this tension by delegating some of her tasks to God. She described her job as
“giving the chance of life to as many embryos as can be, and trusting that God knows which
embryos are going to be human beings.” Sarah’s work within the Blossom office made her aware
that becoming pregnant is not guaranteed, or even probable, for adoptive clients. This awareness
helps her keep in mind that “there are so many other circumstances involved when embryos
don’t become human beings not having to do with frozen embryos. That is God’s will too.”
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Sarah translates Blossom’s mission into work she can manage every day and gives up some of
the labor of rescuing embryos to God.

Justifying Adoption by Erasing Families of Origin
“Children don’t grow in cabbage patches, just waiting for us to find and rescue them.”
- Karen Dubinsky, Historian, quoted in Child-Catchers: Rescue, Trafficking, and the New
Gospel of Adoption
“Embryos are orphans until they are born. They are not being cared for. Well, obviously
they are not orphans in the sense that there are parents who are storing them…”
- Thomas, Pacific Christian Adoptions Executive Director (2012-present)
Despite the power of orphan counts to mobilize Christians into humanitarian action, the
problem with child and embryo estimates is that they exaggerate how many are abandoned or
parentless in order to justify adoption as the responsible solution. Such obfuscations reflect what
journalist E.J. Graff describes as “the lie we love” to believe about the international adoption
industry (Graff 2009). The making of the worldwide orphan crisis through the erasure of families
of origin mirrors what happens in embryo adoption too.
“There are over 143 million children who go to bed each night without parents,” Tim told
the Christian Examiner for an article about National Adoption Month, a sentiment that is
common within Christian international adoption programs endeavoring to rescue the world’s
orphans via adoption. 143 million was originally derived from the 2004 UNICEF report
“Children on the Brink,” though the report itself undermines the sense of crisis that Tim and
others try to achieve when claiming that all 143 million are without family and home (UNICEF,
et al. 2004). The report gathers data on an intentionally broad group of children—those orphaned
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as well as vulnerable—in 93 low and middle-income counties.53 The report defines orphans as
children who have lost one or both parents, a category that is broader than the common meaning
of orphan in Western legal contexts as a child who has lost both parents. Due to the report’s wide
analytical net, the vast majority of children counted in the 143 million total are not parentless but
either living with a surviving parent or relative. Of the approximately 16.2 million “double
orphans” without either surviving parent, many are reported as being cared for by older siblings
or extended family. Efforts to define and count orphans are further complicated by the scores of
children in orphanages placed by families temporarily, the numerous street children beyond the
care of their living parents, and the hundreds of millions of children worldwide under the age of
five without birth certificates. Furthermore, nowhere does the UNICEF report identify
international adoption as a solution for the world’s vulnerable children, but argues instead for
supporting parents and communities to raise their own children.
Nevertheless, the orphan crisis movement mobilizes the UNICEF report’s count of 143
million vulnerable children around the world to promote action among Christians in the face of a
perceived orphan crisis. As a result, children’s origins are actively erased through suggestion that
the alleged orphans are parentless and available for adoption. International adoption emerges as a
humanitarian rallying cry for Christians, the significance of which, as legal scholar David Smolin
argues, “is founded on the insignificance of the adoptee’s original family ties” (Smolin 2011:
317).
Within embryo adoption, a similar process occurs whereby proponents exaggerate
numbers in order to quantify the frozen leftover crisis and justify the adoption of embryo
“orphans” as the solution. For instance, Susan calculated in a footnote that was submitted with
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
53	
  Vulnerable children in this report refer to “those children whose survival, well-being, or
development is threatened by HIV/AIDS” (UNICEF 2004: 6)
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her printed Congressional testimony how many frozen “children could be placed for adoption
and born into the families of infertile married couples in America who seek to raise children.”
She claimed that 12,600 to 35,000 children could be born if all 188,000 estimated frozen
embryos were placed for adoption, thawed, and transferred into uteruses. Like the 143 million
orphans around the world who allegedly go to sleep at night without parents, Susan’s testimony
suggested that all of the nation’s frozen embryos are abandoned, in need, and adoptable—but
they are not.
Susan’s calculation runs counter to the few studies that have examined fertility patient
disposition preferences in the United States, which are challenging to summarize with any
accuracy. The disposition of embryos within the private U.S. fertility industry is not standardized
in a systematic way and fertility patient attitudes about their frozen remainders change over time
(Nachtigall, et al. 2005). Nevertheless, studies available about patient wishes for frozen embryos
report that the majority of embryos banked for the future are not abandoned but claimed
(Hoffman, et al. 2003; Lyerly, et al. 2010); most are stored by patients for future use, designated
for donation to research, or en route to being discarded. Susan’s confidence that “the ‘excess
supply’ of embryos will evaporate... as embryo adoption proliferates in the wake of this
[embryonic stem cell funding] controversy” may be an expression of hope but belies
circumstances like death, divorce, and financial hardship that have rendered many frozen
embryos stuck in perpetual limbo.54 Susan’s testimony illustrates one way the frozen IVF
embryos are abandoned through rhetoric that obscures the ties of kinship and ownership actively
entangling embryo remainders banked for the future. Humanitarian tropes are visible within the

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
54	
  Chapter 5 examines how some donated frozen embryos come to “wait” without foreseeable
redemption.	
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exaggerated embryo estimates that are calculated to promote the notion of a frozen crisis and
embryo adoption as the moral solution.
In sum, this section detailed one facet of the embryo orphaning process: the abandonment
of embryos by obscuring their progenitors. The Blossom program mobilizes orphanhood as a
necessary precondition for IVF embryos to realize their potential via adoption and birth, yet the
erasure of embryo origins is a troubling part of the process for some Blossom donors and
adopters. While the erasure of embryo origins helps generate the notion of embryo crisis and
promote the idea of widespread availability of embryos for adoption, Blossom staff is
overwhelmed by the crises they helped to create and publicize.

Blossom Donors and Adopters on Abandoned Embryos
Blossom program participants are critical of the effects of orphanhood on donors,
adopters, and children born. I was surprised, though, to hear the first critical remark about orphan
embryos from Monica, the Blossom Embryo Adoption program manager. During our first
conversation in 2008, she subtly rejected the idea that any embryo donated for adoption is
abandoned: “I haven’t been around embryos that have been abandoned,” she stated, “because
everyone I’ve talked to owns their embryos.” Over seven years of talking with Blossom donor
and adopter clients, Monica became aware of the limitations and appeals of frozen embryo
rescue. As a result, she stopped using humanitarian orphan language with clients because it does
not acknowledge the efforts of donors to place their embryos for donation. “It implies that the
parents aren’t paying storage fees, waiting to be matched with an adoptive family, etcetera,”
Monica explained. “The embryos aren’t abandoned, but are the opposite: they are loved and
cared for.”

176

How Monica came to manage the Blossom program was a journey that confirmed for her,
as she explained it: “giving life to an embryo is not the same as bringing a kid home from an
orphanage or adopting an infant.” She developed an interest in international orphan care from
living abroad after college as an au pair with a Swedish family and caring for their daughter who
was adopted from China. Upon returning from Sweden, she accepted a front desk job at Pacific
in 2005 where she hoped to eventually work in the international adoption program. “I came to
adoption wanting to help people and especially kids, not the frozen ones though!” When Monica
was asked to assist with the growing Blossom program, she thought it would be a temporary
position from which she would transition into international adoption. When the previous
Blossom manager left in 2005, Monica was the obvious choice as her successor. Monica led the
Blossom program for seven years though continued to feel strongly that embryo adoption
differed markedly from finding homes for orphaned children. “They are totally different,” she
explained. “They are parallel but separate problems.”

‘You rescued our embryos? Really?’: A Donor Couple’s Critique of Orphanhood
Monica’s perspective resonates with the Bakers, a donor couple who experienced deep
pain and offense at the suggestion that their embryos were “abandoned” by them and “rescued”
by an adoptive family. The feeling of erasure led to the dissolution of the relationship between
the Bakers and the Channings, the family that adopted their twenty-four embryos. I interviewed
Sharon Baker and Tara Channing in the summer of 2008, the week they first met in a café. The
next time I spoke to Sharon was four years later when she and her husband Dennis were in the
process of taking their embryos back from the Channings because they considered their
differences irreconcilable.
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The retrieval of embryos that have already been placed with adoptive clients is a rare
situation in the Blossom program. Taking embryos back once they have been “adopted” is a
feature of the Blossom contract, which is not a legal adoption but a transfer of property
agreement. Blossom contracts are “permanent” unless or until either party breaks the agreement.
Each contract includes a “relinquishment clause” to address the retrieval of already given
embryos. To break the contract and relinquish embryos, donors are required to send a letter to
Pacific stating their request to renege the contract with a $500 check and storage agreement form
for shipping the embryos from the adoptive client’s clinic to a new cryostorage facility. For
adopters to break the Blossom contract, they have to send a letter requesting to terminate. In that
case, adoptive clients pay storage for the embryos to remain in their fertility clinic until the
embryos are re-matched with another adoptive family and shipped to their clinic. It is far more
common for adoptive clients to break the Blossom contract when embryos remain after they are
done using them to build their family. The Bakers’ recall of their donated embryos is rare, but
not unique; a few other Blossom donor families retrieved embryos after placement for various
reasons.
The Bakers are a white married couple in their early forties living in the Northeast where
Sharon works as a schoolteacher and Dennis as a software technician. They are members of a
Covenant church congregation in their suburb of a large city where Sharon first explored fertility
services. She gave birth to three children through IVF before facing the decision of what to do
with the frozen embryos that remained. “In the moment the embryologist called to say we had
twenty-four embryos, I cried because I was happy and I cried because we couldn’t parent them
all,” Sharon explained. “I wondered, what have we done? I had this overwhelming sense of
responsibility.”
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The Bakers embarked on what seemed to be an ideal embryo adoption journey with Tara
and Albert Channing. The couples found each other through a Christian online infertility forum,
Hannah’s Prayer, that Sharon and Tara participated in. Sharon had been intrigued to read Tara’s
postings about wanting to adopt embryos and found herself attracted to Tara’s passionate
commitment to pro-life issues informed by her deep Christian faith. The couples lived in
neighboring states and made an effort to meet in person to discuss their idea of partnering
together. Regular communication and reading of each other’s blogs facilitated their budding
relationship. Rather than use an attorney to draft a private contract for the embryo transfer, they
decided to use the services of the Blossom program to coordinate an adoption of the Baker’s
embryos by the Channings. Soon after receiving the embryos at their clinic, the Channings began
a tumultuous multi-year journey of three failed embryo transfers and two miscarriages before
giving birth to their son, Gregory.
The partnership between the Bakers and Channings started breaking down over their
differing perspectives about rescuing orphan embryos. Sharon’s reason for placing her embryos
for adoption with the Channings was because “we wanted to help another family who has been
through what we’ve been through, which is infertility.” She explained that shortly after contracts
were signed,
I learned that she [Tara] was against IVF because she thought the creation of embryos in
a laboratory was sinful… What ended up happening was that they would say things to us,
like “We saved Gregory” and “We rescued him from his frozen orphanage,” referring to
him as an “orphan” and his siblings that were frozen as orphans. They were taking the
standpoint of wanting to spread awareness about embryo adoption from a fundamental
Christian point of view and wanting other people, other fundamental Christians, to get on
board to save embryos whereas Dennis and I went into this trying to help somebody. … It
just made Dennis and I feel terrible. It’s like, ‘Wow, we’re giving you this gift and your
point of view is that you rescued him? You rescued our embryos? Really?’ Their point of
view and our point of view are on two different spectrums.
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Sharon and Dennis were disturbed by the Channings’ approach to embryo adoption as a saving
mission, in large part because it diminished their role as caring parents who made an adoption
plan for their much loved embryos. Their recall of the donated embryos from the Channings was
an uncommon but clear expression of embryo inalienability—the quality of being given without
being given up (Weiner 1992). The Bakers’ experience puts into relief how the erasure of
families of origin through embryo rescue may be injurious to donor families for whom donated
embryos remain intimately connected and anything but abandoned.
The Bakers also worried how being “abandoned” could affect Gregory. “We were
concerned for their son,” Sharon explained. “We didn’t want any children born from the
adoption to feel like they had been rescued by their [adoptive] parents. We never intended that
for them.” How the orphaning of adopted embryos could affect Gregory, and all children born
through the Blossom program, is still to be known.
It matters to many of the Blossom donors who I spoke to that their embryos are
acknowledged as once wanted and made with family-building intentions. Donors expressed their
continued sense of belonging to the embryos and feeling of responsibility for their potential
futures by investing time into choosing an adoptive family and wondering about the people who
adopt their embryos. Many feel at peace with their decision to donate, though mixed feelings
arise around shipping dates, frozen embryo transfer procedures, pregnancy results, and birthdays
of their biological children who are born into other families. While embryo humanitarianism
casts embryos as at risk and in need, Blossom donors reject the notion that their frozen
remainders are ever without parents.
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‘I hate the language because it’s at the expense of somebody else’: An Adoptive Mother’s
Critique of Orphanhood Imagery
Jessica Stohl, an early Blossom adopter and public advocate for embryo adoption,
expressed the most critical perspective I encountered about the negative impacts of embryo
humanitarianism on donor parents as well as the children born. Over time, Jessica came to reject
the orphaning of embryos:
The terminology that adoptive families use that diminishes the role of the genetic and
birth parents subsequently diminishes the child. They don’t see that at the time but
eventually the child does. I have learned to hate the words rescued, orphaned, abandoned,
but I had to be educated into it… I just absolutely hate the language because it’s at the
expense of somebody else. Not to say that there aren’t times when a child, whether born
or unborn, does indeed absolutely need to be rescued, but even if that is the case, I would
hope the rescuing isn’t done from a self-righteous place.
Jessica did not always hold a critical view of embryo orphanhood. Like many Blossom
adoptive clients, Jessica experienced infertility that stretched over seven years of IVF cycles,
four miscarriages, and devastating periods of grieving losses. At the age of thirty, she and her
husband adopted eleven embryos through the Blossom program in 2000, followed by four frozen
embryo transfers, three miscarriages, and one successful birth to her son, Logan. “We were
committed to all eleven of those babies,” she told a Washington Post reporter in 2005 about her
experience with embryo adoption. “We were going to see it through as long as it took.”
Although her hands were full as a professional photographer and stay-at-home mom of
three adopted children—two adopted domestically, and one embryo adoption—Jessica became
active in embryo politics in the early 2000s as a vocal pro-life advocate who regularly used the
language of rescue, frozen orphanages, sacrifice, and risk. She and her husband joined two other
Blossom adoptive families as plaintiffs in a legal case filed against the National Institute of
Health on March 8, 2001 challenging President Clinton’s approval of distributing federal funds
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for embryonic stem cell research. In 2002, she testified as an embryo adoptive mother in a
Wisconsin State Assembly Health Committee Hearing in favor of the Human Embryo Protection
Act to “to help put a real face on a hard-to-visualize group within the human family: frozen
embryos.” A few years later in 2006, she and Logan were one of twenty Blossom families that
traveled to Washington D.C. to attend the press conference where President Bush vetoed the
Stem Cell Research Enhancement Act of 2005 that would have allocated federal funds for
embryonic stem cell research.55 “All of Logan’s uniqueness was in that embryo that was just
waiting for parents,” Jessica asserted.
He wasn’t a person that was yet to be. Who he is now was already there as a tiny being. It
was important to me to help people understand that…. From my experience, when I have
talked to people about embryonic stem cell research, people did not understand the cost
to somebody else to do it until they heard my story. Then they would look at Logan and
then see. There may be some great benefits [from embryonic stem cell research] here but
there are great costs involved too. And you are looking in the face of the sacrifice.
Jessica decided to scale back her advocacy efforts after years of making regular
statements to the press, attending legislative hearings in and beyond her home state, and igniting
debate through her personal blog and participation in the blogosphere. The primary reason for
slowing down politically was that she wanted Logan to have a life outside the limelight. Also,
her perspective on embryo rescue was shifting.56 As Logan and her other children aged, she
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Jessica felt that she and her son were chosen to stand behind President Bush during the press
conference because of Logan’s vibrant red hair, which she feels represents his, and every
embryo’s, uniqueness. “He doesn't look a thing like me. He’s incredibly beautiful. In many ways
I’m grateful that he doesn’t because it testifies to the uniqueness he was before I got him, that the
design for Logan, the blueprint of who he would be, that picture was already stamped before he
was put into my womb. When you see him, it’s very obvious. It happened to be on Logan’s 4th
birthday that we did that, and so they had birthday cake at the White House in Blue Room. After
the President addressed the nation we went in and celebrated his fourth birthday with cake made
by the White House staff and all. That was pretty fun.”	
  
56	
  Jessica elaborated: “When he was little, that was important to me because there weren’t many
people who could stand up to such claims [in favor of embryonic stem cell research] except for
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became sensitive to what humanitarian discourses did to placing families and adopted children.
Part of her advocacy now involves calling out the negative effects of treating frozen embryos as
abandoned orphans. For instance, Jessica expressed a sentiment that many embryo adoptive
families share, which is feeling like a recipient of blessings rather than a provider of them.
I don’t agree with myself now, but at the time [when I was first married], I saw
adoption as a beautiful thing that I could do for this child, you know, a kind of a
rescue. Now, eighteen years later, I would tell you that that is the last reason I
would want to adopt… I started out wanting to rescue babies, but it turned out that
the babies rescued me.
Jessica was initially enthusiastic about contributing to Blossom’s mission of rescuing
orphaned embryos from frozen orphanages, but her perspective changed over time as the effects
of humanitarian rescue became clear to her: embryo donors are obscured, resulting children are
objectified, and adopters are lionized as altruistic do-gooders. Jessica suggests that embryo
orphanhood provides Blossom a language and platform to leverage politically for “pro-life”
causes, but such opportunities come at the expense of embryo donors and Blossom children born.
For Jessica, the costs of orphaning embryos are not worth it.
The severing of IVF embryos from their origins in order to prepare them for adoption is
key to revaluing the potential of IVF remains, yet, as the Bakers and Jessica suggested, is not
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
parents of children who have had babies formerly cryopreserved. I felt like we had something to
say about justice and their personhood. However, as time went on, it’s not that don’t believe
that—I still do believe that—and I still, like talking to you today, still do take opportunities to
speak up for them as I can, but as your child grows, mothering kind of kicks in too… I now feel
more protective of him as a mom until he is old enough to make a choice for himself. When he
was little, it didn’t make difference. He didn’t know what we were talking about. By the time he
got old enough, when he would realize that he was evidence for my soap box—you know what I
mean?—I didn’t want it to give any appearance of that to him. I know there’s a better way to
word that. Now I really don’t step out and say too much on the topic unless I can do in more
private way. Right now Logan just needs to live his life with mom, dad, and siblings. The fact
that he was adopted is really cool but it is not the central theme of his life or mine by any
stretch.”	
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without costs. Their experiences suggest that the erasure of embryo origins is an unnecessary
precondition for embryo adoption. But they and other program participants are not entirely
dismissive of embryo orphanhood. Blossom donors and adopters embrace the other facet of
embryo orphaning that calls for accepting responsibility to facilitate embryo chances.

Making Orphan Embryos: Facilitating Chance
“We believe that every embryo is a baby that deserves a chance at life it was created for.”
- Monica, Blossom Embryo Adoption program manager
I have argued that classifying and counting practices transformed embryos into orphans
without origins, family, or history, or what I refer to as needy objects. These mechanisms for
rescuing embryos mirror REDEEM Biobank’s wasting practices that disentangle embryos,
dispossess donors, and ready embryos for research. This section discusses the last part of the
orphaning process where orphaned embryos become “treasured subjects” whose potentiality as
unborn children can be realized through transfer into an adoptive woman’s uterus. First I revisit
the case of the Korean orphan to illuminate how orphanages and cryopreservation tanks are, in
Christian rescue narratives, spaces that cultivate an orphan’s potential. Then, I examine how
embryo donors and adopters facilitate embryo potential by assuming bodily and Godly
responsibilities to help manifest their chances for birth. Orphanhood, like waste, is a
transformative category embryos pass through that changes them into adoptable preborn
children; rather than lying in waste as abandoned, “needy subjects,” embryos are converted into
“treasured subjects” filled with possibility.
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Frozen Orphanage as Realm of Potential
“I guess that’s true for any child sitting in an orphanage or embryo sitting in a freezer;
unless you expose them or give them the opportunity, you never know what gifts will go
undiscovered.”
- Betsy and Joe Banyon, Blossom adoptive parents
Once classified as orphans, quantified in undifferentiated batches, and severed from
families of origin, orphans enter the orphanage—a material and symbolical space within
Christian rescue tropes where children without origins await what are called “forever families”
(Joyce 2013). International orphanages figure within the worldwide orphan crisis as sites that
standardize children through dress, documentation, and regimen in ways that wipe clean prior
habits and histories. Oh suggests that in the post-war Korean orphanage a child became a “tabula
rasa,” or a blank slate on which to draw a new future. As a result, the Korean orphan “came to
represent a particularly exemplary immigrant due to her youth and perceived malleability” (Oh
2012: 36), allowing her potentiality as an “ideal immigrant” to shine. Anthropologist Ann
Anagnost describes the potentiality of children in Chinese orphanages through the framework of
uncertainty and possibility; she also argues that Chinese orphan potentiality is created by
separating orphans from their origins. In Anagnost’s view, uncertainty and possibility “figure
complexly in the structure of the salvage narrative” that pervades adoption (2003: 399).
Susan and Anna’s Congressional testimonies about frozen orphanages similarly regarded
cryopreservation tanks as realms of possibility and potential where, as they stated, “children are
waiting to be born.” Their invocation of orphanage imagery through the sentimental discourse of
rescue aided their plea to lawmakers about potential harms facing the frozen preborn. They
argued in favor of IVF orphans being saved from the risk of “termination” by scientific research
so that adoptive families may give them a chance to be born. Other Blossom adopters extend the
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metaphor between cryotanks and foreign orphanages as spaces of potential filled with hope.
Louise Hayworth, for example, likened the fertility appointments after her eight adopted
embryos arrived to her fertility clinic and before their transfer into her uterus “like visiting an
orphanage.” Spending time in their fertility clinic where the embryos were stored felt the same to
the Hayworths as visiting orphanages in China, from where they adopted two of their five
children. Louise explained that in clinics and orphanages, “you couldn’t go into the room where
the children were, but your heart is just excited.” Just as they did in a Chinese orphanage, the
Hayworths “prayed and thanked God for the little ones, for their protection, and for the doctors
who’d be handling them” from their fertility clinic waiting room. For Blossom proponents like
Louise, the “frozen orphanage” was not only a tragic space of abandonment but a container of
possibility as well.
Responsibility, as discussed above, is a contemporary moral concept that connotes the
management of risk with respect to oneself as well as higher authorities. Blossom donors and
adopters helped facilitate embryo potential by embracing the call to act responsibly: toward
leftover embryos, through women’s bodies, and in relationship with God.

Blossom Donors and Adopters on Embracing Responsibility
Embryo donors and adopters describe two kinds of responsibilities—through their bodies
and toward God—which they adhere to in order to help embryos manifest their potential for
birth.

186

‘Our one objective was to get embryos into the uterus’: Donor Perspectives on Bodily
Responsibilities
Feelings of bodily responsibility emerge for many Blossom donors when women
encounter obstacles to using their remaining IVF embryos themselves for parenthood. Ten years
passed before Sally and Jonah Anderson, a white Catholic couple with two pre-teen children
living in the Northeast, returned to their fertility clinic to resume using their five frozen embryos.
At the appointment, they learned that Sally’s uterus was no longer compatible with carrying a
pregnancy to term. The Andersons grudgingly started discussing other options for their
remaining embryos. Physically and financially, Sally realized that she “could no longer provide
for them… We weren’t able to be a vehicle to be used for them, and we felt it to be a burden. We
couldn’t accept responsibility anymore to give birth ourselves but we had the responsibility of
finding a solution.” They believed the Blossom program was a good option because it allowed
their treasured remainders the opportunity to be born, even if to another family. Still, Sally felt
“such a mothering feeling towards embryos” that she struggled for over a year to complete the
Blossom donor application. “It felt like being the world’s worst mom even thinking about
adopting them out. For the longest time I couldn’t think about it because I was imagining Jack or
Zoe living with another family.” She crafted multiple drafts of the letter required by the Blossom
program from embryo donors to the prospective adoptive family to complete the donor “profile.”
She read the letter drafts to her husband at night for feedback until the letter, and Sally, felt
ready.
Eileen Tyler, a married Canada-based mother of two and one of the few Blossom donors
who described herself as pro-choice, expressed a similar feeling of responsibility once becoming
aware of her own bodily limitations for becoming pregnant. During her first IVF cycle, Eileen’s
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endocrinologist realized that she had severe problems with her uterine lining that precluded her
from ever carrying a pregnancy. They halted the IVF cycle by freezing six embryos and faced
the problem of having embryos but “nowhere to put them.” The Tylers decided to hire a
surrogate, who received four embryos and delivered twins. With two children to parent and
depleted finances, Eileen felt a responsibility toward their remaining two frozen embryos to not
waste chances. Knowing they would likely not establish a pregnancy in her body, Eileen
approached the decision to donate embryos for adoption as a practical task of getting them into a
uterus:
I view embryos as potential babies and always felt that any embryo created should be put
in and get chance at life or, you know, have a shot. Our one objective was to get embryos
into the uterus. We could have put them in my uterus, which would have been cheapest
way to go, but the medical advice we received was that the embryos wouldn’t survive in
me, so that would be fairly akin to throwing them away. Transferring to me would not
provide them a good chance, not a good enough chance anyway.
Sally’s and Eileen’s experiences evoke different feelings around their inabilities to use the IVF
embryos they made, but both believed—as do many donors I spoke to—that finding a way for
embryos to have a chance in another’s body is their duty.

‘I wanted them to be nurtured’: Adopter Perspectives on Bodily Responsibilities
Adopters also assume responsibilities for embryos by readying their bodies to bring
embryos “home.” Although rarely discussed explicitly by the Blossom program, the first “home”
for adopted embryos is not a nursery but a woman’s uterus. Blossom adoption clients are
required to complete a multi-part application process before being matched with donor families,
which includes a detailed application with personal, financial, and medical histories; a
descriptive family profile; and a traditional adoption home study. The application also requires
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adopters to submit a doctor’s letter verifying the female applicant’s ability to carry a pregnancy
to term. Maria translated Blossom’s desire to find “homes for embryos” into making sure that the
ones she adopted and transferred were received into the safest conditions her body could provide.
From the very beginning I wanted them to be nurtured. I was careful about my diet, and
anything that I could read up on, I did. I started drinking green tea, for instance… I
wanted them to be taken care of and in a good home and have every chance at life.
The preparation of one’s body to receive adopted embryos is distinctly gendered labor
conveyed through themes of nurturance and care. Most of Blossom’s adoptive clients have tried
forms of assisted conception or have histories of reproductive failures. The opportunity to give
birth to an adopted child answers the prayers of Blossom adopters who wish to experience
pregnancy, in addition to control the uterine environment and bond with their adopted child from
the earliest stages of development. At the same time, many of the women experience anxieties
about their bodily performance and feel pressures to reproduce. Even though each donated frozen
embryo averages a 12 percent chance of successful thaw, implantation, gestation, and birth
(Keenan, et al. 2008), Blossom is dedicated to giving every embryo this opportunity. For these
and other reasons, the stakes and hopes are often high for adoptive women on the eve of their
embryo transfers.
After Kate, a recently married white lawyer in her forties living on the East Coast,
transferred four embryos that did not implant successfully, she reconciled herself by saying that
her adopted embryos were at the mercy of chance despite her efforts to provide them a
welcoming “home” in her body.
I tried my best to have them become babies. When you’re going through it, you
automatically think ‘Four little babies!’ but they don’t all take. It’s a very strange
thing. Embryos are not guarantees to make and turn into a baby.
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Even though Kate knew that the odds of becoming pregnant were not in her favor, she felt the
familiar pang of frustration that she had come to know through failed ovarian stimulations,
intrauterine inseminations, and one prior IVF cycle. “I was mad at myself and mad at my body.
Why can’t I carry a pregnancy? I was disappointed in myself.” At the time of our interview, she
was in the process of being re-matched with another set of embryos for another try at pregnancy.
Other adoptive women I spoke with felt the added pressure to have successful
pregnancies for their donor families. Amanda, a married mother of two, “felt a certain degree of
pressure to not let the [embryo] donor family down. They were giving us this gift,” she
explained, which felt “more personal” to her than when she adopted her son Daniel from a
Vietnamese orphanage. Amanda felt that not getting pregnant or miscarrying would let the
embryo donor family down:
They had waited so long for an adoptive family, and knowing they are Catholic and that
the Church frowns on IVF to begin with, [embryo donation] was probably their way of
dealing with that. I felt like I needed to have good pregnancies for us and for them too.
Nearly every Blossom adopter, when asked to describe the ideal future for frozen embryos,
wished that each frozen embryo would have the opportunity to be born. The prospect of birth for
any embryo depends entirely on the gendered labors of the women into whose uteruses frozen
embryos are transferred. Although social workers complete the traditional “home studies” for the
adoptive Blossom applicants, adoptive women submit their bodies to other kinds of “home
studies.” Diet and exercise, medical care, prayer, and emotional management represent the types
of gendered bodily work that adoptive women perform in order to produce pregnancies for the
sake of many: the embryos, their donors, their families, and themselves.
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‘Our job is to be obedient’: Donor Perspectives on Responsibilities to God
Some Blossom donors described the decision-making processes for their remaining
embryos as part of feeling responsible to God. Donors who feel in partnership with God and
committed to carrying out God’s plan distinguish between their duties and those belonging to
God. According to Erin, a married evangelical Christian and mother of two living in the
Northwest, God is in charge of manifesting each embryo’s potential while her job is to obey.
Every baby born has a purpose, a place, however God uniquely arranges this. God
decides their potential and their part in this world. It is all up to God. He works out the
details. I can see his hand throughout. My job is our small little part. God took it so much
further; whatever he chooses to do is the potential and opportunity. Our job is to be
obedient. God certainly could have done without me but He chose for me to be part of it.
Embryo donor Annika, a white born-again Christian raising two sets of twins in the Midwest,
similarly embraces her task of obedience. After two traumatic twin deliveries, Annika and her
husband donated their five remaining embryos to a couple, who afterward gave birth to a son.
Annika approaches the donation of her embryos as she did parenting her four children: as acts of
stewardship toward the lives that came into her care by God’s design. She explained:
I don’t look at it like they are my kids. I look at it like they are on loan to me. They are
not my children. I mean they are my children, but they are God's children. I look at them
like they are on loan to me and He’s entrusted me with four to raise.
Annika enjoys telling her donation story not to be patted on the back for being a responsible
steward of precious lives, but in order to reveal God’s handiwork to others who are willing to see
it:
It’s amazing how many people say, ‘Look what you’ve done!’ and ‘What a blessing
you’ve been!’ They don’t get it. I emphasize it’s not what we’ve done. It’s what God’s
done. We’re not a blessing, but we are being blessed. We are so blessed because God was
able to use us to bring this little boy into the world because he was supposed to be here.
And look at these people, the adoptive family. What have they done? They are sharing
his [child born from embryo adoption] life with us and we are reaping the benefits of that.
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Frozen IVF embryos are entangled in webs of kinship, ownership, as well as stewardship—or the
temporary caretaking of something belonging to another. For some, frozen embryos and their
potential belong to God. As donors like Annika think about how to talk to their children about
the decision to donate embryos to another family, many agree with her conclusion that “it’s
important for them to know that we wanted to be obedient to what God wanted us to do, and
doing so allowed more lives to come into the world.”
Scholars of many faith traditions acknowledge that the convictions of IVF patients with
deeply held religious beliefs are often tested through the veritable rollercoasters of emotions,
losses, and doubts entailed in creating family using reproductive technologies (Inhorn 2006;
Kahn 2000; Roberts 2012). Among Blossom donors, God figures centrally in donation stories; in
some cases, religious convictions were edified while they were called into doubt for others.
Sharon Baker, for instance, continues to identify as a Christian though her once “black-andwhite” perspective shifted as a result of participating in the Blossom program. Now, as she
identifies as pro-choice and participates in birth mother advocacy, Sharon believes that “God
made the world more gray than we give it credit for.”

‘God calls you to be his vessel’: Adopter Perspectives on Responsibilities to God
One way that Blossom adopters express obedience to God is by submitting their
reproductive bodies through embryo adoption for God’s sake. Regardless of pregnancy
outcomes, some adoptive women feel peaceful relief because they offered their bodies wholly to
giving embryos a chance to be born. Soon after Tiffany’s first child was born through embryo
adoption, she began to think about the four embryos that remained in her clinic’s cryotank. “I
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feel a big responsibility to go back to them like a good parent,” she explained. “I probably
haven’t prayed for them specifically but for God’s wisdom. At the moment we are trying to
figure out when the best time to do another transfer, when to give them the best chance.”
After a series of unsuccessful frozen embryos transfers, Carla turned to God to help make
sense of the overwhelming grief and loss she felt. She thawed and transferred eighteen adopted
embryos without establishing pregnancy. Although each negative pregnancy test devastated
Carla, she came to feel privileged to have been chosen by God to help “deliver the babies home
to heaven.”
I couldn’t believe God brought us to this point and didn’t bring us a child. Amy, the
director of the Blossom program at the time, said to me that it’s hard to deal with now but
sometimes God calls you to be his vessel for children to go home to him. It’s hard to
accept but I feel incredibly blessed that God would use me to be a vessel to send babies
home. I don’t want to say I felt like Mary but I felt incredibly chosen. It was so hard
though that didn’t happen, that I didn’t get pregnant. I couldn’t understand it, but to be
used by God for this was an incredible privilege.
During her final embryo transfer, Carla became pregnant with her only daughter. Six years after
her daughter’s birth, Carla felt that she had a role in God’s plan for her adopted embryos: “Out of
19 babies, one survived. I was privileged to send 18 home.” For many embryo adopters, Blossom
provides them a responsible way to solve their fertility problems, contribute to a laudable
mission of saving lives, and obey God’s plan for them and their families.
--Blossom donors and adopters provide critical insight into the processes, limitations, and
appeals of embryo orphanhood. In the view of donors and adopters, the erasure of embryo
origins is risky and undermines the reason Blossom participants come to embryo adoption in the
first place. Donors are propelled to place their embryos through Blossom due to feelings of
responsibility toward their embryos, through their bodies, and with respect to God. Also, donors
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want to give their IVF leftovers the best chance to be born as originally intended. The vast
majority of adopters come to Blossom for the opportunity to “grow” their families and they
appreciate that their family-making motivations can be in accord with responsibilities they feel to
help embryos in need and obeying God’s wishes. For people with and wanting embryos, embryo
humanitarianism may motivate them to walk through the agency door but, in practice,
opportunities to act responsibly facilitate the transfer of leftover embryos into uteruses where
their chances for birth may be realizable.

The Frozen Unborn: Race and Gender Politics in Cultivating Cultural Innocents
Race and gender politics in the United States figure centrally in cultivating cultural
innocents worthy of rescue. The white child, for instance, served as a rich site for moral
inscription and political mobilization within American controversies from abolitionist rhetoric, to
immigration politics, to public education (Levander 2006). IVF embryos, now equated with a
stage of human development described as “the beginning of conception,” are increasingly cast in
debates as “the plausible innocent[s] in whose name moral claims can be made” (Comaroff 1997:
15).
Pacific Christian Adoption is a leading advocate for the rescue of the “frozen unborn”
and one of the few places in the world where embryo rescue operates as the status quo. Blossom
staff works passionately to find a receptive uterus for all adoptable embryos, especially the least
desirable. The agency enshrines embryo personhood values in the organization’s mission by
committing to “recognize and advocate for the personhood of pre-born children.” Blossom
donors and adopters sign embryo transfer contracts that describe embryos as “entitled to the
rights and protections accorded to all children, legally and morally.”

194

In this section, I discuss histories of personhood advocacy and Christian child-saving in
the United States to illustrate how saving ethics and practices commingle in the making of
cultural innocents. My review of historical, social, religious, and political factors beyond the
agency door illuminates some conditions that make it possible to cast frozen embryos as
innocents deserving of rescue from destructive, devaluing forces. Important to these
considerations are the ways race and gender conspire in generating notions of innocence and
social worth.

Politics of Personhood
Advocacy for embryo personhood is a historically recently social movement with roots
dating to the 1776 drafting of the U.S. Constitution wherein the rights of persons as citizens were
first detailed. From the beginning, race and gender logics pervaded legal categories of persons in
the United States. Founders of the republic limited legal personhood to land-owning white males
and many decades passed before personhood rights via citizenship included African Americans,
women, and immigrants.57 Race and gender politics remain constitutive of contemporary battles
over the definition of person in America within which frozen embryo rescue figures centrally.
The Roe v. Wade58 decision legalizing abortion marks the most recent turning point in
personhood advocacy on behalf of embryos. Justice Harry Blackmun, author of the majority Roe
opinion, addressed the question of fetal personhood that arose during the case’s oral arguments.
After finding no basis for attributing personhood status to fetuses, he observed in the court’s
opinion a veritable loophole: “If this suggestion of personhood is established, [Roe’s] case, of
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  The 13th (1865), 14th (1868), and 15th (1870) Amendments to the U.S. Constitution abolished
slavery and extended citizenship and voting rights to black males, followed by the 19th (1920)
Amendment’s extension of voting rights to women.	
  
58	
  Roe v. Wade, 410 U.S. Supreme Court 113, (January 22, 1973)	
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course, collapses, for the fetus’ right to life would then be guaranteed” (Martin 2014).
Antiabortion strategists leapt to action in response to the legal Achilles’ heel that, in Blackmun’s
words, could dismantle the legal right to abortion. Political activism to establish the personhood
of embryos and fetuses launched a week after the Roe decision when a Maryland Congressman
proposed the Human Life Amendment, which sought to amend the Constitutional definition of
person as beginning at the moment of conception.59
Antiabortion lawmakers have built their case and cause for personhood over the past four
decades. Legislatures at the state and federal levels have seen more than 330 variations of
personhood amendments proposed and introduced (Martin 2014). As of March 2015, thirty-eight
states passed “fetal homicide” laws that create increased penalties for crimes, such as violence
toward pregnant women or drunk driving, that result in the death of a fetus, based on their
separate rights (National Conference of State Legislatures 2015). Additionally, pregnant women
in most states are increasingly arrested, detained, and prosecuted for “child endangerment,” such
as exposing their fetuses to illegal substances. Low-income women and women of color—
especially African American women—are disproportionately impacted by fetal homicide and
endangerment policies. For example, twenty-six year old Regina McKnight, an African
American woman in South Carolina, was arrested and charged with homicide after miscarrying
her pregnancy based on allegations that her cocaine use caused the stillbirth. In North Dakota,
the twelve-week pregnant and homeless Native American woman Martina Greywind, was
arrested and charged with reckless endangerment based on the claim that she inhaled paint fumes
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
59	
  The text of the first Human Life Amendment reads: “Neither the United States nor any State
shall deprive any human being, from the moment of conception, of life without due process of
law; nor deny to any human being, from the moment of conception, within its jurisdiction, the
equal protection of the laws.” See U.S. Congressional record:
https://www.congress.gov/bill/93rd-congress/house-joint-resolution/261
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that were toxic to her fetus. Lynn Paltrow of the legal advocacy organization National Advocates
for Pregnancy Women identified 413 cases in the United States like these that treat embryos and
fetuses as separate legal entities at the expense of the personal liberties of women (Paltrow and
Flavin 2013). As fetuses in utero gain legal protections of “personhood,” the rights of women
who bear them wane.
Race and gender politics are evident within fetal personhood activism in other ways, such
as when strategists appropriate Black American history to forward a “civil rights” cause for the
unborn. While antiabortion activism more commonly racializes the fetus as white to justify its
rescue, intersecting race and gender politics also facilitate the making of a “minority unborn”
(Mason 1999) as a cultural innocent. For decades, anti-abortion spokespersons have drawn links
between slavery and abortion that call out black women, among whom abortion rates are highest
in the nation, for being complicit with “black genocide”; the controversial billboard erected in
New York City in 2011 stating “The Most Dangerous Place for an African American is in the
Womb” is an exemplar (Kumeh 2011). Antiabortion campaigns also use tropes of personhood,
rights, and freedom that echo the long struggle for racial justice in America. In 2010, Priests for
Life began a “Pro-Life Freedom Rides” campaign modeled on the anti-segregation bus rides led
by black and white challengers to Jim Crow era oppressions. The goal of the pro-life freedom
rides is to build a popular movement around freedom and justice for all, particularly fetuses at
risk of being aborted.
Similarly, embryo personhood proponents racialize frozen embryos as both white and
black to strategically convey their cultural innocence and worthiness of rescue. Embryo
personhood advocates represent a recent faction of the U.S. antiabortion movement who shifted
political foci from in utero fetuses to ex utero embryos, and from the realm of lawmakers to
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engage the public around the personhood cause. In 2008, twenty-one year old Kristi Burton took
personhood to the voters of Colorado after galvanizing 1300 volunteers and 500 churches to
collect 103,000 signatures that put the “Colorado Definition of Person” initiative on the ballot.
Although voters defeated the constitutional amendment by a three to one margin, it inspired the
formation of Personhood USA to continue grassroots advocacy for embryo and fetal personhood.
Personhood USA became a go-to advocacy organization for embryo personhood whose
mission is to “change the cultural mindset through action to respect the dignity of the human
person” in ways that “glorify Jesus Christ.” In addition to trying to influence a “cultural shift,”
their legal aspirations are in line with mainstream antiabortion legal strategists, suggested by the
opening tagline on their website: “Don’t take Roe for an answer.” Personhood USA spearheaded
efforts to bring personhood initiatives to ballots in Colorado again in 2010 and 2014, Mississippi
in 2011, and North Dakota in 2014. They also supported activists internationally to challenge
legal protections for abortion, such as supporting the ratification of the Dominican Republic’s
pro-personhood constitution in 2009 and the passage of personhood amendments in eighteen
Mexican states. Their work also inspired the formation of new U.S. groups, like the National
Personhood Alliance.60
Frozen embryos within the Blossom Embryo Adoption program are most often racialized
as white. The face of embryo adoption in news media is predominantly white heterosexual
couples, which is also true for promotional materials from the program’s website, brochures, and
informational webinars. In 2008, Blossom created a “multi-ethnic” embryos page to highlight the
small fraction of embryos from non-white donors available for adoption. Monica, the Blossom
program manager, explained why:
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Personhood USA’s website is www.personhood.com and the National Personhood Alliance’s
website is www.personhood.org.
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There was a point in time where the multi-ethnic page didn’t exist at all. We just had the
embryos sitting here being passed over all the time. I felt badly because I started to do
matching with Sarah and it was like, ‘Oh, can’t match them, they’re African American,’
or ‘Oh, can’t match them, they’re Asian.’ The embryos would just sit so I thought we
have to do something. So a webpage was born.
By featuring embryos from non-white donors on the multi-ethnic webpage, the Blossom program
reinforces the idea that all other embryos available for adoption are from white donors.
Representations of embryo adoption as a practice among predominantly white people are
accurate, yet obscure how frozen embryos are also racialized as black, creating a frozen
“minority unborn” worthy of rescue. In 2009, for example, Pacific Christian Adoption agency
and two Blossom program couples signed on as plaintiffs in a suit filed against the Obama
administration by the NAAPC, or National Association for the Advancement of Preborn
Children. In their challenge federal funding for embryonic stem cell research, the filing party
aligned itself with the well-known civil rights organization the National Association for the
Advancement of Colored People and named the case’s chief plaintiff Mary Scott Doe. Doe is a
frozen embryo named after the 1857 Dred Scott case, which denied citizenship to an enslaved
black man suing for his freedom, and a “pseudonym to stand for children in vitro left behind in
America’s frozen orphanages with their souls on ice.”
Other personhood advocates promote a frozen minority unborn by likening the
personhood cause to abolishing slavery and redressing social injustice. To announce the
personhood ballot initiative in Colorado in 2010, Personhood USA devised a radio ad read by a
fictional slave in support of the proposed personhood amendment remarking on the likeness
between chattel slaves and embryos:
I’m George Stevens and I am a person. I was held as property as a child. Even before my
birth I was called a slave in an America you wouldn’t recognize… But today in Colorado,
there are still people called property—children—just like I was. And that America you
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thought you wouldn’t recognize is all around you and these children are being
killed. This November, vote “yes” on Amendment 62. Amendment 62 declares unborn
children persons, not property.
Recently in the state of Missouri, where the Black Lives Matter movement first erupted in 2014
after the killing of Michael Brown, a state legislator introduced a personhood bill for
consideration during the 2016 legislative session entitled the “All Lives Matter Bill.” In an effort
to redress discrimination against embryos by according them legal status as persons, this bill
directly appropriates and rejects the Black Lives Matter movement’s efforts to restore justice to
black and other historically marginalized communities (Levintova 2016). Race and gender serve
as tools within contemporary personhood politics to construct frozen embryos as cultural
innocents worthy of rescue.

Christian Child-Saving
Race and gender politics also play a constitutive role within child-saving efforts, which
began in the mid-nineteenth century in America. The first child-saving movement in the United
States arose among Protestant social reformers during the antebellum era who sought to redress
the effects of industrialism and urbanization upon the “dangerous classes” of poor, urban, and
immigrant youth. Protestant minister and social work pioneer Charles Loring Brace was an early
child-saving leader dedicated to identifying, as he titled his 1859 book, the “best method of
disposing of our pauper and vagrant children” (Brace and Children's Aid Society of New York
1859). Brace established the New York Children’s Aid Society to place “orphaned” youth from
poor, immigrant, and urban households on Anglo Protestant family farms out West. Over the
next eighty years (1854-1929), 250,000 children—many Catholic and Jewish—were transported
on orphan trains from northeastern cities to rural western towns where Protestant families took in
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urban youth as acts of charity. Brace’s broader vision for the trains was to mitigate social ills by
transforming the children of the “dangerous classes” into productive citizens (Gordon 1994;
O'Connor 2001). “Saving” the so-called orphans, who often had one or both living parents when
placed out on western-bound trains, used Christian humanitarian logics to convert the perceived
threats of marginalized races, religions, and classes into a social good (Gordon 1999).
Other Christian child-saving projects gained prominence in the twentieth century after the
orphan trains ended. Christian assimilation intensified around Native American families who had
been broken apart from forced enrollment in Christian boarding schools since the nineteenth
century. The Indian Adoption Project of the Child Welfare League of America (1957-1968) and
subsequent Adoption Resource Exchange of North America (1966-1978) amplified efforts to
save the future of Native American youth by relocating nearly a third of the children from
reservations to white American homes and orphanages. Assimilation and missionizing practices
collaborated for decades and did not slow until the 1978 passage of the Native American
Adoption Act (Jacobs 2014), though the law has been challenged in numerous disputes over the
adoption of indigenous youth.
For instance, national controversy erupted in 2013 over the case of Baby Veronica, the
daughter of a Cherokee man, who was adopted by the Capobianco family without his consent.
The removal of Veronica from her adoptive family’s home inspired a “Save Veronica” campaign
from Christian communities (www.saveveronica.org) where messages of support could be
emailed to prayers@saveveronica.org. The assimilationist and missionizing child-saving
practices that link Veronica’s case with embryo rescue is explicit: Pacific Christian Adoption
agency’s South Carolina office staff facilitated Christina Maldonado’s placement of Veronica
with the Capobianco family. The adoptive Capobianco family won custody of Veronica as a
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result of further eroding of the laws established to protect Native Americans (Briggs 2013).
Christian child-saving also became inextricably linked with the burgeoning international
adoption industry and American war efforts. Following World War II, American families looked
increasingly abroad to adopt children from war-torn and disaster-ridden countries. “Baby lift”
missions, initially in postwar Germany and Japan and later Korea and Vietnam, mobilized the
relocation of thousands of internationally-born children, many the children of American soldiers
stationed abroad and left behind, into American families. The welcoming of foreign orphans into
white American homes, while a seemingly progressive expression of racial liberalism, was
inextricably linked with a Christian American patriotism that fueled Cold War politics (Oh
2012). The rescue of Third World children cast American adopters as heroes and orphans as
innocents whose American upbringing would confirm the U.S. victory in the Cold War.
People like Bertha and Harry Holt, an evangelical family from rural Oregon who adopted
eight children from Korean orphanages, established the legal and procedural groundwork that
made international adoption now common in the United States. The Holts became a celebrity
family when they convinced the U.S. Congress to change adoption law in 1955 to simplify the
international placement of foreign-born children in American homes. They started Holt
International Children Services, today one of the largest and longest lasting Christian
international adoption programs in the world, by appealing to other Christian families to “assume
the responsibility” of rescuing orphans from the “cold and misery and darkness of Korea into the
warmth and love of your homes” (Joyce 2013: 49). Child-saving campaigns of the twentieth
century, forged by Christian missionizing and Cold War patriotism, made the United States the
largest adopter of foreign-born children worldwide.
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The rescue ethos that fueled postwar international adoption fell short domestically due to
racial politics at home. Between World War II and Roe v. Wade, children born to black mothers
in the United States were largely regarded as unadoptable and channeled into the foster care
system (Roberts 2002). Newborns from unwed white mothers, by contrast, were “scooped” up by
white adoptive families in vast numbers. By placing their illegitimate children into socially
acceptable homes, the single white women who were sent away to maternity homes came back
socially redeemed (Solinger 2000). Within the gendered and racial logics of rescue, mid-century
adoption in the United States provided single white women a means to be socially saved while
there existed no parallel recourse for single black women to redeem themselves or their children.
Race continued to shape domestic and international adoption trends through the end of the
twentieth century (Gailey 2009). For example, a wave of would-be adopters in the 1990s
responded to the so-called “crack baby” epidemic by undertaking the expense and difficulty of
adopting children from Romanian orphanages rather than caring for the predominantly black
children within American domestic foster care (Ortiz and Briggs 2003).
Christian saving values shaped the development of adoption as a practice in the United
States, although adoption was not a focus of Christian works until the early twenty-first century
when it became a cause among evangelical Christians. “Adoption is everywhere,” proclaimed an
editorial headline in the July 2010 issue of Christianity Today, “and God is into it too.” Journalist
Kathryn Joyce observed a “sea change” that followed a 2007 summit hosted by the Christian
Alliance for Orphans, the umbrella organization for the growing movement for orphan care and
adoption among American evangelicals. Key Christian leaders in attendance forged a plan that
centralized adoption as a “signature issue” for Christians. They reasoned that by embracing
adoption, Christians would be positioned to fight proactively for something considered good
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rather than being known mainly for what they oppose, like homosexuality and abortion. In the
years that followed the summit, evangelical leaders popularized adoption-related activities, such
as establishing “Orphan Sundays” in congregations worldwide; publishing dozens of new books
that espoused “orphan theology”; and seeking political opportunities to foreground the “orphan
crisis” as the premier concern for evangelicals. By 2010, the nation’s largest adoption agency—
Bethany Christian Services—reported significant increases in adoption inquiries and placements,
which they attributed to the increased mobilization of churches around adoption (Joyce 2013:
56). Tim, reflecting on trends in Pacific’s adoption programs, told the Baptist Press in the same
year, “I think the reason for the upswing in the number of home studies that are being done and
the number of families that are applying is because of this increased awareness within the church
of the need to take care of kids.”
Decades before saving children via adoption became a “signature issue” for evangelical
Christians, saving “unborn children” from abortion served as a cornerstone of Protestant politics.
The 1973 Roe v. Wade decision marked a pivotal moment when born-again Christians became
focused on the unborn. Treated as a declaration of war, legal abortion galvanized child-savers in
defense fetal rights-to-life and the moral fabric of America itself. Following the Roe decision,
evangelical preachers around the nation “biblicalized” what it meant to be antiabortion by
locating absolute moral opposition at the heart of being Christian. The message “abortion is
murder” became the part of the gospel being evangelized in the name of saving children
(Harding 2000: 194).
For Jerry Falwell, evangelical preacher and leader of the Moral Majority, Roe signaled
that “this time preaching would not be enough,” leading him to “realize that there were other
crises facing the nation that required immediate political action from men and women of
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Christian faith” (Lugg 1996: 341). For James Dobson of the evangelical advocacy organization
Focus on the Family, Roe incited a wave of grassroots militancy through a “new Civil War of
values” (Diamond 1998: 2). Rescuing the unborn within the extreme ends of the right-to-life
movement served a particular role for the white, middle-aged male activists drawn to militant
antiabortion activist organizations like Operation Rescue. For them, “the embryo, the fetus, the
unborn have served as proxy victims of the psychological and political abuses some men believe
they have experienced in the wake of social change since the 1960s” (Mason 2002: 193). Randall
Terry, founder of Operation Rescue, considered undermining legal abortion to be a means to a
greater end: “When the Lord put the vision in my heart, it was not just to rescue babies and
mothers but to rescue the country. This is the first domino to fall” (quoted in Ginsburg 1998:
227).
--Logics of race and gender are foundational to discourses of personhood, innocence, and
worth in the United States. Embryo rescue tropes are imbued with race and gender politics that
guide how Blossom proponents promote their moral precepts about valuing life. Christian childsavers, personhood advocates, and embryo adoption practitioners similarly mobilize racialized
and gendered frameworks of rescue to fashion children, fetuses, and now embryos as valuable
and deserving protection.

Conclusion
As historian Karen Dubinsky suggests, I directed my analysis of rescue in this chapter
beneath its sentimental veneer to examine submerged political issues concerning notions of value
and worth. I began in the flooded Louisiana delta with a story about rescued embryos from
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Hurricane Katrina floodwaters. New Orleans served as a fitting place for beginning to explore
the coincidence of rescue and abandonment within life-saving campaigns, which I argue are
inextricably bound to logics of race and gender. Specifically, I demonstrated how race and
gender are constitutive of embryo rescue practices that fashion the frozen embryos as cultural
innocents deserving of social value and protection. I supported this conclusion by illustrating
how the Blossom program deploys Christian rescue scripts that created an orphan embryo crisis
as well as a moral solution. Blossom converts reproductive remainders into the adoptable frozen
unborn, regarded by many staff—though critiqued by some donors and adopters—as orphans
awaiting a uterine home and forever family.
The lens of saving reveals the similar ways Christian adoption and stem cell science
respond ethically and practically to the potentials of IVF leftovers. Like the stem cell researchers
discussed in the previous chapter, Blossom proponents operate within a distinctive ethical
landscape that informs their vision for saving life in American society. Evidence in this chapter
shows how rescuing the frozen unborn articulates an ethic for preserving and creating “good
family” premised on core Christian values of equality, dignity, and duty. As previously
discussed, Christian rescue scripts are fundamentally discourses about family, and traditions of
humanitarianism and responsibility align with Blossom’s core values around extending dignity
and equality to all embryos by assuming the duty to find homes for the remainders. In their
descriptive and critical stories, Blossom donors and adopters also value equality, dignity, and
duty, which they locate within their white, heterosexual, and middle class experiences.
The “good family” moralism that guides Blossom’s activities and advocacy for revering
rather than cheapening human life echoes “Sunbelt” values established by migrant evangelicals
who populated Orange County over the twentieth century. Similar to contemporary embryo
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rescuers, the plain folk, preachers, and entrepreneurs of the 1930s-1960s “assumed responsibility
for protecting their communities and country from those who would undermine them” (Dochuk
2011: xx). Arguably, Blossom’s “good family” ethos cultivates in the twenty-first century what
California’s Sunbelt evangelical visionaries sowed—“a religious culture of entrepreneurialism,
experimentation, and engagement” (Dochuk 2011: xviii), with frozen embryos serving as an
emblem of innocence and possibility within it.
Saving offers a conceptual framework for examining what stem cell biologists and prolife Christian embryo adopters share. I have shown, for instance, that rescue and waste are
kindred practices informed by their respective moral frameworks. In addition to sharing an
ethical commitment to doing good today for the betterment of life in America tomorrow—one on
behalf of science, the other on behalf of family—each alienates IVF remainders from their social
ties and repurposes their potential for new futures. Saving also illuminates Blossom and
REDEEM’s respective blind spots. Cross-cutting both scientific and Christian ideals about
“doing good” are forces of race, class, and gender that stratify societies along variegated lines of
social value and worth. In Chapters 2, 3, and 4, I have brought to the surface topics of inequality
and injustice that challenge both stem cell and Christian ideals of what is meant by good science
and good family. In doing so, I encourage champions and critics of each life-saving program to
evaluate how their redemptive visions for tomorrow align with lived experiences today.
--Despite REDEEM and Blossom’s respective saving aspirations, each is challenged to
sustain embryo potential for all donated leftovers. In the next chapter, I examine the valuation
systems at play that differentially produce “hot commodities” and “special needs” embryos from
donated IVF remainders.

207

CHAPTER 5
Sorting: Archiving Embryos for Viable Futures
“Hallelujah, 2PNs!” Wendy announced one afternoon as she flipped through a stack of
embryology reports in a sun-filled office of Sutter University’s Stem Cell Institute.61 The reports
accompanied a portable cryopreservation tank filled with donated frozen embryos that arrived at
the REDEEM Biobank office via FedEx that day. “Those have to go to the bottom of the tank,”
she said, where they would be immersed safely in liquid nitrogen. “I want to prioritize them.”
Lucia, who utilizes early stage embryos in an ongoing research project, overheard the
commotion. “Welcome, 2PNs!” she said as she walked into the office with a smile. After
reviewing the donation documents confirming receipt of the rare early stage embryos, Wendy
reached for a pair of blue oven-mitt-looking gloves. They protect her skin from the -196 degree
liquid nitrogen filling the Biobank and preserving the thousands of embryos it contains. Standing
atop a footstool with a hooked metal tool in her hand, she reached carefully into the tank’s liquid
depths in search of a new place for the precious embryos that would serve invaluably in ongoing
research projects within Sutter University’s thriving Stem Cell Institute.
In Pacific Christian Adoptions agency, efforts to find homes for valuable frozen embryos
were also underway. “Yes! Yes! Hallelujah!” Monica exclaimed to the good news Sarah shared
with the Blossom Embryo Adoption team. A difficult-to-match embryo donated by the Crown
family had finally been thawed and transferred into adoptive client Marsha’s uterus. Marsha, one
of Blossom’s first single women adopters, drove five hours in a snowstorm to her fertility clinic
for her much anticipated chance at pregnancy and first-time motherhood. “We prayed for this,”
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  2PN, or two pronuclear, describes the first developmental stage of a fertilized egg. A 2PN
embryo typically emerges 18-24 hours after fertilization on the first day of in vitro fertilization.
Each pronuclei at the 2PN stage comes from the nucleus of the sperm and the egg.	
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Monica explained before closing her eyes, saying a private prayer, and whispering to herself:
“Keep growing, keep growing, keep growing.” The team recalled their tumultuous journey over
many years trying to find a home for the Crowns’ less desirable, but still precious, embryo.
“Risa, we saved this embryo.”
As discussed in Chapters 3 and 4, embryos donated to REDEEM and Blossom contain
“potencies” (Munn 1986) to become many different things. Once donated, program staff works
to cultivate opportunities for their future use. Wendy manages the Biobank inventory in
anticipation of transferring donated treasures to the warmed Petri dishes of researchers like
Lucia. The Blossom team, on the other hand, works diligently to “find homes” for precious
orphans by matching donors with adopters like Marsha, who are willing to thaw and transfer
them into their uteruses.
Yet in order for such transfers to be possible, Blossom and REDEEM have to sort
embryos out. At the time of donation, neither organization sets limits for the kinds of embryos
they will receive, a practice that is uncommon among other embryo donation programs in the
United States. Dr. Dunn believes the REDEEM Biobank is an honorable method of disposition
for fertility patients, which informs the staff’s sense that it is disrespectful and impractical to
limit the kinds of embryos that fertility patients can donate. For the Blossom program, their
welcoming of any embryo for adoption placement is a core value of the program’s mission to
acknowledge the personhood of all embryos they regard as equally deserving of a chance to be
born. As a result, numerous “kinds” of embryos are donated based on information extracted from
IVF embryology reports. Embryos arrive representing different developmental stages, grades,
and counts; frozen recently and long ago using different methods; made with egg and sperm
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donors; commissioned by couples young and old; from donors with communicable diseases,
etcetera.
In response to the range of embryos for which the programs work to find a place, each
developed sorting systems to organize their respective embryo “inventories.” Once sorted,
circumstances beyond the cryotanks render donated embryos differently viable for particular
futures. While some embryos become “hot commodities” with streamlined pathways from
freezer to Petri dish or uterus, other embryos are stuck “waiting.”
This chapter examines sorting practices as windows into the circumstances that make
embryos differently viable. I describe the organizing practices within Blossom and REDEEM
that ready embryos for new futures, the broader contexts for these systems, and some of their
effects. Like Geoffrey Bowker and Susan Leigh Star, whose work on classification inspired this
chapter (Bowker and Star 1999), I approach the ordering of things as creative processes, and thus
pay attention to the ways embryo potentiality is created through them. First, I address the varying
ways embryos are archived within each program in order to provide another lens through which
to see how IVF leftovers become renewed treasures. Then I examine the stories of two embryo
donations whose futures were put on hold due to forces active beyond the tank.

Embryo Inventories
Each program serves as a coordinating center for facilitating the futures of frozen
embryos, but they manage their inventories in distinct ways. The following two sections describe
the ordering systems created within the Blossom program and REDEEM Biobank for finding
Petri dishes and uteruses for the once unwanted, still un-wastable frozen remains.
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Blossom’s Adoption Files
The Blossom program coordinates the matching of embryos between donors and
recipients and, like contemporary adoption agencies in the United States, do so without
managing an “orphanage.”62 Despite the faux cryotank they keep stored in the agency conference
room, they specialize in handling embryos like social workers rather than lab technicians. Rather
than keep a frozen inventory of adoptable embryos, they keep files—and a lot of them.
Adoption files were a constant presence during my time in the Blossom program office. I
regularly squeezed myself between blue and brown files stacked on the table at which I sat most
days. Much of the daily work for Blossom staff involves creating and managing client files,
which they use in various ways throughout the day. These hefty blue and brown ethnographic
objects in my midst came to life in a new way when I was allowed to freely look through them
starting in September 2011. I familiarized myself with the structure of the files and the amazing
stories they contained. Such archiving systems are essential to the success of the program as well
as instructive about how IVF embryos become frozen orphans. The history of their potentialities
was literally at my fingertips.
Donor and adopter clients each have a file, and all members of Blossom’s team play a
role in developing them. Client files are comprised of key documents that begin when a donor or
adopter applies to the program. Blossom’s program assistant Sarah works with new donors and
adopters to help them complete their applications in preparation for matching. In 2008,
application materials were organized on colored paper to help staff stay organized, but by the
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  The National Embryo Donation Center is an embryo adoption program based in a fertility
clinic where they do receive and store frozen embryos awaiting placement with an adoptive
couple.	
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time I returned in 2011 the program shifted to organizing files digitally after making applications
available online and accepting materials through email.
While Sarah works with clients, Monica coordinates with their fertility clinics to preempt
any issues that could disrupt a match. Blossom learned from past problems that matching
embryos is not simply a matter of finding two couples to agree on each other. Since embryos are
shipped from one fertility clinic to another, matching also includes making sure that the giving
and receiving clinics are paired well too. For example, Monica implemented a system for making
sure that donors with vitrified embryos would not be matched with adopters whose fertility
clinics were not equipped to thaw embryos frozen by that method.63 Also, all donors are required
to provide proof of testing for cytomegalovirus (CMV), a virus in the herpes family most
frequently passed on to babies during pregnancy; adoptive clients need a letter from their doctor
indicating whether or not they will transfer embryos from donors that are CMV+. Such types of
information populate client files.
A completed donor application includes: donor application with extensive medical
history; donor family profile with a letter, autobiography, and pictures; health authorization
release forms for obtaining embryology reports from their clinic; FDA risk assessment
questionnaire; physical evaluation form from within 12 months of applying; copies of egg and/or
sperm donor profile and consents; and blood work for infectious disease to comply with FDA
regulations.
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Vitrification is a method of storing embryos through a fast-freeze process in which embryos
achieve a “glass-like” solidification. This procedure reduces the risk of ice crystal formation
common within slow-freeze methods, which can damage cells, and shows higher rates of cellular
recovery after thaw. Although Basile Luyet, the father of cryobiology, theorized vitrification
technology in the 1940s, the technique was not clinically available until 2008. 	
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Once donors submit all of the requisite paperwork, Sarah passes their file to the
program’s social worker, Kathy, who conducts an interview about their matching preferences
before entering donors into the “matching pool.” In this conversation, Kathy asks donors about
the preferences they rank on page 4 of the application for qualities they want in adopting parents.
Donors are asked to number from 1-10 the importance of the following qualities in an adopting
family, listed in the order it appears in on the application: religion; educational background;
number of children in the family; prior marriages; length of current marriage; age; works full or
part-time, or at home; ethnic background; and financial position. The Blossom application also
asks donors to indicate if they are open to single women adopters, and how much contact they
desire with the adoptive family: from none to email communication to in-person visits.
During the pre-matching interview with the donor, Kathy fills out the “Fact Sheet for
Embryo Placing Family,” which is a one-page summary of donor preferences that condenses
client information from a dozen application pages to key criteria helpful for matching (See
Figure 11). She also translates matching details into the program’s digital database for quick
sorting of the donor pool by characteristics (e.g., Catholic, donor egg, slow-freeze embryos) and
preferences (e.g., no single mother). Kathy also lets donors know what they can expect during
the matching phase. She notifies donors by email when the team identifies a potential adoptive
match, giving them the opportunity to review the profile and the first chance to approve or
decline the match. If the donor approves, their profile is emailed to the adoptive client for
consideration; if the donor declines, their file returns to the pool.
Blossom adoptive clients are similarly required to submit personal materials to activate
their file, including: adoption application, adoption family profile with a letter, autobiography,
and pictures; adoption home study by a licensed adoption agency; letter from physician stating
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Figure 11. Blossom embryo donor fact sheet64
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no contraindications to pregnancy; signed agreement for adoption services detailing the fee
schedule; and a $500 check to start the file. In the application, Blossom adopters describe
matching preferences, including desired levels of contact with donors; the “racial and ethnic
characteristics” of the gamete donors for the embryos; and whether or not they will accept
embryos created by use of donor egg or sperm. Once the adoptive client’s file is completed, they
are notified by phone of their entry into the matching pool, reminded that they will be contacted
when a donor accepts their profile, and assured that they have the chance to approve or decline
any proposed match.
Matching Embryo Donors and Adopters
“Matching” is an old sorting practice within American adoption premised on finding a
“good fit” for a child by assuming that his or her “best interest” involves placement in a family
with similar racial, ethnic, and religious identities (Modell and Dambacher 1997). Matching
practices maintain a biologically deterministic view that families need to be paired with
phenotypically similar children to maintain the semblance of a naturally formed family unit.
While racial matching ended within U.S. public adoption in the 1970s—with the exception of
placing black children with black families that continues—matching still operates within
international and private forms of adoption (Gailey 2009). Ethno-racial sorting is also active
within the fertility industry. U.S. egg agencies recruit egg donors to meet client desires to
resemble their donor-conceived children (Almeling 2007). The growing demand by white
American fertility patients for affordable egg donors from Eastern Europe exemplifies these
sorting trends in third-party reproduction (Bergmann 2011). As a “bridge” between traditional
adoption and assisted reproduction, embryo adoption also sorts things out through matching
practices designed to find homes for orphan embryos.
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“Matching” within the Blossom program is a general term to describe their process for
evaluating if donor and adopter families are suitably fit. Blossom staff explains that matches are
based on three main factors: program rules, client preferences, and “a little bit of God.” Program
rules established by the agency proscribe which types of clients end up in their piles. At the
beginning of my field research in 2008, Blossom required that all adopters be heterosexually
married for three years, plan to raise their children in a spiritual home, and, for the adoptive
woman, be able to carry a pregnancy. During my last year with Blossom, program rules had
shifted; they began placing embryos with single women as well as adopters who planned to use
surrogates.
During my last visits in 2013, I sensed tension between Blossom staff and Pacific agency
leadership around the topic of placing embryos with gay and lesbian adopters. Increasing
numbers of Blossom donors expressed openness to placing with queer clients, or who were gay
or lesbian themselves. Although Blossom staff was open to matching embryos with gay and
lesbian couples, Thomas’s response to my question about the idea was that Pacific adheres to
Biblical principles that are not open to interpretation around homosexuality. Tim answered with
respect to business; he explained that Pacific “decided on our niche” for addressing the orphan
embryo crisis, and that placing with gay and lesbian couples “is not who we are… If I thought it
would triple the numbers of babies being born, you know I’d have to rethink it, but that isn’t the
case.” Pacific’s institutional policies, flexible in some regards and entrenched in others, are part
of the broader rescuing infrastructure involved in sorting donors and adopters out.
Matches are also driven by client preferences. According to an embryo donor brochure,
“safety and security” and “peace of mind” are benefits for donors being able to select which
families adopt their embryos. Blossom encourages open adoptions, which means adopters benefit
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from being able to turn down a match without penalty as well as to receive information about
donors that is often not available within anonymous donation programs, like contact information.
Staff compiles matching preferences from client applications and interviews onto cheat sheets
and spreadsheets to make matching sessions more efficient. Oftentimes during matching
sessions, staff refers to other items within the client files, like autobiographies, home studies, and
photos, to help “get a feeling” about a possible match or to break a tie. Similar to Ken’s grading
and ranking practices within Harrington’s IVF lab, Blossom clients make ranking and grading
observations about their wishes for a match, which staff reconfigures into their own
classificatory systems for narrowing down families who could help give embryos their chance to
be born.
Lastly, Blossom staff reminded me on many occasions that matching is a process aided
by God. For this reason, they are known to begin matching sessions with a prayer. “Dear God,”
Monica began one morning in 2008,
Thank you for this beautiful day and for bringing us all here safely today and for putting
desire in our hearts to do your work to find homes for these embryos. We thank you for
the parents you’ve brought to this program who desire to give life. We pray that you put
peace into their hearts for the matches that are going to be made and, God, that you be in
control of bringing these embryos, these children, home to the parents they are meant to
have. We pray that you will give them life and fulfill the desire of these parents’ hearts.
In Jesus’s name, Amen.
Although Blossom staff considers program rules, client preferences, and God to be the
main drivers of matching, the matcher’s role in forging connections between donors and adopters
is vital—much like the embryologist’s role in producing IVF embryo potential discussed in
Chapter 2. For instance, I noticed on a few occasions that Kathy broke a tie between two or three
possible matches for an adoptive client by selecting the donor whose embryos had been in the
program the longest. Blossom does not have a policy for matching based on a “first come, first
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serve” basis or length of time in the program, though Kathy’s matching decisions show a
preference for moving old files toward contracts. She learned through experience that finding
homes for all embryos becomes more challenging the “older” frozen embryos are, and therefore
makes matches today in hopes of preventing future struggles tomorrow.
As in traditional adoption and third-party reproduction, the racial and ethnic makeup of
Blossom clients figures centrally within matching decisions. I discussed in Chapter 4 that most
embryos in the Blossom program are racialized as white; this occurs discursively through visual
representations of white people and children in program materials as well as by highlighting
“multi-ethnic” embryos in ways that mark all other embryos as white. On the adopter
application, clients are asked to describe three “Preferences Regarding Embryo,” including
“which racial/ethnic characteristics you prefer in a genetic family (indicate ½ or ¼ where a mix
is acceptable).” The application provides seven options: Any race or combination, Asian, Black,
Caucasian, Hispanic, Middle Eastern, and Native American. Most Blossom adoptive clients
mark a preference for Caucasian embryos, though I discovered in matching sessions that this
category was not always agreed upon among staff. How Blossom staff decides which donors are
and are not white illuminates one of many sorting practices within the Blossom program that
facilitates and hinders the movement of embryos from frozen orphanages to warm uteruses.
Monica and Vera, an early Blossom program assistant, came to different conclusions
about whether the Whittakers were “Caucasian.” When the Whittakers applied to place their five
embryos for adoption, they completed a medical history that begins with a “Physical
Description” of the embryos’ genetic mother, father, and both sets of genetic grandparents. The
Whittakers filled out a table with spaces for self-described information about each person’s
ethnicity, religion, age, height, weight, eye color, hair color, and skin color. At the beginning of
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the matching session, the Whittakers seemed like a good match for a new adoptive client based
on compatible age preferences, number of embryos, and faith, but Monica decided to look more
closely at the Whittakers’ application to be sure.
When Monica came upon their “physical description,” she sought Vera’s help. “Ethnicity
of embryos—Colombian and Anglo,” she read aloud. “Is that not Caucasian?” Vera was quick to
clarify her view that “Colombian is not Caucasian.” Monica flipped to a page of the Whittakers’
file with pictures of their children, and said, “Well these babies look dang white to me.” Vera
responded, “Well so does my brother-in-law, and he’s Cuban.” She chuckled and said, “He’s
fairer than you are and has green eyes.” Monica flipped through other pictures. “Look at this
little boy,” she said as she lifted the image for Vera to see. “Oh, I guess his hair’s beginning to
turn brown. Uh-oh.” They both laughed. “Uh-oh. Not Caucasian enough.” Still looking at the
donor profile, Monica replied with confusion “Well, I don’t understand. Mommy and the
twins… Anglo and Colombian.” Vera said again, hoping it would sink in: “Not Caucasian.”
Monica’s confusion over the Whittakers’ whiteness came to mind months later during
another matching session involving the Figueiroas. This self-described “Portuguese-Caucasian”
donor couple was being considered as a possible match for the Carrolls until Shannon, a Blossom
intern, remembered that the Carrolls preferred Caucasian embryos. I asked why the Figueiroas
were not considered Caucasian, which prompted Kathy to show me pictures of the Figueroa
family compared to the Carrolls, the latter whom she described as “a normal looking white
family.” “They look tan,” Shannon said about the Figueiroas, then reflected that she is not sure if
the Carrolls would want her embryos either because of her mixed heritage with a Caucasian
mother and Guatemalan father. Rather than ask the Figueiroas to clarify if they identify as
“Caucasian,” Kathy decided to email the Carrolls to see if they were “open” to embryos from
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“Portuguese-Caucasian” donors. Although the Carrolls were not interested in the Figueiroas’
embryos, Blossom staff decided to include the Figueiroas in future matching sessions for
Caucasian embryos, rather than leave them out of the pool as “multi-ethnic.” As a result, the
Figueiroas’ embryos were successfully matched with an adoptive couple seeking Caucasian
embryos a few weeks later.
Disagreements, confusion, and decisions among Blossom matchers about categories like
Caucasian are generative moments for understanding the intersecting social forces, institutional
infrastructures, and individual worldviews that impact the viability of embryos’ futures.
Matching practices in embryo adoption reveal the instability of sorting categories and highlight
the fundamentally creative process of sorting things out.
--When matches are made, the donor file is merged into the adoptive client file and
together they enter the next phase of contracts, followed by shipping. Each completed adoption
file includes a contract that donors and adopters sign and notarize. The Blossom “Embryo
Adoption Agreement” does not formalize the transfer of parental rights that is characteristic of
adoption, but enacts the legal relinquishment and transfer of property between giving and
receiving parties. The eleven-page contract was initially drafted by Tim, a lawyer by training,
and has been refined periodically over the years. Client files also contain FedEx shipping records
noting the pickup and delivery dates of embryos from donating to adopting client clinics; copies
of significant email correspondence with Blossom staff; and pages of “Baby Steps,” which are
handwritten notes tracking the various behind-the-scenes activities of staff that move each phase
of the adoption process along.
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The archive of embryo giver and receiver files that Blossom staff works with is organized
primarily by a workflow that converts IVF extras to adoptable orphans. Sarah created a
corkboard with the pictures of unmatched donors and adopters to help personalize the people for
whom she works (See Figure 12). Once Monica gathers the information she needs from a clinic,
she moves the file stacked on her desk to the matching table extending into the middle of the
room where I sat. Problem files that troubled the whole team live in a drawer next to Kathy’s
desk. Completed adoptions with embryos shipped are stored in sequential order from 001-919
(the latter number was the newest file opened when I left the field) in large gray metal filing
cabinets lining the walls outside the program office (See Figure 13). Closed files that did not
result in pregnancy, as well as incomplete files of people dropping out of the program, are
numbered and stored in paper boxes in a storage room alongside other documents that adoption
agencies are legally required to keep.
Figure 12. Active Blossom donor and adopter organization board65
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Figure 13. Drawer of completed Blossom Adoption files66

REDEEM Biobank’s Archives
REDEEM Biobank staff maintains three main archives. A paper archive organizes
donation consent forms into groups according to their different stages of development: in
process; needing correction; in line for shipping; and in storage at Sutter University. The
Biobank itself, the large stainless steel tank chained to the wall in Wendy’s office, is the physical
archive of frozen embryos donated from patients all over the country. Lastly, an Excel
spreadsheet digitally archives data from the received embryology reports as well as the Biobank
“coordinates” that record where to locate the embryos in the Biobank.
During Spring 2013, I assisted with inventorying the materials to make sure all three of
the archives align. This was a hefty task, and unfinished by the time I left Sutter University in
April. We started with the “A” files in the paper archive by reviewing donation consent forms
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and embryology reports to make sure that information from them recorded in the electronic
database is accurate. Specific information from embryology reports tracked in the database
includes: patient’s clinic; female and male date of birth; embryo freeze date; number of embryos;
embryo stage; use of egg and/or sperm donor; storage number on the frozen straw associated
with the fertility clinic’s storage system. Information logged from the donation consent forms
includes: approval for Class 1 (human development), Class 2 (stem cell derivation), or both
classes of research; and approval for being contacted with genetic information or to give
additional health information in the future.
As a result of staff turnover and a series of multiple intern-coordinators, the database had
significant holes. The goal of inventorying was to resolve the problem areas and start from as
clean as slate as possible. Donna was hired as the Biobank coordinator to do exactly this, though
she was only allocated a part-time position initially that, months later, was increased to .8 of a
full-time appointment. Dr. Dunn, Dr. Moto, Wendy, and others have varying opinions about how
many hours it should take to manage the Biobank each week. Those not working regularly with
the files and clients presume that an efficient, part-time staffer can do the job. Donna and the two
embryologists from Sutter’s IVF clinic tasked with helping her for a few months suggest
otherwise. They conveyed stories discussed in Chapter 3 of struggling through logistical hiccups
and unforeseen roadblocks. Having witnessed their challenges, experienced some of them
myself, and known about the three-person team at work in the Blossom program, I felt sympathy
for Donna and the coordinating task before her. By the time I left Sutter in April 2013, we had
only made it through the “G” files in the paper archive; a year later, the inventory remained
incomplete.
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REDEEM’s physical embryo inventory is stored in a large cryopreservation bank in Dr.
Moto’s lab. The inside of the tank is organized by seven pie-shaped quadrants: three in the top
half of the tank, four in the bottom half. Each quadrant fits 14 boxes that are color coded and
numbered (e.g., Upper Blue 10, Lower Red 7). Within each numbered box, up to 16 canes can be
stored. Canes are long aluminum rods topped with a numbered tab and encased in a narrow
plastic sheath. They are designed to hold an average of 3-5 straws or vials, inside of which 1-3
embryos are frozen in each. Upon arrival at the Biobank, the tab at the top of a cane of donated
embryos corresponds with the patient whose leftovers are stored. These tabs, marked according
to the organizing system from a particular fertility clinic, are de-identified and replaced with
neutral numbers 1-14 prior to storage in the tank. Patients with numerous embryos stored after
IVF often have multiple canes. The Biobank has room for a lot of donated embryos: one full box
can contain 240 frozen embryos, a full quadrant can contain 3360 embryos, and a full tank can
hold over 23,000 embryos. (See Figure 14)
The issue of greatest concern to Wendy and Caitlin while I was on site was the Biobank’s
near full capacity and how to better organize the embryos according to “preciousness.” As
described in this chapter’s opening vignette, Wendy and Caitlin periodically move boxes of Day
6 blastocysts from the bottom quadrants, where materials are immersed in liquid nitrogen, to top
racks surrounded by cold vapor. Their logic is to make room at the bottom for the most valuable
of the donated embryos: Day 1 2PNs. Dr. Dunn thinks this is wasted effort based on an
unnecessary worry about the safety of the embryos. Whether they are in liquid nitrogen or vapor,
she conveyed that cryopreservation tanks are designed for all embryos to be equally safe.
Embryo preciousness at REDEEM Biobank is determined primarily by research
priorities. The story of Angela Stoll’s donation to the Biobank later in this chapter explains why

224

Figure 14. Inside the Biobank67

some embryos, like 2PNs, are regarded as “hot commodities” in Dr. Moto’s lab while others, like
blastocysts, are in abundant supply but not demand.
During the same period that I assisted Biobank staff with the paper and digital archive,
Wendy asked me to help with the Biobank’s physical inventory. The goal was to make sure that
the coordinates in the physical archive matched the ones logged in the database. In Chapter 3, I
described a time when Caitlin requested embryos for an experiment, thawed them, and found out
that they were the wrong stage. This kind of mistake can occur at many points: wrongly stored
embryos, incorrectly logged coordinates in the database, or wrongly pulled embryos right before
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an experiment. Such incidents, in conjunction with the holes in the database, hinted at problems
with the physical inventory that needed repair.
For a few afternoons a week over multiple weeks I helped Wendy inventory the Biobank.
I stationed myself at the desk across from the Biobank with the laptop and database opened;
Wendy put on the blue protective gloves and wielded the hook for grabbing boxes (See Figure
15). We started in a chosen quadrant by pulling Box 1 out of the bank and submerging it in a
temporary liquid nitrogen bath in a Styrofoam box on the floor. Within each box we worked
through each numbered cane, up to fourteen. Wendy called out the storage numbers on the
frozen straws within each cane, which I searched for in the database and updated to make sure
the digital coordinates corresponded with the physical location of the donated embryos. Many
entries in the database did not have coordinates, leaving the promising embryos in the cool
depths without any referent for finding them.
Once embryos are in the Biobank, researchers are able to request them for use in
experiments through a simple process. Dr. Moto first approves the use of embryo materials that
the researcher then requests directly from Donna in an email indicating developmental stage of
embryos, number of embryos needed, and class of research. Sometimes researchers include other
criteria, such as Lucia’s request for embryos from younger donors or egg donors. Donna uses the
criteria to sort the database according to the request criteria. Once she identifies one or multiple
batches of embryos that meet the researcher’s needs, Donna forwards the physical coordinates to
Caitlin, who collaborates with the researcher to schedule the experiment. On the day of the
experiment, Caitlin retrieves the embryos located at the coordinates she is given, plunges them
into a mobile box with liquid nitrogen, and walks across the hallway to the “embryo room”
where she begins the embryo thaw process (See Figure 16). Embryo freezing protocols are not
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uniform across fertility clinics, so Caitlin uses a generic method corresponding to whether the
sample was stored via a slow-freeze or vitrification technique.

Figure 15. Inventorying the Biobank68

Figure 16. Embryo research room69
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--Inventorying embryos, whether within Blossom adoption files or REDEEM cryotank
quadrants, involves sorting. Each program categorizes, gathers, and organizes information they
consider pertinent to the embryo futures that they strive to realize. In doing so, their archival
systems and flows show how new embryo potentialities are made, and the files and databases are
“paper trails” of such processes.
Classificatory systems are also windows into the organizations that develop them.
Bowker and Star argue that categories are thoroughly steeped in the contexts within which they
are found; they are “tied to the things that people do; to the worlds to which they belong”
(Bowker and Star 283). I showed in Chapter 2 how embryos at the end of IVF are sorted into
three main groups—transferable, savable, and discardable—based on the IVF goal of producing
a “take home baby.” The goals of the embryo donation programs similarly infuse their mission
into their sorting systems. Within the Blossom program, donor and adopter preferences for the
kind of people and embryos they want to be matched with inform how Blossom staff develop
aids, like the client applications and donor “Fact Sheet,” to help them find suitable homes for
adoptable embryos. Similarly, REDEEM’s database reflects the political climate around human
embryo research that translates into strict ethical protocols for consenting and experimentation.
As a result, the embryo archives are divided into three types of embryos based on how they can
be used in Petri dishes: Class 1 for non-stem cell human development research, Class 2 for stem
cell research, or both. Whether embryos are filed away as precious person or precious 2PN, the
categories that give meaning and movement to the activities within these programs are neither
neutral nor abstract. Rather, they arise from work practices that make up their every ordering of
these frozen things.
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Sorting embryos out in the Blossom program and REDEEM Biobank involves interfacing
with a kind of document discussed previously: embryology reports, those artifacts of clinical IVF
processes introduced in Chapter 2. Embryology reports at Harrington Fertility are artifacts of the
production IVF embryo potential through documentary practices, like grading. In the hands of
embryo donation program staff, embryology reports are better understood as “boundary objects.”
This concept was originally developed to make sense of the different interpretations and uses of
dead birds in a museum. Susan Leigh Star and James Griesemer noticed that amateur
birdwatchers and biologists impart different meanings and find various uses for “the same bird”
in a natural museum archive (Star and Griesemer 1999). Boundary objects describe things that
are flexible and robust, “inhabit[ing] several communities of practice and satisfy[ing] the
informational requirements of each” (Bowker and Star 1999: 297). As the stories in the
following section suggests, categories on embryology reports, like “blastocyst” and “2PN,” have
afterlives beyond the IVF lab with constitutive effects on the viability of remainder embryos.
Embryology reports, as I argued in Chapter 2, are artifacts of broader apparatuses that “culture”
embryo potentials. The factors of interest in this chapter are those that render un-wastable
remainders differently viable.

Embryos Out of Sorts
Unlike fertility clinics and long-term cryostorage facilities that are designed to save for
near and distant futures, Blossom and REDEEM are in the redemption business; each endeavors
to put frozen matter back in place, to use Douglas’s phrase, by finding people with uteruses and
Petri dishes willing to receive them. In their respective ways, Blossom and REDEEM provide
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avenues for transferring embryos from a remaindered to a repurposed state, from suspended
potential into actualized value.
Despite each program’s best-laid plans, problems arise when donated embryos
accumulate in their respective “storehouses” with no place to go. Embryos unable to be matched
with willing recipients challenge the goals of these saving programs trying to find new places for
embryos after IVF. They also provoke important questions about the making of potentiality
explored at length in this dissertation, namely what happens to the promise of the doubly
unwanted embryos. In the following sections, I tell the stories of two donated embryos that
became so-called problem cases: one placed for adoption through the Blossom program and one
donated for research to REDEEM Biobank. Through them, I develop the notion of
circumstantial viability, a concept that puts into relief conditions external to embryos that impact
their possibilities for repurposement.

The Bower Embryo
“Dear Future Mom and Dad,” begins the introductory letter of the Blossom Embryo
Adoption application packet. Answers to common questions about embryo adoption—from
eligibility requirements to agency fees to statistical chances for pregnancy—are outlined in the
twenty-nine pages that follow. “We know you’ve come through a lot to get to this day,” the letter
continues. “The journey might have been frustrating, sorrowful, and intimidating. Maybe you’re
not sure if this is the right adoption choice for you.” For lingering questions, applicants are
encouraged to contact Monica, the Blossom program’s friendly manager. It is her job, the
signatory explains, to “work diligently on our behalf.” The letter is signed: “Sincerely Yours,
The Waiting Embryos.”
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Waiting is a word common within international adoption efforts that seek to find homes
for orphaned children. As analyzed in Chapter 4, international adoption programs often justify
their mission to rescue children “waiting” for homes based on the humanitarian imperative to
relieve human suffering. As such, waiting is a framework that helps to position orphaned
children as legitimately deserving of care and resources (Briggs 2003). Waiting is not a neutral
term for the Blossom program; it draws parallels between embryos and orphans, and is used
intentionally and often to further their mission of revaluing life through the attribution of
personhood to frozen IVF remains.
The Blossom program advocates for treating all frozen embryos as awaiting a particular
future, specifically the chance to be born, though within their program some wait longer than
others. In Fall 2012 I received an email soliciting interest in one of the Blossom program’s
“special circumstances” embryos. “Dear Risa, Are you ready to take a leap of faith? There is a
single embryo waiting for its chance at life. Here is its story…” The email detailed Dennis and
Jolene Bower’s journey with infertility and their desire to find a willing recipient for their single
remaining embryo. The Bower story shows how frozen embryo viability hinges on factors
beyond the cryotank that present obstacles to Blossom’s effort to find home in willing recipients’
uteruses.
After several years of trying to become pregnant, Dennis and Jolene turned to IVF in
1998 for assistance. By year’s end, they had given birth to one son and were paying storage for
seventeen extra embryos. Nine years later, the Bowers decided they were done having children
but wanted to help another become a parent. They completed the Blossom program application
and ranked their top ten preferences for an adoptive family. They desired a religiously moderate,
Caucasian, middle-to-upper class family that would be “college minded” for any resulting
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children. They also preferred a stay-at-home parent but would accept adopters employed full or
part-time. An ideal family would have no prior marriages and would be parenting fewer than
three kids. The ideal adoptive family mirrored the Bowers almost exactly. With respect to
contact with the adoptive family, the Bowers requested photos and letters at least once a year
about any children born and were open to phone calls, emails, and visitations if the adoptive
family would be too.
Within months of applying to the Blossom program in 2007, the Bowers chose the
Daniels to receive their entire batch of seventeen embryos. Once contracts transferring the legal
ownership of the embryos were signed and notarized, FedEx delivered the embryos to the
Daniels’ clinic, where they went quickly to work thawing and transferring embryos. The Daniels
felt their family complete after giving birth to their only child. They had used five adopted
embryos, so decided to “return” the remaining twelve embryos to the Bowers, in effect
relinquishing their rights as the adoptive clients and new embryo owners. The Daniels continued
to pay for storage of the embryos at their clinic while the Bowers reviewed adoptive family
profiles in search of another match.
By early 2008, the Bowers selected the Millers to be the second family to adopt their
remaining twelve embryos. In the required adoption profile letter accompanying the Millers’
application, they explained how they felt when they first learned about embryo adoption: “The
idea that we could share a pregnancy or childbirth was an idea that we had long given up. To
think that we could have that together is priceless! We are ready to give birth to twins or triplets.
We have the room in our house and our hearts, and if that is what we are blessed with, we
believe that God will give us the energy and patience too.”
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Despite their ready home and hearts, the Millers’ prayers to become parents were not
answered. They thawed and transferred eleven embryos without ever becoming pregnant. At the
end of the year, the Millers wrote to the Blossom program expressing their palpable grief and
decision to be done:
Unfortunately, we got the news yesterday that, once again, we are not pregnant. We were
better prepared for that possibility this time. But, it doesn’t hurt any less. The hardest part
is that we are finished. We are financially strapped, emotionally worn out, and just plain
tired of this battle to become parents. Somehow, this is God’s plan for our lives… I have
spent so many years dreaming of being a Mommy, I don’t know what else to dream.
Monica expressed surprise at the Millers’ decision. She shared with me why:
It was very sad to talk with [Ms. Miller] and hear her words which were full of ‘Why
me?’ and ‘This isn't what I would choose.’ I found myself thinking that she didn’t have to
stay this way. She had other options. She had another embryo, for goodness sakes! I don’t
know why she felt she was just not meant to have children and she ‘couldn’t continue.’ I
don't know. Hardly anyone who joins Blossom shares with me that they are just not
meant to become parents. Usually they get pregnant with Blossom or they move on to
other means.
After adoption by two families, the Bowers’ original group of seventeen embryos had
become a batch of one, and the Millers were done trying to become pregnant. Even though they
were grieving the end of their embryo adoption journey, the Millers agreed—like the Daniels
previous to them—to follow through on their commitment to pay storage for the “returned”
embryo until it could be re-matched: “Of course we can store the little guy until you find a place
for him,” the Millers assured in an email to Blossom staff. “We continue to try to tell people
about you guys. We have nothing but positive things to say about our experience even though it
didn't work out for us.”
Finding a place for the single Bower embryo proved difficult and slow. The original
seventeen embryos matched within months, but as the batch reduced in number and the freeze
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date grew more distant, the single Bower embryo’s “special circumstances” became more
pronounced. According to the embryology report, the remaining embryo was frozen in 1998
using a slow-freeze method at Day 1 of development, or at the two pro-nuclear (2PN) stage.
According to Ken and Zhao at Harrington Fertility, this is not a “slam dunk” embryo but one
with questionable potential to establish pregnancy. Coupled with its solo status, the Bower
embryo was rejected numerous times by potential adopters uninterested in the low-graded
embryo.
When a possible adoptive family applied to the Blossom program in 2011, Kathy
contacted the Millers’ fertility clinic where the embryo was stored for an updated embryology
report. She was surprised to learn from the clinic that in the span of a few years, the Millers had
divorced, moved out of state, and left an unpaid $1500 storage bill for the Bower embryo.
According to the fertility clinic, the Millers retained legal and financial rights and responsibilities
as the intended parents that brought the donated embryo into their clinic for use. Before the clinic
would agree to ship the embryo to another adoptive family, the bill needed payment and the
Millers needed to sign paperwork approving its release for shipment. Unless Blossom staff could
surmount these obstacles, the Bower embryo would wait indefinitely in legal, financial, and
frozen limbo.
Blossom staff consulted with Tim and came up with a plan: the Blossom program would
pay the storage fee of $1500 to release the embryo for relocation to a long-term storage facility
where Blossom was prepared to assume legal and financial responsibility as the storage account
holders, if the Millers were not willing to, until the embryo could be matched with its “forever
family.” Assuming such financial and legal burdens is atypical for the Blossom program, but
from my field research observations, is also not unique. “Since the embryo was already in the
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program,” Sarah explained, “we assumed responsibility. There were seventeen embryos to begin
with. We don’t want to give up on one.”
Overcoming the second obstacle depended on the cooperation of the Millers. Locating
and convincing them to help was one challenge; obtaining signatures from a divorced couple on
the clinic release forms posed another. Sarah vented to me one afternoon over the fax machine:
“It is so frustrating because they are the adoptive family. They didn’t transfer the embryo and
they are refusing to pay their storage fees. And now they’re not getting around to sign a simple
form.” Kathy surmised that the Millers’ behavior might be because they do not consider the
Bower embryo to be “theirs,” or to belong to them.
In an effort to leave no stone unturned, Monica reached out to the first adoptive family—
the Daniels—to see if they were interested. They had a son who would be the genetic sibling to
this embryo. When first asked, they did not initially say no. What they said was: “That’s a lot for
one embryo.” Julie Daniel was not concerned about the singularity of the Bower embryo, or its
stage. “Oh, that’s fine,” she told Monica. “All of my embryos were two cells.” The Daniels
ultimately declined the offer, even though Blossom offered some concessions: they would not
have to update their home study or pay an adoption fee. Monica had also reached out to a
reproductive endocrinologist in the area that had a relationship with Blossom to ask if he would
do the transfer for free. The process for Julie still involved too much to go forward. As Blossom
staff worked diligently to maneuver the ever-changing circumstances that halt, slow, and ensnare
the waiting Bower embryo’s chance to be born, they felt the pressure and frustrations of time.
Time, though, was something alleged to be on the side of frozen embryos. When stored at
-196 degrees Celsius, one embryologist explained to me: “You can keep them in there for the
next twenty years, and nothing is going to happen.” But Blossom staff know from experience
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that time does not stand still for waiting embryos. As the clock ticks outside the freezer, the
viability of the leftovers suspended within is subject to countless factors that cause frozen
embryos to “age,” as one said, and bear the social marks of time. The viability of the Bower
embryo for adoption, like all donated embryos, is shaped by many variables beyond the
cryotank. For instance, it remained unused by two adoptive families and abandoned in the wake
of divorce. The Bower embryo’s chance to find a home was impacted by changing laws, political
climates, clinical best practices, personal financial circumstances, fertility histories of potential
adopters, etc. Cryopreservation might pause the effects of time at the cellular level, but frozen
embryos are actively subject to forces and factors beyond the cryopreservation tank that render
them circumstantially viable.
The Blossom team expressed “very little hope that the [Bower] embryo will result in a
pregnancy,” yet they invested time, energy, resources, and prayers into finding a place for it.
After nearly a year of effort, Blossom received and forwarded all of the corresponding
paperwork to release the Bower embryo from the Millers’ clinic. With the bill paid and forms
signed, it was shipped from the Millers’ clinic to a long-term storage facility, “proving,” in
Sarah’s view, “that miracles do happen.” Monica was so personally overjoyed with her staff’s
efforts that her husband sent the team a “Hallelujah!” congratulations card that was displayed in
the Blossom office. One week after the Bower embryo arrived to the new storage facility,
Monica drafted the email sent to all prospective adopters advertising the readiness of this single
embryo, waiting expectantly for its chance to be born. Who among them would be ready to take
a leap of faith?
Despite, or perhaps because of, the Bower embryo’s readiness for adoption, the embryo
faced a different problem once it arrived at the storage facility. To whom did this embryo
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belong? On paper, the storage facility legally recognized the Millers as the storing clients;
meanwhile, Blossom paid the storage bill and the Bowers had the ultimate authority to decide
when, where, and to whom their remaining embryo may be adopted. Without a clear steward,
owner, parent, payer, or categorical place for understanding how frozen embryos relate to their
many handlers, the Bower embryo—like all left over frozen embryos—defied easy
categorization. As Blossom seeks to “place” frozen embryos with adoptive families, embryos
like the Bowers’ provoke fundamental questions about belonging. Where do frozen embryos
belong—materially, culturally, categorically?
The Bower embryo, like all frozen embryos, lingers in anticipation as an unwanted yet
un-wastable reproductive remainder. It waits, according to the Blossom program, like an
orphaned child in need of a forever family. When corresponding with Sarah during a periodic
phone date in November 2013, I asked for an update about the Bower embryo. With a sigh, she
said: “We still own that sucker,” then clarified that she did not mean ownership but something
like the feeling of responsibility to help it find a home. “I think everyone wishes the ‘difficult
cases’ were on their way. I mean it gets so hairy with some of these cases.”
The Bower story illustrates how embryos wait for many reasons beyond the potentialities
presumed to inhere in them. They exist in frozen and categorical limbo, yet are touched by forces
that span the gamut of legal, financial, relational, emotional, geographic, and clinical
circumstance. Blossom’s sorting practices, informed by their moral obligations to find a home
for this hard-to-match embryo, are chief among them. Circumstantial viability is not unique to
the frozen unborn placed for adoption, but is also a common occurrence among embryos donated
for scientific research. Angela Stoll’s donation to REDEEM reveals similar obstacles to fostering
viable futures for leftover embryos.
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The Stoll Embryo
One embryo remained at the end of a series of unsuccessful IVF cycles for Angela Stoll.
At the age of forty-two, she was motivated to start a fresh IVF cycle, and soon. Her fertility
clinic would not begin a new IVF cycle for her until she decided what do to with the one frozen
embryo in storage that she did not plan to use. Discarding the remaining embryo would have
been the quickest and least expensive option, but she decided to donate it for research. Angela’s
donation involved a logistically intensive coordination effort, significant expense to her, and an
indeterminate future for her leftover embryo.
Angela called REDEEM Biobank directly and reached Donna, who explained to her the
process for donation. REDEEM follows inquiries like Angela’s by emailing an introductory
letter, six-page informed consent form, and voluntary health questionnaire. Once patients review
the materials at home and decided to donate, they mark their preferences for how researchers
may use their embryos, sign the donation forms in the presence of a witness, and return the
paperwork to REDEEM for review and final consenting over the phone. REDEEM considers
embryo donations “complete” when patients submit their consent forms free of error to the
Biobank office at Sutter University. The “completion” of donation for fertility patients marks the
first step of many for REDEEM. With a consent for donation form on file, Donna then
orchestrates the retrieval of the embryos from IVF clinics. Once they arrive to the Biobank, she
prepares them through de-identification processes to anonymize the materials for use by research
scientists. In practice, the process is rarely so streamlined. As a result of strict institutional
protocols discussed in Chapter 3, which require the highest ethical standards and legal safeguards
within the political pro-cure climate of human embryo research, the donation of left over,
precious embryos is sometimes stalled.
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Time was of the essence for Angela, and she could not afford a slow, bumpy donation
process. She asked Donna for help and together they tackled the donation forms at Angela’s
fertility clinic and the REDEEM Biobank with uncommon precision. Within a week’s time,
Angela’s completed consent materials were in Donna’s hands, followed soon after by a “Thank
You” card expressing Angela’s gratitude for the quick turnaround.
Before she could move forward with her much anticipated next IVF cycle, Angela faced
an additional hurdle. Her fertility clinic informed her that they would continue charging her for
storing the embryo still at her clinic and would not cease until the Biobank physically retrieved
the embryo. Fertility clinics that manage frozen embryo inventories assume all of the legal and
financial liabilities that responsibility entails. As a result, many clinics consider embryo
donations to be complete not merely when Biobank paperwork is signed but when embryos are
physically removed from cryotanks. As REDEEM builds relationships with fertility clinics
around the United States, they explain that it will likely take the Biobank a few months from the
time a patient submits her donation consent forms to when her embryos will be fetched from the
clinic because of shipping costs. It is more economical for REDEEM to send a $200 portable
shipping container via FedEx to a clinic when there are enough embryos to fill it rather than
sending a tank for each individual donor. In order to relieve patients of any financial burdens for
donating their embryos, REDEEM asks clinics to discontinue charging patients cryostorage
when they complete the Biobank paperwork rather than continue billing until when embryos
physically left the clinic freezer. REDEEM also lets patients know that their embryos will be on
hold for a period of time. The introductory letter to prospective donors explains: “We do not pick
up materials when the consent process is completed, but wait until there are sufficient donations
at one site to send a portable liquid nitrogen tank.”
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Upon hearing the news about Angela’s storage bill, Dr. Dunn expressed frustration. She
vented in a Biobank staff meeting: “To keep the patient’s one embryo is costing them nothing…I
know they run a business but the patient has already paid them $25,000 and they want to
continue charging her?” To avoid the expense of another year’s cryostorage bill, Angela decided
to take matters into her own hands. She commissioned a private reproductive tissue shipping
company to transport her single embryo across the country from her home clinic to REDEEM
Biobank. Donna was touched by Angela’s determination, and was curious how much her
donation to REDEEM Biobank cost her. This was the first time the Biobank had a donor willing
to pay the shipping costs associated with donation.
Prior to embryos arriving to REDEEM, staff do not know what kinds of materials they
are receiving, which means that every tank is greeted with some level of anticipation. Because
REDEEM accepts all embryos for donation, the range of possibility is wide: from Day 1 2PN
stage embryos to Day 6 hatching blastocysts, in batches of any number, frozen using any variety
of method, and made using the sperm and eggs of the intended parents or gamete donors. When
Angela’s embryo arrived with a shipping receipt of $500, Donna and Wendy were shocked and
even more interested to learn what kind of embryo she had given them. They flipped through
seventeen pages of paperwork to come to the embryology report describing the left over treasure
that lay inside: one vitrified grade 5AA Day 6 blastocyst made with donor egg and sperm.
According to IVF clinic standards, Angela’s embryo received the highest grades for
establishing pregnancy. Had she instead decided to donate her “slam dunk” embryo to the
Blossom program for adoption, Kathy, Sarah, and Monica would have had little difficulty
matching her embryo with the pool of adopters hoping for pregnancy and parenthood. But for
REDEEM, Angela’s embryo joined a long line of donated remainders that had little use value to
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researchers at the time. “Ninety percent of the embryos in the bank are blastocysts,” Wendy
explained to me as she moved Angela’s embryo from the shipping container into the Biobank.
“And they probably represent ten percent of the value.”
The need for blastocysts to derive human embryonic stem cell lines, as discussed in
Chapter 3, was the original impetus for the grant that established REDEEM Biobank. Since
opening in 2008, research agendas within Sutter’s Stem Cell Institute labs shifted in new
directions in response to developments within stem cell biology. The establishment of induced
pluripotent stem cell technology (iPSC), for instance, allows researchers to derive pluripotent
stem cells from easily obtained human skin cells rather than having to rely on the stem cells
contained within hard to obtain and controversial human embryos. The Biobank originators
could not know that the common blastocysts left over from IVF clinics would be less useful for
Sutter University stem cell scientists than initially imagined. During my period of research, the
most common users of donated embryos at Sutter were Class 1 researchers studying human
development, for whom Day 1 2PNs were better than gold. Wendy chose a spot for Angela’s
embryo in the top rack of the Biobank because the lower racks, deep in the liquid nitrogen, were
reserved for the most valuable 2PNs embryos that aligned with the lab’s current research needs.
Even though Angela’s embryo made it successfully to the Biobank, it remains in limbo
slated for neither a researcher’s Petri dish nor the trash. Similar to the early twentieth century
embryological specimens preserved in formaldehyde that Lynn Morgan discovered in the
basement of Mount Holyoke College, frozen blastocysts like Angela’s become “specimens [that]
proliferated not because anyone necessarily wanted many of them, but because it was awkward
to refuse a well-intentioned gift” (Morgan 2009: 61). Wendy explained why receiving wellintentioned gifts of frozen blastocysts poses real problems for the Biobank. “We can’t just keep
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getting blasts from people who want to donate,” she told me. “It ends up being storage for them
that they don’t have to pay for.” Right after saying this, she corrected herself. “It’s not that
patients intend that when they donate.” I understood what she meant: People donate their
embryos to REDEEM, as I discussed in Chapter 3, with hope that their extra materials will be
used for good. But the reality of the situation for embryos like Angela’s is that they are not
currently viable as research materials. Rather, their utility as a tool for research—for which they
are newly intended—is determined by political, technical, and financial circumstances. Chances
are high that the Stoll embryo will remain unused for an indefinite length of time until
circumstances beyond the tank make them viable for use in research.
“You never know down the road what you're going to need,” Caitlin remarked in
response to the growing problem she perceived within the Biobank. “Blastocysts are not being
used as quickly as they are coming in but I think things go full circle sometimes. I feel like
science is like that.” At the same time, she questions if the resources being used to receive and
store embryos like Angela’s “that aren’t going to be used, or at least not going to be used yet”
make sense. She and other Biobank staff worry about the day in the near future when the tank
reaches capacity—filled with embryos without present day purpose—and wonder what they
would do next: Invest in a new tank? Limit the kinds of donations they receive? Close the bank
altogether, as many other tissue banks in universities around the country have done? Caitlin
believes that if REDEEM is going to continue receiving embryos like Angela’s, “we should be
doing more collaborations with other researchers around the university to get the blastocysts
used. I'm not really sure that's being done.” In the meantime, Wendy continued to monitor the
tank’s liquid nitrogen levels on a weekly basis. Caitlin admitted to having nightmares about
accidents that devastate their precious supply. Despite the burdens of caretaking embryos with no
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current use, REDEEM staff continues to care for the frozen remainders for some future day when
research needs may be otherwise.
After I left Sutter in April 2013 and Caitlin moved out of state in the following August to
start a faculty position, some of her questions about the future of the Biobank were answered.
That fall, the Biobank launched a “soft close” by limiting the kinds of embryos they received for
donation only to 2PNs and diseased embryos from PGD screening, like the Golds’ ML4 embryo.
Since it was one of the only tissue banks in the United States that received embryos without
restriction for donation, word spread quickly among fertility clinic staff; emails seeking
clarification about the Biobank’s new policy circulated on EmbryoMail, a public embryology
listserv. Dr. Dunn was opposed to saying anything publicly that sounded as if the bank was
closed because, as Wendy relayed, “It takes a long time to turn around and get started again if
they say they are closed.” But in Wendy’s view, the closure was necessary. “In reality, if we ever
use these blastocysts up it will be astounding.” In October 2012, Donna sent notification to
EmbryoMail explaining the new situation for Biobank donors:
We want to update everyone about the recent change in the program policy here at Sutter
University REDEEM Biobank in regards to acceptance of human embryo donation
mentioned in a recent embryo mail.
The Biobank has stopped accepting donation of embryos cryopreserved at the blastocyst
stage, as we have reached our maximum capacity. At this time we are unable to predict
when we will resume accepting blastocysts, as it depends on the need and usage of such
embryos by the research teams. We will keep everyone posted of any changes.
We are still accepting new consents for PGD and/ or PGS tested and affected embryos as
well as 2PNs. Please refer patients who fit the above criteria and we will gladly help them
complete our donation process.
We cannot stress enough how valuable your efforts have been in making our program a
success and we truly are very grateful to everyone who supported it since it’s [sic]
inception.
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The Biobank agreed to receive the blastocysts of donors who had already consented and were
“still in the pipeline.” By the following spring, staff was still working on getting the pipeline
embryos shipped to Sutter. Even though the bank had effectively closed six months prior,
managing the remaining frozen remains seemed without end.
The news of REDEEM’s closure might have been a story already foretold; other tissue
banks at universities around the country opened, received embryos for research, and eventually
shuttered, like banks at Harvard, Michigan, and University of Connecticut. The bank’s closure
did not surprise me as much as the fact that the talented staff I worked alongside were unable to
realize their vision of a functional and vibrant tissue bank to support Dr. Moto’s research.
Finding adequate resources to staff the Biobank was a constant challenge, at the heart of which is
the belief that managing the afterlives of IVF embryos is a straightforward process of deciding,
signing, sending, and storing. But as I came to learn, spinning embryo trash into gold can be
understood in one of two ways: the stuff of fairytales or, as staff on the ground at both REDEEM
and Blossom claimed, alchemy that requires an intense amount of work.
Coinciding with the whispered news of the Biobank’s closure was another stunning
announcement: Dr. Moto was leaving Sutter University. In October 2013, she announced that in
January of the next year, she would begin a new post as Vice President of Research at another
university. She explained that in this new role, she planned to bring more scientists and
researchers to a very small school in a rural state plagued by poverty to see if her efforts can
foster growth in the region. The community she hoped to energize was the one from which she
and her husband originated.
Much like the speculative economies shaping the California frontier from the Gold Rush
booms through the dot-com bust, Dr. Moto’s quick move to and from Sutter University
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exemplifies twenty-first century science in myriad ways. In 2008, Dr. Moto had brought a few
students with her from her previous university to join the faculty at Sutter, where she had played
an instrumental role in securing grant funds to build the Stem Cell Institute. She recruited
talented investigators, students, and postdocs from around the world to populate the dozens of
Institute labs and initiated a novel doctoral program bridging stem cell biology with translational
medicine. Her leadership encouraged new interdisciplinary collaborations unseen before at
Sutter, earning her an endowed professorship that was announced during the Fall 2012 semester.
In the spirit of mentoring stem cell leaders of the future, she made her lab an active training
space for researchers worldwide to take courses in stem cell derivation. And, of course, Dr. Moto
mobilized the funding necessary to start the REDEEM Biobank as a resource for her lab
members, for Sutter investigators, and—had the vision panned out—for researchers across the
state of California. Dr. Moto’s vision brought to Sutter millions of dollars and talent that
cultivated the vibrant world I entered the year before she announced that she was leaving.
Speaking with Uma, a second-year doctoral student who had come to Sutter specifically
to work with Dr. Moto, helped clarify how Dr. Moto’s decision to leave Sutter behind is
indicative of the speculative logics informing modern science today. Uma expressed admiration
for Dr. Moto’s desire to help her community of origin. Herself a minority in the sciences as a
woman with multi-ethnic Native American, Mexican-American, and white heritage, Uma has a
strong desire to use her career path to help her communities too: “I want to do that someday for
my community.” Uma also saw Dr. Moto’s shift to V.P. of Research in a poor community as an
extension of what Dr. Moto does so well: conduct experiments. In a way, all that Dr. Moto
developed at Sutter was similar to the everyday lab bench activity of cultivating a stem cell line
and nurturing a regenerative colony that could sustain on its own. To extend the metaphor, Dr.
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Moto’s move to the other university was like the passaging of a stem cell colony, which involved
relocating good cells to another Petri dish where their growth could be nurtured. The stem cell
experiment Dr. Moto carried out at the scale of Sutter University shifted to one much more
ambitious: to the regenerative potential of an entire state’s economy. While such big visions have
impacts on countless people at many levels, Uma understands such gambles as normal within the
life sciences.
I don’t think that things are going to fall apart in these people’s absence. I don’t think
they are irreplaceable. That’s why we have grad students and postdocs so that we can
keep recycling people into these positions. Life in general is like this. You have to deal
with change all the time: people, the environment, refits and remodels, all are moving…
You always hope that things will continue to evolve in positive direction when changes
like this happen.
Seasoned scientists and students alike responded quickly to the news of Dr. Moto’s
departure. Doctoral students Eric and Jackie fast-forwarded their research to defend their
dissertations sooner while Madison and Uma, graduate students in earlier stages toward their
degree, found co-advisors and made homes in different labs. Luke, Jay, and other postdocs fasttracked their job search and moved manuscripts more quickly toward publication. Also, Dr.
Moto used her professional network to help other mentees who were caught in limbo. Two
postdocs decided to relocate with Dr. Moto to her new university in order to continue their
research.
The closure of the Biobank and dissolution of Dr. Moto’s lab brought urgency to
questions of what would happen with the thousands of embryos like Angela’s in storage at Sutter
University. I decided to visit what was left of Dr. Moto’s lab in April 2014 following a
conference I attended nearby to see how people were negotiating the tides of change. Certainly, I
was also curious about the future of the Biobank. On numerous occasions during field research,
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staff, researchers, and I talked hypothetically about Dr. Moto’s leaving because it made for good
conversation around the question, to whom does the Biobank belong? At the time, Lucia said the
embryos belonged to Dr. Moto, Caitlin guessed Sutter University, and Luke laughed at them
both stating that they clearly belonged to the donors.
As I sat down to Wendy’s familiar desk within the old Biobank office, we discussed the
tasks before her that involved closing up the lab and managing grant reports and budgets. She
explained to me the particulars of what happens with capital equipment purchased through grant
money, such as the physical Biobank tank. Factors like the value of the equipment and wishes of
the home department, Dean’s office, and university determine what happens in a circumstance
like this one. Our conversation turned to the challenge of applying these logics to the Biobank;
while the tank itself could be claimed as Sutter University property, to whom the contents of the
tank belong is murky. Wendy proffered an uncertain guess: “It’s a Sutter consent, so I imagine
the embryos belong to Sutter? I don’t know…”
I noticed that the Biobank was not in its usual spot by the door, and asked where it went.
They had moved it down to a storage closet in the hallway in anticipation of rolling it over to the
School of Medicine. “We’re trying to get the Biobank adopted by the OB/GYN department,” she
said. “The bank is in need of a home.” When I remarked on her interesting choice of words, she
clarified: “By adopted I mean paying to support it.” Dr. Moto did not want to take the Biobank
with her to the next university, which left the precious materials—whose funding source would
dry up in a few months—without a home. She mentioned a couple of names of people who might
assume responsibility for the tank, but as we sat at her desk those decisions had not yet been
made. Wendy seemed confident that the Biobank would find a home:
Sutter is a big enough place. Before they let publicity out that the Biobank closed and
discarded all of the donated embryos, I think the Dean would step in and pay a couple
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hundred bucks a month for filling the tank. I can say that it will be taken care of but I
don’t know for sure and the decision is above my pay grade. I think they are too valuable
of a research asset to dispose of in that way, but I don’t know how exactly how it’s going
to be done.
Before leaving the remnants of Dr. Moto’s once vibrant lab, I asked Wendy if she thought it was
worth it. Were all of the efforts she and others made to collect frozen embryos from around the
country worth the hassle? In her view, human embryos are vital for “good, valid research” and
“how things will progress” for treating human disease. “You have to make it worth it,” she said.

Conclusion
Sorting, according to anthropologist Anna Tsing, is an art of creating classes for
specialized purposes (Tsing 2013). Tsing comes to this conclusion while musing about niche
markets for matsutake mushrooms—the world’s most valuable fungi—that are hunted in Oregon
forests. The creative art of sorting, as this chapter showed, proves to be salient for invaluable
frozen embryos too. Sorting IVF leftovers into different categories and types is a process that
contributes to transforming embryo potential into new forms: as adoptable orphans and
laboratory treasures. I explored how the criteria used to organize the respective embryo
inventories, archives, and databases within Blossom and REDEEM arise from significant work
efforts and worldviews about the best use of reproductive remainders. In these ways, sorting
practices also reveal why certain classes and categories are incorporated into the structure of a
particular system and others are not.
Sorting also provides a window into the circumstances that make embryos
circumstantially viable. Read together, the Stoll and Bower stories offer a contrastive picture for
why some embryos are quickly consumed as “hot commodities” while others are unviable for
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any future prospect. Had the Bowers and Angela Stoll donated their respective embryos to the
other embryo redemption program, their materials may have different stories to tell. The Bower
embryo was passed over repeatedly by potential Blossom adopters, but if donated to REDEEM it
would have been received with glee by Caitlin and Lucia, who consider rare 2PN stage embryos
invaluable for their Class 1 human development experiments. Similarly, Angela’s embryo is
stored high in the Biobank racks because it ranks low for research needs, and yet vitrified
blastocysts made with donor eggs like hers are snatched up quickly in Blossom’s matching pool
because of their desirable probabilities for establishing pregnancy. Neither embryo is more or
less valuable inherently, but valuable because they are viable circumstantially. Potentiality in the
embryo donation programs, as these cases show, is created through sorting processes and made
intelligible through the idea that viability, like value, is dependent on context.
Even though embryos like the Bowers’ and Stolls’ are circumstantially unviable, and
despite all of the challenges associated with repurposing leftover frozen IVF embryos, their
preservation still seemed to be “worth it,” as Wendy stated. The remaining remainders pose
myriad problems as their newly redirected potential contextually bottoms out, yet they do not
seem to lose their value for Blossom or REDEEM staff. Sarah continued to work with the
Bowers to help them find their ideal match. Wendy accepted that the ultimate decision for the
Biobank was out of her hands, but she helped the embryo consents “in the pipeline” get shipped
to Sutter, monitored the bank’s liquid nitrogen levels every week, and held out hope for its
“adoption.” Saving embryos with no place to go yet is a worthwhile effort common to both stem
cell tissue bankers and embryo adoption proponents.
But why were these doubly unwanted embryos still worth saving? Saving ethics and
practices are actively at work within REDEEM and Blossom and most evident here as an
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underlying moral obligation to “do good” today on behalf of tomorrow. The Blossom program
“assumed responsibility,” as Sarah explained, for the original batch of seventeen donated by the
Bowers and do not want “to give up on one.” To do otherwise undermines their familial notion
of leaving none left in the cold. Similarly, Wendy’s remark that you have to “make” the banking
of embryos worth it aligns with the ethos of doing good stem cell science; in a political
maelstrom where human embryos for research are seemingly in short supply, saving embryos for
future use is the sine qua non of protecting opportunities now and in the future for “good, valid
research” and “progress.” Potential, as explored in this dissertation, is a powerful substance. The
possibilities associated with potentiality articulate, across Christian adopters and stem cell
researchers, a collectively held faith in the promise of the future.
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CHAPTER 6
Redeeming: Claiming Potential Makes Moral Cents
This chapter analyzes two experiments in redemption carried out by embryo givers and
receivers claiming the potential of frozen embryos. First, I discuss the Darlings’ adoption of nine
embryos through the Blossom program, and then I return to the Golds’ donation of the ML4
embryo to the REDEEM Biobank. Common to each story is something that many embryo donors
and recipients talk about but few have done: both families filed tax returns claiming credits and
deductions based on their embryo saving activities. The Darlings and Golds illustrate how the
moral drive to save that undergirds efforts “do good” operates among givers and receivers of
frozen embryos. Their stories accentuate the role of fertility patients not only as commissioners
of IVF embryos, but as makers, managers, and claimers of their potentials too. The Golds’ story
in particular illuminates points of convergence between the contested embryo saving programs
that inform their desires to contribute both to “good science” and foster “good family.”

The Darlings: An Experiment with Adoption Tax Credit
Ester and Dave Darling adopted nine embryos through the Blossom Embryo Adoption
program in 2008. After their second biological child was diagnosed with an inheritable genetic
condition, the Darlings decided to explore adoption: “Why not start with a different genetic base
and not take the risk of bringing in another child that may have those sort of problems?” They
first heard about the Blossom program from a Focus on the Family Christian radio broadcast that
featured the story of the Drylers, the first Blossom family introduced in Chapter 4. Embryo
adoption met their needs for growing their family and resonated with their evangelical values
around protecting “life.”
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“It’s a great way to save lives,” Ester explained during our first conversation in July
2008. A few days prior, she had transferred the first two adopted embryos into her uterus. We
reconnected in August 2012, when I learned that she had given birth to two sets of twins through
embryo adoption and was planning for more. The Darlings found embryo adoption to be an ideal
way to expand their family and welcomed the chance, as Ester explained, to “actually play a role
in saving the life of a child. Life begins at conception and embryos are the smallest place that
you can start with that.”
The mission of the Blossom program aligns with Ester’s religious and political beliefs.
She is a committed pro-life proponent who joins annual prayer chain activists in opposition to
abortion and attends national right-to-life marches. When nine months pregnant in 2006, she
traveled to Washington D.C. to attend the press conference where President Bush vetoed the
Congressional bill for funding embryonic stem cell research. Her values inform how she relates
to the nine adopted embryos in her charge.
If you ask Ester, she is the proud parent of ten children: one biological child, five children
adopted as Blossom embryos and born, three frozen embryos waiting to be transferred to her
uterus, and one embryo that was thawed, transferred, and did not establish a pregnancy that, she
says, “I won’t be able to hold until I’m in Heaven.” This latter statement is a more subtle form of
her pro-life advocacy. Ester publicly grieves the loss of the one adopted embryo that was
transferred into her uterus without establishing pregnancy. She named the embryo Rose and
commemorates the loss she experienced annually on her Facebook wall. She also participates in
online forums for grieving parents of miscarried pregnancies and early infant loss. This is not
common among the embryo adopters I spoke to because, as many experienced, embryo attrition
in IVF is quite common.
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Adoption Tax Credit
The U.S. adoption tax credit is an economic incentive that provides support to families
who assume parental responsibilities through adoption for children in need of guardianship. U.S.
Congressional law governs the adoption tax credit and the Internal Revenue Service determines
eligibility. The Economic Recovery Tax of 1981 established an itemized deduction for expenses
related to adoption, which was replaced by a tax credit in 1996.70 The U.S. Congress made the
adoption tax credit permanent in 2013, allowing taxpayers six years to use the credit from the
time the adopted child enters into their custody and home. The current credit, according to the
United States Internal Revenue Service, “offsets qualified adoption expenses, making adoption
possible for some families who could not otherwise afford it. Your tax liability may be reduced if
you adopt an eligible child and qualify for the Adoption Credit.”71 In 2014, the nonrefundable
tax credit capped at $13,190 per child. The Darlings were aware of the tax benefits available to
traditional adoptive families who bring born children into their homes because they have adopted
nieces and nephews in their extended family. After their first child’s birth from embryo adoption
in 2009, the Darlings explored if and how they could apply for an adoption tax credit too.
Every year, Blossom staff receives inquiries from embryo adoptive clients like the Darlings
about filing for the adoption tax credit with questions that are difficult for staff to answer: Does
embryo adoption count as an adoption for the IRS? Does an embryo qualify as an “eligible
child”? Which adoption expenses can Blossom families claim exemptions for (e.g., home study,
agency fees, medical costs for frozen embryo transfer)? Which date is an embryo adoption
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  One of the effects of this shift was that the relative cost of private adoption was decreased
while families who adopted children through foster care did not receive benefits because they did
not have any associated “costs” after federal matching funds that covered their up-front costs.
The Adoption and Safe Families Act of 1997 brought reform to foster care and adoption.
71
See the IRS website: http://www.irs.gov/Individuals/Adoption-Benefits-FAQs	
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finalized – contract signing, shipment, embryo transfer, birth? Would the Blossom contract work
in lieu of an adoption “certificate” or “decree”? The Blossom team is unable to provide
conclusive answers for clients and typically refers people back to their tax preparer for advice.
Tim, the former Director of Pacific Christian Adoptions, is not discouraged by the fact that
embryo adoption is not included explicitly in the IRS’s adoption credit literature:
The language in the law and forms you have to file say it has to be legal adoption. It
isn’t an illegal adoption. Does the federal government recognize it as an adoption?
Well, they’ve spent 3-4 million dollars making the public aware of embryo
adoption so I think that they believe it’s adoption. I just don’t think they’ve stopped
to think if it’s the same as adoption that’s eligible for a tax credit.
The issue of legality does not concern Kathy, the Blossom program social worker, as much as the
financial risks that Blossom clients take when signing up for embryo adoption. The overall cost
for Blossom adopters averages $12-15,000, which includes the $8000 program fee to be matched
with a set of embryos, an adoption home study, and frozen embryo transfers with their fertility
clinic. Within international and domestic adoption, Kathy explained: “The odds are very high
that you’re going to get a child, eventually. There’s not a guarantee, but for the most part we’re
going to have a child at some point in the future.” By contrast, the risks for adoptive clients in
the Blossom program are not becoming pregnant or carrying a pregnancy to term. In Kathy’s
view, embryo adoption “is a very costly thing to go through and not have a result.” She
explained that families who adopt domestically or internationally “can wrap their head around
[the tax credit] and make it financially okay,” but Blossom clients are in a different position.
“People aren’t real sure if they can take any of that [embryo adoption expenses] off their taxes
and we’re not even sure if they can. So, financially, they are just out the money and they may or
may not have a baby.” I was surprised to hear critique of the tax credit from within the Blossom
program, and specifically from the Blossom program manager, Monica. She is aware that some
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of her personal opinions are not popularly held among adoptive clients and other staff, but in her
view: “Being reasonable about who the adoption tax credit is intended for, I don’t think Blossom
families fall under the category.”
In the absence of specific guidance or precedence about the adoption tax credit for
Blossom clients, adoptive families share with each other various resources, tips, and experiences
through the program’s client listserv. Some feel perplexed by the responses they receive from the
IRS. “I am still very confused by the process,” shared one adoptive father, “and I’m an
accountant; I can read tax code.” Some families reported successful filings for their first children
born through embryo adoption, which were followed by confusing denials from the IRS when
they submitted materials for their second and third born. Instead of the adoption decree requested
by the IRS for the tax credit, Carol sent copies of her home study and the Blossom contract as
supplementary materials in her adoption tax credit filing. “And they still think it is not an
adoption?!” she posted to the Blossom listserv after being denied the adoption credit. “Perhaps I
should have sent them a picture!”
Laura, a Blossom adoptive mother and Certified Professional Accountant, took the extra
legal step of requesting a judge to provide an adoption decree. “It was a pain and it cost extra,
but in the end it paid for itself,” Laura assured the Blossom listserv after receiving news that her
tax credit was approved. Adopting her child in the courts provided Laura the adoption certificate
that the IRS requests to be considered for the adoption tax credit. In many state courts, families
like Laura’s are denied the request because she is already considered the legal mother as the
bearer of her child. In the state of Missouri, though, some judges have granted adoption
certificates to couples after they gave birth to embryos received through the Blossom program.
Recouping adoption expenses is only part of the motivation for some Blossom families to
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file for the credit. For instance, Martha expressed hope that efforts to obtain an adoption tax
credit would encourage the U.S. government to acknowledge the practice of embryo adoption as
adoption. In a note to the adoptive client listserv, she wrote:
We are praying for guidance and direction - we feel so strongly about claiming
this adoption tax credit. Receiving this credit would just give more affirmation to
our 100% belief that she WAS a human being as an embryo, and share that
message even further… My little girl WAS adopted, and it hurts to see it in
writing that they don't consider her as a human life when we adopted her. I know
you girls get it - why can't the rest of the world?
Similarly, the Darlings were motivated to legitimize the saving of unborn lives.
When Ester’s family members questioned if embryo adoption was a “true” adoption, her
response was prepared:
For me, these embryos are children and they need someone to take care of them just
as much. I know there are so many children out in the world and I’d love to help all
of them if I could. But I feel that this is the way the Lord has led us to adopt
children. I think all of them are in need of somebody to help them.
When it came time to file the tax return with the adoption credit claimed, Ester was of the
opinion that “whether they felt it was a ‘true’ adoption or not, it was. I was going to apply for
[the tax credit] whether they liked it or not. We would just take it from there and see what
happens.”
Ultimately, the Darlings’ claim was accepted. The IRS audited their 2009 tax return in
which they claimed their first child born through embryo adoption for the tax credit. The IRS
asked them to provide a “certificate of adoption” for their daughter, which they did not have, so
they sent copies of their home study and receipts for the Blossom agency fees.
In terms of saving money, the Darlings used the $12,150 credit to offset their personal tax
liabilities for 2009 and 2010. When it comes to the saving of lives, they feel that the IRS
“accepted” embryo adoption as an eligible practice, which they interpret as a win for their pro-
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life Christian and political commitments. The approved adoption credit gives the Darlings a
financial break as well as contributes to their long-standing commitment to valuing unborn lives
morally, which in their case includes economic forms of valuation too.

The Golds: An Experiment with Tax Exemption
This section returns to the story from the opening pages of the dissertation involving the
Gold family. Like the Darlings, Adam and Julie are a devoutly religious couple parenting a child
with a genetic disorder. They also decided to experiment with their tax return to claim the
potential of their ML4 embryo for their family and cause.

A Sense of Responsibility
The stakes felt high as the Golds reviewed Sutter’s informed consent form about research
options for their single ML4 embryos. They chose Class 2 research, initialing next to the
description on the consent form that read:
This research will try to make new cell lines from embryos. Through genetic
reprogramming, certain genes containing DNA could be put into the embryo to study
how the cells can be changed, or reprogrammed, into embryonic-like cells. Donated
embryos may be broken up into cells or cell clusters and researchers will try to grow
cultures of new cells that come from the embryo. Cells multiply by dividing in two, and
the genetic material is replicated every time a cell divides. These cells, which can live
indefinitely, will contain your DNA.
Once submitting their signed forms to REDEEM and their fertility clinic, the next steps involved
shipping. The Golds were in touch with their fertility clinic liaison, who coordinated with Donna
to have their single embryo shipped via FedEx across the country to Sutter University. Adam is a
self-described “Type A personality” and “a CPA [Certified Professional Accountant] that likes to
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dot all the I's and cross all the T's.” Signing and shipping their “one-shot deal” was stressful for
him:
I was just terrified that this one chance that we had to create stem cells for our
daughter was going to get thawed out of mistake at the IVF doctor’s office or not
shipped properly or not received properly at Sutter. My only anxiety was: is it
going to get to the right hands and be able to start growing stem cells?
The Golds’ donation of their ML4 embryo involved a mixture of hope, worry, and uncertainty.
Giving up their precious embryo also provided a way for them to follow through on the sense of
responsibility they felt since learning of Alice’s diagnosis. “We felt an obligation,” Julie
explained, “to make sure this doesn’t happen again. I love Alice with every fiber of my
being…but it is heartbreaking. I would never want this to happen to anyone else.”
One way they approached their sense of responsibility was by addressing the lack of
knowledge about genetic diseases within the Jewish community. With the support of the Atlantabased Marcus Foundation and Victor Center, the Golds launched Atlanta Jewish Gene Screen in
2011, a non-profit organization that provided community genetic screening, counseling, and
education for health care professionals, clergy, and individuals about pre-conception screening.
The Golds were acknowledged as “Jewish Community Heroes of the Year” with a $25,000
award for establishing the genetic screening program.
Despite the recognition they received for their community project, the Golds felt that
education was insufficient without affordable access to a full genetic screening test. To resolve
this problem, Adam and Julie worked with community partners to raise $1.5 million to co-found
JScreen, a non-profit public health initiative that provides affordable at-home education and
carrier screening for all 19 known Jewish genetic diseases. During my first conversation with
Adam in November 2012, JScreen was a few months away from going national.
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For the Golds, as for the Darlings, advocacy plays a formative role in their everyday
lives. “I don’t think Adam or I could have lived with ourselves if we didn’t do as much as
possible to promote screening for all 19 known preventable Jewish Genetic Diseases, which
includes sometimes having to educate your doctor about what you should be tested for,” Julie
explained. “Our message is that you have the control if you are screened.” Proponents of
standardized genetic screening like the Golds hope that pre-conception information can spare or
prepare other couples interested in growing their family. From Adam’s perspective, Alice is the
driving force behind his moral commitments.
She is the catalyst behind everything I think about all day long. I run a company of 100
people. I work really hard and probably always would but work even harder because of
Alice. She is going to have medical needs and, because of her situation, I work harder to
raise money to cure disease, work harder to make sure JScreen will be successful.
Outside of work, I can't tell you how many hours I spend on ML4 and JScreen… Every
piece of my life revolves around this little girl. I may be the voice she doesn't have. My
legs might run to do work she can't do. She's the reason for it all. In her merit all of this is
happening.
Care in Dr. Blythe’s Lab
Despite their clinical designation as medical waste, embryos that have undergone
preimplantation genetic diagnosis (PGD) like the ML4 embryo are among the most highly prized
materials available in stem cell science. PGD embryos reflect the “ultimate trash to treasure
scenario” in moving from the IVF clinic, where they are nonviable options for establishing
pregnancy, to the research lab. For these reasons, genetically abnormal embryos donated to
Sutter receive special treatment. Donna typically collects completed consent forms in files
organized by clinic until five to ten accrue. At that point, she calls FedEx to schedule the pickup
and return of a portable cryopreservation tank to be delivered to the clinic for filling with the
embryos slated for donation. Each round trip shipment costs the Biobank $300 regardless of
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volume within the tank. Since the Biobank assumes the cost of shipment for donated embryos,
they prefer to receive the frozen materials in batches from clinics rather than from each donor at
the time of consenting. But when a consent form is received for PGD embryos, a tank is sent
immediately to the donor’s IVF clinic, even to retrieve a single embryo like the Golds’. The
Biobank also typically allows a brief waiting period after embryos are received before using
them for research in case donors change their minds. PGD embryos, on the other hand, are
transferred immediately to researchers for thawing, sometimes within hours of arrival.
The Gold embryo was received at Sutter University by Dr. Judy Blythe’s lab, which was
ready for its arrival. The goal of Dr. Blythe’s ongoing study of genetically abnormal human
embryos is to derive new human embryonic stem cell lines that contain, as her lab website
describes, “disease-associated mutations for the future disease research and therapies.” If Dr.
Blythe’s lab were to successfully establish a cell line from a diseased embryo like the Golds’, it
could mean opportunities for patents and in vitro models for screening drugs. A cell line could
also attract the attention of investors wanting to produce and package marketable therapies. Even
if these larger dreams are never realized, the establishment of a diseased stem cell line could
result in publications, which are their own form of currency within the hard sciences that help
secure real grant dollars and accelerate careers. As discussed in Chapter 3, the promised hopes of
stem cell science to produce life-saving and extending therapies are inextricably tied to the
politically volatile topic of funding streams for such work in the United States.
In the Blythe lab, the work of establishing embryonic stem cell lines is the project of Lin
Bao, a Taiwanese postdoc with a PhD in molecular and cell biology. Lin came to Sutter because
she was attracted to working with human embryonic stem cells due to the novelty and
opportunity to make an impact within the new field of stem cell biology. “Not many people have
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touched it,” Lin explained, “so you can find the new… If I get a [stem cell] line, a paper will
come out. It’s exciting and a lot of people would be interested. There is so much potential with
this kind of opportunity.” Lin found that the “main hurdle about this project is how many
embryos we can get; it’s not that much.” From 2009-2013, she recalled fewer than ten PGD
donations, one of which was the Golds’: “This embryo is very precious. In a whole year we get
less than ten embryos.”
Trying to establish a human embryonic stem cell line is labor intensive and timeconsuming. Some cells are more forgiving than others in vitro, but human embryonic stem cells
are among the hardest type to work with. Lin explained that is it important to “keep the pace… I
think for several years you need to come weekends and holidays.” Once the inner cells from the
embryo are extracted and plated in a Petri dish, Lin’s initial work involves watching and feeding.
She uses her expert eyes, feelings, and judgments to make adjustments to the cell conditions and
documents her decisions in a large lab journal. Living cells need warmth, nourishment and a safe
place to grow in order to thrive. “If I feel a feeder is not that great, I will change the media or
make a combined media. There’s really not that much that I can do but, still, I need to find a way
to make them grow.” Some stem cells look robust in the beginning with cell growth patterns that
appear tight, strong, and clear, which suggests they may grow quickly toward a line. “Sometimes
you can feel that they grow stronger.” In other instances, for no discernible reason, the colony
disappears and Lin “begins to lose hope.”
Despite the sacrifices Lin makes personally and professionally to “keep the pace” by
showing up at the lab every day and tending meticulously to finicky cells, she is clear that her
work with human embryonic stem cells boils down to chance: “It’s kind of about luck, right?
Sometimes weird things happen.” And when they do, Lin’s work becomes a mission of rescue
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and recovery. “When unexpected things happen, it feels terrible. In the moment I have to come
down and change my strategy, to rescue the cells. Most cell lines [I work with], I rescued them.”
The variables of luck and chance are an accepted part of scientific inquiry that Lin and other
stem cell scientists confront each day that they agonize over the microscopic activities in their
Petri dishes. Even when hope may be lost, Lin feels that “we cannot give up. You don’t know
what will happen. The cells could adjust themselves to the outside environment and they will…
who knows? It’s hard to control and even hard to say.” Saving cells from the brink is the
everyday task of stem cell biologists committed to doing good science. Like many at Sutter, Lin
hopes her efforts may contribute to real world therapies that could, one day, save lives.

Care at Home
Lin’s lab work might be described as an ongoing “labor of love,” which Adam and Julie
understand all too well. As full-time professionals and parents of three children, the Golds are
familiar with the day-to-day sacrifices people make to care for a family. Like a new stem cell
scientist working with embryos for the first time, new parents experience anxiety, restlessness,
and stress around the intense time and energy involved in caring for a newborn. Stem cell
scientists and parents similarly watch over, feed, nurture, and help grow their precious entities. In
family and lab life, the unexpected can almost certainly be expected, as it was for the Golds
when they learned about Alice’s rare genetic condition. Tending to Alice’s special needs has
become full-time work for Adam and Julie, and their ongoing labors of love.
Daily care for Alice requires a sophisticated coordination of skill, resources, time, and
professional assistance. At five years old and 35lbs, Alice was just learning to crawl yet
remained largely immobile. “We pick her up in the morning from her bed, bring her to the
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breakfast table, back to her room, that kind of thing.” Adam and Julie do everything for Alice
that a typical five year old could do for her self when it comes to bathing, being fed, and dressing
for bed. Feeding her is an especially arduous task. “She can bring a spoon to her mouth—she’s
got the mechanics down—but we basically have to feed her every meal.” Because she has a
delayed reflex, Alice is at risk of choking. Adam has had to perform the Heimlich maneuver on
her at least six times to dislodge food stuck in her airway.
Beyond the daily challenges that Alice and her family surmount each day, the rareness of
ML4 means that the Golds face many unknowns. Part of the reality of Alice’s surprising
diagnosis involves addressing the uncertainties about her future health. By the age of twelve,
doctors anticipate Alice to be blind; already her retinas are deteriorating and her corneas show
signs of clouding. She has a very strong eyeglass prescription, but they cannot accurately tell the
detail of what she sees or how far because she is not able to communicate typically. When Adam
comes home, “she knows that I walked in. I think she can see me, but I don’t know if she sees
my form, or if she hears my voice and that’s what tips her off. We just don’t know.” As Alice
learns how to maneuver her world with degenerating eyesight, her family is figuring out how to
respond without a clear vision about what the future entails. “The way I see it,” Adam began,
you really only have two choices in this situation. If you don’t keep moving
forward, you just crumble under the weight of the emotion, stress, sadness, anger,
grief, and all of that stuff. You can’t allow yourself to live in that moment. You
can experience that moment from time to time, are entitled to and probably
should, but you can’t live there forever. I focus on the fact that Alice is this
gorgeous little girl, absolutely adorable…The work that I’m putting in to educate
others so that they know what to do to avoid this kind of situation, or to find a
cure for ML4, helps me focus my energy toward the goal that might otherwise be
sort of misdirected toward the sadness.
Alice attends school every day from 8 a.m. to 1 p.m. and works with various therapists
each afternoon. The public school near her home integrates special needs kids and typical kids in
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the same classroom and provides an assistant to Alice, who is with her at all times. For 2-3 hours
after school, Alice works with physical, occupational, and speech therapists. “We give her more
therapy than any other kid with ML4 has ever gotten,” Adam explained. “That’s really by choice
because we are not willing to not give her therapies just because were are not sure that they are
working. I’d rather give her therapies and learn that they didn’t work than not give her therapies
and wish that we had.” Caring for Alice any other way is not worth the gamble for her parents.
The issue of lifelong care for Alice is emotionally taxing and financially stressful for the
Golds: “We can’t even address the question of where she would live if she wasn’t living in our
house because it is a very difficult, emotional topic.” As children with ML4 age and grow, they
become more challenging and costly to care for. For this reason, children like Alice typically do
not live at home into their teens and twenties. The Golds’ objective has been to find a way for
Alice to remain at home with her parents and siblings as opposed to in a facility. To this end, the
Golds decided to invest in building a home around Alice’s care needs so that she can live out her
days with her family. All of her anticipated needs, from a wheelchair accessible bathroom to a
“ridiculously expensive” elevator, are structural cues in the house’s blueprint of their efforts to
“plan for down the road.” Alice’s application for Medicaid assistance was approved through the
Katie Beckett waiver, but according to Adam, “it’s still going to be financially difficult for us.
Caring for Alice is clearly going to require a significant amount of money.”

Pricing Potential
With these financial obstacles in mind, the Golds initiated an embryo experiment of their
own. Adam explained how they idea for a tax deduction arose:
Subsequent to donating the embryo I realized that the embryo itself was
incredibly unique and that the donation of the embryo might afford me and Julie a
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tax deduction for IRS purposes. This was a wonderful revelation as we are
currently trying to determine how we can fund the long-term healthcare and
lifestyle costs of our 5-year-old daughter who will likely maintain the mental
capacity of an 18-month-old into adulthood.
When the idea of a tax deduction first came to mind, Adam contacted ML4 researchers around
the country about the utility of such an embryo and asked accounting colleagues to research tax
law for similar cases. No precedent could be found, but the Golds’ case seemed arguable, in their
opinions. On October 15, 2012, Adam and Julie filed a tax exemption with the IRS for the
charitable donation of their property to the non-profit organization, Sutter University.
The IRS requires taxpayers who desire an exemption for donated property to fill out
Form 8283 for “noncash charitable contributions.” Section B is reserved for property valued over
$5000, which is where the Golds began filling in their information. Donors are first asked to
describe the type of property being donated: Is it art, collectible, real estate, intellectual property,
a vehicle, securities, or equipment? The Golds checked the box for “Other.” “Mucolipidosis
Type IV embryo” is how they described their donated property. For the “brief summary of the
physical condition of the property at the time of the gift,” the embryo was noted to be “Perfect.”
They listed May 2011, the date of their last IVF cycle, as the date they acquired the property,
which they claim to have gotten via “Purchase.” (See Figure 17)
Section B donors are also required to include an appraisal of the property justifying its
reasonable “fair market value” at the time of donation. The Golds compiled statements from a
team of experts—a bioethicist, active ML4 researcher, venture capitalist in drug development,
and value consultant—to compose their report. To convey that taking a tax exemption for this
donation is ethical as well as to justify the classification of the ML4 embryo as “property” on the
form, Adam contacted the Director of Emory University’s Center for Ethics, Dr. Peter Warner,
for an expert opinion. Dr. Warner cited to Adam U.S. divorce cases, like Davis v. Davis,
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Figure 17. The Golds’ embryo donation tax exemption form72

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
72
Photo by author.
266

discussed in the Introduction, in which some courts regarded the frozen embryos in dispute as
property.
Adam took from his conversation with Dr. Warner confidence that he had a case to make
for owning the ML4 embryo:
If embryos are litigated over and the decisions are made about who has rights to them,
clearly we’re talking about something that is property. As property, there is a value that
can be assigned to [the embryo] like other types of property. If the embryo had no
inherent value then Sutter wouldn’t want it for research purposes in the first place.
The main value Adam saw in the ML4 was its potential to generate therapies, even a cure. “Here
we were with the opportunity to produce something that could create a research opportunity,” he
said. “It could create a drug opportunity and somewhere along the line could end up benefiting
kids with ML4. There’s real value there. There’s no question that there is value behind that
concept.” From the vantage point that the ML4 embryo contained the potential to cure, the
challenge facing the Golds in their tax preparation was how to put a price on such a priceless
embryo.
Toward narrowing down a price in the appraisal report, the Golds first established the
embryo’s value to laboratory researchers. Ruth Bargal, the geneticist who led the all-Israeli team
that discovered the gene associated with ML4 in 2000, contributed a statement (Bargal, et al.
2000). She explained how the embryo might benefit research on ML4 in addition to the broader
group of inherited diseases known as lysosomal storage disorders. Central to Dr. Bargal’s
statement was the point that stem cells will be one of the materials helpful in forwarding
“breakthroughs.”
The Golds assigned the task of estimating and substantiating the embryo’s monetary
value at the time of donation to a value consultant and a venture capitalist with expertise in drug
development, whom I describe as the estimators. In the absence of a market in the United States
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that puts a dollar value on embryos themselves, the estimators turned to the speculative logics
within the biotech industry for ideas. The estimators argued that the price of the ML4 embryo
should be based on the prospective market value of a drug that could result from the derivation
of a stem cell line. Specifically, they outlined a profitable pathway for the potential of the ML4
embryo: if the donated embryo established a stem cell line, it could be used to test therapies that,
if promising in in vitro and animal models, could translate to the clinical trial phases which, if
successful, could undergo FDA review for approval to go to market. Adam uses the metaphor of
steps to clarify the valuation process of the embryo:
We tried to determine what the market was, or the value on the open market of a
drug that might come about. If today we’re at Step 1 and there are 100 steps to get
to the drug, we have to value the [embryo] material that we have at Step 1. We
can’t value it at step 100 because we’re so far away from creating the drug. Tax
law didn’t define how to value it; it just defined that it needs to have a value. We
used an approach to the market value of the drug and backed it up to Step 1 of
many, many steps to drug production to come up with the value.

In other words, they regard the ML4 embryo as an invaluable resource—a spring of potential—
that was considered in biotech industry terms an “upstream” material that had potential to lead to
sizable “downstream” profits.
In the space for question 5C on the 8283 form, the Golds entered the settled on value for
their embryo’s potential on the day it left their clinic’s freezer for the REDEEM Biobank: $3.124
million dollars. When asked what he thought about the estimated value of the embryo, Adam
stated:
I don't really have a concept of what the value should be… If the value is $20 million it
wouldn't have mattered to me because I’m limited to so much that I can deduct. For the
purposes of what I’m trying to accomplish, which is to create an ability to fund Alice’s
care, the value itself is really not important… That I get as much value as the tax law will
allow is my only concern.
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He made a point to clarify that “the value of the embryo is in the donation, not in the result of the
research.” This distinction is worth parsing out because it made their claim of property and the
tax exemption experiment possible.
The REDEEM Biobank’s informed consent materials state explicitly, as discussed in
Chapter 3, that donors forfeit their claim to financial benefit from any commercial value that may
result from products or patents derived from their materials. When Adam and Julie signed the
Biobank’s consent form, they gave up their chance to receive compensation from possible future
profits. At the time of their donation and before Lin’s laboratory experiment began, the Golds
argue that the embryo’s potential was appraised to be worth three million dollars. They suggest
that their embryo’s promise and the associated dollar value were independent of the actual
outcome of Lin’s lab efforts. Coming to the three million dollar value involved freezing the
frozen embryo’s potential in time, fixing it at the moment of donation per IRS rules, and then
calculating its “upstream” value by projecting “downstream” into the future. In a letter to Sutter
explaining their request for Dr. Dunn’s signature on the Golds’ tax form certifying receipt of the
donation, Adam makes his case for why it is reasonable for Sutter to sign:
Julie and I freely signed the consent forms that you provided prior to our donation and
those forms clearly state that we cannot be paid for or induced to provide the embryo,
have no future right to the embryo, and no right to any commercial benefit created by
Sutter University from use of the embryo. This is an important and relevant consent in
that had we intended to receive any benefit from Sutter at all, the charitable deduction
would be disallowed by the IRS. So the consent form that we signed actually supports our
position that this donation is reasonable.
Sutter’s team of lawyers reviewed the request and approved it. Dr. Dunn’s signature on the
Golds’ form was like the receipt given by staff at Goodwill to a donor in acknowledgment of
their donation. Sutter’s lawyers knew that the burden of justifying the value of the gift to the
IRS—whether a couch to Goodwill or a diseased embryo to the Biobank—is on the donor.
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With the tax experiment underway and in the hands of the IRS, what happened with the
stem cell experiment? The ML4 embryo shipped directly to the Blythe lab where Lin took over.
Some early successes provided hope: the embryo survived the thaw and its inner cell mass
containing the stem cells was successfully isolated. During the first three weeks after plating
when Lin feeds, observes, and rescues the cells from the brink, she hopes to see a particular kind
of cellular activity that indicates a budding stem cell colony, at which point she will do a
“passage.” Passaging is a technique common among stem cell biologists that involves isolating
the best looking cells in a dish, dividing them into sections, and transferring the pieces to new
plates where it is hoped they will thrive and grow. The Gold embryo was passaged successfully
five times, yet the cells ultimately did not remain “robust” enough to stay in their pluripotent
state. The time came for Lin to give up hope and summarize her results in a post-experiment
report:
The initially formed stem cell colony associated with ML4 was not robust,
containing a lot of differentiated cells (Fig 1F). We split cells to more than 5
passages, however, every time some pieces of cells failed to attach, and the
attached cells couldn’t proliferate well. Usually differentiated cells have lower
capability of self-renewal and proliferation. Probably that’s [the] reason why stem
cell colonies couldn’t attach and expand well.
Unsurprisingly, Adam and Julie were disappointed with the results, shared with them by Dr.
Dunn. “We were really hoping that this could be a breakthrough in the disease for our daughter,”
Adam said. “It was really disappointing that it didn’t take but we knew ahead of time that the
odds were very, very slim that we were going to get stem cells out of it.” By the time the Golds
filed their tax exemption, the ML4 embryo’s future had already been foreclosed; its three million
dollar value concerned not what could still be but what could have been.
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I first learned about the Gold embryo when Dr. Dunn received Adam’s letter requesting
his signature on the 8382 form. I spoke with Adam a few weeks later in November 2012 soon
after they filed the tax exemption, and have followed up with him two more times since. During
our first conversation, Adam expected the IRS to respond with an audit, and had no idea what
would follow.
I don’t know if they are going to allow the deduction, or disallow it. Say it's
reasonable or unreasonable. I don’t know if they are going to fight me on the legal
concepts, if they are going to fight me on the value, if they are going to fight me
on the deductibility. We’ll just have to wait and see.
Despite the disappointing laboratory experiment with the three million dollar embryo, Adam and
Julie remain hopeful that their ongoing tax experiment will pan out. As of my last
correspondence with the Golds in July 2014, no tax audit has occurred. As a professional
accountant who is familiar with IRS behavior, Adam considers no news from the IRS to be good
news. In November 2015, the IRS’s window to audit lapsed. “If it works, it will be a real game
changer in Alice’s life,” said Adam. “Not just for me and Julie, but really for Alice’s life, and
that's the only reason that any of this matters to me.”

Conclusion: Lively Potentials
The adoption and donation stories of the Darlings and Golds describe two attempts to
claim the potential of frozen embryos as a way to express and generate values. Both stories
showed forms of “moral pioneering” (Rapp 1987) within even newer saving frontiers that
characterize the afterlives of reproductive remainders. The redemption that both sought was not
the capitalized value of their priceless possessions but acknowledgement of their contributions to
the greater good: through child saving, child rearing, and sacrificing for scientific progress.
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Each family expressed saving values that they enacted through their respective claims to the state
via income taxes as parents and property owners.
Together, the Golds’ and Darlings’ stories exemplify sociologist Viviana Zelizer’s
perspective on the relationship between money and morality, which is that the priceless child
often has a price and intimate relations are not beyond purchase (Zelizer 1979; Zelizer 1985). For
the Christian embryo adoptive couple the Darlings, seeking recognition for their embryos to
count as adoptable children was affirmed with the receipt of a tax credit from the IRS. They may
not consider life to be “cheaper by the dozen,” but the receipt of dollars makes moral sense for
their religious opposition to abortion and for recouping some of the costs of adopting embryos.
The Golds’ story of embryo donation introduced concerned parents who are propelled by
feelings of responsibility for the well being of their daughter Alice and the broader Jewish
community. Each year that passes with IRS approval of their tax exemption is like a stem cell
passage that establishes a new colony of hope that the Golds plan to harness toward the care of
their sick daughter. The lens of saving foregrounds their shared ethic of responsibility for
preserving and advancing the kind of society within which each wants to live.
Their stories also contribute to the extended discussion in this dissertation about the
production of potential. Each offers a nuanced case that I examine in turn. The Darlings seem to
have successfully claimed their daughter’s birth to the state as evidence of the potential
contained within their adopted embryos. But, while the IRS “accepted” the tax filing for their
first born through embryo adoption, the other eight embryos they adopted from Blossom were
not included or counted (Hacking 1986). This was not a point that Ester dwelled on in our
conversations, nor did the Darlings submit a tax filing for the four additional children born from
their adopted embryos. Rather, she emphasized how excited their accepted tax filing made them
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feel because it suggested that the U.S. government acknowledged the value of all frozen embryos
awaiting their chances to be born. The Darlings’ tax credit affirmed for Ester the inherent value
of the potential she knows to exist within frozen embryos, and is a story she is inclined to share
“with anyone who will listen.”
Claiming the ML4 embryo’s potential reveals other mechanisms through which potential
is produced. The estimators who the Golds hired to appraise the value of their ML4 embryo
approached it as a resource. In the fullest meaning of the word resource, the value estimators
considered it a natural wellspring of possibility. It was positioned upstream, in “Step 1” of a
linear, multi-stage progression toward the development of a drug therapy that could come to
fruition downstream in the future. The perceived generativity of embryos like the Golds’ and
other biological materials is increasingly common within the decades following the biotech
revolution, which I reviewed in Chapter 3. Within this era of expanding efforts to prospect
biological matters for new forms of biowealth, the Golds are proving to be ahead of the curve.
The Golds learned from cases that came before theirs, like the use of property in the
Davis divorce trials and the denial of John Moore’s claim to ownership and profit from the Mo
line derived from his spleen cells. With these lessons in mind, they freely signed Sutter’s consent
form giving up their ownership rights to future commercialized products that they hoped to see
produced by Sutter researchers. But in signing, they did not fully give up their claim of property
or their stake in the promises of the future.
The Golds argued that in donating their embryo to the REDEEM Biobank, they forfeited
their property, a point that Sutter’s entire legal team did not dispute. On the tax exemption form,
the limbo legal status of embryos in the United States allowed them to fit their ML4 embryo into
the “Other” category at the same time that they claimed their ownership of it as an item they
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“Purchased” the day of their IVF cycle. Owning their embryo at the time of donation was the
stake they needed to collect on the future.
The embryo appraisal report paints a picture of their vision for the future and valuation of
it, a gesture not so different from other entrepreneurs in speculative markets (Peterson 2014).
The three million dollar value of the ML4 embryo was a number plucked from a particular slice
in time: at the moment of donation before the lab experiment commenced. In that instance, the
ML4 embryo contained myriad potentialities, not least of which was promising cells that could
be derived as a stem cell line. This kind of potential is certainly one that many recognize as such
moments of possibility come and go in our lives, yet the Golds found a way to take this narrow
span of time and put it to work. The tax exemption materials they submitted to the IRS were the
means for the kind of end they hoped would pan out, which is to have sufficient resources to care
for Alice for the duration of her life.
I have shared this story with diverse groups, from stem cell biologists and social
scientists to abortion policy researchers, and the three million dollar number has elicited a broad
range of reactions. At one end of the spectrum, some wish that the IRS looks kindly upon the
Golds’ tax return so that Alice gets quality care; at the other end, some express disgust with the
“shrewd” way this family is “in it for the money” in tones that sound anti-Semitic to my ear. My
interest in the number is not its size but in the unprecedented kind of potential it represents. It is a
kind unseen in the examples discussed in this dissertation, and provokes some questions about
the basic premises of my argument, which I review in brief.
I have argued throughout that potential is a naturalizing concept that imparts inherent
possibility and power to things. Important to my argument is laying bare the circumstances that
produce and impact what are the presumably inherent, unchanging capacities of an embryo. For
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this reason, I talk about viability as circumstantial and take interest not in how frozen embryos
are categorized but in the saving ethics and practices deployed to figure out where they belong.
In all of these ways, I show the potentials of embryos—and values they generate—to be
completely cultured and vibrantly alive.
The ML4 embryo enshrined in the Golds’ tax return suggests that potentiality need not be
lively to be generative. Instead, the case of the ML4 embryo introduces petrified and ghostly
potentials. Like a fossil, the three million dollar embryo was fixed in a moment, yet petrified
beyond the reach of its material and contextual referents. While the ML4 embryo and its cells
perished in Lin’s Petri dish in 2012, its promissory value lives on. Like the undead, the ML4
embryo haunts the Golds’ tax return with the ghosts of cells that were not immortalized and
hopes of a cure now extinguished. The new colonies of hope that are cultivated each year that the
IRS “accepts” the Golds’ tax return are shadowed by the remains of a past future. These ghostly
remains are the left overs not of what could still be but of what could have been.
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CONCLUSION
What Remains

Saving is a topic that features regularly in news headlines in the United States. “Save
Fetal Tissue Remains, and Save Lives” featured on the New York Times editorial page in
response to a national controversy about aborted fetuses—another kind of reproductive remain—
in which both science researchers and abortion foes claim to be on the side of saving lives for the
greater good. Activists fighting to stop the Keystone XL oil pipeline appeal to saving ecosystems
for future generations while pipeline proponents fight for saving jobs and economies.
Breastfeeding advocates counter outcries about nursing in public with news reports citing studies
about how “Breastfeeding Could Save More than 800,000 Lives a Year.” Meanwhile,
commercial breast milk banks that sell “white gold” to neonatal intensive care units appeal to
mothers with surplus breast milk to “help save the country’s most fragile infants.” After
reviewing the financials, Fortune magazine declared, “Yes, Premature Babies are Worth
Saving,” though the underlying causes for the high rates of premature deliveries among black
women continue to receive little attention. Diverse invocations of saving can be expected in a
country that is home to cutting-edge medical fields and scientific research, a vibrant Christian
political movement, and a deeply entrenched capitalist economy.
In this dissertation, I explore the saving in America that happens beyond headlines and in
the hands of people and programs striving to do their best in the face of life’s uncertainties. I
cohere my questions and conclusions around a central question: how and why are America’s
frozen embryos saved at the turn of the twenty-first century? I traveled within the frontier lands
of California to two pioneering organizations on the vanguard of embryo saving: a Christian
embryo adoption program, and stem cell institute tissue bank. Both solutions for America’s
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embryo surplus express agreement on what makes embryos valuable, which is their potential.
Whether embryos contain promise as a precious resource for research or a couple’s hoped-for
child, embryo savers regard potential as something inherent to the frozen remainder. I took this
idea that frozen embryos are naturally potent, and therefore valuable, as a starting place for
exploring how and why these remainders are saved.

Saving: Ethics, Practices, Infrastructures
I entered the U.S. frozen embryo debate with an ethnographer’s interest in the processes
through which frozen IVF embryo potential is produced and valued. Rather than fix my attention
on the novel ethnographic object in my midst, or the polarizing forces common to life politics, I
focused on understanding the dynamics of saving—the active realms of moral orientations, daily
practices, and structural environs that collaborate in making things matter to particular people
and in specific places. By holding simultaneous its multiple significances in medicine,
Christianity, and capitalism, saving provides a framework that puts into relief points of
convergence among different approaches to life’s uncertainties. Convergences are sites of
mixture and tension that I examine in three main ways: ethics, practices, and infrastructures.
Through the lens of saving, stem cell tissue bankers and embryo adoption proponents
converge around a shared commitment to “do good.” On the one hand, Sutter University Stem
Cell Institute researchers try to adhere to and model the principles of “good science,” at the heart
of which is the responsibility to not be wasteful. Blossom proponents, on the other hand, strive to
live according to Christian values of equality, dignity, and duty by modeling social forms of
inclusion through “good family.” Embryo savers demonstrate their respective commitments in
diverse ways via ethical pronouncements and practical activities. Saving also puts into relief
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underlying structures that prop up their meaningful activities through which frozen embryos
come to matter. In this study, property and personhood are key organizing logics that suffuse the
everyday within each program. In what follows, I discuss how I identified these convergences as
I explored how and why frozen embryos are valued for their potential.
How frozen embryos come to contain potential and how that potential is deemed valuable
are the topics of Chapter 2. Embryologists Ken and Zhao at Harrington Fertility Clinic in
Southern California proved to be useful guides for illuminating how potentiality is “cultured” in
the IVF lab. I used culturing as a concept to help reveal connections between what happens
cellularly in Petri dishes and the forces beyond the dish—e.g., stratified reproductions, histories
of modern standards, school report cards, etcetera—that inform how clinics and patients “make
babies.” Ken and Zhao’s bench-top and desktop tasks in Harrington’s IVF lab showed how Petri
dishes, paperwork, and standards collaborate in making IVF embryos contain potential.
I took particular interest in the grades marked on embryology reports, which sort out
which embryos are thought to have the best chance to establish pregnancy. Ken described his
grades as letting embryos “speak” what their destinies may be, which was my first ethnographic
encounter of the naturalizing presumption that potential is linear and inherent to not-yet-entities,
an idea that was first articulated by Aristotle. Rather than see it as he did—as an objective
discovery of embryo potentiality—I suggested that Ken’s tracking techniques, report
compilations, and expert interpretations actively brought embryo potentiality into being. These
potentials are then directed toward different futures through scales of value established by
fertility clinics that categorize embryos as transferrable, savable, or discardable. In a fertility
clinic, savable IVF embryos are plunged into liquid nitrogen for possible use another day.
Although unwanted today, they are also un-wastable because their potential is considered
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valuable. This chapter established that embryo potential is made through various culturing
forces, which laid the foundation for examining how their mutable, contingent potentials are revalued within post-IVF embryo saving programs.
Chapters 3 and 4 enter into the embryo saving worlds of the REDEEM Biobank in Sutter
University’s Stem Cell Institute and the Blossom Embryo Adoption program of Pacific Christian
Adoption agency where IVF leftovers become precious treasures and adoptable orphans. Saving
ethics, practices, and infrastructures are fundamental to the daily rigors of stem cell tissue
banking as well as Christian embryo adoption. Each saving program’s commitment to doing
good for the betterment of life in America—preventing waste on behalf of science, for one, and
rescuing in the name of family, for the other—involves alienating IVF remainders from their
social ties in order to repurpose their potential for new futures. Through the lens of saving, I
found many points of convergence between these two programs, some of which I revisit here.
Dr. Moto’s lab at Sutter University was an ideal place to learn about waste, which I
explored in depth in Chapter 3. Attitudes of responsibility on behalf of the future were strongly
felt among researchers, who planned careful experiments and maximized the use of cells. Peter’s
efforts to “freeze down” extra cells and Luke’s conservative requests for 2PN embryos expressed
a widely shared value around preventing the waste of precious embryo resources. For them,
embryos were made more precious by the contentious environment in the U.S. around stem cell
research, yet their anxieties about resource scarcity sounded odd coming from inside one of the
biggest, best funded labs in the largest stem cell research building in the world located in a state
with unprecedented funding dedicated to stem cell research. Caitlin’s worry about the near-full
reserve in the Biobank inventory exemplified for me the pressures of doing good science in
uncertain times where the boom can become a bust at anytime. Although the blastocysts in the
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REDEEM Biobank were considered burdensome to caretakers like Wendy, Caitlin rested assured
knowing they were there because science, as she explained, sometimes circles back around.
Despite common regard for frozen embryos as un-wastable, the Biobank’s procurement
strategies “trashed” clinical embryos in order to transform them into precious research materials.
These transformations involved the work of property, or the cutting of ownership ties between
donors and embryos so that researchers may establish new property relations through them, like
patents. The lens of saving brought Sutter into view as both a responsible redeemer and rubbish
collector within a global reproductive waste sector that transforms biological potentialities into
new valuable forms. The story of potential at Sutter is about turning trash into treasure.
Life in the Blossom Embryo Adoption program tells a similar story. The first program of
its kind in the world, Blossom puts pro-life Christian values into practice by striving to find
homes for adoptable embryos cast through humanitarian rhetoric as orphans in the midst of
crisis. Tim and the Drylers launched the program in response to a perceived “cheapening of life”
within the United States; they sought to reaffirm the value of embryonic life—and by extension,
Christian family values of equality, dignity, and inclusion—by facilitating their chances to be
born.
Blossom is one of the few places where embryo personhood operates as the status quo,
which they integrate into their mission, materials, and everyday practices. Over 450 “blossoms”
have been born to date through the giving and receiving of embryos among people who are
compelled by feelings of responsibility. Donors like Annika want to be good stewards of their
embryos by giving them to others who can bring them in from the cold. Adopters like Maria care
for their bodies—the first homes for embryos—and submit to God’s plan for their reproductive
futures. Blossom staff commits whole-heartedly to finding adopters for even the most taxing of
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cases, like the Bower embryo discussed in Chapter 6. Yet in order to make orphans of embryos,
Blossom has to strip IVF leftovers of their kinship ties of with donors. Embryo humanitarianism
casts embryos as at risk and in need, but Blossom donors like the Bakers were clear that their
frozen remainders were never without parents. The lens of saving illuminates the racial and
gendered logics involved in cultivating frozen embryos as cultural innocents, which sheds a
different light on Blossom’s expressed values of equality, dignity, and inclusion. Although
committed to rescuing all embryos toward a societal embrace of family values, the families into
which the Blossom program invests their energies are predominantly white, middle class,
heterosexual, and Christian. Stories from Chapters 3 and 4 reveal synergies and alignments
across the hard line drawn between pro-science and pro-Christian answers to life’s problems.
Blossom emerged, like the REDEEM Biobank, as a program in the business of salvaging
reproductive leftovers and repurposing frozen treasures for future use. Christian strategists as
well as stem cell scientists mobilize IVF surpluses to forward moral agendas about doing good.
Once frozen embryos are donated and undergoing transformation into orphans and
treasures, each program’s staff works hard to cultivate futures for them. In order for such futures
to be possible, Blossom and REDEEM have to sort embryos out. The sorting practices I examine
in Chapter 5 served as windows into the circumstances beyond the cryotank that make embryos
differently and circumstantially viable. Some embryos become “hot commodities” with
streamlined pathways from freezer to Petri dish or uterus, while other embryos are stuck
“waiting.” Had the Bowers donated their single 2PN embryo to the REDEEM Biobank,
researchers would have shouted “Hallelujah!” for their good fortune, but it proved unviable as an
adoptable orphan in the Blossom program. Similarly, Angela Stoll’s “slam dunk” blastocyst
would have had a strong case for adoption in the Blossom program, but joined ranks in the top
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racks of the Biobank with other embryo types in oversupply. The futures of these two embryos
were put on hold due to myriad forces beyond the tank. Their cases illustrate how neither embryo
was more or less valuable inherently, but viable circumstantially. The lens of saving helps
explain why, despite the hardships of continuing to care for unviable embryos, staff at Blossom
and REDEEM are driven by a moral obligation to save, or to “do good” today on behalf of
possible tomorrow. In Caitlin’s view, blastocysts might not be a usable research material in the
Stem Cell Institute today, but shifting trends in scientific innovations might make it invaluable in
the future. Even with the dissolution of Dr. Moto’s lab, I am confident the orphaned Biobank
will undoubtedly find a home because preparing for unknown futures is so strongly felt to be
worth it among stem cell researchers. A similar belief is true for embryo adoption advocates. The
possibilities associated with potentiality articulated across Christian adopters and stem cell
researchers a shared faith in the promise of the future based on the good efforts of today.
Although I focused on the managers of embryo afterlives based in institutions like
Blossom and REDEEM, fertility patients are also active makers, managers, and claimers of their
potentials whose perspectives are easily lost in the mix of embryo saving middlemen making
their own claims on frozen futures. For this reason, it is imperative to hear from donors and
adopters, and consider the kinds of claims they also make on their frozen remainders. In Chapter
6, I examine two experiments carried out by the Darlings and Golds that introduce other ways of
claiming the potential of frozen embryos. I discuss the Darlings’ adoption of nine embryos
through the Blossom program as well as the Golds’ donation of their ML4 embryo to the
REDEEM Biobank. Common to each story is something few have done: both families filed tax
returns claiming credits and deductions based on their embryo saving activities. Despite the
many differences between the Darlings and Golds, both couples are religiously devout parents to
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children with genetic disabilities with passionate commitments to life-saving advocacy in their
respective communities. In filing their tax returns, neither was solely driven by the capitalized
value of their priceless possessions but sought acknowledgement for their contributions to the
greater good: through child saving, child rearing, and sacrificing for scientific progress. Their
stories provoke questions about how making such claims—in their cases, to the state—as parents
and property owners articulates a stake in a different notion of good: in the collective goods of
society, available to those who can verify their do-gooding efforts.
“Good,” as should now be clear, figured centrally within my explorations of embryo
saving. First and foremost, good is a concept discovered ethnographically to be active in the lives
of the embryo savers with whom I spent time during research in California. They cued me to see
“good” as a centrifugal force for the morals, actions, and conditions that propel them to do good
for science and family today in hopes of a better tomorrow. In my analysis thus far, I have
discussed good in ways that my interlocutors will recognize and, in doing so, contribute to an
“anthropology of the good” called for by Joel Robbins. “To study the good as anthropologist,” he
argues:
…we need to be attentive to the way people orientate to and act in a world that outstrips
the one most concretely present to them, and…avoid dismissing their ideals as
unimportant or, worse, as bad-faith alibis for the worlds they actually create (Robbins
2013: 457).
What my interlocutors might not recognize are the parallels I discern between their
respective life-saving campaigns. I arrive at this conclusion by approaching “good” in different
way: as an analytical pivot point between two ethico-political formations that champion saving
in order to make the best use of the privately held and valuable frozen goods of today for the socalled collective good of tomorrow. Between stem cell research and embryo adoption, I highlight
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many sites of convergence and alignment that challenge the way America’s embryo savers are
often antagonistically polarized. Among these convergences, none go further than the Golds’
story to disrupt presumptions that doing “good family” and “good science” are distinct projects.
As a result of this research, I am convinced that they are not. Rather, the colonies of hope
cultivated by the Golds’ tax return that may generate resources for their daughter’s care dissolve
false dichotomies characterizing how embryo saving efforts are often cast, such as cure versus
dignity, profit versus morals, and progress versus conservatism. Instead, what comes into relief
through their particular story is how saving—as ethical practice, political claim, and condition of
possibility—operates as a hegemonic temporal politics within American contestations around
“life.”

Contributions
Saving provides an intersectional framework for understanding the politics of
regenerating value when “life” is in surplus (Cooper 2008) and capital is in crisis—both of which
are increasingly commonplace within speculative markets and societies. Through this lens,
Blossom and REDEEM come into view as intermediary organizations—similar to traditional
banks—at the forefront of managing unwanted but un-wastable forms of “frozen capital.” In this
dissertation, I argue that the opposing missions of stem cell researchers and Christian adopters
belie common saving efforts within capital crises that transform frozen, or illiquid, forms of
capital from devalued trash into potent treasure. In addition to offering a revision to scholarly
understandings of biocapital from the perspectives of evangelical Christians, IVF patients, and
stem cell scientists, this dissertation extends theories about the generation and valuation of
potential. While potentiality is the subject of growing theoretical and ethnographic interest, this
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project addresses critical lacunae by demonstrating how potentiality operates in tissue economies
as a discourse about reproduction. At the confluence of feminist theories on reproductive
technologies, politics, and economies, I argue that IVF and cryopreservation function not just as
reproductive, but also speculative, technologies in the contemporary United States. As a result,
they provide a critical lens for understanding reproductive remains as novel forms of
“cryocapital” and explaining why speculative financial practices are attracted to the value of
reproductive potential.
Theoretically and methodologically, this dissertation builds on efforts that began four
decades ago when feminist scholars started systematically dragging reproduction to the center of
social theory, expanding its definition beyond biological procreation, and demonstrating the
invisible centrality of reproduction to social life (cf. Ginsburg and Rapp 1995). Stories from
embryo savers speak to recent feminist literatures that theorize labor and value with respect to
growing global hungers for “biovalue” presumed to be latent within reproductive tissue
economies, such as donated eggs and surplus embryos (Cooper and Waldby 2014). By bringing
ethnographic attention to the lived experiences of American savers with and wanting leftover
embryos, this research revises how we may understand implosions between the life sciences and
finance capital by illuminating the foundational role of evangelical Christianity in generating
values within U.S. reproductive economies. The new species of speculative biocapital
exemplified by surplus IVF embryos cannot be adequately understood by only attending to the
imbrications between biomedicine and capitalism. Rather, this dissertation makes a case for
polysemy, or analyses that account for multiple intersecting frameworks and realities, as
demonstrated by the concept of saving. Previous chapters show how religious moralities and
laboratory ethics shape rescue and waste prevention practices in embryo saving programs, as
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well as highlight the financial logics infused within evangelical Christian adoption. Such
intersectional analyses are indebted to feminist scholars of color (Collins 2000; Crenshaw 1989;
Dill and Zambrana 2009) who first articulated the necessity of scholarship that accounts for the
simultaneous forces of race, class, and gender. Intersectional analysis informs the next
generations of feminist research, like this one, that develop polysemous theories to address
twenty-first century reproductive politics.
This research also contributes to feminist interrogations of binary thinking, or as
Haraway describes it, the “antagonistic dualisms” that organize Western discourse and ideas
about modernity. Saving, as the sampling of headlines at the opening of this chapter indicates,
serves as a compelling framework in American politics for “doing good” when futures are felt to
be uncertain. The seeming imperative to save in the twenty-first century—evident across stem
cell research labs, IVF clinics, Christian adoption agencies, and may other political formations—
may ultimately be complicit in emptying saving of its ethical and political meaning. At the time
of writing this dissertation, calls to save still rally people into moral action, though it may soon
join the ranks of other fetishized concepts—like “life”—as a four-letter word that declares war
but means little at all.
More importantly, by questioning polarizing logics within saving discourses, this
dissertation makes space for the quieted politics and remaindered ideas that have not fit neatly
within the dominant trope of saving in the United States. The false binaries proffered by saving
campaigns have elbowed out alternative formulations to doing good. Although alternative
political articulations to embryo saving campaigns were not the focus of my research, some
marginalized perspectives to the saving tropes I studied found their way into the edges of my
chapters. For instance, I highlighted frameworks for doing good in the midst of California’s
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struggling economy, like redistributive and restorative justice for historically marginalized
communities and addressing the underlying causes of health disparities. I asked how our
communities might redress stratified reproductive potentials if our collective charge was to make
babies thrive rather than just make babies. And in contrast to the saving logics informing the
“politics of disposability” during Hurricane Katrina and the appropriations of Black histories in
creating savable innocents in America, I am interested in the alternative framings posed by the
Black Lives Matter movement to the imperative to save. These and other remaindered topics on
the political terrains dominated by saving provide useful directions for future research.

Future Directions for Research
Race
Race, as Dorothy Roberts argues, is inextricably bound to politics of reproduction in the
United States (Roberts 1997). This dissertation demonstrates that leftover IVF embryos provide a
new locus for understanding the imbrications between race and reproduction. Examples
discussed in this dissertation, ranging from the racialization of rescuable embryos to the
underlying grammars shaping how embryos are sorted out, reveal that race operates as a
structuring logic for contemporary embryo saving practices. But many questions remain about
the particular role of race in producing cultural notions of value and worth in the United States.
One avenue for exploring these questions involves examining the role racial sciences and other
racialized knowledges about “prisms of heritability” (Duster 1990) play within IVF, human
embryonic stem cell research, and embryo adoption. Critical race scholars of science and
technology (Fullwiley 2007; Kowal 2013; Nelson 2016; TallBear 2013; Wailoo, et al. 2012)
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offer foundational frameworks for pursuing such topics in the aftermaths of IVF and other
cryopolitical domains.
Future research on the relationship between race and value may also direct attention to
the legal realm, where race and reproductive science actively intermix within disputes over the
definition of personhood in the United States. Critical race and feminist theories, and historical
and ethnographic methods, may be used fruitfully to examine legal claims about the moral and
material worth of frozen embryos, which use embryological science and Black American
histories of slavery to forward a civil rights cause for the “frozen unborn.” By analyzing legal
activism over the status of frozen embryos—championed by Christian pro-life law firms like the
Thomas More Society—these studies could shed light on the interconnecting roles of
reproductive science, race, law, and Christianity in constructing notions of value in America.

Disability
Anthropologists Faye Ginsburg and Rayna Rapp describe tensions around two cultural
values in the United States—one focused on perfection and enhancement, and the other on
expanding the rights and inclusion of people living with disabilities—or what they call the
“double telos of modernity and technology” (Rapp and Ginsburg 2001). These tensions are
constitutive of intersections between disability and reproductive technologies in the United
States where achieving perfectibility in pregnancy comes into conflict with a growing acceptance
of individuals and groups with screenable disabilities. For instance, disability subtends prenatal
care in the U.S. through the availability of screening and diagnostic tests, like amniocentesis and
newer forms of non-invasive prenatal testing, used to assess risk for genetic abnormalities in
pregnancy. Also, since the 1990s, IVF patients desiring a “take home baby” have had access to

288

preimplantation genetic screening (PGS) or diagnosis (PGD) for in vitro embryos prior to
transfer (Franklin and Roberts 2006). PGS/PGD are also used for “family balancing,” a practice
of selecting the sex of the embryos transferred. Recently, the Francis Crick Institute in the U.K.
received approval to use gene-editing technology on human embryos, a controversial technique
exemplifying tensions between eradicating genetic disease and the embrace of human diversities.
Suffusing such reprogenetic technologies are notions of normalcy and desirability that shape how
patients decide to proceed with pregnancy, including decisions to transfer as well as to terminate.
Within stem cell research advocacy, discourse about disability also features prominently,
For instance, individual members of affected communities are often included in media to raise
resources for finding cures for disease and debilitating conditions. Yet, the scripting of
disabilities as having or needing a cure casts disability as a medical phenomenon rather than a
complex social condition shaped by dis-abling circumstances, such as prevailing notions of what
is “normal” (Ginsburg and Rapp 2013a). Possible directions for future research include
understanding alternative perspectives about “cure” and “disease” from people living with
various kinds of disabilities or diseases targeted for cure by science. While their lives are often
marked by biomedical knowledge, their lived experiences are not often integrated into scientific
developments involving their bodies, capacities, and futures (Ginsburg and Rapp 2013b; Taussig,
et al. 2003).
Embryo adoption, as a type of third-party reproduction, also provides a promising venue
for exploring how disability is conceived and managed. The Blossom Embryo Adoption program
treats all embryos as deserving a chance to be born, though staff expressed disappointment when
embryo adoptive clients appeared to be “shopping” for embryos. In response to embryos leftover
from “picky” client criteria, Blossom staff created an advertising webpage for “special case”
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embryos that listed embryos requiring “more advocacy,” according to the program manager,
Monica, to help them find a home. Included on the list were embryos from donors with
conditions ranging from multiple sclerosis, 21-hydroxylase deficiency, and Hepatitis A to
embryos with full genetic siblings diagnosed with neurofibromatosis, autism, and a non-specified
developmental disability. Future research may examine how disability is constructed and
negotiated among embryo savers, and how rescuing logics operate within the interplay between
wishes to become pregnant and living in accordance with religious values.

Kinship and Ownership in Third-Party Reproduction
Critical feedback from adult adoptees about their experiences has had significant impacts
on the field of adoption, such as the monumental shift of norms from closed records to open
adoptions. Similar trends are underway within the newer field of assisted reproduction, and
especially forms of third-party reproduction that include sperm, egg, and embryo donation and
surrogacy. Donor conceived children, many of whom are born with closed records without
access to information about their biological heritage, are increasingly voicing critique about
anonymity within third-party reproduction and creating new mediums for connection, such as the
online Donor Sibling Registry.
Embryo adoption is one of the newer forms of third-party reproduction available to
prospective parents, with the oldest “blossom” now 16 years old. Many of the Blossom donor
and adopter families in my study felt challenged to talk about their particular family formations
due to inadequate language, children’s books, grieving spaces, and other systems to support their
novel family forms. In response to these lacunae, many created their own. Future scholarship on
the perspectives of children born through embryo adoption, including kinship narratives among
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participants in embryo adoption, would find an eager audience among contemporary adoption
and fertility clinic professionals.
Another area for exploration is how embryo adoption enacts forms of “rent” common
within financialized capitalism. The Blossom contract signed by embryo donors and adopters is
modeled on legal transfers of property that includes a clause about relinquishment and renewal
sustaining donor rights to embryos for a designated period of time. These clauses, as
demonstrated by the conflict between the Bakers and Channings, open up rather than resolve the
question of embryo ownership within adoption economies. How this form of “embryo renting”
parallels trends within financialized markets may elucidate other ways in which excess embryos
operate as lively forms of frozen capital (Sunder Rajan 2012).

Beyond the United States
California, as a frontier land for prospecting new biovaluables, offers a compelling site
for understanding embryo saving projects, though this case may benefit from comparative
international studies that put into relief how reproductive remainders are handled in other
settings. For example, the United Arab Emirates offers a possible location for examining the
savability of frozen embryos in the context of cross-border reproductive care and shifting
national law. In 2010, the UAE banned embryo freezing, which left international fertility patients
who traveled there for services not offered in their home countries wondering about the fates
their frozen remainders stored abroad (Inhorn 2015). The shifting policies and cultural norms
regulating assisted reproductive technologies, embryo cryopreservation, and embryonic stem cell
research will continue to offer generative sites for comparatively exploring the meanings and
flows of frozen reproductive remains.
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Small Things Considered
“Scientists and artists know that the way to handle an immense topic is often through
close attention to a small aspect of it, revealing the whole through the part.”
- Ursula le Guin, in review of Anna Tsing’s book The Mushroom at the End of the World:
On the Possibility of Life in Capitalist Ruins
Akin to the way the shape of a finch’s beak gives insight into the whole of evolution,
frozen embryos are small things through which big stories can be told. In the United States,
efforts to save frozen embryos illuminate widely felt obligations among Americans to do good
during uncertain times. These unwanted but un-wastable remainders prove to be cultural
touchstones constitutive of new thresholds between kinship and property, Christianity and
science, and presents and futures. The value of their potentiality implicates the global human
tissue trade, expanding property regimes, national economies, reproductive tourisms, etcetera.
All told, saving frozen embryos is never simply a matter of economic crisis, heroic medicine, or
religious salvation. Rather, keeping these knotty things around suggests an unshakable faith in
the promise of tomorrow delivered through good works of today.
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